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ABSTRACT 
 
Transposable elements (TEs) are ubiquitous components of plant and animal genomes 
and constitute more than ~45% of the human genome.  Though originally considered as 
„parasitic‟ or ‟junk‟ DNA, TEs are now thought to have played a role in shaping 
genomes during evolution, contributing to genome plasticity and diversity.  All classes 
of retrotransposons accumulate in the genome via a process termed retrotransposition, 
wherein the elements are reverse transcribed into RNA and inserted into the genome as 
DNA.  Exaptation of these elements can provide additional or novel function for 
endogenous genes.  Mammalian-wide interspersed repeats (MIRs) are short interspersed 
nuclear elements (SINEs), belonging to the non-autonomous class of retroelements and 
are found in all mammals.  The recruitment of an MIR element by a gene may provide 
insight into mammalian evolution and gene function.   
 
The human genome was screened for genes that have exaptated MIR elements and the 
compiled dataset was analysed to determine any commonality which may suggest 
conserved function(s).  Subsequently 1359 genes were identified that have exaptated 
MIR elements, constituting 5% of the total genes in the human genome.  MIR elements 
may be multifunctional, as 1% of the total human genes contain MIRs that are spliced 
and/or are contributing to protein coding sequences.  Subsequently sequence motifs 
were identified in the MIR consensus sequences which resemble canonical mammalian 
splice sites; therefore MIR elements recruited in the 5‟-UTR and coding sequence may 
be a result of the exonisation of intronic elements.  The MIR-containing transcripts are 
frequently expressed in neurological tissue, suggesting a role in neuronal function.  
Moreover a number of MIR-containing mRNA transcripts are known to be localised to 
the dendritic compartment of the neurone, and ciliated region of photoreceptors.  Some 
of the localised mRNAs contain putative microRNA binding sites within the MIR 
sequence, and possible dsRNA structures were noted between MIR elements.  It is 
proposed that exaptated MIR elements may be a source of cis-acting regulatory 
elements, involved in post-transcriptional control of gene expression, including 
localisation of mRNA to distinct intracellular compartments.   
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1.       INTRODUCTION  
 
1.1.     Early history of non-coding and repetitive DNA 
 
The phenomenon of transposition was first suggested by Barbara McClintock in the late 
1940s; when observing mosaic colour patterning in maize (Zea mays); she noted a 
variation in the pigmentation of individual maize kernels.  She identified specific loci 
(Ds and As) responsible for unstable inheritance of mosaicism between generations, and 
later suggested As could change the chromosome position (transpose) of Ds, resulting in 
the mosaic patterning (McClintock, 1944; McClintock, 1950).  These Ds and As 
elements were often referred to as „jumping genes‟ or „controlling elements‟; however 
McClintock‟s hypothesis received scepticism from the scientific community and 15 
years elapsed until McClintock revisited her original ideas (McClintock, 1961).  Both 
Ds and As were later discovered to be a class of DNA transposons (Peterson, 1981; 
Fedoroff, 1989) and Barbara McClintock went on to be the first women to receive an 
unshared Nobel Prize for her efforts, 30 years after discovering mobile genetic 
elements.  
 
The pioneers in repetitive DNA research were Roy Britten and his colleagues.  In the 
1960s a DNA-agar procedure was developed, which enabled the measurement of DNA 
hybridisation between the DNA of different species (Marmur and Doty, 1961; 
McCarthy and Bolton, 1963).  Britten and Kohne (1968) used this technique to 
demonstrate the hybridisation of large sections of DNA between divergent species, and 
noticed the frequent hybridisation of regions of 200-300 base pairs (bp).  They 
suggested that the hybridisation was a consequence of DNA sequence homology and the 
re-association of interspersed repeat elements, and was not the result of non-specific 
aggregation as previously thought (Britten and Kohne, 1968).  Britten further suggested 
that non-coding repetitive DNA may play a fundamental role in gene expression, 
regulation and arrangement and the Britten-Davidson model was proposed (Britten and 
Davidson, 1969).  They hypothesed that genome complexity involves the coordination 
and regulation of unrelated genes via a regulatory element, which could target specific 
unlinked genes, and they suggested the regulatory sequences were the previously 
described interspersed repeat elements (Britten and Davidson, 1969).  Britten and Kohn 
further suggested that repetitive DNA may be a core component in phenotype diversity, 
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and provide a means of modifying genomes during speciation and evolution (Britten 
and Kohn 1970; Britten and Kohn 1971).  However this model was received with some 
scepticism and shortly after Ohno (1972) proposed that non-coding DNA (ncDNA) was 
“junk” or “parasitic” material with little or no biological function.  It is worth noting 
that Ohno argued that there may be an advantage to having non-coding intronic and 
intergenic DNA (Ohno, 1972). 
 
Similar questions over the significance of repeat sequences are raised by the c-value 
paradox, whereby there appears to be no correlation between genome size and organism 
complexity or diversity (Zuckerkandl, 1976; Gregory, 2001; Petrov, 2001; Kidwell, 
2002; Patrushev and Minkevich, 2008).  In vertebrates a large proportion of ncDNA is 
composed of transposable elements (TEs), many of which are propagated by the 
mechanism of retrotransposition (Deininger et al., 2003).  In the past 15 years there has 
been renewed interest in TEs and the importance of these elements has been reassessed, 
as a result the term “junk DNA” is now viewed with a different understanding.  For 
example, everyday household junk may be stored in the event it will be of some use in 
the future whereas rubbish is thrown away and discarded, and ncDNA is now 
considered more as a genomic scrap yard (Brenner, 1990; Makałowski, 2000).   
 
A large portion of ncDNA will be non-functional, representing fossils of past 
evolutionary events or „natures experiments‟, which have been maintained merely due 
to the lack of selective constraints.  Likewise there are regions of ncDNA which have 
become vital components of the functional genome through exaptation (for a review see 
Mattick and Makunin, 2006).  Following the recruitment of a repeat element there will 
be additional nucleotides available which may allow for the modification of gene 
function and/or expression, and contribute to alternate splicing, polyadenylation features 
and additional protein coding information (Lev-Maor et al., 2003; Lee et al., 2008; 
Nekrutenko and Li, 2001).  It is now accepted that modern genomic DNA (gDNA) may 
have evolved in close association with TEs, with retrotransposition providing additional 
raw genetic material, which may be utilised to adapt new phenotypes, shaping genomes 
during evolution (Roy-Engel et al., 2002). 
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1.2.     Classification of transposable elements (TEs) 
 
The understanding of repetitive DNA and transposons in particular has improved 
greatly following the sequencing of the human genome (Lander et al., 2001).  
Approximately 1.2% of the total human genome encodes for protein, whereas almost 
half is derived from TEs (Lander et al., 2001).  In comparison 37% of the mouse 
genome is repeat-derived (Waterson et al., 2002), and in both the mouse and human 
genomes 60% of these repeats are retained within intronic sequences (Sela et al., 2007).  
However it is worth noting that not all TEs will have been positively identified, and the 
estimations outlined in figure 1.1 are likely to be an underestimate of the total number 
of TEs in the human genome.  Most transposons are inactive and have been for millions 
of years, therefore many have fragmented and diverged to a point where they are no 
longer distinguishable, creating problems when using current algorithms.  When 
predictions are made using the evolutionary-based „repeat probability cloud‟ detection 
method as described by Gu et al., (2008) it is suggested that only half of the actual 
transposons may have been annotated.   
 
TEs fall into three categories; DNA transposons, long terminal repeat (LTR) 
retrotransposons and non-LTR retrotransposons (Deininger and Batzer, 2002).  The 
retrotransposons spread via an RNA intermediate and comprise the majority of 
mammalian TEs.  In contrast, DNA transposons spread directly as DNA without 
transcription and constitute a small proportion of the total repeat elements in the human 
genome (Deininger et al., 2003).  DNA transposons are considered the least successful 
of the TEs due to a less efficient mode of transposition, as these elements propagate via 
a „cut and paste‟ mechanism and do not increase in number. 
 
Autonomous retrotransposons have the capacity to direct their own amplification; long 
interspersed nuclear elements (LINEs) and LTR retrotransposons are autonomous 
elements.  In contrast the short interspersed nuclear elements (SINEs) are non-
autonomous and rely on co-opting the retrotranspositional machinery encoded by other 
elements, predominantly LINEs (Dewannieux et al., 2003).  Retrotransposons vary 
considerably in their structure as outlined in figure 1.2.      
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Figure 1.1.  The principal components of the human genome 
Almost 26% of the total human genome is composed of intronic sequence whereas only 1.2% 
encodes for protein. TEs comprise 44% of the total genome sequence, with the most abundant 
elements being the LINE and SINE repeats which comprise 21.1% and 13.1% respectively 
(Lander et al., 2001).  
 
 
 
 
 
Figure 1.2.  Schematic representation of the major categories of retrotransposons 
A, Retrovirus, the retroviral genes are in italics: B, LTR retrotransposon, similar in structure to 
the retrovirus though lacking the env gene; C, non-LTR retrotransposons, the promoter regions 
have been included as have the poly(A) tails. The LINE element contains two open reading 
frames (ORF1 and ORF2). The promoter boxes for the SINE elements are labelled A and B and 
the target site duplications are indicated by black arrows. 
                      LINE: Autonomous  retrotransposon (~5 kb) 
pol II              ORF1                           ORF2                                         aaaaa 
SINE: Non-autonomous retroposon (~250 kb) 
       A        B                                                                                  aaaaa 
 
                                              LTR retrotransposon (~6 kb) 
LTR                    gag                                                     pol                                  LTR 
 
 
 
                                                     Retrovirus (~7 kb)  
LTR                       gag                                   pol                              env                 LTR 
 
 
 
A 
 
B 
 
C 
 
Pseudogenes <1% 
L1 (LINE) 16.9% 
L2 (LINE) 3.2% 
Alu (SINE) 10.6% 
MIR (SINE) 2.5% 
LTR elements 8.3% 
DNA elements 2.8% Introns 25.9% 
Simple repeats 3% 
  Protein coding 1.2% 
Miscellaneous 24.5% 
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1.2.1.    LTR retrotransposons and endogenous retroviruses 
 
LTR retrotransposons are ubiquitous across species, ranging from single-celled 
organisms to humans, and resemble exogenous retroviruses in arrangement (Deininger 
et al., 2003).  This family of repeats contain flanking long terminal repeats (LTR), are 
of a similar size to retroviruses and encode for gag and pol genes, but lack a functional 
env gene (Havecker et al., 2004).  LTR retrotransposons comprise 8% of the human 
genome (see figure 1.1), the majority of which are immobile, with a small number of 
exceptions such as the Tf1/sushi group (Butler et al., 2001) and human endogenous 
retroviruses (HERV) (Medstrand and Mager, 1998).  In contrast, rodent genomes 
contain an abundance of active LTR retroelements including the intracisternal A-
particles (IAPs), MaLR, VL30 and ETn elements (French and Norton, 1997; Gwynn et 
al., 1998; Mager and Freeman, 2000; Baust et al., 2002).   
 
It has been argued that retroviruses may have originally evolved from LTR-
retrotransposons following the acquisition of the envelope gene.  However the most 
likely scenario is that retroviruses originated from a provirus, with the endogenous 
retrovirus losing the capacity to form the viral envelope, subsequently resulting in the 
early LTR-retrotransposon (Xiong and Eickbush, 1990; Hughes and Coffin, 2002). 
 
1.2.2.    Long interspersed nuclear elements (LINEs)   
    
The most ancient and possibly the most successful class of retrotransposons are the 
LINEs, of which there are three distinctive families; (L1, L2 and L3) numbered 
according to their age, with the L1 elements being the youngest of the group (Lander et 
al., 2001).  The most abundant and only active LINE elements in the human genome are 
the L1 family, with over 500,000 copies, constituting almost 17% of the total genome 
sequence (figure 1.1).  
 
LINE repeats are typically 6-7 kb when full length and contain two open reading frames 
(ORF).  ORF1 is ~1 kb in length and encodes for a protein which has nucleic acid 
binding capacity and is hypothesised to bind to the LINE template RNA during 
retrotransposition (Kolosha and Martin, 1997).  The larger ORF2 of ~4 kb encodes for a 
multifunctional protein with reverse transcriptase and endonuclease activity (McClure, 
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1991).  LINE elements contain an internal polymerase II promoter, which is located 
downstream of the transcription start site; as a consequence the promoter is preserved 
following retrotransposition (Minakami et al., 1992). L1 elements are non-LTR 
retrotransposons and therefore do not contain LTRs, however they do contain a poly(A) 
tail (Shedlock and Okada, 2000).     
 
There are an estimated 80 to 100 L1s which remain active in the human genome 
(Brouha et al., 2003); in contrast as many as 3000 L1 elements may be active within the 
mouse genome (Goodier et al., 2001).  The most active L1 element in humans is the Ta 
subfamily, estimated to be ~2 million years old, a third of which remain full length 
(Boissinot and Furano, 2001).  The retrotransposition frequency of LINE elements in 
humans is relatively high, with an integration rate of 1:50 sperm and a new event is 
documented in every 10 to 250 human individuals born (Ostertag and Kazazian, 2001).  
L1 elements remain a constant source of mutation, and a number of human diseases are 
caused by de novo insertions of these elements (Ostertag et al., 2003; Narita et al., 
1993; Deininger and Batzer, 1999).   
 
1.2.3.    Short interspersed nuclear elements (SINEs)  
 
SINEs are short sequence elements ranging between 70-500bp in length, depending on 
the sub-class.  Unlike LINE elements, SINEs are non-autonomous and lack the ability to 
encode any proteins such as reverse transcriptase and transposase, and propagate by 
utilising the enzymatic machinery encoded by the LINE elements (Eickbush, 1992).  
Three distinct SINE families exist in the human genome; the active primate specific Alu 
and SVA elements and the inactive ancient mammalian-wide interspersed repeats 
(MIR), each of which are comprised of several sub-families (Lander et al., 2001; 
Ostertag et al., 2003).   
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1.2.3.1.   The origin of SINE elements and the LINE/SINE relationship  
 
SINE elements require enzymes encoded by LINEs to transpose and some SINE 
families may have acquired independent retrotranspositional activity by the fusion of 
the core tRNA-like sequence with the 3‟-portion of a LINE repeat (Daniels and 
Deininger, 1985).  Sharing the 3‟-end with a LINE may provide SINEs with the 
enzymatic machinery critical to complete retrotransposition (Okada and Hamada, 1997).  
For instance the 3‟-end of the MIR elements shares considerable sequence identity with 
L2 and L3 elements (Gilbert and Labuda, 1999; Okada and Hamada 1997).  Other 
examples of LINE-derived 3‟-ends of SINE repeats include the Anolis sauria SINE and 
Bov-B LINE (Piskurek et al., 2008) and the SINE Bov-tA and LINE Bov-B (Gilbert 
and Labuda, 1999).   
 
SINEs are divided into three classes according to their origin.  The major class are those 
derived from transfer RNA (tRNA).  The majority of SINEs, including the mammalian 
MIRs, rodent B2 elements and sauria SINEs are derived from tRNA genes (Labuda et 
al., 1991; Deininger et al., 2003; Piskurek et al., 2006), with tRNA
Lys
 being the most 
common ancestor (Shedlock and Okada, 2000).  The minor classes of SINEs include 
those derived from the signal recognition particle RNA (7SL RNA) and ribosomal RNA 
(5S RNA).  Examples of 7SL RNA-derived SINEs include the primate specific Alu 
repeats and the rodent B1 elements.  These elements actively transpose via a close 
relationship with the active L1 elements.  The 5S RNA derived class of SINEs are the 
relatively newly identified SINE3 elements, which are thus far exclusive to fish and 
insect genomes (Kapitonov and Jurka, 2003; Kohany et al., 2006).  There is shared 
homology of the 3‟-end of SINE3s with that of the CR1-like non-LTR retrotransposons 
and it is thought that SINE3 elements actively transposed by utilising the necessary 
enzymes encoded by these CR1-like elements (Kapitonov and Jurka, 2003). 
 
The polymerase promoters of SINE elements are situated within the tRNA-related 
region however in the case of the non-tRNA elements such as the Alu and B1 repeats 
the promoter region is within the left monomer which is not descended from the 7SL 
related sequence and shares some sequence homology to a tRNA structure (Kriegs et 
al., 2007).  Suggesting all SINEs may be descendant from transfer RNA. 
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1.2.3.2.   The active primate SINEs; Alus and SVA elements 
 
The Alu repeats are the most abundant SINEs in the human genome and similar 
sequences are also present in other species for example the rodent B1 elements (Labuda 
et al., 1991).   Alus are short sequences of ~300bp, accounting for 10.6% of the total 
human gDNA sequence, with an estimated 1.2 million copies (Jurka, 2004).  These 
elements derive their name from an endonuclease site located within the middle of the 
consensus sequence (Houck et al., 1979).  Alus are specific to primate genomes and 
first appeared ~65 million years (myr) ago and the AluY sub-family are actively 
propagating today (Bennet et al., 2008).  The species specificity of Alus is a useful tool 
in understanding primate lineages and has been utilised in understanding complex 
phylogenies including the great apes and old world monkeys (Salem et al., 2003).   
 
The SVA family of repeats have been described relatively recently and are suggested to 
be the youngest of the SINEs in primate genomes.  SVA elements are estimated to be 
~20 myr old and as such the copy number in the human genome is much less than other 
SINEs, due to the short activity time (Wang et al., 2005, Ostertag et al., 2003). The 
SVA repeats were originally designated SINE-R elements by Ono et al., (1987) who 
suggested they were descendants of a retroviral fragment which was later confirmed as 
a HERV.  The SINE-R repeat was subsequently identified in the C2 gene, which 
contains a variable-number-of-tandem-repeats (VNTR) locus (Zhu et al., 1992).  Shen 
et al., (1994) developed this further and noted that the SINE-R.C2 element was 
associated with an antisense Alu sequence and were the first group to refer to these 
composite repeats as SVA elements, which is the acronym for the three components 
described (SINE-R, VNTR and Alu).  SVA elements are still actively propagating 
within the human genome and like Alus require active L1 repeats (Ostertag et al., 
2003).   
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1.2.4.    Mammalian-wide interspersed repeats (MIRs) 
 
One evolutionary ancient group of SINEs and the focus of this study are the MIR 
elements which are identifiable in all mammals including marsupials and monotremes.  
MIRs comprise a family of at least seven repeat elements, which vary slightly in their 
consensus sequence (table 2.1; figure 3.2).  All MIR families have a distinct structural 
arrangement and are composed of a 5‟- tRNA related sequence containing the RNA 
polymerase III promoter, a highly conserved core-SINE and a LINE related sequence 
located at the 3‟-end.  There is a short AT rich region at the 3‟-end which serves as the 
priming region during retrotransposition (figure 1.3).  It is thought that the MIR may 
have arisen following the fusion of a tRNA molecule with the 3‟-end of an existing 
LINE (Tulko et al., 1997; Terai et al., 1998).   
 
 
 
 
 
Figure 1.3.   Representation of the structure of the ancient MIR element 
The A and B box promoter regions are situated within the tRNA related region.  There is a 
highly conserved central core-SINE sequence of ~ 70bp.  At the 3’-end the MIR element shares 
homology to a LINE2 repeat and at the terminal end there is an AT rich reagion. 
 
1.2.4.1.    Evolution and conservation of MIR elements 
 
MIRs were first identified by Degen and Davie (1987), with a consensus sequence of 
~70bp (Degan and Davie, 1987; Donehower et al., 1989; Armour et al., 1989).  These 
early elements were subsequently named the mirror B1, or MB1 element, as the 70bp 
fragment was similar to the reverse sequence of the rodent B1 repeat, which is 
homologous to the primate-specific Alus (Korotkov, 1991).  Subsequent analysis 
demonstrated that the full length MIR element was ~260bp (Smit and Riggs, 1995).  
The original 70bp region is currently known as the core-SINE which is highly 
conserved across mammals explaining the original assumption that it was the full length 
of the MIR. 
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5’                                                                                                                                     3’                                                                                                     
 
                                                                                                            
 
               Simple repeats 
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One intriguing observation with these ancient elements is the level of conservation of 
the core-SINE between mammalian genomes.  Considering that MIRs are inactive and 
have been for ~150 myr, the accumulation of mutation and divergence is less than 
anticipated, and the core-SINE of the MIRs has been shown to acquire mutations at a 
slower rate than that of neutral DNA (Sironi et al., 2006).  The reduced mutation rate is 
currently unexplained; however, this observation has lead to the premise that the core 
region may be providing some functionality to mammalian genomes (Smit and Riggs, 
1995).  
 
MIR elements were actively propagating prior to the radiation of mammals and before 
placental mammals separated; therefore the age of the MIRs was originally estimated at 
~130 myr (Smit and Riggs, 1995; Jurka et al., 1995).  However Chaley and Korotkov 
(2001) suggested that the core-SINE may have originated ~550 myr ago, due to the 
similarities observed between the placental MIR consensus Ter-1 and the SINEs of non-
mammals such as reptiles, birds and octopuses (Gilbert and Labuda, 1999).   
 
On average 10% of mammalian genomes are derived from SINEs, with 2% being of 
MIR origin (table 1.1).  MIR elements would have been present in a common ancestor 
of all mammals, as orthologue sequences are detectable in the human genome and the 
distant monotremes.  This degree of negative selection suggests that the ancient MIR 
elements may confer a yet to be determined advantage to all mammalian species.   
 
Species 
SINEs genome 
coverage (%) 
MIR genome 
coverage (%) 
Publication 
Human 13.63 2.91 Lander et al., 2001 
Dog 10.57 2.7 Lindblad-Toh et al., 2005 
Cat 11.20 3.1 Pontius et al., 2007 
Mouse 7.96 0.58 Sela et al., 2007 
Opossum 10.43 2.2 Mikkelsen et al., 2007 
Wooly mammoth 6.95 0.71 Zhao et al., 2009 
 
Table 1.1.  Percentage of mammalian genomes derived from MIR elements.   
The percentage genome coverage of MIR elements and SINEs are those estimated following 
the initial sequencing of the listed genome.  The human genome comprises the largest 
percentage of SINEs with ~3% of the human, dog and cat genome being derived from MIR 
elements.  The mouse genome has recruited the least number of MIR elements. 
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1.2.4.2.    Functional role of MIR elements in mammalian genomes 
 
There are few documented examples of MIR elements playing a specific role in gene 
regulation, though validated examples are slowly emerging.  Previous studies have 
largely focussed upon the young retroelements, namely the primate-specific Alus and 
L1 family of elements.  There are occasional validated observations of older elements, 
such as the MIRs, providing a function to specific genes.  The gene 
proopiomelanocortin (POMC) encodes a neuronal hormone precursor polypeptide.  In 
mammals, hypothalamic expression of POMC is regulated by two upstream nPE 
enhancer sequences (nPE1 and nPE2).  The nPE2 enhancer is highly conserved in all 
mammals including marsupials and monotremes, and was later noted to be derived from 
an MIR element (Santangelo et al., 2007).  Smith et al., (2008) also identified an MIR 
element 1kb upstream of the stem cell leukaemia (TAL1) transcription factor enhancer.  
The MIR element has been demonstrated to both regulate and significantly increase 
TAL1 enhancer activity.  There is also a reported example of a mutation detected within 
an MIR element activating a cryptic splice site in the gene CYBB, leading to the human 
genetic disorder chronic granulomatous disease (Rump et al., 2006).  
 
One area of research which has been shown particular interest in recent years is the 
premise that ancient retrotransposons are a source of microRNA (miRNA) precursors 
and/or target sites.  It has been previously hypothesised that MIR elements have the 
potential to form dsRNAs due to the homology between individual MIR insertions 
(Hughes, 2000).  These dsRNA may then be cleaved into small interfering RNAs 
(siRNA; Zeng and Cullen, 2005).  SINEs have also been suggested as a source of 
miRNA precursors and the miRNAs; miR-95 and miR-151* display sequence 
complementary to the MIR/L2 elements located within the 3‟-UTRs of mammalian 
mRNAs (Smalheiser and Torvik, 2005).  In a similar study Piriyapongsa et al., (2007) 
identified 18 human miRNAs derived from transposable elements, 14 of which are 
related to the ancient L2 and MIR families.   
 
Similar observations have been made in the dog genome, with five MIR-derived 
miRNA precursors formed from adjacent MIR elements recruited in opposite 
orientations (Zhou et al., 2002).  Overall it appears that the recruitment of the more 
ancient TEs, such as the MIRs and L2s may have played a crucial role during 
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mammalian evolution by generating miRNA target sites and as miRNA precursors.  
Furthermore, the mechanism described by Smalheiser and Torvik (2005) appears to be a 
phenomenon exclusive to the expansion of mammalian genomes, as no similar miRNA 
precursors were detected in chicken, D. melanogaster or C.elegans (Smalheiser and 
Torvik, 2005).   
 
1.2.4.3.    Distribution of MIR elements  
 
The global distribution of MIR elements in the human genome is unknown, though they 
are documented to reside predominantly in GC-rich regions (Medstrand et al., 2002).  
The number of positively identified MIRs in the human genome is regularly increasing, 
Smit and Riggs (1995) who first identified the full length MIR estimated there to be 
>300,000 copies.  Following the analysis and sequencing of the human genome the 
figure rose to ~446,000 MIR sequences in the whole genome (Lander et al., 2001).  A 
more recent study identified ~548,000 copies in humans and ~116,000 in the mouse 
genome (Sela et al., 2007).  These figures are likely to be underestimated due to the 
methods of detection and it has been suggested that less than half of the total genomic 
MIR elements have been identified using conventional methods (Gu et al., 2008). 
 
The number of genes which have exaptated MIR elements still remains unclear.  Chaley 
and Korotkov (2001) reported MIR sequences present in the coding sequence (CDS) of 
254 human transcripts, however this number does not represent single genes and several 
genes are represented by multiple transcripts with others exaptated within the 
untranslated region (UTR).  Sela et al., (2007) more recently identified 181 MIRs 
located within the UTR and CDS of human genes, of which 78 have been recruited in 
the CDS (Sela et al., 2007).   
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1.3.      Mechanism of retrotransposition  
 
The mechanism of how transposons replicate and move through the genome varies 
between classes. The DNA transposon move through a „cut and paste‟ process and as 
such the element is transposed to a different genomic region, retrotransposons however 
propagate via a „copy and paste mechanism‟ known as target-primed-reverse-
transcription (TPRT) (Cost et al., 2002).  TPRT is an accumulative process as the 
original copy is not removed from the genome; secondly the internal promoter, poly(A) 
tail and ORFs are contained within the newly integrated elements.  The ability of 
retroelements to maintain the transcriptional machinery explains the abundance of these 
elements within vertebrate genomes compared to the DNA transposons. 
 
During TPRT the initial step is the transcription of the LINE into RNA via the internal 
RNA polymerase promoter, located within the 5‟-UTR (Roy et al., 2000).  The RNA 
molecule is then transported to the cytoplasm where both ORFs are translated.  These 
LINE-encoded proteins then bind to the RNA template to form a cytoplasmic 
ribonucleoprotein (RNP) complex.  The RNP complex then travels to the nucleus where 
insertion takes place (Finnegan, 1997).  The insertion process involves the cleavage of 
the first strand of the target gDNA, generating a 3‟-OH nick, facilitated by the LINE-
encoded endonuclease.  There appears to be a preference for a gDNA target site of 
~15bp, which contains the conserved cleavage site, 5‟ TT|AAT on the antisense strand 
(Feng et al., 1996).  The 5'-end of the template RNA which contains the poly(A) tail, or 
in the case of MIR elements the AT rich region, anneals with the cleavage target site by 
base pairing with the nicked gDNA.  The exposed 3‟ hydroxyl serves as a primer for 
first strand synthesis (Luan et al., 1993), this process is facilitated by the reverse 
transcriptase encoded by the retroelement as demonstrated in figure 1.4.   
 
SINEs do not encode a reverse transcriptase, so in the case of SINEs, such as the MIR 
elements, it is thought that the reverse transcriptase of LINEs is utilised, possibly 
encoded by L2 and L3 elements, for their
 
amplification (Deininger and Batzer, 2002; 
Terai et al., 1998).   
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Figure 1.4.  The retroelement transposes via an RNA intermediate  
The retrotransposon is transcribed to generate the template RNA which is reversed 
transcribed to produce a DNA copy of the original element.  The target genomic sequence is 
nicked which acts as a primer for target primed reverse transcription, following which the 
dsDNA copy is reinserted into a unique region of the genome. 
 
 
Finally a second DNA strand is synthesised to form a RNA/DNA hybrid and the second 
gDNA strand is cleaved.  The target site is filled with a double-stranded DNA (dsDNA) 
copy of the original retroelement.  When TPRT is completed the single-stranded DNA 
(ssDNA) remaining at the nicked target site is filled, producing target site duplications 
(TSD; figure 1.5).  In younger elements, these flanking TSD can be a „signature‟ of the 
insertion of a retroelement into the genome (Jurka and Klonowski, 1996).  Some 
insertions have been noted which do not contain TSD (Han et al., 2005); however the 
TSD of older elements will contain indels and may no longer be recognisable.  Several 
of the mechanisms involved in retrotransposition remain to be clarified.  The process by 
which the 5‟-end of the newly transcribed template RNA associates with the cleaved 
target DNA is unclear.  Similarly the process of the degradation of the target RNA, 
second strand synthesis and the mechanism of target site duplication is also speculative 
(Cost et al., 2002). 
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  Genomic target DNA                              Target site duplication  
  Integrated MIR element   
 
Figure 1.5.  Target site duplications flanking an integrated MIR element   
Genomic DNA is represented in pink and the MIR element in blue.  The genomic target site is 
nicked at the consensus TTAAT which then anneals to the AT rich region at the 3’-end of the 
MIR consensus.  When target primed reverse transcription is complete the nick is filled 
producing target site duplications (boxed green). 
 
 
1.4.      Retroelements, human disease, and the process of exonisation 
 
When a retroelement has been transposed to a new genomic region it will 
predominantly reside within intronic sequences or intergenic regions (Sela et al., 2007), 
with no discernible impact on gene expression patterns and protein function.  However 
retrotransposons may be transposed directly into an exon of a gene and behave as 
insertional mutagens by disrupting reading frames and regulatory elements.   
 
The mutagenic potential of retrotransposons is clearly observed following de novo 
insertions of active elements.  Current retroelement activity in the human genome is 
largely due to the Alu and L1 families of retrotransposons.  Chen et al., (2005) who 
studied Alu and SVA repeats, noted 40 insertional events into genes which resulted in 
human disease (Chen et al., 2005).  Alu elements have been suggested to play a role in 
the development of 0.3% of human genetic disease (Deininger and Batzer, 1999) and an 
estimated 0.1% of all human germline disease is due to insertion of L1 elements (Li et 
al., 2001).  For example the insertion of an L1 into exon 14 of the factor VIII gene has 
been demonstrated in an haemophilia A patient (Kazazian et al., 1988).  L1 insertions in 
the dystrophin gene (DMD) have been shown to cause a frameshift and skipping of 
coding exon 44; responsible for the development of Duchenne muscular dystrophy 
(Narita et al., 1993).  Similar has been observed following the integration of an Alu 
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element in the NF1 (neurofibromatosis 1) gene which causes exon skipping and shifts 
the reading frame resulting in neurofibromatosis type 1 (Wallace et al., 1991).  The de 
novo insertion of an SVA element in the α-spectrin gene (SPTA1) also results in exon 
skipping in cases of hereditary elliptocytosis (Hassoun et al., 1994). The 
retrotranspositional insertion rate varies between mammals, for example 
retrotransposons account for 0.2% of spontaneous mutations in humans but comprise 
>10% in rodents (Ostertag et al., 2003).  However the genomes of some mammals such 
as the South American rodent Oryzomys appear to contain no active retroelements 
(Casavant et al., 2000).   
 
Most exonic integrations will be selected against and as such will no longer be 
detectable, and the observed exonic retrotransposons will most likely have integrated in 
intronic regions and were incorporated into the CDS via exonisation (Lei et al., 2003).  
Exonisation of a retroelement occurs when the repeat contains sequences which are 
recognised as splicing motifs, or alternatively mutations within the recruited element 
may generate cryptic splice sites or optimise an existing splicing signal.  In the majority 
of cases, the recruitment of a retroelement will introduce an alternative reading frame, 
which may ultimately result in a truncated protein of either no function or with altered 
expression levels (Krull et al., 2005).  Premature termination codons may trigger 
nonsense-mediated decay (NMD) of the mRNA transcript if a polyadenylation signal is 
not in close proximity (Chang et al., 2007).   
 
One of the earliest observations of the exonisation of a retrotransposon occurred more 
that 15 years ago.  Mitchell et al., (1991) studying mutations in the ornithine-
aminotransferase gene (OAT), demonstrated that a point mutation within an Alu 
element (residing within an intron) produced a cryptic splice site.  This aberrant splicing 
generated an alternative reading frame and thus a premature in-frame stop codon 
(Mitchell et al., 1991).  The truncated protein is a contributing factor in ornithine 
aminotransferase deficiency, the causative agent of the autosomal recessive eye disease, 
Gyrate Atrophy (Simell and Takki, 1973).   
 
A further example of Alu exonisation is noted following a deletion located within an 
Alu element, residing within an intron of the glucuronidase-beta gene (GUSB).  The 
deletion produces a cryptic donor splice site and as a consequence individuals develop 
Chapter 1. Introduction  
 
  
17 
 
  
Mucopolysaccharidosis type VII (Sly syndrome).  This mutation produces an alternative 
exon which results in the skipping of a constitutive exon, therefore causing a mild form 
of Sly syndrome (Vervoort et al., 1998).  Numerous other cases of Alu-based 
exonisation have been documented (for a review see Sorek et al., 2002).   
 
There is one reported example where an inserted MIR element contributes to a human 
genetic disorder.  In a chronic granulomatous disease (CGD) patient, Rump et al., 
(2006) identified a mutation within the CYBB gene (cytochrome b-245, beta 
polypeptide) which activated a cryptic splice site in the middle of an intron. Inclusion of 
this novel 56bp exon results in a reading frame with a termination codon, which 
encodes a truncated protein.  Previous investigations have reported the exonisation of 
LTR elements, Alus and MIR repeats (Piriyapongsa et al., 2007; Sela et al., 2007; Krull 
et al., 2007), and the Alus have been shown to contain motifs in the repeat consensus 
sequence resembling classical splice sites (Sorek et al., 2002). 
 
1.5.      Transposable elements as markers for evolution  
 
SINE elements are useful tools for defining monophyletic clades and assist in 
understanding complex lineages.  SINEs help identify ancient radiations, which would 
otherwise be undetectable due to the accumulation of mutations over time.  The 
majority of SINEs insert into a genome with little or no impact and therefore provide a 
record of biological history and as such are considered as neutral genetic markers 
(Shedlock and Okada, 2000).   
 
The use of SINEs can prove more effective at studying evolutionary relationships 
between species than single-nucleotide-polymorphisms (SNPs) and nucleotide 
substitutions, as they may have integrated following numerous independent mutations 
and are not inherited from a common distant ancestor.  SINEs are thought to represent 
identity by descent and the probability of two individual elements integrating 
independently at the exact location of a chromosome is small (Salem et al., 2005).  
Therefore the problem of parallel mutation and ambiguous results due to outgroup 
selections is less likely (Shedlock and Okada, 2000).  Transposable elements are a 
useful tool at deciphering complex and/or closely related lineages, due to the mode of 
evolution being unidirectional, as there is currently no known mechanism for the 
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removal of SINEs from a genome following recruitment (Salem et al., 2005; Shedlock 
et al., 2004).  However there are some caveats when conducting phylogenetic analysis 
using transposable elements, for example it is possible that insertion homoplasy may 
occur between species of different ancestry over time.  Furthermore repeat sequences 
can be lost by deletion (Salem et al., 2005) 
 
1.5.1.    Retrotransposons and complex lineages  
 
The African cichlid fish (AFC) family are found in Lakes Victoria, Malawi, and 
Tanganyika, and have captured the interest of researchers for many years.  This endemic 
species exhibits extraordinary levels of diversity for each lake as a consequence of 
explosive adaptive radiation that occurred independently and in parallel (Terai et al., 
2004; Terai et al., 2003; Takahashi and Okada 2002).  AFC SINE elements have been 
used as genetic markers for phylogenetic analysis to delineate the complex radiation of 
the cichlid fishes.  Similarly, analysis of Alu lineages has been used to assess 
relationships between the primate lineage of humans, gorillas and chimpanzees (Salem 
et al., 2003; Roy-Engel et al., 2002).  The study assisted in understanding primate 
phylogeny and to reconstruct the demographics of human populations.  The sister 
relationship between humans and chimpanzees is clearly distinguishable following the 
application of SINEs (Salem et al., 2003).  SINE elements have been used to elucidate 
the origin of whales.  Shimamura et al., (1997) determined that the order Cetacea 
(whales, porpoises and dolphins) form a monophyletic group with ruminants and 
hippopotamuses and not Atriodactyla, as had been previously suggested.  This was 
supported with the systematic use of SINEs by Nikaido et al., (2001).   
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1.6.      Functionality of retrotransposons 
 
The integration of a retroelement will provide additional genomic material and therefore 
may have contributed to genome plasticity, allowing for accelerated evolutionary 
changes in protein structure and gene expression (Häsler and Strub, 2006; Szmulewicz 
et al., 1998).  There is increasing evidence to support the idea that retrotransposons 
allow for the modification of gene function and/or expression by providing regulatory 
elements, alternate splice sites, polyadenylation signals and additional protein coding 
information (Nekrutenko and Li, 2001; Lev-Maor et al., 2003; Baertsch et al., 2008).    
 
1.6.1.   Pseudogenes 
 
Pseudogenes represent copies of functional genes which have been inserted into a novel 
location within the genome, and generally have no protein coding capacity, due to the 
failure of transcription or translation.  The nucleotide sequence will be highly similar to 
the parental gene but may contain mutations or lack functional sequences, as a 
consequence the reading frame may be interrupted and regulatory elements rendered 
inactive.  There are two classes of pseudogene; processed pseudogenes are generated by 
reverse transcription of RNA whereas non-process pseudogenes are derived directly by 
an increase in DNA content.  Non-processed pseudogenes usually spread via gene 
duplication, so are commonly clustered and situated near the original functional gene.  
This class of pseudogenes contain introns, flanking sequences, including the upstream 
promoter and will usually contain multiple in-frame stop codons.  DNA-derived 
pseudogenes theoretically have the potential to be functional if the original promoter is 
included; however the majority are present as redundant copies which have accumulated 
mutations.   
 
Processed pseudogenes are generated by the reverse transcription of mRNA, tRNA and 
ribosomal RNA (rRNA) and are also termed retrogenes (Krasnov et al., 2005).  This 
category of pseudogenes are thought to have relied on retrotransposons for their 
amplification (Esnault et al., 2000), and many have flanking retrotransposons and share 
the poly(A) tails and TSD of the repeat elements (Deininger and Batzer, 2002). These 
pseudogenes will contain the features of the original RNA so are intronless and 
commonly contain the original poly(A) tails.  Processed pseudogenes are usually 
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truncated at the 5‟-end and as such lack upstream promoters, and processed 
pseudogenes are generally considered as “dead” following integration (Graur et al., 
1989).  Even though processed pseudogenes are considered “dead on arrival”, some 
remain as protein-coding intronless retrogenes (Marques et al., 2005).  Retrogenes may 
not encode for the gene product of the original paralogue gene as there is no need to 
maintain two genes of identical function, secondly processed pseudogenes are usually 
truncated at the 5‟-end resulting in an alternative reading frame and hence a different 
peptide sequence.  Some pseudogenes may remain as functional ncRNAs (ncRNA) 
(Sasidharan and Gerstein, 2008).  With all retrotransposons being derived from RNA 
genes it is thought that the original „master‟ repeat elements may have been a successful 
pseudogene which continued to retrotranspose effectively (Shen et al., 1991; Deininger 
et al., 1992).     
 
Functional processed pseudogenes are often derived from X-linked genes, for example 
phosphoglycerate-kinase (PGK)2.  PGK2 is a glycolytic enzyme which is encoded by 
an intronless gene derived from the intron-containing paralogue PGK1 (McCarrey et al., 
1996).  PGK1 has a similar function to PGK2, but PGK2 is expressed exclusively in 
spermatocytes (McCarrey et al., 1996).  Uechi et al., (2002) identified a new family of 
ribosomal protein genes designated RPL10L, PRPL36AL and RPL39L, which appear to 
have originated through the retrotransposition of an X-linked ribosomal gene.  These 
ribosomal retrogenes are primarily expressed in the testes and are thought, as with 
PGK1 to have evolved as a means of compensating for the reduced dosage of X-linked 
genes, which may be silenced during spermatogenesis (Uechi et al., 2002). This 
mechanism would presumably allow for the processed copy of the gene to specialise in 
testes function while the parental gene maintains the original function in somatic tissues 
(Shiao et al., 2007).  Other pseudogenes, which seem to have evolved as a means of 
compensating in this manner, include glucose-dehydrogenase (G6pd), X-linked XAP-5 
(FAM50B) and the testes-specific pyruvate-dehydrogenase subunit (PDHA2) (Dahl et 
al., 1990; Hendrikson et al., 1997; Sedlacek et al., 1999). 
 
Retrotransposition has also contributed to the evolution of salivary amylase.  The 
amylase gene family consists of two pancreatic amylases and three salivary amylases.  
Salivary amylase (AMY1) is thought to have evolved from pancreatic amylase 
(AMY2), a process which was facilitated by the insertion of a processed gamma-actin 
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sequence into the promoter of the original ancestral amylase gene (Ting et al., 1992).  
This event is likely to have been selected for due to the need for salivary amylase when 
there was an increase in the ingestion of starch in the human diet following the 
development of agriculture (Caldwell et al., 2004). 
 
1.6.2.   Retrogenes and mammalian evolution 
 
More than 90% of G protein-coupled receptors (GPCRs) are encoded by an intronless 
gene.  It has been suggested that these genes share a common ancestor, which may have 
been a retrogene (Gentles and Karlin, 1999).  Being intronless suggests that a gene may 
be derived following retrotransposition as processed-pseudogenes are transposed from 
mature mRNA.  Eliminating post-transcriptional splicing would result in a faster rate of 
protein expression, which may be advantageous to GPCRs.  This improved efficiency 
would be beneficial when there is a need for rapid protein expression, such as in the 
central nervous system, leading to the idea that retrotransposition was important in the 
evolution of increased cognitive capacity in humans (Gentles and Karlin, 1999).   
 
Glutamate dehydrogenase (GLUD)1 is a mitochondrial matrix enzyme, which functions 
in glutamate and nitrogen metabolism (Smith et al., 2001). GLUD2 is an intronless 
pseudogene of GLUD1, derived from GLUD1 by retrotransposition during a time that 
coincides with a period of a notable acceleration of evolution and increase in brain size 
of hominoids (Burki and Kaessmann, 2004).  It is thought that higher neural activity co-
evolved with greater brain size, and may have been aided by retroelement activity 
(Burki and Kaessmann, 2004).  Retrotransposition has also been implicated in other 
areas of primate evolution.  Marques et al., (2005) estimate that there are ~75 retrogenes 
which emerged during and after the primate burst of retrotransposition.  It was also 
noted that the majority of these retrogenes were expressed in the testes and originated 
from X-linked genes, and have evolved functional roles in spermatogenesis.  It is 
suggested by Marques et al., (2005) that the compensation of X-linked genes through 
retrotransposition may have assisted human evolution, as autosomal substitution during 
X inactivation would primarily enhance male germline function allowing for rapid 
primate evolution (Marques et al., 2005).   
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The total number of human retrogenes currently identified is 163 and similar numbers 
are observed across mammals (Pan and Zhang, 2009).  There also appears to be a burst 
of young retrogenes appearing in mammals occurring prior to that discussed with 
primates, which may have aided mammalian evolution (Pan and Zhang, 2009).   
 
1.6.3. Imprinting, epigenetics and microRNAs 
 
Genetic imprinting occurs when a gene is differentially expressed, depending on the 
origin of the inherited allele, either maternally or paternally.  The differential expression 
is referred to as the parent-of-origin effect.  There are ~80 human imprinted genes, at 
least 11 of which are retrogenes (Morison et al., 2005).  Several others display the 
features of retrotransposed genes and many retrogenes are located within imprinting 
regions (Walter and Paulsen, 2003).  Due to this commonality of retrogenes with 
imprinted genes it is thought that imprinting may have occurred as a secondary effect 
following the defence against foreign DNA, as active repeat elements are rendered 
inactive by DNA methylation (Wood et al., 2007). 
 
It has been suggested that a large number of microRNAs (miRNA) may have evolved 
from TEs, as the genome responds to a retrotranspositional event by attempting to 
deactivate and degrade the TE via DNA methylation and RNA degradation (Suzuki et 
al., 2007).  Silencing of TEs by genomes is mediated by siRNAs, which are derived 
from the repeat element target itself (Piriyapongsa et al., 2007; Buchon and Vaury, 
2006; Vaughn and Martienssen, 2005).  For example the epigenetic machinery present 
in plants is thought to have evolved in this manner (Zilberman and Henikoff, 2005), and 
miRNAs have been demonstrated to be encoded by a short DNA transposon known as a 
MITE in A.thaliana and O.sativa (Piriyapongsa and Jordan, 2008).  MiRNAs can also 
be transcribed by the RNA polymerase III promoter of the Alu elements (Borchert et al., 
2006).   
 
Evidence is increasing to support the idea that miRNA precursors are derived from TEs; 
including MIR/L2 repeats (Smalheiser and Torvik, 2005), L1 elements (Devor et al., 
2009) and Alu repeats (Smalheiser and Torvik, 2006; Devor, 2006).  Piriyapongsa et al., 
(2007) identified 14 human miRNAs which appear derived from L2 and MIR elements.  
Similar observations have been made with the dog genome.  Five MIR-derived miRNA 
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precursors were identified by Zhou et al., (2002), who noted that stem-loop structures 
are formed between adjacent MIR elements when recruited in opposite orientations.   
 
1.7. Concluding remarks 
 
The majority of studies have focussed on the analysis of active retrotransposons such as 
Alus and L1 repeat sequences.  There has been limited investigation of the exaptation of 
MIRs (Krull et al., 2007; Sela et al., 2007; Chaley and Korotkov, 2001).  MIR elements 
have been resident in the genome since the mammalian radiation and are ubiquitous 
across mammals; therefore they have the potential to provide insight in mammalian 
gene evolution through history.  Furthermore the highly conserved core-SINE region is 
not only conserved between different genes of a single species but between divergent 
species.  However to date few groups focus on this particular class of elements, possibly 
due to the level of divergence observed with respect to the age of the elements.   
 
Previous publications have identified MIR-containing genes (Chaley and Korotkov, 
2001; Sela et al., 2007), although the number of coding transcripts remains small and 
none have systematically looked for a functional role of these ancient elements.  A 
preliminary analysis of the human genes which have recruited MIRs identified a 
possible link with dendritic localisations of mRNA transcripts to the neurone (Hughes, 
2000; Hughes, unpublished data).  This localisation has been implicated in synaptic 
plasticity, and a role in neuronal function has been supported by the discovery of 
mutations in some of these genes in cases of mental retardation.   
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1.8. Aims and objectives of the study 
 
The primary aim of the project is to identify MIR-containing genes, which following 
bioinformatics and laboratory analysis may provide insight into the potential role of 
MIR elements in mammalian gene evolution, and to determine the functional 
significance of the exaptation of this family of repeats.   
 
 
The key areas are as follows: 
 
 To identify human genes which have exaptated MIR elements by the use of 
bioinformatics and data mining tools. 
 
 Following acquisition of the MIR-containing genes to outline the distribution of 
these repeat sequences by determining if there is a preference to recruit MIR 
elements in a particular orientation, gene/genomic region or of a particular MIR sub-
family.  
 
 To establish if there is a commonality in function between the MIR-containing 
genes, such as protein function, interactions and biological pathways. 
 
 Determine if exonisation of the MIRs has occurred to produce transcript variants 
which may contribute to human disease, differential expression or gene function. 
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2. MATERIALS AND METHODS 
 
2.1. Bioinformatics analysis 
 
2.1.1. Acquisition of MIR-containing genes 
 
Retrotransposon consensus sequences were obtained from the Repbase Update which is 
provided by the Genetic Information Research Institute (GIRI; table 2.1).  The Repbase 
Update is a reference source and database of repetitive DNA for numerous eukaryotic 
genomes (Jurka et al., 2005; http://www.girinst.org/repbase/update/index.html).  
 
 
Repeat 
Type 
Repeat 
 Sub-type 
Aliases Size (bp) Species origin 
SINE MIR MB1, MER24, MIR1 262 Mammalia 
SINE MIRc - 268 Mammalia 
SINE MIR3 L3, MIR 224 Mammalia 
SINE MIRb SINE2 268 Mammalia 
SINE MIRm MON1, THER1, THER2 273 Monotremata 
SINE MIR_Mars THER1, THER2 263 Metatheria 
SINE THER1_MD - 275 Didelphidae 
 
Table 2.1. MIR element sub-families contained in RepBase 
The MIR element subfamilies are catagorised according to the RepBase annotations.  The size 
of the consensus sequences are in the range of 224-275bp.  The earliest mammal the MIR 
element is thought to have been actively transposing is listed if known. 
 
Potential MIR containing nucleotide sequences were collected by screening human 
genes for homology to the MIR consensus using the „BLAST‟ analysis program 
(Altschul et al., 1990; http://www.ncbi.nlm.nih.gov/BLAST/).  Repeat elements were 
alternatively identified by searching the „Genomic ScrapYard‟, which is a database 
compiled of transcripts that are known to contain all families of transposable elements 
including SINEs, LINEs, DNA and LTR transposons (Makalowski, 2000; 
jhttp://warta.bio.psu.edu/ScrapYard/). Only a proportion of the MIR-containing genes 
identified in this study were available in the Genomic ScrapYard; however, it was a 
useful resource. 
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2.1.2. Validation and annotation of MIR elements  
 
„RepeatMasker‟ was the primary tool utilised to confirm the presence of an MIR 
element.  The „RepeatMasker‟ is a software resource which screens query sequences for 
interspersed repeat elements (http://www.repeatmasker.org/) using the transposons 
consensus sequences in the Repbase.  The orientation of the repeat sequence within the 
transcript can be determined, as can the coordinates, size and the repeat sub-family.  
Transcripts which were noted to have recruited an MIR element were validated by 
assigning the sequence to a specific gene (http://www.ncbi.nlm.nih.gov/gene/) and 
confirming that the sequence was either a current reference sequence or by searching for 
ESTs (expressed sequence tags) which correspond to the nucleotide and by noting  
published examples.  Only annotated „named‟ genes were included in this study and 
hypothetical sequences discarded as they are unconfirmed sequences which may 
represent sequencing errors, pseudogenes or non-functional „fossil‟ genes. 
 
2.1.3. Repeat sequence location 
 
The position of the MIR element within a gene was determined using the sequence 
alignment program „Spidey‟, and „Entrez Gene‟. Both sites are located at NCBI 
(http://www.ncbi.nlm.nih.gov/IEB/Research/Ostell/Spidey/;jhttp://www.ncbi.nlm.nih.g
ov/gene/). Spidey is an alignment tool which when aligning mRNA to the 
corresponding gDNA determines the exonic arrangement and provides the genomic and 
mRNA coordinates for each exon determined.  Splice sites were then scored using the 
online GENIE program available at the Zhang laboratory website 
(http://rulai.cshl.edu/new_alt_exon_db2/HTML/score.html; Reese et al., 1997; Zhang, 
1998). 
 
The genomic locations for all of the human genes identified were mapped using 
„KaryoView‟ at Ensembl (http://www.ensembl.org/Homo_sapiens/karyoview).  The 
density of human genes for a given chromosome was calculated according to the NCBI 
36.2 assembly of the human genome, which is currently used in the Ensembl release 43.   
The coordinates for all of the MIR subfamilies were plotted using the SUMPRODUCT 
function available in excel, which calculated the number of total transcripts that 
corresponds to each nucleotide of the MIR consensus sequence.   
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2.1.4.     Sequence homology 
 
Multiple sequence alignments were generated using the EBI ClustalW2 server 
(http://www.ebi.ac.uk/Tools/clustalw2/index.html; Larkin et al., 2007).  Clustal 
alignments of >20 sequences were generated using the WebLogo browser application 
(Crooks et al., 2004; http://weblogo.threeplusone.com/).  WebLogo provides a clear 
graphical description of sequence conservation. The alignment generates a stack of four 
letters representing each nucleic acid (A, C, G, T) with the overall height signifying the 
frequency of each nucleotide.  The top letter in the alignment is most conserved, 
allowing for the identification of patterns otherwise difficult to perceive when aligning 
large numbers of sequences with ClustalW2.  Sequence conservation between species 
was viewed using the ECR browser (http://ecrbrowser.dcode.org/; Ovcharenko et al., 
2004), which displays evolutionary conserved genomic regions.  
 
2.1.5.     Protein function and peptide sequences 
 
Nucleotide sequences were translated into the six potential reading frames using the 
translator feature at JustBio (http://www.justbio.com/tools.php) and conserved protein 
domains were obtained from the Pfam database of protein families 
(http://pfam.sanger.ac.uk/;  Finn et al., 2008) and the Conserved Domains and Protein 
Classification (CDD) database  (http://www.ncbi.nlm.nih.gov/Structure/cdd/cdd.shtml). 
 
2.1.6. Functional enrichment analysis 
 
The significance of the MIR dataset of genes was further investigated using the web-
based functional annotation tool D.A.V.I.D (Database for Annotation, Visualisation and 
Integrated Discovery; Huang et al., 2007; http://david.abcc.ncifcrf.gov/home.jsp).  The 
gene identifiers for the MIR-containing genes were uploaded to D.A.V.I.D and screened 
against a large number of databases for functional enrichment.  Databases accessible 
through D.A.V.I.D, used during the investigation include OMIM (Online Mendelian 
Inheritance in Man; http://www.ncbi.nlm.nih.gov/omim/), the Genetic Association 
Database (GAD; http://geneticassociationdb.nih.gov/), the Gene Ontology database 
(http://www.geneontology.org; section 2.1.6.1), SwissProt (http://www.expasy.ch/cgi-
bin/keywlist.pl), KEGG for pathway maps (http://www.kegg.com; Kanehisa et al., 
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2008; section 2.1.6.2) and the U133A/GNF1H tissue expression panel 
(http://wombat.gnf.org/; Su et al., 2004).  The U133A /GNF1H human expression data 
includes a panel of 79 tissue typesand the corresponding data for >40,000 human genes.   
 
2.1.6.1.   Gene Ontology  
 
Gene ontology (GO) data was retrieved from the GO consortium and EBI gene ontology 
annotation service (http://www.ebi.ac.uk/GOA/; http://www.geneontology.org).  The 
gene ontology is a controlled vocabulary used to describe gene function, products and 
sub-cellular locations.  The total number of human genes which have recruited MIRs 
that have been assigned a specific GO term were determined using the data mining tool, 
„MartVeiw‟ located at Ensembl (http://www.ensembl.org/Multi/martview) and FatiGO 
at Babelomics v3.1 (Al-Shahrour et al., 2007; http://babelomics.bioinfo.cipf.es).  The 
frequencies of MIR-containing genes which have a particular GO term assigned were 
compared to the frequency of the total number of genes in the human genome with the 
same GO accession.  If a GO term was overrepresented for the MIR group of genes 
compared to the genome may suggest function, statistical significance was calculated 
using D.A.V.I.D.  
 
2.1.6.2.   Regulatory pathways  
 
The involvement of the MIR-containing genes in metabolic and signalling pathways 
was determined by comparing to the known regulatory pathways listed in the Kyoto 
Encyclopaedia of Genes and Genomes (KEGG) database (Kanehisa et al., 2008; 
http://www.kegg.com).  The significance of the MIR-containing genes involved in each 
pathway was determined using the web-based analysis tool D.A.V.I.D. 
   
2.1.6.3.   MicroRNAs (miRNA) and miRNA binding sites 
 
Potential microRNA (miRNA) binding sites were identified by accessing the data 
available in the „miRBase‟, the miRNA registry available at the Sanger Institute, which 
contains >5000 miRNA gene loci (http://microrna.sanger.ac.uk/).  The most effective 
approach is to use „miRBase Targets‟, firstly searching for a gene of interest, then 
identifying if the transcript with the MIR is present and finally to establish if the target 
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site is located within the MIR sequence, this can be further verified using „Spidey‟.  
Alternatively miRNA target sites can be detected using „TargetScan‟ (Lewis et al., 
2003; http://www.targetscan.org/).   
 
2.1.6.4.   Regulatory RNA, motifs and elements 
 
A query sequence was screened for regulatory RNAs such as splice enhancers, splice 
silencers, motifs within the 3‟- and 5‟-UTRs using the „RegRNA‟ software (Huang et 
al., 2006; http://regrna.mbc.nctu.edu.tw/html/prediction.html). Alternatively 5‟- and 3‟-
UTR motifs were identified in a query sequence using UTRScan (Mignone et al., 2005; 
http://www2.ba.itb.cnr.it/UTRSite/).  Motifs and elements were only accepted as true if 
there were publications to verify the sequence.   
 
2.1.6.5.   Disease associations 
 
The involvement of gene transcripts in human disease was determined by visiting 
OMIM at NCBI (http://www.ncbi.nlm.nih.gov/sites/entrez?db=omim) and AceView 
also at NCBI (http://www.ncbi.nlm.nih.gov/IEB/Research/Acembly/index.html), details 
were confirmed by current journal articles.  Disease association of the MIR-containing 
genes was also determined using the Genetic Association Database (GAD; 
http://geneticassociationdb.nih.gov/) accessible through D.A.V.I.D.  Databases for 
specific human diseases were also visited, including Retina International 
(http://www.retina-international.com/sci-news/disloci.htm) and the Retinal Information 
Network (RetNet
TM
; http://www.sph.uth.tmc.edu/retnet/). 
 
2.1.7.    Statistical analysis 
 
Calculating a P value which entails multiple tests may produce false positives, therefore 
the Fisher's exact test was adjusted using the false discovery rate (FDR) corrected 
method (Al-Shahrour et al., 2007; Benjamini and Hochberg, 1995).   P ≤ 0.05 (95% 
confidence limit) was deemed significant and P < 0.01 (99% confidence limit) was 
considered extremely significant.  The unadjusted Fisher‟s exact test was used to 
provide a general indication of any trends which may suggest a potential function of the 
MIR-containing genes, though without statistical significance.   
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2.2. Tissue preparation, homogenisation and RNA extraction 
 
2.2.1.   Tissue and cell culture preparation 
 
Adult male and female Wistar rats were sacrificed by cervical dislocation in accordance 
with the Animals (Scientific Procedures) Act 1986, UK.  Tissues were rapidly excised 
in a sterile environment, rinsed in 0.1% (v/v) DEPC-treated H2O and flash-frozen in 
liquid nitrogen.  The rat tissues used in this study are detailed in table 2.2.   
 
Tissue Source (Adult Winster Rats) Experimental Procedure 
Brain Male x 3; Female x 2 RT-PCR 
Brain Male x 2; Female x 3 Radioactive in situ hybridisation 
Heart Male x 3; Female x 3 RT-PCR 
Kidney Male x 3; Female x 3 RT-PCR 
Liver Male x 3; Female x 3 RT-PCR 
Lung Male x 3; Female x 3 RT-PCR 
Pancreas Male x 3; Female x 2 RT-PCR 
Spleen Male x 3; Female x 3 RT-PCR 
Testis Male x 3 RT-PCR 
 
Table 2.2.  Dissected rat tissues used for RT-PCR and in situ hybridisation experiments 
Whole dissected rat tissues have been listed with the number of animals sacrificed, the sex of 
the animal and the tissue excised for each procedure.  
 
 
2.2.2.   Extraction of total RNA  
 
The tissues were weighed and diced prior to homogenisation. 1ml of TRI reagent
®
 
(Ambion; containing phenol) was added per 100mg of tissue and per 5-10 x 10
6
 of 
cultured cells.  Cells were homogenised by pipette mixing and animal tissue was 
homogenised for a period of 30 seconds to a few minutes for hard or fibrous tissue using 
a manual glass-teflon homogeniser (Scientific Laboratory supplies Ltd).  C6 cells were 
donated by Dr A Hargreaves (Nottingham Trent University) and RNA was isolated 
(section 2.2.2).  The BRIN-BD11 cell line was donated by Dr E Verderio-Edwards 
(Nottingham Trent University) and grown in culture (section 2.8). 
 
The homogenised cells/tissues were aliquoted 1ml per 1.5ml Eppendorf tube and 
incubated at room temperature in the fume cupboard for 5 min.  200µl of chloroform 
was added to each suspension, and gently vortex mixed (Vortex-Genie
®
 2; Sigma) for 
10 sec and incubated on ice for 5 min.  The samples were then centrifuged at 12000 x g 
for 20 min at 4
o
C (Mikro 20 microcentrifuge (Hettich) for all instances unless stated 
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otherwise).  Following centrifugation the suspension consists of three layers; protein, 
fat/lipids and nucleic acids, the upper clear aqueous layer containing the RNA/DNA 
mix was transferred to a fresh Eppendorf tube.  If the intermediate phase was disturbed 
the solution was re-centrifuged.  500μl of isopropanol was added to each tube 
containing the supernatant, vortex mixed briefly and incubated on ice for a further 
10min.  The samples were centrifuged at 12000 x g for 10 min at 4
o
C.  The supernatant 
was removed by gentle aspiration using a micropipette and the pellet washed using 1ml 
of 75% (v/v) ethanol.  The pellet was centrifuged at 7500 x g for 10 min at 4
o
C, 
following which the ethanol was removed by gentle aspiration and the pellet was left to 
air dry in the fume cupboard for 2-5 min until almost dry.  The isolated RNA was re-
suspended in 20-100µl of RNase and DNase H2O depending on the pellet size.  For 
large pellets re-suspension was aided by heating at 50
o
C for 5 min.  The concentration 
of the RNA was calculated using a spectrophotometer (section 2.4.3).  The RNA was 
used directly for cDNA synthesis or stored in 2.5 volume absolute ethanol at -80
o
C until 
required.   
 
2.3.      The storage, recovery, concentration and quantification of nucleic acids  
  
2.3.1.   Storage and ethanol precipitation of nucleic acids 
 
Isolated RNA and cDNA were recovered from storage and concentrated by precipitating 
with ethanol.  The nucleic acids were precipitated in 0.1 volume of sodium acetate (3M, 
pH5.2) and 2.5 volume absolute ethanol.  The precipitating RNA was inverted to mix 
and stored at -80
o
C for 30min.  The suspension mix was centrifuged at 12000 x g for 20 
min at 4
oC.  For high concentrations of RNA (>150μg) the suspension was centrifuged 
for 30 sec and half of the solution aliquoted to a fresh Eppendorf tube and centrifugation 
of both continued for 20 min.  The supernatant was removed by gentle aspiration using 
a micropipette; 1ml of 75% (v/v) ethanol was added to the pellet and re-centrifuged at 
12000 x g for 5 min at 4
o
C.  The supernatant was carefully removed using a 
micropipette and the pellet was left to dry in the fume cupboard for 3-5 min.  The 
nucleic acids were re-suspended in RNase and DNase free H2O, for stock which may be 
subject to numerous freeze thaw cycles 1X TE buffer (10mM Tris-HCl, 1mM EDTA; 
pH 8.0) was used as an alternative. 
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2.3.2.   RNA storage, purification using FTA cards 
 
Homogenised tissue and cells suspended in phosphate-buffered saline (PBS; 137mM 
NaCl, 2.7mM KCl, 10mM Na2HPO4, 1.8mM KH2PO4; pH 7.6) were alternatively stored 
on FTA micro cards (Whatman
®
).  The tissue culture cells were applied to the FTA card 
evenly (125µl) with a minimum concentration of 100 cells/µl.  The card was then left to 
dry for 1hr at room temperature after which the FTA card was stored at -20
o
C to extend 
the storage time.  Tissues which did not contain a high content of fibrous or 
extracellular material were homogenised in PBS and also applied to FTA cards and 
stored in the same manner.  The RNA processing buffer required for extraction of the 
RNA from the FTA card was made up as follows: 
 
Tris-HCl (10mM) to final volume of     400µl 
Glycogen (200µg/ml; Sigma)     40µl 
EDTA (0.1mM)      20µl 
RNasin (40U/µl; Promega)     4µl 
DTT (dithiothreitol, 2mM; Promega)    2µl 
 
A sample disc was punched from the FTA card using a 2mm Harris Micro-Punch 
(Whatman
®
) over a cutting mat.  The FTA disc was ejected into a sterile 0.5µl 
Eppendorf tube containing the 400µl of RNA processing buffer and the sample was 
incubated on ice for 15 min and vortex mixed at 5 min intervals.  The RNA was 
precipitated from the wash solution by adding 0.1 volume of NaAc (3M; pH 5.2) and 1 
volume of absolute isopropanol.  The sample was then incubated at -20
o
C for 1 hr 
following which the sample was centrifuged at 12000 x g for 5 min at 4
o
C and the 
supernatant removed.  The pellet and disc were washed by adding 500µl of 75% (v/v) 
ethanol and centrifuged at 12000 x g for 5 min at 4
o
C.  The supernatant was removed 
and pellet air dried in the fume cupboard for 3-5 min.  The RNA pellet was then 
resuspended in 25µl of TE buffer (10mM Tris-HCl, 0.1mM EDTA; pH 8.0), less EDTA 
was used to reduce the interaction of the EDTA with the the FTA disc.  The total RNA 
yield per extraction was approximately 12ng/µl. 
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2.3.3.   Quantification and purity of RNA 
 
RNA solutions were measured at absorbance 260nm and 280nm using a DU
®
 530 
UV/vis spectrophotometer (Beckman Coulter).  Samples were diluted 1:100 with 0.1% 
(v/v) DEPC-treated H2O, total 0.1% (v/v) DEPC-treated H2O was used to calibrate the 
spectrophotometer.  The purity of the RNA sample was determined by the ratio of 
A260nm /A280nm.  The RNA concentration (µg/ml) was calculated as follows:  
 
A260nm x dilution factor x 40µg/ml. 
 
2.4.      First strand synthesis of complementary DNA  
 
Complementary DNA (cDNA) was synthesised from 1μg of total RNA, isolated from 
several rat tissues (section 2.2.1).  A human multiple tissue cDNA panel was purchased 
from BD Clontech, UK (Human MTC Panel I).  All human cDNAs in the panel are free 
of genomic DNA have been fully normalised to four house keeping genes. 
 
2.4.1.   Removal of genomic DNA (gDNA) and phenol /chloroform precipitation 
 
Before cDNA synthesis could commence gDNA had to be broken down and removed. 
The following components (RQ1 components from Promega) were added to a 1.5ml 
eppendorf tube and incubated at 37
o
C for 1 min: 
 
Total RNA (25µg)      20-30µl 
10x RQ1 RNase-free DNase buffer (Promega)  5µl  
RQ1 RNase-free DNase (1U/µg RNA; Promega)  25U 
RNase and DNase free H2O to final volume of   50μl   
   
Following incubation, 5µl of RQ1 DNase stop solution (20mM EDTA (pH 8.0); 
Promega) were added and the sample incubated further at 65
 o
C for 10 min. 
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2.4.2. Phenol chloroform precipitation and wash 
 
The RNA was purified to remove the digested DNA, protein and salt.  An equal volume 
of phenol/chloroform/isoamyl alcohol (PCI; ratio of 25:24:1; pH 4.5) solution was 
added to the tube.  The RNA solution was manually shaken for 30 sec and centrifuged 
at 12000 x g for 5 min at 4
o
C.  The upper aqueous phase was transferred to a fresh 1.5ml 
Eppendorf tube and an equal volume of chloroform/isoamyl alcohol (CI; ratio of 24:1) 
added.  The mixture was shaken for a further 30 sec and centrifuged at 12000 x g for 5 
min at 4
o
C.  The upper aqueous phase was transferred to a fresh Eppendorf tube and an 
ethanol precipitation was performed (section 2.4.1).  The purified RNA pellet was 
resuspended in 50µl of 0.1% (v/v) DEPC-treated H2O and incubated at 65
 o
C for 5 min. 
 
2.4.3.   cDNA synthesis with RNA isolated from tissue and cells 
 
Complementary DNA was synthesised by adding the following components to a sterile 
0.5ml Eppendorf tube: 
 
Total RNA             1μg 
Oligo(dT)15 primers (0.5µg/µl; Promega)   1μl 
RNase and DNase free H2O to final volume of      
  
The RNA suspension was incubated at 70C for 5 min to allow for primer annealing, 
after which the mix was cooled on ice and the remaining components were added to the 
RNA mix: 
 
5x M-MLV buffer (Promega)     5μl 
deoxyNTP mixture (10mM; Promega)   1μl 
RNasin (40U/µl; Promega)     0.5μl 
RNase and DNase free H2O to final volume of   25μl   
   
The sample was incubated at 37C for 5 min, cooled on ice and 1µl of M-MLV reverse 
transcriptase (200U/µl; Promega) was added.  The reaction mixture was further 
incubated at 37C for 70 min and cooled on ice.  The sample was then vortex mixed 
briefly and heated at 90C for 10 min to stop the reverse transcriptase activity.  The 
10μl 
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cDNA was stored at -20C or used directly for RT-PCR.  The cDNA panel of rat tissue 
was normalised for subsequent RT-PCR experiments.  All cDNA synthesis reactions 
were performed with 1µg of total RNA which was quantified spectrophotometrically 
(section 2.4.4).  Following quantification RT-PCR was performed using primers 
specific to a fragment of the house-keeping gene GAPDH, to visualise the purity and 
concentration of each cDNA template (figure 2.1).  
 
 
   
 
Figure 2.1. Expression analysis of GAPDH amplified from a rat cDNA tissue panel  
Rat cDNA synthesised from 100ng/μl total RNA were used as template to amplify a 738bp 
fragment of GAPDH.  The PCR reaction was run for 35 cycles (95°C-1 min; 59°C-30 sec; 72°C-
1 min) and the products visualised on a 1.5% agarose gel with 1X SYBRsafe.  Tissues are 
abbreviated as follows: Br, brain; Ht, heart; Kd, kidney; Li, liver; Lu, lung; Pc, pancreas; Sp, 
spleen and Ts, testis.  RNase and DNase free H2O has been used a replacement for cDNA in the 
negative control. 
 
2.4.4.    Quantification of DNA 
 
Both dsDNA and ssDNA were quantified using the Quant-iT™ assay kit (Quant-iT™ 
dsDNA BR and ssDNA Assay Kit; Invitrogen).  200µl of Quant-iT™ working solution 
was prepared for each sample by diluting the Quant-iT™ reagent 1:200 volume in 
Quant-iT™ DNA buffer. 1-10µl of DNA sample (depending on the concentration) was 
made upto 200µl with the working solution and vortex mixed for 3 sec.  The sample 
was left to incubate at room temperature for 2 min.  The machine was first calibrated by 
using the standards provided with the kit, following which a reading can be taken.  The 
Qubit™ fluorometer provides a reading in μg/ml, which represents the concentration 
after the sample was diluted in the working solution.  To calculate the concentration of 
the sample the following equation was used:  QF value x (200/×).  Where the QF value 
is that given by the Qubit™ flurometer and × is the volume of DNA sample added to 
the working solution. 
         Br            Ht           Kd           Li            Lu           Pc           Sp           Ts        -ve       
       
 1.5 kb 
1 kb 
700 bp 
500 bp 
2 kb 
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2.5. Polymerase Chain Reaction (PCR) 
 
2.5.1. Primer design and PCR Reaction mix 
 
Primers were designed which would target several MIR-containing genes (table 2.3).  
The primers were generated so the forward oligonucleotide corresponds to the sense 
strand of the target sequence and the reverse primer to the reverse complement.  All 
reverse primers either cross exon splice sites of the mRNA or are in downstream exons 
to the sense primer to eliminate gDNA amplification.  The criteria for primer design 
were ~50% GC content, with a melting temperature between 57-64
o
C with a minimum 
sequence length of 19bp.   
 
PCR reaction mixes were prepared in a 0.2ml thin walled PCR tube (Dutscher 
Scientific) and the following constituents were added: 
 
5x GoTaq Flexi buffer (Promega)     10μl 
MgCl2 (25mM; Promega)      5μl 
deoxyNTP mixture (10mM; Promega)   1μl 
Forward primer x (20mM; Sigma)    0.5μl 
Reverse primer y (20mM; Sigma)    0.5μl 
GoTaq DNA polymerase (5U/μl)    0.5μl 
cDNA template (20ng)     5μl 
RNase and DNase free H2O to final volume of   50μl   
 
Negative and positive controls were also prepared.  The cDNA template was substituted 
with RNase and DNase free H2O in the negative control and for the positive control the 
primers were replaced with those of housekeeping genes (table 2.4).  Following 
preparation of the PCR master mix and adding of the DNA polymerase the samples 
were placed in a PCR thermal cycler (Labnet MultiGene II).  All samples were 
denatured once for 2 min following which three steps (denaturation, annealing and 
extension) were repeated 40 times.  Denaturing steps were at 96
o
C, annealing was for 30 
sec at varying temperatures and the extension stage was performed at 72
o
C for 1 min/kb 
of amplicon.  The annealing temperatures for each primer combination have been 
included in table 2.3.   Following the repetition of the 3 steps the samples were further 
heated to 72
o
C for 5 min to ensure full extension of the PCR products. 
  
Sp. Primer 
name 
Primer sequence (5’-3’) Transcript details 
% GC  
content 
Melting  
temp (oC) 
Annealing 
temp (oC) 
Product 
(bp) 
Hs AHI1 F1 TTGGAACCCAGAAACAGGAG 
Paired with both Abelson helper 
integration site 1 (AHI1) reverse primers 
50 64 60 - 
Hs AHI1 R1 GCTGCCATACCACCAGTCTT Full length transcript of AHI1 55 64 60 594 
Hs AHI1 RT CAGGTCGGCTCAGTTCTTCT Read-through transcript of AHI1 50 64 60 670 
Hs CIITA F1 AGCTGTGTCACCCGTTTCAG 
Paired with the class II, major 
histocompatibility complex, transactivator 
(CIITA) reverse primers 
55 67 60 - 
Hs CIITA Sh TTTGAGCCCAGGTCAGTCTC Read-through transcript of CIITA 55 65 60 303 
Hs CIITA Lg TTTCCCAGGTCTTCCACATC Full length transcript of the CIITA 50 64 60 161 
Hs NRL F1 ACCCACCTTCAGTGAACCG 
Paired with  Neural retina leucine zipper 
(NRL) reverse primers 
55 64 62 - 
Hs NRL Sh TTTTTTGCTAATTACAGCTTTAA Alternative truncated 3-UTR 22 57 62 966 
Hs NRL Lg AGGACCCAGGTTTCCAGACT Reference sequence full length NRL 55 64 62 1198 
Hs GSG1L F1 AATGTCGCAGCTTCATTGAC 
Paired with the GSG1-like (GSG1L) reverse 
primers 
45 63 59 - 
Hs GSG1L RX CCTCTCTGTGCCTCGATTTG Specific to the MIR-derived exon of  GSG1L 55 65 59 489 
Hs GSG1L R1 CCCTCTTCTCCATCCTCTCC Reference sequence full length GSG1L 60 64 59 499 
 
Table 2.3.   Primer sequences and thermal cycling conditions for human and rat RT-PCR experiments. 
All primers used in this study have been listed, including the melting temperature calculated from the primer sequence and the annealing temperature used 
during thermal cycling.   Where the primers are species specific the species is indicated as follows: Hs, homo sapiens; Rn, rattus norvegicus. 
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Sp. 
Primer name Primer sequence (5’-3’) Transcript details 
% GC 
content 
Melting 
temp (oC) 
Annealing 
temp (oC) 
Product 
(bp) 
Rn 5TG ACTTTGACGTGTTTGCCCAC Paired with 3TG-S and 3TG-L 50 57 59 - 
Rn 3TG-S GCTGAGTCTGGGTGAAGACACAG 
Tissue transglutaminase splice variant  
TGM2_dLg  (Tolentino et al., 2002) 
56 63 59 414 
Rn 3TG-L CAATATCAGTCGGGAACAGGTC 
Tissue transglutaminase splice variant 
TGM2_wLg  (Tolentino et al., 2002) 
50 59 59 513 
Rn TG2 F Vs  GGAACTTTGGGCAGTTTGAG Paired with TG2 Rn R Vs 50 57 59 - 
Rn TG2 R Vs TTCAGGGTATGGAACTCATGG Tissue transglutaminase splice variant TGM2_Vs 48 58 59 488 
Rn TG2 F Sh CAGGAGAAGAGCGAAGGAAC Paired with TG2 Rn R Sh 55 59 59 - 
Rn TG2 R Sh CAGGCAGAGCCTTACCAGAG Tissue transglutaminase splice variant TGM2_Vs 60 61 59 544 
Hs TG2_1 CCTAGACATCTGCCTGATCC Paired with TG2_Vs (Hs) and within exon 5 55 62 59 - 
Hs TG2_Vs TCATGACCCACATCCCAGC 
Tissue transglutaminase splice variant TGM2_Vs 
(Hs) 
58 60 59 
323 
Hs TG2_2 CTGAGCACCAAGTACGATGC Paired with TG2_Sh (Hs) and within exon 9 55 62 59 - 
Hs TG2_Sh AACACAGGGCTTTACCAGAG Tissue transglutaminase splice variant TGM2_Sh  50 60 59 481 
Hs TG2 Hs F Tc  CACATTCCTTCCCCTCTCTG 
5’-truncated TGM2 splice variant, paired with 
TGM2_R Tc 
55 64 59 - 
Hs TG2 Hs R Tc CACAGAGCATTCCTCACAGC Tissue transglutaminase splice variant TGM2_Tc 55 62 59 482 
 
Table 2.3.   Primer sequences and thermal cycling conditions for human and rat RT-PCR experiments continued. 
Primers used to amplify TGM2_wLg and TGM2_dLg were designed by Tolentine et al., (2002).  
3
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Species Gene Primers (5’-3’) Product (bp) 
Homo sapiens G3PDH 
TGAAGGTCGGAGTCAACGGATTTGGT 
CATGTGGGCCATGAGGTCCACCAC 
983 
Rattus norvegicus Gapdh 
GGCTGCCTTCTCTTGTGAC 
GGCCGCCTGCTTCACCAC 
738 
 
Table 2.4.  Primer sequences for the house keeping gene used as a positive control. 
The house keeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH) has been used 
as a positive control for RT-PCR analyses.  
 
2.5.2. Gel electrophoresis  
 
All PCR amplification products were mixed with a 6x loading dye (0.25% (w/v) 
bromophenol blue, 40% (w/v) sucrose, 4ml (v/v) TE buffer, 10.8ml 0.1% (v/v) DEPC-
treated H2O).  Samples were separated in a 2% agarose gel, prepared with agarose 
powder (Bioline) dissolved in 100ml of 1x TAE buffer (40mM Tris-base, 20mM glacial 
acetic acid, 5mM EDTA; pH 8.0), at 100V for 1hr.  Once the agarose solution reached 
55-60
o
C 10μl of the DNA gel stain SYBR Safe (Invitrogen) was added.  A molecular 
marker was included to monitor the migration distance (HyperLadder™ IV, Bioline; 
1kb ladder, Promega) and was visualised using a transilluminator emitting UV light 
(Syngene). 
 
2.5.3. Sample purification and sequencing 
 
The PCR products were purified directly when a single amplicon is present, the gel 
band was excised if there were large primer dimers, smearing or if a sample was to be 
used in cloning techniques.  All DNA fragments were purified using the Wizard® SV 
Gel and PCR Clean-Up System (Promega) following the manufacturer‟s instructions.  
The kit functions by binding the DNA to silica membranes of a spin column and 
impurities removed by a series of washes before eluting the DNA.  Purified DNA 
fragments were then confirmed as the sequence of interest:  10ng of purified product 
was mixed with 3.2pmol of reverse primer and made up to 10µl using RNase and 
DNase free water.  Reaction mixes were sent to the Functional Genomics and 
Proteomics unit at the University of Birmingham for sequencing using a 3730 DNA 
analyser.  
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2.6. Molecular cloning using the pGEM
®
-T Easy vector 
 
PCR products with low yields and poor sequence data were cloned using the pGEM-T 
Easy cloning vector (Promega).  The vector contains two RNA polymerase promoters, 
SP6 and T7 flanking a multiple cloning region within the coding region of β-
galactosidase (lacZ).  Cloning within this region allows for colour screening of 
recombinant DNA. 
 
 
 
Figure 2.2. Map of the pGEM-T Easy cloning vector with sequence reference points 
The pGEM®-T Vector is derived from the pGEM®-5Zf (+) Vector (GenBank accession number 
X65308). The vector contains two RNA polymerase promoters, SP6 and T7 flanking the coding 
region of β-galactosidase (lacZ).  The Ampr gene allows for the identification of ampicillin 
resistant E.coli colonies. The positions of the Ampicillin resistance region (restriction sites (1-
141bp) and the phage f1 region (f1 ori) have been indicated. 
 
2.6.1. Preparation of E. coli XL1-blue cells 
 
A colony of E. coli XL1-blue cells (genotype: recA1, endA1, gyrA96, thi-1, hsdR17 
(rk-, mk+), supE44, relA1, lac [F‟ proAB, lacIqZΔM15::Tn10(tetr)]) were selected from 
an LB agar plate (1% (w/v) tryptone, 0.5% (w/v) yeast extract, 1% (w/v) NaCl, 1.5% 
(w/v) agar (Becton Dickinson Company)) containing tetracycline (5g/ml) and placed 
in 5ml of LB medium (1% (w/v) tryptone, 0.5% (w/v) yeast extract, 1% (w/v) NaCl) 
containing 0.1% tetracycline (5g/ml).  The cell suspension was incubated at 37oC in an 
orbital shaker (Gallenkamp) at 200rpm overnight.   
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4ml of the overnight culture was added to 100ml of LB medium tetracycline (5g/ml).  
A 1.5ml aliquot of the inoculated medium was added to a 1ml plastic cuvette (Sarstedt) 
to calibrate the spectrophotometer. The remainder was incubated at 37
o
C on a shaking 
platform (200 rpm; Luckham R100) for 3hr. The absorbance was then measured at 
A660nm every 30 min thereafter until an optical density of 0.5 was obtained 
(approximately 4.5hr). The inoculated LB medium was split into two 50ml tubes 
(Sarstedt) and centrifuged at 3000 x g at 4
o
C for 15 min. The supernatant was discarded 
and each 50ml tube of pelleted cells were resuspended in 20ml of filter sterilised 
(0.22nm) ice-cold TFBI solution (30mM KAc, 50mM MgCl2, 100mM KCl, 10mM 
CaCl2, 15% (v/v) glycerol; pH 5.8) and briefly vortex mixed and incubated on ice for 30 
min. The cells were then centrifuged at 3000 x g at 4
o
C for 20 min. The supernatant was 
discarded and the cells were resuspended in 2ml of filter sterilised ice-cold TFBII 
solution (10mM Na-MOPS, 75mM CaCl2, 10mM KCl, 15% (v/v) glycerol; pH 6.5) per 
tube and the cells were gently resuspended. 100μl aliquots of the competent cells were 
prepared and stored at 
–
80
o
C until required. 
 
2.6.2.   Ligation and transformation using the pGEM T-Easy vector 
 
The purified DNA fragments (insert) were ligated into the pGEM-T® Easy cloning 
vector.  The volume of insert (ng) required for each reaction was calculated with a 
insert/vector molar ratio of 3:1. 
 
vector (ng) x insert (kb) x insert:vector molar ratio 
                                         vector (kb) 
 
 
The following reagents were added to 0.5ml Eppendorf tubes. 
 
2x rapid ligation buffer (Promega)       5l  
pGEM T-Easy vector (50ng/l; Promega)     1l 
Purified insert (50ng/l)       3l 
T4 DNA ligase (1U/μl; Roche)       1l 
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The sample was incubated at room temperature for 1hr.  The ligation product of the 
insert and vector were then transformed into E. coli XL1-blue cells.  The ligation 
mixture was added to a 2ml Eppendorf tube with 100µl of competent XL1-blue cells.  
The recombinant plasmid cell suspension was then transformed into incubated E.coli 
XL1-blue cells via „heat shock‟ by placing on ice for 45 min then at 42oC for 1 min.  
The cells were then incubated on ice for 2 min and 150l of SOC medium (1% (w/v) 
tryptone, 0.5% (w/v) yeast extract, 10mM NaCl, 2.5mM KCl, 10mM MgCl2, 20mM 
MgSO4, 20mM glucose; pH 7.0), was added and incubated at 37
o
C in an orbital shaker 
at 200rpm for 1 hr.  
 
The presence of the -galactosidase encoding gene (lacZ) in the cloning vector allows 
for the positive identification of colonies containing the insert, therefore 100l of the 
lacZ inducer IPTG (isopropyl--D-thiogalactopyranoside; 200mg/ml; Bioline) and 60µl 
of the artificial substrate X-GAL (5-bromo-4-chloro-3-indolyl--D-galactoside; 
20mg/ml; Bioline) were spread onto LB agar plates (containing 0.1% (v/v) ampicillin 
100) using glass beads.  20μl of the transformed cells were then spread in the same 
manner onto the agar plate and incubated in a moist chamber at 37
o
C overnight. Single 
white colonies were picked and subcultured in liquid LB medium overnight (see 2.6.1). 
 
2.6.3.   Isolation of plasmid DNA  
 
Plasmid DNA Mini-preparations were prepared, according to the manufacturer‟s 
instructions of (Wizard ® plus SV minipreps DNA purification system; Promega).  The 
kit comprised a series of solutions to lyse bacterial membranes, neutralise the reaction 
mixture and remove impurities including by using spin columns.  The columns bind the 
plasmid DNA to a matrix until it was eluted and resuspended in RNase and DNase free 
water. A final ethanol precipitation was conducted to concentrate the purified plasmid 
DNA (section 2.3.1).  Following plasmid isolation the purified plasmid was loaded onto 
a 2% agarose gel to confirm the presence of the insert; following confirmation, the 
purified plasmid DNA was used as a template for PCR, using the original primers and 
cycling conditions of the insert.  The PCR product was then purified (section 2.5.3) and 
sent for sequencing. 
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2.7. Radioactive in situ hybridisation  
 
Radioactive in situ hybridisation was used to localise the transcript variants of tissue 
transglutaminase in the adult rat (Wistar) brain. 
 
2.7.1. Probe selection and design  
 
The read-through transcripts for rat tissue transglutaminase (TGM2) were predicted by 
generating composite transcripts from the gDNA sequence (Accession NC_005102.2, 
base 148832866 to 148862385). A 45bp antisense oligonucleotide was designed 
specific to each isoform with a GC content of 50-60%; necessary to ensure sufficient 
probe binding with the minimal background interference.  
 
A 45mer oligonucleotide was designed to recognise the shortest transcript variant 
(TGM2_Vs) which is generated following the skipping the donor splice site of exon 6, 
and reading through into the consecutive intron which contains an in-frame stop codon. 
5‟-CACAAGTTGGTGGTGAACTTCCAGTGTGACAAGCTGAAGTCGGTC-3‟ 
 
A sequence was selected which is specific to rar TGM2_Sh mRNA, an isoform also 
created by reading-through the donor splice site of common exon 10, and similarly a 
stop codon is recruited. 
5‟-GGATGAGACCATTCCGAGACGGACACGCACGGACCTTGTAGGTCC-3‟ 
 
The isoform which has been called TGM2_dLg is a splice variant generated via an 
alternative donor and acceptor spice site in constitutive exons 12 and 13.  As a 
consequence 210bp of mRNA is excluded from the full length transcript.  The atypical 
splicing generates an alternative reading frame and subsequently an alternative stop 
codon.  The isoform specific oligonucleotide sequence for this transcript is as follows: 
5‟-GACCGACTTCAGCTTGTCACACTGGAAGTTCACCACCAACTTGTG-3‟ 
 
An oligonucleotide was designed which was specific to the full length reference 
sequence (RefSeq) for tissue transglutaminase (TGM2_wLg). 
5‟-CTGGCAGGTGATGGGCTGAGTCTGGGTGAAGACACAGTCATACAG-3‟ 
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 2.7.2. Silanisation of slides and cryostat sectioning 
 
Microscope slides (VWR) were silanised to aid the fixing of brain sections.  Pre-cleaned 
slides were baked in an oven (Sakura) at 180
o
C for 2 hr following which they were 
transferred to glass racks and subject to a selection of baths: acetone for 1-2 min; 
acetone and silane (3-aminopropyltriethoxysilane) mix of 49:1 for 5 min; acetone for 1 
min twice and in 0.1% (v/v) DEPC-treated water for 1 min three times. The slides were 
air dried for 1 hr and baked at 180
o
C for a further 2 hr.   
 
Frozen brains were mounted, over dry ice, onto a mounting plate using Tissue Tek 
(Sakura) and left to equilibrate in the cryostat for 1 hr.  10µm coronal brain sections 
were cut using a cryostat (CM1900, Leica) at –16oC and mounted onto the slides.  
Samples were stored at –80oC until required to preserve the RNA.   
 
2.7.3  Tissue fixation    
 
The tissue sections were fixed to the microscope slides via a sequence of baths. The 
slides were bathed in chilled 2% (w/v) paraformaldehyde (5g PFA in 200ml 0.1% (v/v) 
DEPC-treated water and 50ml 5X PBS; pH 7.4) for 10 min. The sections were then 
bathed twice in 1x PBS.  Following which the tissue sections were dehydrated by 
bathing once in 70% (v/v) ethanol, once in absolute ethanol and air dried for 30 min. 
 
 
2.7.4. Labeling and purification of radiolabeled probe 
 
The oligonucleotide probes were labeled with the radioisotope sulphur-35 [-35S] by 
adding the following constituents to a sterile 0.5ml Eppendorf tube: 
 
RNAse and DNAse-free water       16.25µl 
5x terminal deoxynucleotidyl transferase (TdT) reaction buffer         5µl 
Antisense oligonucleotide (5ng/µl)             1µl 
[-35S] dATP (12.5mCi/ml; PerkinElmer Life Sciences Inc.)    1.25µl 
rTdT (20U/ml; Promega)           1.5µl 
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The un-purified probe was incubated at 37
o
C for 75 min in a designated water bath.  
Residual [-35S] dATP was removed using Sephadex columns (Amersham Pharmacia).  
The column was centrifuged at 735 x g for 4 min to remove the matrix which was 
discarded.  1μl of the incubated labelling reaction was added to 5ml of scintillation fluid 
(Ultima Gold; Packard Bioscience) to determine the activity of the [-35S] dATP 
labelled to the oligonucleotide. The remaining labeling reaction was placed in the 
Sephadex column, and centrifuged at 735 x g for 4 min.  The columns contain tiny 
beads which bind to any unattached nucleotides and only labelled probe is eluted.  1μl 
of elute was added to 5ml of scintillation fluid to compare the activity to that prior to 
purification.  The radioactivity of the samples was measured using a Liquid Scintillation 
Analyser (Tri-Carb 2250CA; Packard).  
 
2.7.5.     Hybridisation  
 
Each slide required 200µl of hybridisation buffer which was prepared by adding the 
following to a 50ml sterile tube: 4x standard saline citrate (SSC; 0.3M tri-sodium 
citrate, 3M NaCl (pH 7)), 5x Denhardt‟s solution (1% (w/v) polyvinylpyrrolidone, 1% 
(w/v) bovine serum albumin (BSA; fraction V), 1% (w/v) ficoll), 25mM sodium 
phosphate (0.5M Na2HPO4 (pH 9) and 0.5M NaH2PO4 (pH 4); pH 7), 1mM sodium 
pyrophosphate (0.6M Na4P2O7; pH 10.4) and 10% (w/v) dextran sulphate.  The buffer 
was vortex mixed for 10 min and the remainder added:  10mM DTT, 120μg/ml heparin 
(Grade I-A; from porcine intestinal mucosa), 100μg/ml polyadenylic acid, 200μg/ml 
denatured DNA from salmon testes, 50% (v/v) formamide.  The mixture was adjusted to 
50ml using 0.1% (v/v) DEPC-treated water.  For each slide 100,000cpm of the purified 
labelled probe was mixed in 200l of hybridisation buffer.  The hybridisation buffer 
was evenly distributed across the sections and parafilm (Pechiney Plastic Packaging) 
was positioned over the sections, which were then placed in a home-made humidified 
case.  The cases were incubated in a hybridisation oven (Bibby Stewart Scientific) at 
42
o
C overnight.  Negative control hybridisations were prepared by adding a 200-fold 
excess of the same unlabelled oligonucleotide to the 100,000cpm radiolabeled probe.   
The 200x excess is sufficient to compete with the labelled probe if specific 
hybridisation occurs.  Unspecific binding of the oligonucleotide has occurred if a signal 
is present in the negative control  
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2.7.6.   Washing 
 
Sections were washed to remove the hybridisation buffer and excess radiolabeled 
oligonucleotide.  The parafilm was removed from the sections by bathing the slides in 
1x SSC for 30 sec at room temperature.  Following which the slides were then washed 
twice in 1x SSC for 30 min at 55
o
C using a water bath shaker (Clifton) at 200rpm. The 
slides were then transferred to 1x SSC at room temperature for 30 sec and bathed in 
0.1x SSC for 30sec.  The brain sections were dehydrated by bathing once in 70% (v/v) 
ethanol, once in absolute ethanol and air dried for 30 min 
 
2.7.7.   Film exposure and visualisation 
 
The radiolabeled slides were exposed to X-ray film (Kodak Biomax MR, PerkinElmer 
Life Sciences Inc) for 4-6wks and developed using an automatic developing machine 
(Compact X4, Xograph).  The film was visualised by being placed on a light box (UVP 
Inc) and images were captured using a CCD camera system and associated software 
(Euresys Multicam).  Rat brain regions were mapped using the interactive databases 
BrainMaps (http://brainmaps.org/index.php) and the Allen Brain Atlas 
(http://www.brain-map.org/). 
 
2.8. Cell culture 
 
2.8.1.   Culturing and maintenance of BRIN-BD11 cells 
 
BRIN-BD11 cells were kindly donated by Dr Verderio-Edwards, Nottingham Trent 
University.  BRIN-BD11 cells are a clonal insulin-secreting rat cell line, which were 
cultured for the study of tissue transglutaminase expression by reverse transcriptase-
PCR (RT-PCR).   Cell culture was performed using aseptic techniques within a class II 
medical safety cabinet (Walker).  The cells are routinely stored in the gaseous phase of 
liquid nitrogen, suspended in freezing medium containing 95% (v/v) foetal bovine 
serum (FBS; Cambrex) and 5% (v/v) sterile DMSO (Sigma Aldrich).  A vial of BRIN-
BD11 cells (Passage 28; 4 x 10
6
) were recovered from storage in liquid nitrogen and 
rapidly thawed in a 37°C water bath.  The cell suspension was transferred to a sterile 
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75cm
2
 (T-75) tissue culture flask (Sarstedt) containing 15ml of fresh RPMI-1640 
growth medium, supplemented with 10% (v/v) heat-inactivated foetal bovine serum 
(FBS; Cambrex), 2mM L-glutamine (Cambrex), penicillin (100U/ml) and streptomycin 
(100µg/ml; Cambrex).  
 
Cells were grown in an incubator (Sanyo) at 37
o
C with a humidified atmosphere of 95% 
(v/v) air/5% (v/v) carbon dioxide and cells were assessed for viability via an inverted 
light microscope (Nikon).  The cells were incubated for 24h to allow for attachement, 
following which the cell monolayer was rinsed with 5ml of complete growth medium to 
remove residual freezing medium.  The cells were further incubated in 15ml of 
complete growth medium to obtain ~80% confluency. 
 
2.8.2.   Sub-culture and detachment 
 
When a sufficient number of cells were present (~80% confluent) the culture medium 
was removed from the flask and the cell monolayer rinsed with serum-free medium to 
remove traces of serum.  The cell monolayer was detached using trypsin-EDTA (trypsin 
0.5mg/ml; EDTA 5mM; 1ml/25cm
2
).  After 5 min, or when sufficient detachment had 
occurred, the trypsin was deactivated by adding complete serum equal to 2x the volume 
of trypsin.  The cell suspension was transferred to 15ml tubes and centrifuged at 300 x g 
for 4 min (Harriot 18 (MSE)).  The supernatant was carefully discarded and the pellet 
resuspended in 4ml of complete medium.  The cells were added to a T-175 culture flask 
with 26ml of complete medium and incubated at 37
o
C with a humidified atmosphere of 
5% carbon dioxide until ~80% confluent, following which the cells were counted and 
RNA extracted (section 2.2.2).   
 
2.8.3.   Cell counting and viability 
 
The cells were counted using a Neubauer glass haemocytometer.  A 10µl sample was 
transferred to the 0.1mm deep well of the haemocytometer and visualised using an 
inverted microscope. The cells were counted in four fields of 1mm
2 
at 100x 
magnification.  The cell density/ml was calculated as follows: 
Mean cell number x 10
4
 x dilution factor 
The cells were then suspended in PBS and used for RNA extraction (section 2.2.1). 
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3. THE NUMBER, DISTRIBUTION AND CONSERVATON OF MIR  
 ELEMENTS WITHIN THE HUMAN GENOME 
 
3.1. Introduction 
 
The number of positively identified MIRs in the human genome is regularly increasing, 
with the latest estimate in excess of 548,000 copies (Sela et al., 2007).  Fewer MIRs 
have been identified in the mouse genome, (~116,000 copies; Sela et al., 2007).  
However the number of genes which have recruited MIR elements still remains unclear.  
Chaley and Korotkov (2001) reported MIR elements present in the CDS of 254 
transcripts corresponding to 50 known human genes, and suggested that the remaining 
MIR elements are likely to be situated within introns and intergenic DNA. A recent 
investigation, describes a total of 181 MIRs located within both the UTR and CDS of 
human genes of which 78 have been recruited in the CDS (Sela et al., 2007).  
 
The distribution of MIR elements in the human genome has not been documented, 
however SINEs, including Alus and MIRs, are known to reside predominantly in GC-
rich regions (Medstrand et al., 2002).  Younger SINEs, such as the AluY family (<5 
myr old) are most frequently located in AT-rich regions (Medstrand et al., 2002), 
whereas LINE elements are integrated and maintained in AT-rich regions of the 
genome, regardless of age (Jurka et al., 2004).  The global distribution of MIR elements 
is unknown, whereas other retrotransposons such as the Alus are suggested to be 
distributed non-randomly throughout the genome (Grover et al., 2004). 
 
To determine the role of MIR elements in mammalian gene function and evolution, it 
was necessary to first generate a dataset of genes which have exaptated at least one MIR 
element.  Furthermore the distribution and conservation of exaptated MIR elements 
within the human genome has not previously been investigated; therefore the global 
distribution and degree of conservation of MIRs has been determined. 
 
Chapter 3.  The number, distribution and conservation of MIR elements within the human genome 
 
  
49 
 
  
3.2. Identification of MIR-containing human genes within the human genome 
 
Genes which have recruited MIRs were detected and analysed as follows:  
 
 Identification 
Human MIR-containing genes were identified through three processes: 
1. BLAST searches against non-redundant nucleotide sequence databases using the 
MIR core-SINE consensus sequence.  
2. Genes which are known to have recruited a SINE element were obtained from the 
Genomic ScrapYard database and screened using RepeatMasker for MIR elements. 
3. Genes reported in journal articles to have recruited MIR elements were noted.  
 
 Verification 
The presence of an MIR element was confirmed with the RepeatMasker tool following 
which: 
 The position of the repeat in the mRNA sequence was recorded. 
 The coordinates of the MIR consensus retained, repeat orientation and MIR sub-
family were noted. 
 
 Annotation 
Following the verification of the recruitment of an MIR element in a sequence the 
corresponding gene was determined: 
 The gene symbol and description was noted and alternative transcript variants 
screened for MIR elements using RepeatMasker. 
 The gene region which the MIR element has been recruited was noted by 
determining the exonic composition; regions recorded as the 5‟- or 3‟-untranslated 
region or the CDS. 
 The position of the MIRs and the gene regions which they are located was 
determined using Spidey which aligns mRNA to genomic DNA providing the 
exonic organisation. 
 Genes without a confirmed open reading frame or protein sequence listed in the 
database were considered as ncRNA. 
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The total number of human genes identified in this study which have exaptated MIR 
repeats is 1575, 1359 of which are annotated and validated genes (appendix 9.1).  The 
remaining 216 transcripts are currently annotated in GenBank as either hypothetical 
proteins, or genes of unknown function (appendix 9.2).  Only the named genes were 
included in subsequent analyses.  The MIR elements identified were catagorised 
according to the MIR sub-family. RepeatMasker annotates the MIR sub-type by 
comparing the element to the concensus sequences listed in Repbase (table 2.1).  The 
orientation and location of the MIR within a nucleotide sequence was determined with 
the alignment programme Spidey and subsequent sequence analysis (table 3.1).  Several 
human genes contain more than one MIR element, therefore a total of 1854 MIRs have 
been listed.  It appears that there is no preference to recruit an MIR element in the direct 
or inverse orientation in the mRNA sense strand.  The majority of the repeat elements 
are located within the 3‟-UTR (75%), with 14% in the 5‟-UTR and 9% in the CDS of 
the gene.  There are also 35 MIR elements located within transcripts which are recently 
annotated and have no corresponding peptide sequence, so have been listed as ncRNA 
(see table 3.1).  MIR elements are least frequent in the CDS, however they do provide 
initiating methionines and stop codons for 86 genes, resulting in transcript variants, 
frameshifts, truncated proteins and nonsense mediated degradation.  
 
 
Table 3.1.  Distribution of MIR sub-families in human genes  
MIRs have been organised according to the MIR sub-type, the orientation (+, sense; -, 
antisense) and the gene region to which it has been recruited.  5’-untranslated regions (5’-
UTR), 3’-untranslated regions (3’-UTR) and protein coding sequence (CDS).  The CDS is further 
divided accordingly; ATG represents MIRs which provide an initiating methionine and TAG 
represents MIRs which provide a stop codon.   
 5' UTR 3' UTR ATG TAG CDS ncRNA TOTAL 
 [+] [-] [+] [-] [+] [-] [+] [-] [+] [-] [+] [-] [+] [-] 
MIR 48 68 217 156 2 4 12 13 5 24 9 9 293 274 
MIRb 33 50 289 267 1 5 12 10 12 14 3 7 350 353 
MIR3 18 24 170 145 3 4 6 6 5 8 0 3 202 190 
MIRm 5 4 34 25 0 0 1 1 1 1 1 1 42 32 
THER1_MD 4 4 19 16 0 0 0 0 0 0 0 1 23 21 
MIR_mars 0 2 17 19 1 0 1 0 2 0 0 0 21 21 
MIRc 0 2 8 13 1 0 2 1 1 3 0 1 12 20 
TOTAL 108 154 754 641 8 13 34 31 26 50 13 22 943 911 
TOTAL 262 1395 21 65 76 35 1854 
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Figure 3.1.  Distribution of MIR elements within the human genome   
Each MIR sub-family are grouped according to the gene region they reside which includes both 
the 3’- and 5’-UTRs and protein CDS.  The MIRs are also organised as either in the sense 
orientation (+) or antisense (-) orientation. 
 
 
The MIR elements identified were catagorised according to the sub-families listed in RepBase 
(table 2.1).  The predominant MIR elements identified in the human gene dataset are the 
MIRb and MIR sub-families, with no apparent preference for the repeat sequence to be 
recruited in either the direct or inverse orientation.  Several MIR sub-families exist due 
to sequence changes of the consensus during evolution, with each sub-family having a 
different evolutionary age.  It is thought that few repeats remain active at any one time, 
with several master elements being the source of amplification (Deininger et al., 1992).  
MIR elements were actively transposing for >350 myr, therefore if only a single sub-
family is active at any one time, sequence drift and divergence over time may occur, 
generating the numerous sub-families observed today.  As such the most abundant 
elements identified, the MIRb and MIR sub-families, are the youngest of the repeats 
with the MIRm and MIR_mars elements representing the more ancient of the MIRs. 
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3.3. Conservation of human MIR elements 
 
MIRs comprise a family of at least seven repeat elements, which vary slightly in their 
consensus sequence and there is a high degree of sequence conservation between the 
core-SINE region (65bp) of all MIR-family members (figure 3.2).  Core-SINE 
sequences for a number of species were obtained following performing BLAST 
searches against genomic DNA databases.  After which it can be determined that 
conservation is maintained equally in intergenic DNA and mRNA sequences, with 94% 
sequence homology between the core-SINE of human and montremata intergenic DNA 
and 91% between human and montremata mRNA (figure 3.3).  
 
In order to determine whether there is selection for any part of the MIR sequence, the 
nucleotide positions of the exaptated MIRs were determined for each transcript.  The 
percentage of MIRs which correspond to each nucleotide of the consensus sequence was 
calculated (figure 3.4), demonstrating that the core-SINE is the most highly conserved 
region, coinciding with previous observations made by Chaley and Korotkov (2001).  
There is a steady decline in both the tRNA and LINE regions, yet you would anticipate 
a uniform decline of the consensus sequence if there was a steady rate of divergence, 
unless there was a positive selective pressure maintaining this core sequence.  Once 
again there appears to be no preference to maintain the MIR repeat in a particular 
orientation; a similar pattern of conservation was also detected when plotting the 
conservation of the MIRs recruited in the CDS or UTRs independently (appendix 9.3). 
 
Some MIR elements may be spliced and as a consequence only the exonised portion of 
the MIR element will be included in the mature mRNA sequence, with the remaining 
fragment being intronic.  However only a small number (<1%) of the MIR-containing 
genes have recruited MIR elements in the coding sequence and, as such, these will not 
be reflected in this analysis (figure 3.4).  MIR-mediated exonisation is discussed further 
in chapter 5.   
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               Box A                                   
MIR_Mars TGAGGCAGCTAGGTGGCGCAGTGGATA-GAGCGCTGGACCTGGAGTCAGGAAGACCTG 
THER1_MD -AGGTCAGCTAGGTGGCACAGTGGATA-GAGTACTGGGCCTGGAGTCAGGAAGACCTG 
MIRc  CGAGGCAGT---GTGGTGCAGTGGAAA-GAGCACTGGACTTGGAGTCAGGAAGACCTG 
MIR  ----ACAGY---AYAGCATAGTGGTTAAGAGCACGGRCTCTGGAGCCAGACTG-CCTG 
MIRb  CAGAGGGGCAGCGTGGTGCAGTGGAAA-GAGCACGGGCTTTGGAGTCAGGCAGACCTG 
MIRm  -AGAGAAGCAGCGTGGCCTAGTGGATA-GAGCACGGGCCTGGGAGTCAGAAGGACCTG 
MIR3  ----CTGGCAGAGTGGCTGAGCAGAGA-GAGCAC-GGACTGGGAGTCAGGA-GACCTG 
         *       *   **  *  * ***  * *     **** ***   * **** 
 
 
 
              Box B 
MIR_Mars AGTTCAAATCCGGCCTCAGACACTTACTAGCTGTGTGACCCTGGGCAAGTCACTTAAC 
THER1_MD AGTTCAAATCTAGCCTCAGACACTTACTAGCTGTGTGACCCTGGGCAAGTCACTTAAC 
MIRc  AGTTCGAGTCCTGGCTCTGCCACTTACTAGCTGTGTGACCTTGGGCAAGTCACTTAAC 
MIR  AGTTCGAATCCCGGCTCTGCCACTTACTAGCTGTGTGACCTTGGGCAAGTTACTTAAC 
MIRb  AGTTCGAATCCTGGCTCTGCCACTTACTAGCTGTGTGACCTTGGGCAAGTCACTTAAC 
MIRm  AGTTCTAATCCNGGCTCTGCCACTTGTCTGCTGTGTGACCTTGGGCAAGTCACTTAAC 
MIR3  AGTTCTAGTCCCAGCTCTGCCACTAACTMGCTGTGTGACCTTGGGCAAGTCACTTCAC 
   **** * **    *** * ****     *********** ********* **** ** 
 
 
 
       CORE-SINE 
MIR_Mars CTCTGTCTGCCTCAGTTTCCTCATCTGTAAAATGGGGATAATAATAGC------ACCT 
THER1_MD CTCTGTTTGCCTCAGTTTCCTCATCTGTAAAATGGGGATAATAATAGC------ACCT 
MIRc  CTCTCTGAGCCTCAGTTTCCTCATCTGTAAAATGGGGATAATAATACCTGCCCTGCCT 
MIR  CTCTCTGTGCCTCAGTTTCCTCATCTGTAAAATGGGGATAATAATAGT------ACCT 
MIRb  CTCTCTGAGCCTCAGTTTCCTCATCTGTAAAATGGGGATAATAATA---------CCT 
MIRm         TTCTCTGTGCCTCAGTTACCTCATCTGTAAAATGGGGATTAAGACTGTGAGC---CCC 
MIR3         CTCTCTGGGCCTCAGTTTCCTCATCTGTAAAATGAGGGGGTTGGACTAGATGATCTCT 
   *** *  ********* **************** **                   *  
 
 
MIR_Mars     ACCTCCCAGGGTTGTTGTGAG-GATCAAATGAGATAATATTTGT-AAAGCGCTTTGCA 
THER1_MD     ACCTCCCAGGGTTGTTGTGAG-GATCAAATGAGATAATAATTGT-AAAGTACTTAGCA 
MIRc         ACCTCACAGGGTTGTTGTGAG-GATCAAATGAGATAATGTATGTGAAAGCGCTTTGTA 
MIR          ACCTCATAGGGTTGTTGTGAG-GATTAAATGAGTTAATAYATGT-AAAGCGCTTAGAA 
MIRb         ACCTCGCAGGGTTGTTGTGAG-GATTAAATGAGATAATGCATGT-AAAGCGCTTAGCA 
MIRm         ATGTGGGACAGGGACTGTGTCCAACCTGATTAGCTTGTATCTACCCCAGCGCTTAGAA 
MIR3         AAGGTCCCTTCCAGCTCTGAC--ATTCTATGATTCTATGATTC--------------- 
  *              * **    *    ** *     *   *   
 
MIR_Mars     AA---CCTTA--------AAGCGCTATATAAATGCTAGCTATTATTATTAT-- 
THER1_MD     CAGTGCCTGGCACATAGTAAGTACTATATAAATGTTAGCTATTATTATTATTA 
MIRc         AA---CTGTA--------AAGTGCTATACAAATGTAAGGGGTTATTATTATT- 
MIR          CAGTGCCTGGCACATAGTAAGCGCTCAATAAATGTTRGYTATTATT------- 
MIRb         CAGTGCCTGGCACACAGTAAGCGCTCAATAAATGGTAGCT-CTATTATT---- 
MIRm         CAGTGCTTGGCACATAGTAAGTGCTTAACAAATACCA-TAATTATTA------ 
MIR3         ----------------------------------------------------- 
 
Figure 3.2.  Multiple sequence alignment of the MIR family of repeat elements 
MIR consensus sequences were obtained from RepBase, the primary reference database of 
prototypic repetitive DNA sequences.  The MIR sub-families are names according to the 
nomenclature provided by Repbase (table 2.1).  Completely conserved sequences are in green, 
identical residues in pink, similar residues in blue and different residues in black.  The promoter 
boxes A and B have been highlighted in red and the core-SINE in blue. 
tRNA related sequence  
Line related segment 
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A  Generic consensus sequence for the core-SINE  
 
 GCTGTGTGACCtTGGGCAAGTcACTTaACcTCTcTgtGCCTCAGTTtCCTCATCTGTAAAATGgGG 
 
 
B  Genomic DNA sequence 
 
      GCTGTGTGACCTTGGGCAAGTCACTTAACCTCTCTGTGCCTCAGTTTCCTCATCTGTAAAATGGGG 
     GCTGTGTGGCCTTGGGCAAGTCACTTAACCTCTCTGTGCCTCAGTTTCCCCATCTGTAAAATGGGG 
     GCTGTGTGGCCTTGGGCAAGTCACTTAACCTCTCTGTGCCTCAGTTTCCCCATCTGTAAAATGGGG 
    ACTGTGTGACCTTGGGCAAGTCACTTCACCTCTCTGTGCCTCAGTTTCCTCATCTGCAAAATGGGG 
     GCTGTGTGACCTTGGGCAAGTTACTTAACCTCTTTGTGCCTCAGTTTCCCCATCTGTAAAACGGGG 
     GCTCTGTGACCTTGGGCAAGTTACTTAACCTCTCTGGGCCTCAGTTTCTTCATCTGTAAAATGGGG 
     GCTGTGTGGCCTTGGGCAAGTCACTTAACCTCTCTGTGCCTCAGTTTCCCCATCTGTAAAATGGGG 
     GCTATGTGACCCTGGGCTAGTCACTGAACTTCTCTGATCCTCTGTTTCCTCAACTGTAAAATGGGG
     GCTGTGTGACCTTGGGCAAGTCACTTAACTTCTCTGTGCCTCAGTTCCCTCATCTGTAAAATGGGG 
     GCTGTGTGACCTTGGGCAAGTCACTTAACTTCTCTGTGCCTCAGTTCCCTCATCTGTAAAATGGGG 
 
 
C  mRNA sequence 
 
     GCTGTGTGACCTTGGGCAAGTCACTTAACCTCTCTGTGCCTCAGTTTCCTCATCTGTAAAATGGGG 
     ACTGTGTGACCTTGGGCAAGTCACTTCACCTCTCTGTGCCTCAGTTTCCTCATCTGCAAAATGGGG 
     GCTGTGTGGCCTTGGGCAAGTCACTTAACCTCTCTGTGCCTCAGTTTCCCCATCTGTAAAATGGGG 
     GCTGTGTGGCCTTGGGCAAGTCACTTAACCTCTCTGTGCCTCAGTTTCCCCGTCTGTAAAATGGGG 
     GCTGTGTGGCCTTGGGCAAGTCACTTAACCTCTCTGTGCCTCAGTTTCCTCATCTGTAAAATGGGG 
     GCTGTGTGACCTTGGGCAAGTTACTTAACCTCTTTGTGTCTCAGTTTCCCCATCTGTAAAATGGGG 
     GCTGTGTGGCCTTGGGCAAGTCACTTAACCTCTCTGTGCCTCAGTTTCCCCATCTGTAAAATGGGG 
     CCTGTGTGACCTTGGGCAAGTCACTTAACCTCTTTCTGTCTCAGTTTCTTCATCTGTAAAATGGGG 
     GCTGTGTGACTGTGGGCAAGTCACTTAACTTCTCTGTGCCTCAGTTACCTCATCTGTAAAATGGGG 
 
 
 
Figure 3.3. Multiple sequence alignment of MIR elements from a number of mammalian 
species 
 
A) A generic core-SINE consensus sequence was predicted from the multiple sequence 
alignment of the MIR element sub-families shown in figure 3.2.  B) MIR elements detected 
within intergenic DNA sequences of mammalian genomes (RefSeq_genomic); C) MIR elements 
located within cDNA clones and EST sequences (dbESTs, nonRefSeq_RNA).  Completely 
conserved sequences are in green, identical residues in pink, similar residues in blue and 
different residues in black.  Sequence conservation was determined using the ClustalW2 
alignment tool (http://www.ebi.ac.uk/Tools/clustalw2/index.html; accession numbers 
appendix 9.3).  All available mammalian sequences have been included in the alignments 
shown. The generic core-SINE consensus was then used to detect homology for mammalian 
genomic DNA and mRNA sequences using BLASTn.  
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          Direct orientation                                            Inverse orientation 
 
 
Figure 3.4. Conservation of all exonic human MIR elements from all gene regions 
The number of MIR elements which correspond to each nucleotide of the generic consensus 
sequence has been plotted.  All of the MIR sub-families located within all gene regions 
including the 3’-UTR, 5’-UTR and CDS were analysed.  A similar pattern of conservation was 
detected when plotting the MIRs recruited in the CDS or UTRs independently (appendix 9.3). 
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3.4. Distributions of MIR elements 
 
Approximately 5% of the genes in the human genome have exaptated MIRs, although it 
is not clear whether this is entirely random.  Determining the chromosomal distribution 
of the MIR-containing genes will indicate if there is clustering of the MIR elements, or 
likewise if the MIRs are exaptated randomly. 
 
3.4.1.   Chromosomal locations of the MIR-containing genes 
 
The number of genes which have recruited MIRs was determined for each chromosome 
and the percentage of the total MIR-containing genes per chromosome compared to the 
total number of genes in the human genome for each corresponding genomic region.  
Assuming that MIR elements have inserted randomly within the genome, it would be 
expected that the number of MIR-exaptated genes on a chromosome would be 
proportional to the number of genes on that chromosome.   
 
Chromosome 
MIR-containing 
genes (%) 
Total genes in the 
genome (%) 
Normalised 
percentage 
1 10.9 9.60 2.14 
2   5.4 6.56 1.82 
3   6.4 5.09 2.26 
4   3.3 4.01 1.82 
5   4.7 4.41 2.07 
6   5.6 5.19 2.08 
7   3.0 5.02 1.60 
8   2.9 3.41 1.85 
9   5.8 3.96 2.46 
10   3.6 3.85 1.94 
11   7.4 6.44 2.15 
12   5.0 4.78 2.05 
13   1.5 1.90 1.79 
14   3.4 4.44 1.77 
15   4.7 3.21 2.46 
16   3.5 3.85 1.91 
17   4.9 4.92 2.00 
18   1.1 1.51 1.73 
19   6.5 5.87 2.11 
20   4.1 2.57 2.60 
21   1.1 1.16 1.95 
22   2.0 2.58 1.78 
X   3.3 4.59 1.72 
Y   0.8 1.07 1.75 
 
Table 3.2.  Percentage of MIR-containing genes for each human chromosome      
The percentage of genes which have recruited MIRs for each chromosome compared to the 
percentage of the total human genes for all chromosomes.  The percentage of MIR-containing 
genes are normalised: (% MIR-genes + % genes in genome)/% genes in genome. 
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Figure  3.5.  Percentage of MIR-containing genes for each human chromosome  
The percentage of genes which have recruited MIRs for each chromosome is shown in blue. 
The percentage of the total human genes for all chromosomes has been provided as a 
reference (red), and the values are plotted according to the chromosome size in base pairs. 
 
 
 
Overall it appears that the exaptation of MIRs is a random process (table 3.2, figure 
3.5).  There is a slight over-representation for the MIR-genes on chromosomes 3, 9, 15 
and 20.  However, the normalised percentage demonstrates that the MIR-containing 
genes are equally distributed between all chromosomes (table 3.2).  It has previously 
been reported that Alu repeats are not distributed randomly throughout the human 
genome.  However, these data represent the distribution of all genomic Alu elements not 
those which have been exaptated by human genes (Grover et al., 2004). 
 
The sub-chromosomal locations of the genes which have recruited MIRs were also 
investigated to determine if there is any clustering of these genes (figure 3.6).  There is 
apparent clustering of MIR-containing genes on several chromosomes including 
chromosomes 11, 14, 15, 19 and 20.  These chromosomes are known to contain 
imprinted domains, the MIR elements of which have been further investigated in section 
3.4.3. 
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Figure 3.6.  A schematic representation of the density of genes which have exaptated MIRs 
for each chromosomal location 
 
The blue represents the frequency of MIR elements for each loci, the maximum number of 
genes in any one plot line has been supplied for reference along with the total number of MIR 
genes for each chromosome.  The chromosome banding (grey) indicates the standard human 
karyotype, stained with Giemsa dye. 
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3.4.2. Gene distances between MIR-containing genes 
 
The distances between the MIR-containing genes were noted for each chromosome to 
further illustrate if the genes are randomly distributed or clustered within the human 
genome (figure 3.7a).  As a comparison the average distance between the MIR-
containing genes was compared to the average distance between genes of the human 
genome (Figure 3.7b).  Genes that have exaptated MIRs are most commonly located 
within the range of 0-200kb, which is similar to that of the remainder of the genes in the 
genome. This similarity in distribution, on first impressions, may suggest that clustering 
is occurring in gene-rich regions.  However, when comparing the MIR-gene dataset to a 
random collection of human genes (figure 3.7c) a similar trend to the MIR-containing 
genes is observed, confirming that MIRs may have been randomly exaptated. 
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Figure 3.7. The distance between MIR-containing genes in the human genome 
A) The percentage of MIR-containing genes has been calculated for each human chromosome 
for distance ranges in multiples of 100kb; B) The average distance between MIR-containing 
genes (blue) and the distance between all genes on chromosome 5 is provided as a 
comparison (red); C) The frequency of MIR-containing genes (blue) for chromosome 5 
compared to the same number of genes chosen randomly from human chromosome 1 (red).  
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3.4.3. MIRs within imprinting regions and disease loci 
 
It has been noted previously that imprinted regions are rich in repetitive sequence and it 
has been suggested that they may act as imprinting markers (Walter et al., 2006).  MIR 
elements have not been specifically implicated in imprinting.  However, following 
analysis of the frequency of MIR-containing genes for each chromosomal location 
(section 3.4.2), dense regions are notable in chromosomes which possess large 
imprinting domains.  There are 41 known imprinted genes (Morison et al., 2005) and 
106 further predicted for the human genome (Luedi et al., 2007; 
http://www.geneimprint.org/).  There are 11 MIR-containing genes listed in the 
GeneImprint database, 8 of which are known to be imprinted and the remainder being 
predicted (table 3.3).  The density of MIR-containing genes in imprinted regions and the 
disease loci of chromosomes 11, 14, 19, 20 and 21 are detailed in figure 3.8. 
 
 Gene 
symbol  
Gene name Location Allele ICR Reference 
 CCBL2* cysteine conjugate-beta lyase 2 1p22.2 M - Luedi et al., 2007 
PLAGL1 
pleiomorphic adenoma gene-
like 1 
6q24-q25 P - Arima et al., 2006 
FAM50B* 
Family with sequence similarity 
50, member B 
6p25 M - Luedi et al., 2007 
DHCR7  7-dehydrocholesterol reductase 11q13.4 M - 
Schulz et al., 
2006 
AMPD3  
adenosine monophosphate 
deaminase 3 
11p15.4 M - 
Schulz et al., 
2006 
MEG3 maternally expressed 3 14q32 M 
P 
DMR 
Miyoshi et al., 
2000 
RASGRF1 
RAS protein-specific guanine 
nucleotide-releasing factor 1 
15q24 P P 
de la Puente et 
al., 2002 
ZNF597 Zinc finger protein 597 16p13 M - Pant et al., 2006 
HM13  histocompatibility (minor) 13 20q11.21 M - Wood et al., 2007 
L3MBTL l(3)mbt-like 20q13.12 P DMR Li et al., 2004 
SIM2* 
single-minded homolog 2 
(Drosophila) 
21q22.2 P - Luedi et al., 2007 
 
Table 3.3.   Imprinted genes which have recruited MIR elements 
 
Expression is from either the paternal (P) or maternal (M) allele.  The imprinting control region 
(ICR) has been included if known with two paternal examples and one differentially 
methylated region (DMR). Genes with the symbol * are listed as predicted in the Gene-Imprint 
database (Luedi et al., 2007). 
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Figure 3.8.  The density of genes which have 
exaptated MIR elements for chromosomes that 
are known to contain imprinting domains. 
 
Recognised imprinting regions and chromosomal 
areas dense in imprinted genes are outlined in 
blue.  Sections where the densities of MIR-
containing genes appear greater than the 
frequency of genes in the genome are boxed 
(green).  The location of the known imprinting 
genes which have exaptated MIR elements; 
DCHR7, AMPD3, MEG3, HM13, L3MBTL and 
SIM2, are illustrated with red arrows.  
 
The red histogram indicates the frequency of 
known genes for each chromosomal region and 
the blue trace the frequency of MIR-containing 
genes. The chromosome banding (grey) indicates 
the standard human karyotype, stained with 
Giemsa dye. 
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Known chromosome regions associated with Alzheimer’s disease are boxed (grey dashed).  The red box 
signifies a group of six genes in a genomic region associated with Joubert syndrome. The red histogram 
indicates the frequency of known genes for each chromosomal region and the blue trace the frequency of 
MIR-containing genes.  The chromosome banding (grey) indicates the standard human karyotype, stained 
with Giemsa dye.  
 
              
 
 
Figure 3.9.  The density of human genes which have exaptated MIR elements for disease loci. 
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3.6. Discussion 
 
Compilation of a dataset of human genes which have recruited MIRs, identified ~5% of 
the genes in the genome that have exaptated one or more MIR element.  This 
corresponds to 1359 known and validated genes that have recruited MIRs in exons 
which are either protein-coding or within untranslated regions.  This figure is likely to 
be an under representation of the true number of genes which have recruited MIRs, as 
many elements may be difficult to detect due to sequence drift and divergence. 
 
The majority of the MIR elements are within the 3‟-UTR (75%), and the remainder 
within the CDS (9%) and 5‟-UTR (14%).  The prevalence of MIR element within the 
3‟-UTR was expected as on average the 3‟-UTR is six times larger than the 5‟-UTR 
(Zhang, 1998).  Secondly the MIR elements have integrated less commonly within the 
CDS, as a novel insertional event would likely disrupt open reading frames and/or splice 
sites.  MIRs within the 3‟-UTRs are more tolerable as protein synthesis can continue 
undisrupted.  Furthermore the frequency of MIR elements in each gene region (5‟-UTR, 
CDS and 3‟-UTR) is comparable to that observed for other TEs, with the exception of 
LTR elements (Piriyapongsa et al., 2007; Jordon et al., 2003; Nekrutenko and Li, 2001; 
Makałowski, 2000).  The abundance of MIRs in the 3‟-UTR may merely reflect a lack 
of selection against the integration of the element due to it being less disruptive.  
However, it is also possible that some of these MIRs may have been co-opted to 
produce cis-acting regulatory sequences which may play a role in post-translational 
processes.  Likewise MIR elements exaptated in the 5‟-UTR and CDS could be 
providing functional sequences.  It has been shown previously that due to the sequence 
composition some repeat elements, such as Alus can form double-stranded RNAs 
(dsRNA) which may then be targets for RNA interference (RNAi) pathways, and A-to-I 
editing (Kim et al., 2004), similar has been suggested for MIR elements (Hughes, 
2000).  Further roles of the 3‟-UTR MIR elements may include regulating translational 
rates, possibly via miRNA target sites, and altering mRNA stability (Muotri et al., 2007; 
Smalheiser and Torvik, 2005).   
 
There are a number of MIR elements which reside within the CDS of the genes 
identified; however, it is likely that rather than integrating within a coding exon an 
intronic repeat underwent sequence changes to produce a cryptic splice site, thus 
generating alternative transcript variants (see chapter 5).  There are several examples 
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where the MIR is providing translational signals such as initiating methionine codons 
and stop codons thus contributing alternative transcript variants.   Following collection 
of the dataset it also appears that there is no preference to recruit an MIR element in the 
direct or indirect consensus in relation to the mRNA orientation.  
 
The conservation of the exaptated MIR elements was investigated and demonstrated 
that the core-SINE region is highly conserved, similar to a previous study (Gilbert and 
Labuda, 1999).  The conservation of the MIR elements located in both the UTRs and 
CDS were studied independently, as were each MIR family member, and there appears 
to be a similar trend to conserve the core-SINE irrespective of MIR sub-type and 
orientation, or the gene region the element is exaptated.  The core-SINE is not only 
highly conserved between human genes but also between species, with a surprising 94% 
sequence similarity between the core region of human intergenic MIRs and those 
retainined in intergenic regions of the platypus genome, a similar level of conservation 
of core-SINEs exaptated within mRNA sequences is also high between these two 
species (91%).  However if MIR elements are non-functional it might be expected that 
there would be a constant rate of divergence along the whole consensus, yet the core-
SINE is highly conserved not only between genes of a single genome but also between 
species suggesting that the MIR may be functional and maintained due to a selective 
advantage.   
 
All retrotransposons are thought to have integrated randomly throughout the genome, 
and various investigations were performed to determine the distribution of the human 
genes which have exaptated MIR elements.  This was achieved by noting the frequency 
of MIRs for each chromosome and secondly the distribution along each chromosome 
and comparing to the general distribution of all human genes.   If the MIR elements 
have exaptated randomly within the genome then it would be expected that the number 
of MIR-containing genes would be proportional to the total number of genes on each 
chromosome, which is what was observed for the human exaptated MIR elements.  
When observing the distribution of the MIR-containing genes in more detail there are 
notable areas where there are high concentrations of the MIR-gene dataset compared to 
the frequency of the genes in the rest of the genome, specifically in known imprinted 
regions. There is increasing evidence to support the idea that retrotransposons may 
contribute to genomic imprinting (Suzuki et al., 2007; Walter et al., 2006; Walter and 
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Paulsen, 2003), and at least eight imprinted genes appear to have arisen through 
retrotransposition (Morison et al., 2005; Lander et al., 2001).  Secondly 
retrotransposons which are located either within gene regions or in close proximity have 
been shown to epigenetically control phenotypic variations in mammalian species 
(Lippman et al., 2004; Morgan et al., 1999).  Furthermore whilst little is known about 
the epigenetic mechanisms that occur in imprinted domains, it has been suggested that 
repeat elements may carry the signature sequences which distinguish imprinted genes 
from other non-imprinted genes or genomic regions (Walter et al., 2006).  These 
signature elements, potentially carried by retrotransposons may then direct the 
machinery necessary for epigenetic modifications to these areas.  It has further been 
suggested that epigenetic regulation of genes and DNA methylation may have evolved 
originally as a defence mechanism against the intrusion of a TE and has been 
demonstrated with A. thaliana (Zilberman and Henikoff, 2005; Chan et al., 2005; 
Lippman et al., 2004).   
 
One of the major chromosomes involved in imprinting is chromosome 11, and there are 
fourteen genes which have recruited MIRs in the imprinting region 11p15.2-15.5 
(appendix 9.5).  Secondly eleven of the MIR-containing genes identified are currently 
known to be imprinted or are predicted imprinted genes (Luedi et al., 2007).  In addition 
there are several chromosomal areas which display a high concentration of MIR-
containing genes in regions where evidence supports the parent-of-origin effect in 
human disease.  For example high levels of hypermethylation were observed in patients 
with the uniparental disomy (UPD) -like phenotype [upd(14)mat] in the DMR region of 
the MIR-containing gene, maternally expressed 3 (MEG3) (Zechner et al., 2007; Hosoki 
et al., 2008).  There are also dense regions of genes which have exaptated MIRs in 
chromosome loci with linkage to specific disease. For instance there is a cluster of 24 
MIR-containing genes in the known Joubert syndrome (JBTS) locus, 11p12-q13.3 
defined by Valente et al., (2005; appendix 9.5).  Moreover there is an MIR-gene rich 
region located at position 14q32.2-13 where there is linkage to Alzheimer‟s disease and 
UPD-like phenotype [upd(14)mat] (Zechner et al., 2009; Lee et al., 2007).  A further 
Alzheimer‟s disease locus has been mapped to 19q13.2, a region which contains 14 
MIR-containing genes, including periaxin (PRX) which is essential for the maintenance 
and stabilisation of peripheral nerve myelin (Williams and Brophy, 2002).   
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3.7. Conclusion 
 
In summary, 5% of the total human genes have exaptated at least one exonic MIR 
sequence in either the UTRs (91%) or CDS (9%), with more than 1850 exaptated MIR 
elements identified.  There appears to be no preference to recruit an MIR in the direct or 
indirect orientation and the majority (75%) are retained within 3‟-UTR exons.  The 
core-SINE of the MIR consensus sequence is highly conserved between mammalian 
species, including the ancient orders monotremata and marsupialis.  Sequence identity 
of >90% is detected for core-SINEs integrated in intergenic DNA and mRNA across 
mammals.  The MIR elements appear to be distributed randomly in genes throughout 
the human genome, as indicated by the density of MIR-containing genes for each 
chromosome and the sub-chromosomal locations.   
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4. THE FUNCTIONAL SIGNIFICANCE OF THE EXAPTATION OF AN 
MIR ELEMENT 
 
4.1. Introduction  
 
TEs are ubiquitous component of all eukaryote genomes and constitute a large portion 
of the host genomic sequence.  As such, TEs are suggested to play a major role in the 
evolution of eukaryotic complexity (Jurka, 2008; Medstrand et al., 2005; Bowen and 
Jordan, 2002).  It has been suggested that the immune system may have evolved by co-
opting transposons (Schatz, 1999).  Adaptive immunity has developed a means of 
precisely targeting specific pathogens through the production of a myriad of 
immunoglobulin (Ig) proteins.  Ig proteins are encoded by three gene families; V 
(variable), D (density) and J (joining) which reside within the V(D)J locus.  During 
lymphocyte differentiation somatic recombination occurs of the V(D)J gene region 
producing a composite gene made up of segments of the three families.  V(D)J 
recombination is fundamental in generating a diverse collection of Ig proteins and T cell 
receptors, and is catalysed by a number of proteins including RAG1 and RAG2 (Lewis 
and Wu, 1997; Schatz  et al., 1989).  The activation mechanism is not dissimilar to the 
„cut and paste‟ mode of transposition observed in DNA transposons and RAG1 is now 
known to be derived from the Transib DNA transposase (Kapitinov and Jurka, 2005; 
Spanopoulou et al., 1996), RAG2 is also thought to be TE-derived (Schatz, 1999).  It is 
worth noting that the human RAG1 gene has recruited an MIR element in the 3‟-UTR 
(appendix 9.1).   
 
Taking together the similarities between retrotransposition and V(D)J recombination 
and that RAG1 is TE-derived supports the role of TEs in the evolution of the vertebrate 
immune system (Schatz, 1999; Bowen and Jordan, 2002), and there is increasing 
evidence to suggest a role of TEs in other aspects of immune responses.  For example 
the expression of type III interferons (IFN) is thought to be regulated by NF-kappaB, 
through a cluster of NF-kappaB binding sites located in the IFN promoter region.  These 
binding sites are derived from Alus and LTR elements (Thomson et al., 2009).  
Similarly the promoter region of human IFN-γ also contains Alu-derived binding sites 
for NFAT (nuclear factor of activated T-cells) and NF-kappaB (Ackerman et al., 2002). 
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TEs have the potential to provide cis-acting regulatory elements which may then be 
involved in the regulation of gene expression.  At least 10% of human transcription 
factor binding sites are TE-derived (Polavarapu et al., 2008).  MIR elements which have 
been transposed into gene regions predominantly reside within the 3‟-UTRs (chapter 3), 
which is the site most miRNAs are known to target.  The introduction of a novel TE 
into a gene region may be deleterious to the organism and numerous examples exists 
whereby human disease has been attributed to an integrated retrotransposon (reviewed 
in Deininger and Batzer, 1999; Ostertag et al., 2003; Callinan and Batzer, 2006).  There 
are few publications which demonstrate similar activity occurring with inserted MIR 
elements, with the exception of the example discussed in section 1.4 and the alternative 
splicing of gene CYBB.  The aim of this chapter is to categorise all of the MIR-
containing genes which are implicated in the development of disease.  The MIR 
elements may not necessarily be involved in the pathology as such, but sorting in this 
manner will highlight the functional importance of these genes and may provide a 
possible indication or hint as to the role of these elements.  Similarly the overall 
functions of the MIR-gene dataset will be sorted to screen for any themes or 
commonalities, following which specific functional roles will be discussed, such as the 
involvement in dsRNA-mediated gene expression and RNAi. 
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4.2. Data mining to search for commonalities in the MIR-containing genes 
 
The functional significance of the exaptation of MIR elements was unravelled using a 
number of sources, aiming to distinguish enriched biological themes and functionally 
related genes, specifically using Gene Ontology (section 4.2.2) and tissue expression 
data (section 4.2.3).  The involvement of the MIR-dataset of genes in biological 
regulatory pathways and gene-disease associations were also investigated.  The MIR-
containing genes were first analysed using D.A.V.I.D (Database for Annotation, 
Visualisation and Integrated Discovery; Huang et al., 2007), to search for significant 
terms, collected from multiple databases.  This preliminary analysis screened all of the 
available databases accessible through D.A.V.I.D including GAD, OMIM, NCBI, 
SWISSPORT and KEGG.  The overrepresented significant key terms (P < 0.005) 
include alternative splicing, glycoprotein, the membrane, interleukin activity and metal 
binding (table 4.1). 
 
 
Keyword 
Number of MIR- 
containing genes 
Ratio 
FDR adjusted 
P value 
Alternative splicing 486 37.67% <0.001 
Glycoprotein 306 23.72% <0.001 
Membrane part 446 34.57% <0.001 
Interleukin activity 13 1.01% 0.001 
Metal-binding 212 16.43% 0.004 
Neurotransmitter transport 12 0.85% 0.007 
Disease mutation 122 9.46% 0.008 
Vision 20 1.55% 0.02 
Zinc-finger 136 10.54% 0.02 
Transmembrane protein 62 4.81% 0.04 
Retinitis pigmentosa 12 0.85% 0.09 
Signal-anchor 39 3.02% 0.12 
Immunoglobulin domain 54 4.19% 0.19 
Symport 14 1.09% 0.28 
Palmitate 21 1.63% 0.46 
Tyrosine-protein kinase 15 1.16% 0.46 
 
Table 4.1.  Significant key terms detected for the MIR-containing gene dataset 
Keywords were detected using D.A.V.I.D (Huang et al., 2007).  The number and ratio of the 
total MIR-containing genes is listed for each term.  Statistical significance is calculated using 
the Benjamini-Hochberg (1995) method for false discovery rate control. 
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4.2.1. Metabolic and signalling pathways 
 
Investigating the involvement of MIR-containing genes in regulatory pathways may 
highlight common metabolic and signalling processes.  The pathway information was 
collected from the Kyoto Encyclopaedia of Genes and Genomes (KEGG) database 
(Kanehisa et al., 2008).  The number of MIR-containing genes for each pathway was 
noted and the frequency compared to the total number of genes reported.  Filtering the 
MIR dataset of genes in this manner may indicate a shared function and subsequently a 
potential role for the MIR elements.   
 
The significance of these results was determined using FDR-corrected method 
calculated by the functional enrichment tool FatiGO at Babelomics v3.1 (Al-Shahrour et 
al., 2007).  A total of 70 different KEGG pathways were noted to involve genes which 
have recruited MIR elements (figure 4.1; appendix 9.6).  However no pathways were 
deemed significant (P < 0.05) and all groups gave a P value of 1.  The Fisher‟s exact 
test highlighted four pathways which have an uncorrected P value of < 0.05 (table 4.2).  
These results have not been calculated using the Benjamini-Hochberg correction 
method, so can not be considered statistically significant.  The pathways fall into two 
groups: 1) Cellular communication; including cytokine receptor interaction and Jak-
STAT signalling and 2) neuronal development.  The neuronal pathways are axon 
guidance and the development of Amyotrophic lateral sclerosis (ALS), also known as 
Maladie de Charcot, which is the most common form of motor neuron disease in young 
adults (Mitchell and Borasio, 2007).  
 
 
Pathway name KEGG ID 
Number of  
MIR-genes 
%  
(norm) 
Uncorrected 
P value 
1 
Cytokine-cytokine receptor interaction  hsa04060 12 66.57 0.02 
Amyotrophic lateral sclerosis hsa05014 2 87.35 0.05 
2 
Jak-STAT signalling pathway hsa04630 7 70.31 0.03 
Axon guidance  hsa04360 7 77.27 0.02 
 
Table 4.2.  KEGG pathways which have a large number of MIR-containing genes 
The KEGG pathway name and the identification numbers are listed.  The total genes involved in 
the pathways identified are; 66/1359 MIR-containing genes and 1139/31524 genes of the total 
genome.  P values (Fisher’s exact test) are calculated using the functional enrichment tool 
Babelomics (Al-Shahrour et al., 2007).  The percentage of MIR-containing genes have been 
normalised: (% MIR-genes + % genes in genome)/% genes in genome. 
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4.2.2. Gene Ontology 
 
The Gene ontology (GO) is the primary database of controlled terms used to annotate 
gene functions, products and sub-cellular locations.  The GO database is made up of 
three main ontologies (trees); biological process (BP), molecular function (MF) and 
cellular component (CC).  Each „tree‟ is structured in a hierarchical manner of multiple 
branches (nodes), which are organised by parent–daughter relationships between 
ontologies, with each node branching to a further more detailed GO annotations. 
 
This controlled vocabulary of GO terms is a useful resource which can assist in 
identifying if there are any common functions shared between the dataset of MIR-
containing genes.  Accessing the GO may assist in highlighting specific functional 
groups; however, the GO is an incomplete and growing database, with many genes 
having yet to be assigned GO terms.  Secondly, many terms have few genes assigned.  
These small sample sizes may result in the FDR-correction method missing potentially 
significant groups.  Therefore the Fisher‟s exact test was used to reveal trends which 
may highlight common themes and functional areas which may warrant further 
investigation.  Revisiting the GO in the future, when the database has expanded may 
provide more significant results. 
 
GO terms and accessions were collected for all of the MIR-containing genes, 
corresponding to a total of 2669 ontology terms.  It was necessary to categorise these 
terms into specific levels and relationships, as a gene may have multiple GO terms 
attributed which belong to the same parent-daughter relationship.  The main top level 
ontologies (incorporating nodes 3 and above) are outlined in table 4.3.  Of the top three 
nodes studied, none of the GO terms were found to be statistically significant (table 
4.3a).  When consulting the two-tailed Fisher‟s exact test the MIR-containing genes 
appear to be involved primarily in ion binding and transport, neurotransmitter transport, 
immune responses, homeostasis, intracellular signalling, peptide binding and receptor 
activity (table 4.3b; figure 4.1). 
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A 
ONTOLOGY TERM MIR-genes Ratio (%) % (norm) 
FDR-correct 
P value 
Receptor activity 128 13.5 51.6 0.35 
Homeostasis 35 4.0 59.4 0.51 
Cell communication 273 30.3 51.2 0.54 
Signal transduction 247 28.2 51.0 0.61 
Reproduction 18 2.0 54.7 0.64 
Neurotransmitter transport 12 1.5 78.6 0.65 
Peptide binding 18 1.9 62.8 0.65 
Cell differentiation 159 18.2 53.1 0.69 
Metabolism 485 53.9 49.8 0.83 
Localisation 178 19.8 51.9 1 
Ion binding 321 33.9 55.0 1 
Immune response 70 7.8 59.1 1 
Intracellular signalling cascade 111 13.5 54.6 1 
Ion transport 63 7.7 55.8 1 
Cellular development 159 17.7 53.1 1 
Transcription 163 19.8 50.9 1 
Apoptosis 52 9.0 50.1 1 
DNA Replication / Modification 9 11.9 52.9 1 
Nucleic acid binding 211 22.3 48.8 1 
Protein localisation 40 4.4 45.7 1 
Translation 25 3.2 41.6 1 
 
B 
 
ONTOLOGY TERM MIR-genes Ratio (%) % (norm) 
Uncorrected 
P value 
Ion binding 321 33.86 55.02 <0.001 
Neurotransmitter transport 12 1.46 78.58 <0.001 
Immune response 70 7.78 59.1 0.002 
Homeostasis 35 4.00 59.39 0.02 
Intracellular signalling cascade 111 13.49 54.61 0.03 
Peptide binding 18 1.90 62.78 0.03 
Ion transport 63 7.65 55.78 0.04 
 
Table 4.3. Gene ontology categories for all of the MIR-containing genes  
The gene ontology terms are from the top three nodes of the main ontology trees (BP, CC and 
MF).  The percentage of MIR-containing genes has been normalised: (% MIR-genes + % genes 
in genome)/% genes in genome.  Statistical significance was calculated using the Babelomics 
resource.  A) The FDR-correction method demonstrates that none of the top ontology terms 
are statistically significant (P < 0.05).  B) The Fisher’s exact method reveals seven GO terms 
with a P < 0.05. 
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Figure 4.1. Gene ontology categories for MIR-containing genes and all genes of the genome 
 
The categories are derived from the Gene Ontology functional classification system.  Top level 
ontology terms are included from all main ontologies; cell component, biological process and 
molecular function.  Blue bars represent the percentage of the total data set of MIR-containing 
genes which has the GO term assigned and the red line represents the P value.  The green 
threshold line signifies the uncorrected P < 0.05. 
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The full collection of gene ontology terms were grouped into specific groups to 
facilitate the analysis (Nodes 4 and below). The functional groups included growth and 
development, mammalian reproduction, neurological function, cell component, immune 
responses and binding activity (figures 4.2-4.7; appendix 9.7).  Of these categories only 
four terms were considered statistically significant (FDR-corrected P < 0.05); which 
include the plasma membrane, metal ion binding, cation binding and the golgi apparatus 
(table 4.4a).  The Fisher‟s exact test reveals three trends (table 4.4b): 1) Neuronal 
function; neuronal-related terms include the dendrite and neurone projection, GPCR 
activity and the photoreceptor.  Photoreceptors are a specialised type of neurone 
specifically located in the retina, which are involved in phototransduction and vision.  
Note that key terms listed in table 4.1 include retinitis pigmentosa and vision. 2) 
Immune responses; predominantly the response to wound injury by cytokines, 
Interleukin activity was identified as a significant key term in table 4.1 (P < 0.001).  3) 
Growth and development; specifically related to skeletal and organ development.  
 
 
 
 
 
Table 4.4. Gene ontology categories for the MIR-containing gene dataset  
The GO terms are from nodes 4 and below.  The percentage of MIR- genes are normalised: (% 
MIR-genes + % genes in genome)/% genes in genome.  A) The FDR-correction method (P < 
0.05).  B) The uncorrected Fisher’s exact method.  
ONTOLOGY TERM MIR-genes Ratio (%) % (norm) 
FDR-correct 
P value 
Plasma membrane 164 20 56.2 0.01 
Metal ion binding 317 37.8 54.8 0.02 
Cation binding            295 35.2 54.7 0.02 
Golgi apparatus 40 6.8 63.2 0.05 
 
ONTOLOGY TERM MIR-genes Ratio (%) % (norm) 
Uncorrected 
P value 
1 
Neurotransmitter transport 12 1.5 78.6 <0.001 
GPCR activity 14 1.8 65.9 0.02 
Dendrite 6 0.8 73.5 0.03 
Neuron projection 11 1.4 66.1 0.04 
Photoreceptor inner segment 2 0.2 90.5 0.04 
2 
Cytokine receptor activity 71 1.6 82.6 <0.001 
Immune response 7 7.8 59.1 0.002 
Wound healing 7 1.9 68.1 0.006 
3 
Skeletal development  28 3.6 66.1 0.001 
Organ development         97 11.8 55.1 0.03 
Organ morphogenesis             34 4.4 58.2 0.04 
B 
A 
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Figure  4.2. MIR-containing genes for the gene ontology terms in the functional group 
protein binding 
 
Gene ontology terms are from all Ontologies (BP, CC and MF) nodes 4 and below.  The blue bar 
represents the percentage of MIR-containing genes assigned each ontology term.  The red line 
signifies the uncorrected P value.  The green threshold line represents a P value of 0.05.  The 
top three terms (Uncorrected P < 0.05) are metal ion binding, cation binding and peptide 
binding.  
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Figure  4.3. MIR-containing genes for the gene ontology terms in the functional group growth 
and development 
 
Gene ontology terms are from all Ontologies (BP, CC and MF) nodes 4 and below.   The blue 
bar represents the percentage of MIR-containing genes assigned each ontology term.  The red 
line signifies the uncorrected P value.  The green threshold line represents a P value of 0.05.  
The top four terms (Uncorrected P < 0.05) are skeletal development, anatomical structure and 
development, organ development and organ morphogenesis.  
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Figure  4.4. MIR-containing genes for the gene ontology terms in the group neuronal function 
 
Gene ontology terms are from all Ontologies (BP, CC and MF) nodes 4 and below.   The blue 
bar represents the percentage of MIR-containing genes assigned each ontology term.  The red 
line signifies the uncorrected P value.  The green threshold line represents a P value of 0.05.  
The top three terms (Uncorrected P < 0.05) are neurotransmitter transport, GPCR receptor 
activity and neuron projection. 
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Figure  4.5. MIR-containing genes for the gene ontology terms in the functional group 
mammalian reproduction  
 
Gene ontology terms are from all Ontologies (BP, CC and MF) nodes 4 and below.   The blue 
bar represents the percentage of MIR-containing genes assigned each ontology term.  The red 
line signifies the uncorrected P value.  The green threshold line represents a P value of 0.05.  
Lactation is the only ontology terms with an uncorrected P < 0.05 suggesting MIR elements do 
not play a role in mammalian reproduction.    
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Figure  4.6. MIR-containing genes for the gene ontology terms in the functional group cell 
compartment  
 
Gene ontology terms are from all Ontologies (BP, CC and MF) nodes 4 and below.   The blue 
bar represents the percentage of MIR-containing genes assigned each ontology term.  The red 
line signifies the uncorrected P value.  The green threshold line represents a P value of 0.05.  
The top ontology terms (P < 0.05) are the plasma membrane, golgi apparatus, the dendrite, 
neurone projections and photoreceptors.   
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Figure  4.7. MIR-containing genes for the gene ontology terms in the functional group 
immune responses 
 
Gene ontology terms are from all Ontologies (BP, CC and MF) nodes 4 and below.   The blue 
bar represents the percentage of MIR-containing genes assigned each ontology term.  The red 
line signifies the uncorrected P value.  The green threshold line represents a P value of 0.05.  
The top three terms (P < 0.05) are cytokine receptor activity, the immune response amd 
wound healing.   
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4.2.3. Tissue expression profile of the MIR-containing genes reveals a potential 
role in neuronal function and mRNA localisation 
 
Studying the tissue-specific expression pattern of mRNA may provide an indication of a 
shared function of the MIR dataset of genes.  Expression data was collected from the 
human tissue atlas datasets U133A and GNF1H, (Su et al., 2004) which includes whole-
genome gene expression arrays and expression profiles for >40,000 human genes 
(annotated and predicted) across a panel of 79 tissue types.   
 
The tissue expression profiles of the MIR-containing genes were examined to determine 
if the dataset is overrepresented for any of the specific tissue types.  The expression data 
was analysed using the D.A.V.I.D functional enrichment analysis tool (Huang et al., 
2007) to determine if the MIR-dataset of genes are expressed in a particular tissue more 
frequently than the total genes included in the tissue atlas.  The MIR-containing genes 
were noted to be expressed in 29 of the 79 tissues with a significance value of P < 0.05.  
Interestingly half of these tissues are rich in neurones; brain, spinal cord and the eye 
including the ciliary ganglion which is a type of neurone located at the posterior orbit of 
the eye (figure 4.8; table 4.5)).  Other highly significant (P < 0.05) tissues include the 
testis, thymus, whole blood, kidney, prostate, uterus and bone marrow.   
 
The identified tissues were organised into functional groups with four groups being 
apparent (table 4.5).  Overall it appears that the MIRs are preferentially recruited and 
maintained in genes expressed in tissues rich in neurones (48%), mammalian 
reproductive tissues (15%), muscular tissue (12%) and tissues critical in the production 
of immune cells (9%).   
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Tissue Type 
Number of 
MIR-genes 
Ratio (%) 
FDR-correct  
P value 
1 
Amygdala 331 25.7 <0.001 
Ciliary ganglion 360 27.9 <0.001 
Pituitary 292 22.6 <0.001 
Occipital Lobe 286 22.2 <0.001 
Olfactory bulb 258 20 <0.001 
Prefrontal Cortex 273 21.2 <0.001 
Cerebellum 697 54 0.001 
Temporal lobe 294 22.8 0.005 
Sub-thalamic nucleus 216 16.7 0.01 
Cingulate cortex 179 13.9 0.02 
Pons 410 31.8 0.02 
Cerebellum peduncles 125 9.7 0.03 
Spinal cord 166 12.9 0.04 
Whole eye 367 28.5 0.04 
2 
Testis 268 20.8 <0.001 
Prostate 673 52.2 <0.001 
Uterus 227 17.6 <0.001 
Ovary 207 16.1 0.003 
3 
Smooth muscle 330 25.6 <0.001 
Tongue 276 21.4 0.002 
Skeletal muscle 487 37.8 0.03 
4 
Whole blood 415 32.2 <0.001 
Thymus 229 17.8 <0.001 
Bone marrow 182 14.1 0.002 
 Colorectal Adenocarcinoma 321 24.9 <0.001 
 Atrioventricular node 132 10.2 <0.001 
 Kidney 460 35.7 <0.001 
 Bronchial epithelia 146 11.3 0.003 
 Appendix 274 21.2 0.02 
 
Table 4.5. Tissue expression profile for all of the MIR-containing genes from the human 
tissue atlas (U133A and GNF1H). 
 
The experession profiles of the MIR-containing genes was calculated according to the human 
tissue atlas datasets U133A and GNF1H The MIR elements are predominately expressed in four 
tissue groups: 1) Tissues rich in neurones; 2) tissues of the mammalian reproductive system; 3) 
tissues rich in immune cells and 4) muscular tissue. Statistical significance was determined by 
the FDR-correction method calculated using the Babelomics resource.   
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Figure 4.8. Tissue expression profile of the MIR-containing genes 
The blue bar represents the frequency of MIR-containing genes expressed in each tissue type.  
The pink line represents the FDR-corrected P value; orange line P < 0.001 and the green line P 
< 0.01. 
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Zhong et al., (2006) identified genes which were overrepresented in the dendritic 
compartment (compared to the cell body) and annotated 154 genes where the mRNA is 
localised to the dendritic compartment.  Of these genes 18 are noted to have exaptated 
MIR elements (table 4.6).  Therefore of the genes described which demonstrate 
dendritic localisation, 10.5% have been found to contain MIRs (for comparison the total 
number of genes in the human genome which have recruited these repeats is ~5%).  Of 
these genes none have MIR elements recruited in the coding sequence and the majority 
have exaptated MIRs in the 3‟-UTR (89%) with three having recruited MIR elements in 
the 5‟-UTR.   
 
HGNC  
Symbol 
Gene Description 
Transcript 
Accession 
Position 
APLN Apelin, AGTRL1 ligand NM_017413 3’-UTR 
CAMK2A Calcium/calmodulin-dependent protein kinase II alpha 
NM_015981 
NM_171825 
3’-UTR 
3’-UTR 
CD4 CD48 antigen NM_000616 
3’-UTR 
3’-UTR 
CD59  CD59 antigen 
NM_000611 
NM_203329 
NM_203330 
NM_203331 
3’-UTR x5 
3’-UTR x5 
3’-UTR x5 
3’-UTR x5 
CLDN10 Claudin 10 
NM_182848 
NM_006984 
3’-UTR 
3’-UTR 
DDN Dendrin NM_015086 3’-UTR 
EDG6 Endothelial differentiation, lysophosphatidic acid GPCR 2 NM_003775 3’-UTR 
FILIP1 Filamin A interacting protein 1 NM_015687 3’-UTR 
IGSF1 Immunoglobulin superfamily, member 1 NM_205833 3’-UTR 
KCNK3 Potassium channel, subfamily K, member 3 NM_002246 3’-UTR 
MAP3K8 Mitogen-activated protein kinase kinase kinase 8 NM_005204 3’-UTR 
NEURL Neuralized-like (Drosophila) NM_004210 3’-UTR 
NTSR2 Neurotensin receptor 2 NM_012344 3’-UTR 
PCBP4 Poly(rC) binding protein 4 
NM_020418 
NM_033009 
5’-UTR 
5’-UTR 
RNASE4 Ribonuclease, RNase A family 4 NM_194430 5’-UTR 
RPL28 Ribosomal protein L28 NM_000991 
3’-UTR 
3’-UTR 
TSPAN2 Tetraspanin 2 NM_005725 3’-UTR 
WIT1 Wilms tumour upstream neighbour 1 NM_015855 
5’-UTR 
5’-UTR 
5’-UTR 
                                   
    
Table 4.6.  Genes showing dendritic localisation which have recruited MIR elements 
 
Genes where the mRNA is localised to the dendritic compartment as identified by Zhong et al., 
2006 and Pinkstaff et al., 2001.  The gene symbol, protein description and GenBank accession 
number is included. The gene region the MIR has exaptated is listed as CDS (coding sequence) 
or UTR (untranslated region). 
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4.3.  MIR elements and human disease 
 
The functional importance of a gene in a particular tissue is clearly demonstrated if 
mutations in that gene disrupt normal tissue function and thus disease.  The MIR-
containing genes which are involved in human diseases were identified and grouped to 
assist in further understanding the commonality in function of the dataset.  The MIR 
elements may not necessarily be involved directly in the pathology of a disorder, but 
sorting in this manner will highlight the importance of these genes in specific tissue 
functions.  The disease data was collected from AceView at NCBI, which contains 
sequences of human genes involved in disease, either directly via mutation, or 
indirectly.  Therefore information was only included in the analysis if peer reviewed 
publications implicated the gene directly. 
 
It became apparent that a number of MIR-containing genes are implicated and/or 
mutated in a number of human neurological disorders such as Huntington‟s disease, 
mental retardation, schizophrenia and Alzheimer‟s disease (table 4.7).  Other key 
disease groups were noted including, diabetes and insulin resistance, deafness, 
inflammation, rheumatoid arthritis and hypertension.  A total of 28 genes which have 
recruited MIRs were noted to be mutated in retinal degenerative disorders and related 
syndromes (table 4.7).  This retinal disease category was selected for further analysis, 
due to the previous observations of MIR elements being significantly (P < 0.001) 
expressed in neuronal tissues, including the whole eye and the occipital lobe (visual 
processing centre of the brain; figure 4.5).  Retinitis pigmentosa was also a key term 
observed in table 4.1, and the photoreceptor and photoreceptor inner segment where two 
ontology terms noted previously (table 4.4, figure 4.6).  Finally photoreceptors are a 
specialised polarised cell type, with at least one example of an MIR-containing mRNA 
being localised to the photoreceptor outer segement, critical in photoreceptor 
development (Gomi et al., 2000). 
 
The retinal disease category was sorted into particular conditions such as cone/rod 
dystrophies and retinal degeneration, retinitis pigmentosa and Leber congenital 
amaurosis (LCA) which is an autosomal recessive disorder resulting in blindness due to 
abnormal photoreceptor development (table 4.8).  Furthermore some of the conditions 
such as retinal degeneration and mental retardation are characteristics of particular 
syndromes such as Joubert syndrome and Usher syndrome.   
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Disorder  MIR-containing gene  
Alzheimer’s disease  
ADAM19, BCAS2, C1RL, CCR5, CD59, DENND2C, DHCR24, ESR1, HFE, IL1A, 
IREB2, KLC1, MAOB, MAPKAPK2, MPO, PSEN2, SERPINA5, TAP2, TGFB1, 
TGM2, WIT1, YWHAZ  
Deafness and  
hearing loss  
ATP6V1B1, BSND, CATSPER2P1, FXC1, GJB3, KCNK6, IGF1, LHFPL5, MYO15A, 
MYO7A, PIK3AP1, POLG, SCARB2, SLC45A2, TMC1, TP53, TRIOBP, UBE3B, 
USH2A, ZFAND5  
Huntington’s disease  
CCBL2, HAP1, IGF1, IL12RB2, IL8, MAOB, MSX1, SH3BP2, TGM2, TMEM139, 
TP53  
Mental retardation  
ARHGEF6, CHL1, CLN8, DCX, FGD1, FKRP, FREQ, IGF1, JARID1B, LRRC48, 
OPHN1, PIK3AP1, SMC1A, SRGAP3  
Retinal diseases  
AHI1, AIPL1, ATM, BBS7, CACNA2D4, CLN5, CRB1, CX3CR1, CYP4V2, EFEMP2,  
GUCA1B, HPS1, KCNJ13, LRAT, MC1R, MYO7A, NPHP1, NR2E3, NRL, RD3, 
RGS9BP, RHO, RIMS1, SAG, SLC45A2, TGFB1, TPP1, USH2A 
Schizophrenia  
ADRA1A, AHI1, CHL1, CNTF, DBH, DISC1, DPSL2, ERBB3, FREQ, GPR78, HTR4, 
IGF1, MAOB, PLXNA2, SH3TC2, SLC1A2, SYNGR1, TGM2, TP53, VDR, ZFP91  
Diabetes 
(Type I, II and MODY)  
ACE2, ADIPOQ, BDKRB2, BTC, CASR, CCR5, CD4, CD48, CPM, DPP4, ENSA, 
FABP2, FXN, HFE, HK2, HNF4A, IGF1, IL1A, ITGA2, ITGB3, LEP, MAP4K5, MBL2, 
MICA, MYCBP, OAS1, PLAGL1, SAPS3, SCD, SERPINA5, SLC2A5, SLC2A10, 
SLC9A1, SLC11A1, TAP2, TCF2, TGFB1, TGFBR2, TGM2, TNRC6A, TP53, VDR  
Insulin resistance  ADIPOQ, BCAS2, BDKRB2, DENND2C, FABP2, HFE, HNF4A, LEP, SEPN1  
Obesity  
C11orf57, DBH, HFE, IL8, IREB2, MAOB, MAP3K14, POLG, SERPINA5, SFXN5, 
SYT11, TOR1A, VDR  
Hypertension  
ACE2, ADD2, ADIPOQ, ADRA1A, AVPR2, BDKRB2, BMPR2, CAPN5, CCR5, DBH, 
ESR1, IGF1, IL8, LEP, NFXL1, PRRX1,  PTGIS, SCNN1G, SERPINA5, SRC, TGFB1, 
VDR  
Rheumatoid arthritis  
ATP6V1G2, BCAS2, C1RL, CASP10, CDKN2A, CIITA, CUL1, DENND2C, ESR1, 
FSTL1, GAB2, GALNT10, HFE, MFAP3, MBL2, MICA, OSM, RUNX1, SERPINA5, 
SLC11A1, TAP2, TGFB1, TP53, VDR  
 
Table 4.7.  MIR-containing genes which are known to be mutated and/or implicated in 
human disease 
 
The MIR-containing genes are implicated in a large number of human disorders, those 
conditions which appear more commonly have been listed.  The gene symbol is included, 
consult appendix 9.1 for details regarding the MIR coordinates and gene position it has been 
recruited.   
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4.3.1.   Usher syndrome 
 
Usher syndrome is an autosomal recessive condition of which there are three types, 
numbered type I-III, according to the severity, with type III being the least severe 
(Pennings et al., 2003; Möller et al., 1989).  The condition is characterised by 
congenital deafness and blindness including retinitis pigmentosa.  Mutations in MYO7A 
(Myosin VIIA) are associated with the type I syndrome (40% of cases) and mutations in 
USH2A (Usher syndrome 2A) are responsible for most cases of type II Usher syndrome 
(60%; Maubaret et al., 2005).  Both of these genes express mRNA transcripts which 
have recruited MIR elements in the coding sequence.  A splice variant of MYO7A 
where the stop codon is provided by the MIR element, results in a truncated protein 
product (appendix 9.8), of which the MIR element is providing the stop codon.  Two 
transcript variants of USH2A have also been described and an MIR element has been 
exaptated in the middle of protein-coding exon 45 of the full length isoform. 
 
4.3.2.   Joubert syndrome 
 
Joubert syndrome (JBTS) is an autosomal recessive disorder characterised by multiple 
symptoms including retinitis pigmentosa, renal disease, physical deformities and 
malformation of the brain and subsequently ataxia and mental retardation (Valente et 
al., 2008).  Genes which have recruited MIR elements and are mutated in JBTS are 
AHI1 (Abelson helper integration site 1) and NPHP1 (nephronophthisis 1 (juvenile)).  
There is an alternative truncated transcript of AHI1 in which an MIR element is 
providing the stop codon; this is discussed further in chapter 5.  NPHP1 has exaptated 
an MIR element in the 3‟-UTR and mutations in NPHP1 are known to be responsible 
for Joubert syndrome, furthermore NPHP1 is the causative agent in the majority of 
juvenile nephronophthisis cases, a type of autosomal recessive kidney disease and a 
symptom developed in Joubert syndrome cases (Simms et al., 2009).   
 
 
  
Gene 
Symbol 
Gene description 
MIR 
location 
Disorder details 
AHI1 Abelson helper integration site 1 TAG RD; Recessive JS (includes RP and LCA). 
AIPL1 Aryl hydrocarbon receptor interacting protein-like 1 3'-UTR 
Dominant CRD; Recessive LCA and other early onset severe retinal 
dystrophies. 
BBS7 Bardet-Biedl syndrome 7 3'-UTR Recessive Bardet-Biedl syndrome. 
CACNA2D4 
Calcium channel, voltage-dependent, alpha 2/delta 
subunit 4 
3'-UTR 
3'-UTR 
3'-UTR 
RD; Recessive CRD. 
CLN5 Ceroid-lipofuscinosis, neuronal 5 3'-UTR Neuronal ceroid lipofuscinosis. 
CRB1 Crumbs homolog 1 (Drosophila) 3'-UTR 
Recessive RP; Recessive LCA; Dominant pigmented paravenous 
chorioretinal atrophy; Early onset severe retinal dystrophies; Blindness. 
CYP4V2 
Cytochrome P450, family 4, subfamily V, polypeptide 
2 
3'-UTR RD; Recessive Bietti crystalline corneoretinal dystrophy. 
GUCA1B Guanylate cyclase activator 1B (retina) 3'-UTR RD; Dominant RP; Dominant MD.  
HPS1 Hermansky-Pudlak syndrome 1 3'-UTR Oculocutaneous albinism. 
KCNJ13 
Potassium inwardly-rectifying channel, subfamily J, 
member 13 
3'-UTR Dominant vitreoretinal degeneration, snowflake. 
LRAT 
Lecithin retinol acyltransferase (phosphatidylcholine-
retinol O-acyltransferase) 
3'-UTR RD; Blindness; Recessive RP; Recessive LCA.  
MC1R 
Melanocortin 1 receptor (alpha melanocyte 
stimulating hormone receptor) 
3'-UTR Oculocutaneous albinism. 
MYO7A Myosin VIIA TAG Recessive US type 1b; Recessive congenital deafness without RP. 
NPHP1 Nephronophthisis 1 (juvenile) 3'-UTR 
Recessive Senior-Loken syndrome; Recessive nephronophthisis, juvenile; 
Recessive JS; RD; RP. 
NR2E3 Nuclear receptor subfamily 2, group E, member 3     5'-UTR 
Recessive enhanced S-cone syndrome; Recessive RP; dominant RP; RD; 
MD; Retinal dysplasia; Retinal dystrophies. 
NRL Neural retina leucine zipper  3'-UTR Dominant and recessive RP; RD; Blindness. 
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Gene 
Symbol 
Gene description 
MIR 
location 
Disorder details 
RD3 Retinal degeneration 3 3'-UTR RD; Recessive LCA and other early onset severe retinal dystrophies. 
RGS9BP Regulator of G protein signalling 9 binding protein 5'-UTR Recessive delayed cone adaptation; Brandyopsia; Retinal and MD. 
RHO Rhodopsin (opsin 2, rod pigment) (retinitis 
pigmentosa 4, autosomal dominant) 
3'-UTR 
3'-UTR 
Dominant RP; Dominant congenital stationary night blindness; Recessive 
RP; Retinal dystrophies; RD; MD 
RIMS1 Regulating synaptic membrane exocytosis 1 3'-UTR RP; Dominant CRD. 
RPGR 
Retinitis pigmentosa GTPase regulator 3'-UTR 
Recessive; X-linked RP, Dominant; X-linked CRD 1; Recessive X-linked 
atrophic MD. 
SAG 
S-antigen; retina and pineal gland (arrestin) 3'-UTR 
Recessive Oguchi disease; Recessive RP; Congenital stationary night 
blindness. 
SLC45A2 
Solute carrier family 45, member 2 
3'-UTR 
3'-UTR 
Oculocutaneous albinism. 
TPP1 Tripeptidyl peptidase I 3'-UTR Neuronal ceroid lipofuscinosis. 
USH2A Usher syndrome 2A (autosomal recessive, mild) CDS Recessive Usher syndrome, type 2a; Recessive RP. 
 
Table 4.8. The involvement of MIR-containing genes in specific retinal disease and associated syndromes  
The HGNC gene symbol, protein description and position of the exaptated MIR element are listed; CDS, coding sequence; UTR, untranslated region; TAG, MIR 
element provides termination codon sequence.  Retinal diseases are abbreviated as follows: CRD, cone rod dystrophies; JS, Joubert syndrome; LCA, Leber 
congenital amaurosis; MD, macular dystrophies; RD, Retinal degeneration; RP, Retinitis pigemntosa; US, Usher syndrome. 
 
 
C
h
ap
ter 4
. F
u
n
ctio
n
al sig
n
ifican
ce o
f th
e ex
ap
tatio
n
 o
f an
 M
IR
 elem
en
t  
9
1
 
Chapter 4. Functional significance of the exaptation of an MIR element 
 
  
92 
 
  
When analysing the MIR-gene dataset a total of 12 genes were noted to be mutated in 
recessive, dominant and X-linked retinitis pigmentosa cases (table 4.8).  For example 
RPGR (retinitis pigmentosa GTPase regulator) and NRL (neural retina leucine zipper) 
have recruited MIR elements in the 3‟-UTR.  Mutations in RPGR are responsible for the 
majority of cases of the X-linked form of retinitis pigmentosa (RP), and there are two 
splice variants of RPGR with the full length transcript being composed of 19 exons 
(Khanna et al., 2005).  A second transcript referred to as RPGR-ORF15 is generated by 
reading through the donor splice site of exon 15 into the intronic region which contains 
the exptated MIR element; translation terminates at an alternative in-frame stop codon 
(figure 4.9).  This novel region of RPGR-ORF15 is mostly comprised of a GAA triplet 
repeat sequence and as such is a source of glutamic acid, the function of which is 
undetermined.  
 
The significance of this splice variant is demonstrated by the mutations observed in the 
novel coding region, of which 80% of the documented RPGR mutations are located and 
60% are specifically linked to X-linked RP (Jin et al., 2007; Vervoort and Wright, 2002; 
Vervoort et al., 2000).  When looking specifically at the exaptated MIR element of 
RPGR-ORF15 the MIR sequence demonstrated sequence identity to miRNA target sites 
(section 4.4), which may be a means of regulating or suppressing the expression of the 
isoform predominantly responsible for the retinitis pigmentosa cases; however the non-
mutated form of the shorter transcript may be significant as once expressed will be a 
rich source of glutamate, essential in neuronal excitability. 
  
 
      
 
 
 
 
 
Figure 4.9.  Major isoforms of human retinitis pigmentosa GTPase regulator (RPGR) 
 
The exonic composition begins at constitutive exon 7.  A) The full length RPGR mRNA transcript 
composed of 19 exons; B) Truncated transcript of RPGR due to reading-through intron 15 
which contains 80% of the RPGR mutations, an MIR element is recruited in the 3’-UTR (green). 
  Exon 7                 8          9    10  11             12 13   14 15                              16 17 18         19 
A 
 
B 
Coding exon       Untranslated region                 MIR element 
Intronic sequence      Mutation hotspot  
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NRL is an intrinsic regulator of mammalian photoreceptor differentiation and function, 
and missense mutations are associated with the development and progression of 
recessive and dominant RP (Bessant et al., 2003).  The common reference nucleotide 
sequence of NRL is composed of three exons with an MIR element recruited in the 3‟-
UTR.  The NRL transcript is <2 kb with a protein product of ~26 kDa.  A further non-
reference cDNA clone was identified in the sequence databases (accession number 
BC012395), which is truncated due to an alternative polyadenylation (poly(A)) site 
(figure 4.10a).   
 
There is a canonical poly(A) site (ATTAAA) 20bp upstream of the cleavage site (figure 
4.10b).  To confirm the expression of the shorter transcript RP-PCR was performed to 
amplify fragments of the two transcript variants from human retina cDNA.  The 
antisense primer of the shorter transcript incorporated a portion of the poly(A) tail so as 
to differentiate between the two isoforms, following which both transcripts were 
amplified (figure 4.10c). The poly(A) site of the shorter transcript appears to be 
conserved only in primates with similar but incomplete sequences in earlier mammals 
(figure 4.10d).   
 
Intriguingly the protein-coding sequence will be retained in both the NRL products with 
the only notable difference being the addition of 720bp of nucleotide sequence in the 3‟-
UTR of the longer transcript (with the MIR).  If these isoforms display differences in 
function, stability or localisation it is possible that the additional nucleotide sequence is 
involved in this control.  A similar observation has previously been made with 
mammalian insulin-like growth factor 1 (IGF1), whereby a splice variant encodes an 
identical protein but with a larger MIR-containing 3‟-UTR exon (Hughes, 2000).  The 
larger IGF1 mRNA has been demonstrated to have a significantly higher rate of decay 
compared with the other IGF1 isoforms (Hepler et al., 1990), and it has been suggested 
that the MIR element may play a part in the reduced half-life (Hughes, 2000). 
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   Lg        TTCAGGGTTTTCAACCTGTAACACATTAAAGCTGTAATTAGCAATGAGGC 1248 
   Sh        TTCAGGGTTTTCAACCTGTAACACATTAAAGCTGTAATTAGCAAAAAAAA 1250 
             ********************************************  *           
           
   Lg        TGTATTTTCATTCTGAAGCTTGTAACCTCCCCATTTTAGCACTACAGAAT 1298 
   Sh        AAAA---------------------------------------------- 1254 
 
   Lg        TTTCAAGATTTCAATATCCAACAACTAGATAGATTAGGACCTCTATCCGA 1348 
   Sh        -------------------------------------------------- 
 
 
                 
 
 
  Human     TAATTCAGGGTTTTCAACCTGTAACACATTAAAGCTGTAATTAGCAATGAGGCTGTATTT 3798 
  Chimp     TAATTCAGGGTTTTCAACCTGTAACACATTAAAGCTGTAATTAGCAATGAGGCTGTATTT 3435 
  Macaque   TAATTCAAGGTTTTCAACCTGTAACACATTAAAGCTGTAATTAGCAATAAGGCTGTATTT 3854 
  Dog       TAATTCAAGGTTTTCAACCTGTAGTGCATGAAGGTGGTAATTAGCAATGAAGCC-T---- 2131 
  Cow       TAATACAAGGCTTTCAACCTGTAGTGCAGTAAGGTGGTAATTAGCAATGAGGCTGTGTTT 2056 
  Mouse     TAATTCAAGGTTTTCAATCTGTAGTGCATTAATGCTGTAATTAACAATGAAGCTGCATTT 4100 
  
 
 
Figure 4.10.  Transcript variants of human neural retina leucine zipper (NRL) 
Abbreviations: Lg, full length NRL mRNA transcript; Sh, Isoform with a shorter 3’-UTR exon due 
to an earlier poly(A) site (accession: Sh, BC01239; Lg, NM_006177).   A) Exonic arrangement of 
NRL outlining the alternative polyadenylation sites, the MIR element (green) is located in the 
full length transcript only.  Coding regions are in red and UTR exons in blue.  B) Pairwise 
sequence alignment of the full length transcript and the shorter cDNA sequence highlighting 
the position of the poly(A) site (boxed red) and the poly(A) tract (italics).  C) Gel 
electrophoresis image of fragments amplified using RT-PCR confirming the expression of the 
alternative transcripts.  Visualised on a 2% agarose gel with 1X SybrSafe.  DNase and RNase-
free water was used as a negative control and GAPDH (738bp) as a positive control.   Fragment 
sizes are 966bp (Sh) and 1198bp (Lg). D) Multiple sequence alignment the NRL cDNA sequence 
highlighting the conservation of the poly(A) site (boxed red) for a selection of mammals.  
Green sequences are completely conserved, pink identical residues, blue similar and black 
completely different.  Sequence conservation was determined using the ClustalW2 multiple 
alignment tool (http://www.ebi.ac.uk/Tools/clustalw2/index.html; accession numbers 
appendix 9.3).  
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4.4. The role of MIR elements in the localisation of mRNA 
  
MiRNAs have been shown to block protein translation and alter mRNA stability of 
target genes (Bartel, 2004).  The ability to suppress translation allows for mRNA 
translocation to specific cellular compartments and spatial expression of protein 
(Svoboda and Cara, 2006).  It has been suggested that retrotransposons may be 
precursors for miRNAs (Devor et al., 2009; Piriyapongsa et al., 2007; Smalheiser and 
Torvik, 2006; Smalheiser and Torvik, 2005).  Given that several of the MIR containing 
mRNAs are known to be dendritically localised (potentially via miRNAs) a number of 
genes were selected and screened for putative miRNA binding sites and precursor stem-
loops.  Due to the size of the dataset of genes which have recruited MIR elements 
(appendix 9.1) genes were selected specifically if mRNA localisation had been 
previously suggested or if the genes were known to be functional in polarised cells 
where mRNAs are frequently reported to be localised.  Using this approach eight 
transcripts were found to contain one or more miRNA target sites located within the 
exaptated MIR sequence (table 4.8; figure 4.8). 
 
Of the genes investigated in detail, AHI1, NRL, RHO and RPGR have been described 
earlier in this chapter, as they are known to be mutated in retinal disease (table 4.7; 
Valente et al., 2006; Bessant et al., 2003; Liu et al., 2009; Vervoort et al., 2000).  The 
mRNA transcripts for CAMK2A, DDN and NEURL are localised to the dendritic 
compartment of hippocampal neurones and are suggested to be involved in synaptic 
function and plasticity (table 4.5; Kremerskothen et al., 2006; Timmusk et al., 2002; 
Mayford et al. 1996) and CD59 is a leukocyte antigen involved in the complement 
cascade and the mRNA is also noted to be dendritically localised (table 4.5). 
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Gene  
symbol 
MicroRNA 
Name  
Type mRNA  (bp) MIR  (bp) Details 
AHI1 
hsa-miR-345 
hsa-miR-615-5p 
Target 
Target 
1851  1873 
1882  1905 
1835  1947 Photoreceptor 
CAMK2A 
hsa-miR-24-1* 
hsa-miR-940 
Target 
Target 
4108  4130 
4225  4247 
4087  4250 
Dendritically 
localised 
CD59 
hsa-miR-175 
hsa-miR-640 
Target 
 Stem-loop 
5474  5497 
5951  6012 
5456 5560 
5900 6098 
Dendritically 
localised 
DDN 
hsa-let-7a  
hsa-miR-466 
Target 
Target 
3624  3645 
3662  3684 
3548  3730 
Dendritically 
localised 
NEURL hsa-miR-1291 Target 3835 3866 3833  3952 Dendritically 
localised 
NRL 
hsa-miR-1207 
hsa-miR-1266 
hsa-miR-615-5p 
Target 
Target 
Target 
1486  1510 
1501  1518 
1479  1504 
1441  1603 Photoreceptor 
RPGR 
hsa-miR-136 
hsa-miR-101* 
Target 
Target 
4375  4396   
4397  4420 
4351  4435 Photoreceptor 
RHO 
hsa-miR-20b 
hsa- let-7a-2* 
Target 
Target 
1744  1757 
1758  1779 
1610  1781 Photoreceptor 
 
Table 4.9.  MIR-containing genes which have sequence homology to known miRNA targets 
The miRNA name has been included and the co-ordinates of the mRNA where the homology 
has been detected.  The position the MIR element has been recruited is included as a 
comparison.   
 
 
 
A   AHI1 
         hsa-miR-345                                                      hsa-miR-615-5p 
microRNA       CUCGGGACCUGAUCCUCAGUCG         CUAGGCUCG--UGGCCCCUGGGGG 
                ||| || ||||  |:||||||         || |:||||  ||| ||||:||| 
Human   GUGGAAAAAGCACUAGACUCAGGGUCAGCCAGCCAGAAGAACUGAGCCGACCUGGGAUCCCACCA 1910 
 
B   CAMK2A 
 
                                                                                    hsa-miR-24-1* 
microRNA                      UGACUAUAGUCGAGUCAUCCGU  
                      | |||| | :| | ||||||| 
Human   GUGGACUGCAGGGGAAAGAGCAGUGAUUUGGGGUGAGUAGGCUUCAAUUCCCAGCUCUGACCA  4150 
 
 
                                                                                    hsa-miR-940 
microRNA                          CC-CCUC-GCCCCCGGGACGGAA  
                             || |||| | | ||:|||||||| 
Human    CUGCCAGAGGAAACUGAGCUGGAGGAGCCUGAGGUCCUGCCUUUCAUUGGCUGACACACCUCC  4267 
 
 
 
5’                                                                                                                                                          3’ 
5’                                                                                                                                                    3’ 
5’                                                                                                                                                      3’ 
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C   CD59  
    
                                                                                 hsa-mir-640     
Hairpin   GUGACCCUG-GGCAAGUUCCUGAAGAUCAGACACAUCAGAUCCCUUAUCUGUAAAAUGGGCA  61   
          | ||||||  |||||||| || ||  | | |  | |||| |  || ||||| |||||| | | 
CD59      GCGACCCUCAGGCAAGUUACUUAACCUUACAUGCCUCAGUUUUCUCAUCUGGAAAAUGAGAA  6012  
 
 
                                                                               hsa-miR-175 
microRNA            UCGAUCAGUU-CGCGCCAAC-ACCCCC 
            ||||||::| || |||||| ||||| 
Human     GCCCAAGGUAGCAUGGCUAGUUGAUGCCGGUUGAUGGGGCUUAAACCCAGCUCCCUCAUCU  5521 
 
 
D   DDN 
              hsa-leU-7a                                                                     mmu-miR-466  
       UUGAUAUGUUGGAUGAUGGAGU                cAGAAUACACACGCACAUACAUa 
      :: | ||:|| |  |||||||:                 |:| ||| |    ||||||||    
Human GGGUUUAUAAACACCUACCUCGCAGGGUUGUUGUGAGGAUUUAAUGCGAUAAUGUAUGUAA  3684 
 
 
E  NEURL 
 
                                                                                      hsa-miR-1291 
microRNA                 UGACGACCAGA---A--GUCAGUCCCGGU   
                           |||||   |||   |  ||| ||||||   
Human       UUGCAUCCAUCAGAGACUGCACCUCUGUGUGGCAGGCAGGGCAUGGGUUUUAGU  3874 
 
 
F   NRL 
 
                                                                               hsa-miR-1207                              
microRNA                      GGGGAGGGU---C-GGAGGGACGGU  
                               |:||:|||   | :| |||||:|| 
Human        CCUGGGUCCUAGUCCCAGCUCUUCCAUGGGAUCCCCCUGUCACCCUGAGCAAAUCAGU  1526 
 
 
 
                                                                                                                       hsa-miR-1266                              
microRNA                                    UCGGGACAAGAUGUCGGGACUCC  
                                              ||||||    || ||||||| 
Human       CCUGGGUCCUAGUCCCAGCUCUUCCAUGGGAUCCCCCUGU----CA-CCCUGAGCAAAU  1522 
 
 
 
                                                                   hsa-miR-615-5p                              
microRNA               CUAGGCUCG---UGG-CCCCUGGGGG 
                         ||| |||    ||  ||||:|||| 
Human        CCUGGGUCCUAGUCCCAGCUCUUCCAUGGGAUCCCCCUGUCACCCUGAGCAAAUCAGU  1526 
 
 
5’                                                                                                                                                      3’ 
5’                                                                                                                                                  3’ 
5’                                                                                                                                                  3’ 
5’                                                                                                                                  3’ 
5’                                                                                                                                          3’ 
5’                                                                                                                                             3’ 
5’                                                                                                                                          3’ 
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G   RPGR  
 
                                                    hsa-miR-136                             hsa-miR-101* 
microRNA       AGGUAGUAGUUUUUUUACCUCAUCGUAGUC-GUGACACUAUUGAC 
       |:| |||||   |||||||||| | || || :: ||||||||||| 
Human CUCAGUUUCUUCAUCUCUAAAAUGGAGUUGGAUGAGAUGAUGUGAUAACUGCAGUCC  4426 
 
 
 
H   RHO  
                 
                                                            hsa-miR-20b                                    hsa-let-7a-2* 
microRNA           GAUGGACGUG-AUACUCGUGAAAC ccUUUCGAUCCUCCGACAUGUC 
           |||: ||::: | | |||||||||   | ||| | || ||||||||| 
Human  UGUGUGUGUCUAUGUGUGUGUUUCAGCACUUUGUAAAUAGC-AAGAAGCUGUACAGAUUCUAG  1788 
 
 
 
 
Figure 4.11.  MiRNA targets or stem-loop precursor sequences identified within recruited 
MIR sequences 
Potential miRNA binding sites were identified by accessing the data available in the miRBase, 
the miRNA registry available at the Sanger Institute, which contains >5000 miRNA gene loci 
(http://microrna.sanger.ac.uk/).  All predicted miRNA target sites outlined (orange) reside on 
the sense strand and within MIR sequences which have been recruited in the 3’-UTR of the 
transcript. A) A truncated transcript of the gene Abelson helper integration site 1 (AHI1) has 
two miRNA target sites (accession NM_001134832).  B) The reference sequence of the CD59 
antigen, complement regulatory protein (CD59) has recruited a total of five MIR elements and 
has 18 different miRNA target sites and a putative precursor miRNA sequence had also been 
detected (accession NM_000611).  C) Calcium/calmodulin-dependent protein kinase IIα 
(CAMK2A) has two predicted miRNA target sites which is present in both reference sequences 
(accession NM_015981).  D) Dendrin (DDN) whose function is unknown, but is found to be 
localised to the dendritic compartment, has two miRNA binding sites in the reference 
sequence (accession NM_015086). E) Neuralized homolog (Drosophila) (NEURL) has a miRNA 
target site also in the reference sequence (accession NM_004210).  F) Neural retina leucine 
zipper (NRL) contains three miRNA target sites which are not present in non-reference 
sequence with the shorted 3’-UTR (accession NM_006177).  G) The truncated transcript of 
Retinitis pigmentosa GTPase regulator (RPGR) has two potential miRNA target sites (accession 
NM_001034853).  H) Rhodopsin (RHO) has two miRNA target sites positioned within an MIRb 
element which has been exaptated in the 3’-UTR of the RefSeq transcript (accession 
NM_014850).   
 
 
5’                                                                                                                                        3’ 
5’                                                                                                                                                      3’ 
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4.5. Discussion 
 
A large area of research has focussed on the 'parasitic' role of TEs, and the deleterious 
and mutagenic impact on the host following insertion (Kidwell and Lisch, 2001).  
Ultimately many TEs behave as mutagens due to the abundance of repeat elements in all 
genomes; however it is also inevitable that some may become „domesticated‟, given 
sufficient time (Sinzelle et al., 2009; Volff, 2006; Miller et al., 1999).  Over the past 15 
years attention has focussed primarily on the role of TEs in shaping genomes during 
evolution, and TEs have long been known to play a part in the evolution and function of 
plant genomes (Zilberman and Henikoff, 2005; Piriyapongsa and Jordon, 2008).  Less 
information is available for a general functional role of retrotransposons in vertebrates; 
even though TEs would have provided a source of raw genetic material, which may 
have assisted in the evolution of many species (Makałowski, 2000).  Most TEs are 
located predominantly within introns, suggesting that the elements are providing cis-
acting regulatory sequences, which may be involved in mediating gene expression 
(Jurka, 2008; Sela et al., 2007; Britten, 2006; Nekrutenko and Li, 2001).   
 
Approximately 1359 human genes (5%) have recruited MIRs, although this is likely to 
be an underestimate, as there may be as yet undiscovered MIR-containing transcripts, 
particularly ncRNAs.  It is not clear whether exaptation is a random event, or whether 
there is any selection for the exaptation of MIRs on a genome-wide scale.  It is likely 
that for any one gene there may be a selective advantage, or at least no selective 
disadvantage in exaptation.  Particularly when retained in coding sequence or when 
providing alternative splicing, which may have participated in the modification and 
development of novel gene function, shaping the mammalian genome and 
transcriptome.   
 
The dataset of human genes which have recruited MIR elements were screened for 
commonality in function by collecting and examining gene ontology data, tissue 
expression profiles, potential miRNA targets sites or precursors and the involvement of 
the genes in human disorders.   Throughout this process specific functional roles were 
consistently noted, predominantly neuronal function, vision and immune responses.  For 
example examining gene expression profiles revealed a significant proportion of the 
MIR-containing genes being expression in neuronal tissues specifically brain regions. 
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Significant overrepresentation (P < 0.001) was noted for the amygdala, which is 
involved in fear, emotion and aggressive behaviour; the olfactory bulb which is the site 
of sensory perception and smell, and the occipital lobe which is the visual processing 
region in the mammalian brain, it is also the area where epileptic seizures originate.     
 
The Gene Ontology (GO) was a useful resource when collecting functional information 
and a number of ontology terms were overrepresented for the MIR-containing genes 
when comparing to the rest of the genome, including the dendrite, photoreceptor, and in 
neurotransmitter transport. Further significant ontology terms were noted relating to 
immunological responses such as wound healing and cytokine receptor activity.  When 
collating the known disorders which the MIR-containing genes are implicated or 
mutated, several groups included neurological conditions; specifically Alzheimer‟s 
disease, retinal degeneration, Parkinson‟s disease, schizophrenia and mental retardation. 
 
4.5.1. MIR elements and the mammalian visual system 
 
The involvement of the MIR-containing genes in the mammalian visual system and in 
retinal disease was a recurrent observation.  Preliminary screening of the genes for 
significant keywords revealed „vision‟ and „retinitis pigmentosa‟ as two top terms.  
Furthermore when examining tissue expression data for the complete set of the genes 
which have recruited MIRs, three were significantly overrepresented (P < 0.01); the 
ciliary ganglion, occipital lobe (vision processing centre) and the whole eye.  The ciliary 
ganglion is a structure situated behind the orbit of the eye and is rich in sensory 
neurones and regulates the constriction of the pupil when exposed to light (Thakker et 
al., 2008).   
 
Vision in mammals is a complex sequence of events, involving multiple cell types.  The 
retina consists of photoreceptors, retinal ganglion cells, amacrine cells, müller cells and 
bipolar cells (Jeon et al., 1999).  Photoreceptors are a specialised neurone which 
function exclusively in phototransduction and perceive an image as a pattern of light.  
The light is converted into neuronal signals and transmitted to the brain via the retinal 
ganglion cells.   Positioned at the distal end of the photoreceptor, away from the nucleus 
is the outer segment which is composed of a collection of stacked membrane disks.  The 
outer segment contains visual pigments and other phototransduction components and is 
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the region where the visual transduction cascade occurs (figure 4.9; Pepe, 2001).  In 
vertebrates there are two classes of photoreceptor cells, rods and cones.  Rods are the 
most abundant cell type in the retina and make up at least 70% of the total cells (Carter-
Dawson and LaVail, 1979).  Rods mediate vision during dim light and produce 
achromatic vision (black and white) and as such contain only one photopigment (Oh et 
al., 2008).  Photoreceptor cones are less sensitive to light and are responsible for vision 
during bright light.  In humans and closely related primates there are three types of 
photopigments in cone cells, which detect different wavelengths of light, the 
information perceived by both types of photoreceptor is processed in the occipital lobe; 
a region noted where the MIR-containing genes are frequently expressed (P < 0.001).   
 
 
           
 
 
 
Figure 4.12.  Anatomy of a rod photoreceptor cell 
The inner segment mainly houses mitochondria and ribosomes.  The outer segment consists of 
a tightly packed membrane discs bearing the photopigment (rhodopsin).  The synaptic 
terminal connects to bipolar cells and the outer segment is connected to the retinal pigment 
epithelium (RPE) which is situated just outside the retina (Image adapted from Liu et al., 2007)  
 
The single photopigment present in rod cells is encoded by the GPCR rhodopsin 
(RHO), which is expressed almost exclusively in this cell type.  RHO detects 
electromagnetic radiation when bound to a derivative of vitamin A and when activated 
undergoes a conformational change triggering the visual transduction cascade.  When 
photons of light decrease RHO is phosporylated by rhodopsin kinase.  Phosphorylated 
RHO is a substrate for arrestin (SAG), which renders it fully deactivated.  Both RHO 
and SAG have recruited MIR elements in the 3‟-UTR.  Two further genes which have 
also exaptated MIR repeats in the 3‟-UTR are the transcription factors neural-retina-
leucine-zipper (NRL) and NR2E3, which is a photoreceptor-specific orphan nuclear 
receptor.  Both NRL and NR2E3 are key components of mammalian photoreceptor 
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differentiation and retinal development (Hendrickson et al., 2008).  For example NRL 
determines the fate of precursor photoreceptor cells, by mediating the formation of rods 
at the expense of cone development, partly by modulating the expression of NR2E3 by 
directly bind to the promoter region (Oh et al., 2008).  In transgenic mice lacking NRL 
expression, rod cells are converted to cones and NR2E3 expression is abolished (Mears 
et al., 2001).  NRL is also noted to regulate the expression of RHO by binding to the 
promoter region (Mitton et al., 2000).   
 
Other genes have recruited MIRs which are important in retinal function but are not 
mutated in retinal disease.  Ciliary neurotrophic factor (CNTF), is encoded by a single 
transcript with an MIR element in the 3‟-UTR.  CNTF promotes rod photoreceptor 
survival, reduces RHO protein levels and upregulates SAG expression in vivo (Wen et 
al., 2006).  CNTF is generally involved in the survival of neurons and as such mutations 
are noted in a number of neurological disorders including schizophrenia, Huntington‟s 
disease and multiple sclerosis (Lin and Tsai, 2004; Emerich et al., 1997; Giess et al., 
2002).  The retina specific protein PAL (LRIT1) is expressed specifically in 
photoreceptors and has been shown to be significant in the development of the outer 
segment, as the mRNA is specifically localised to this region of photoreceptors (Gomi 
et al., 2000).  The retina-specific gene F379 (confirmed by RT-PCR and northern blot) 
is composed almost entirely of TEs, with an Alu and MIR element comprising the 
majority of the predicted coding sequence and an LTR element in the 3‟-UTR (Mah et 
al., 2001).  F379 is uncharacterised and there is currently no evidence to support the 
translation of a protein product, either in the sequence databases or in publications.  
Sequence homology detected to other proteins is due to the recruitment of other Alus 
and/or MIR elements and it is possible that F379 functions as an ncRNA. 
 
4.5.2. MIR elements and the translocation of mRNA in neuronal cells 
 
It is clear that a number of genes which have recruited MIR elements are expressed in 
polarised cell types including neurones of the brain, photoreceptors and lymphocytes.  
The process of translocating mRNA in asymmetric polarised cells has long been 
observed in drosophila during oogenesis (Berleth et al., 1988; St Johnston, 1995) and 
the mechanisms in vertebrates are being unravelled.  It appears that mRNA localisation 
is achieved by a number of means, including diffusion to a localised anchor, active 
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transport and via miRNAs; processes directed by cis-acting elements, which are usually 
in the 3‟-UTR (Mohr and Richter, 2001; Ben Fredj et al., 2004).  Fine tuning protein 
expression and post-transcriptional control may be crucial when rapid responses and 
changes in protein levels are required.  The full activities of cis-acting elements in the 
3‟-UTRs of vertebrates remain to be determined; however the formation of dsRNA 
structures and the binding of complementary ncRNAs are known components (Mohr 
and Richter, 2001; Le and Maizel, 2007). 
 
Many human transcripts do not encode for protein such as tRNA, rRNA and small-
nuclear RNA (snRNA) and the role of other ncRNAs in gene regulation is gradually 
becoming clear with many being known gene regulators.  ncRNA has been shown to 
mediate processes such as mRNA metabolism, stability, RNA editing, imprinting and 
long-term memory (Claverie, 2005; Mattick and Makunin, 2006; Storz et al., 2004; 
Royo and Cavaillé, 2008; Mercer et al., 2008).  A widely studied class of ncRNAs are a 
family of small (20-22nt) RNAs which are divided into the small-interfering RNAs 
(siRNA) and miRNAs (Ambros and Chen, 2007).  It is also apparent that human gene 
expression may be regulated by miRNAs and Friedman et al., (2009) predicted miRNA 
target sites in the 3‟-UTRs of >45,000 human transcripts.   
 
The transport of RNA to the dendritic compartment is an essential process in synaptic 
plasticity, and is linked to learning and memory (Sossin and DesGroseillers, 2006).  As 
RNA transport to post-synaptic sites and translational suppression allows for local, 
selective protein synthesised on demand, in response to synaptic stimulation.   As a 
consequence synapses have individual molecular identities and regulate their own 
morphology and efficiency (reviewed by Dahm et al., 2007).  Calcium/calmodulin-
dependent protein kinase II alpha (CAMK2A) is known to be involved in synaptic 
plasticity; the mRNA of dendrin (DDN), a gene of unknown function, is also 
dendritically localised suggesting a role in synaptic function and plasticity 
(Kremerskothen et al., 2006; Pinkstaff et al., 2001).  Both of these genes have recruited 
two independent MIR elements in the 3‟UTR.   
 
CAMK2 is encoded by four genes α, β, γ and δ, of which CAMK2A is the only subunit 
which is translocated to the dendrite for translation (Tobimatsu and Fujisawa, 1989).  
Mori and colleagues (2000) identified two dendritic-targeting elements (DTE) within 
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the 3‟-UTR and a third DTE was identified in a different region of the 3‟-UTR by 
Blichenberg et al., (2001).  CAMK2A has recruited two MIR elements one of which is 
located within the DTE region of CAMK2A identified by Mori et al., (2000), the 
second MIR element was noted to contain two predicted miRNA target sites following 
screening against miRNA databases.  DDN has a DTE situated within a 1kb region of 
the 3‟-UTR (Kremerskothen et al., 2006), an MIR element resides directly within the 
central region of this control element.  The second MIR is situated 200bp upstream of 
the DTE and further investigation revealed two putative miRNA binding sites located 
within this MIR element.  One detail to consider is that all neuronal cis-acting 
localisation elements, including DTEs and miRNAs targets are situated exclusively in 
the 3‟-UTR, and almost 75% of the MIRs have been integrated in this untranslated gene 
region. 
 
Recent studies reveal that miRNA-mediated translational control appears to be a 
fundamental process in synaptic plasticity. Several components of the RNAi 
interference pathway are found to be enriched in dendritic spines, compared to the cell 
body; Dicer the endonuclease which cleaves pre-miRNA and initiates the formation of 
the RNA-induced-silencing-complex (RISC; Bernstein et al., 2001) and eIF2c a 
component of the RISC (Lugli et al., 2005).  MiRNAs can silence translation and assist 
in translocating mRNA to the dendritic compartment, and upon deactivation the 
suppression is released targeting protein expression to the synapse (Ashraf and Klunes, 
2006; Schratt et al., 2006; Kosik, 2006).   
 
Ashraf and colleagues (Ashraf et al., 2006) noted persistent mRNA localisation in the 
antennal lobe synapses of the fruit fly following olfactory-avoidance learning.  The 
team further observed a 25-fold increase in CAMK2A expression in the brains of dicer-
2 null mice, suggesting that RNAi pathways may participate in mRNA localisation and 
translational regulation.  Ashraf et al., (2006) further identified two putative miRNA 
target sites in the 3‟-UTR of CAMK2A and concluded that miRNAs and the RISC 
pathway play a crucial role in regulating localised protein synthesis in the synapse 
during long-term memory formation.  
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4.5.3. MIR elements as a source of miRNA targets sites and precursor sequences 
 
It has been previously hypothesised that MIR elements have the potential to form 
dsRNA due to the homology between individual MIR insertions (Hughes, 2000).  These 
dsRNA may then be cleaved into siRNAs (Zeng and Cullen, 2005).  SINEs may also be 
a source of miRNA precursors and the miRNAs; miR-95 and miR-151* display 
sequence complementary to the MIR-LINE2 elements located within the 3‟-UTRs of 
mammalian mRNAs (Smalheiser and Torvik, 2005).  Piriyapongsa et al., (2007) 
identified 18 miRNAs derived from transposable elements, 14 of which are related to 
the LINE2 and MIR families.  Overall it appears that the recruitment of TEs may have 
played a crucial role during mammalian evolution by generating miRNA target sites and 
possibly as miRNA precursors.  Furthermore, the mechanism described by Smalheiser 
and Torvik appears to be a phenomenon exclusive to the expansion of mammalian 
genomes as no similar miRNA precursors were detected in chicken, Drosophila or 
C.elegans (Smalheiser and Torvik, 2005).   
 
Putative miRNA target sites were identified within the exaptated MIR sequence of eight 
human genes; including AHI1, CD59, NEURL, RPGR and the recently discussed NRL, 
RHO, DDN and CAMK2A.  All eight genes demonstrate localisation of mRNA to 
specific subcellular compartments, such as the dendritic compartment of neurones or the 
outer segment of rod photoreceptor cells (Zhong et al., 2006; Timmusk et al., 2002; 
Pinkstaff et al., 2001).  It is possible that the predicted miRNA target site located within 
the recruited MIR sequence may be suppressing translation during this process.  CD59 
is a leukocyte antigen involved in the complement pathway which is expressed in a 
number of tissues and CD59 deficiency is involved in the development of several 
disorders including Alzheimer‟s disease and neurodegeneration (Yang et al., 2000).  
CD59 has also been suggested to protect neurones against complement-mediated 
damage (Pedersen et al., 2007).  Neuralized homolog (NEURL) is thought to be 
involved in neurogenesis and is suggested to be a tumour suppressor (Nakamura et al., 
1998).  A further example includes the gene retinitis pigmentosa GTPase regulator 
(RPGR), which is mutated in X-linked retinitis pigmentosa.  The truncated protein 
RPGR-ORF15 is known to interact with two chromosome-associated proteins, SMC1 
and SMC3, and RPGR-ORF15 is involved in regulating the transport of SMC proteins 
to the ciliated region of the photoreceptor outer segment (Khanna et al., 2005).   
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One gene which belongs to the SMC family, SMC1A, is encoded by a single transcript, 
and has recruited seven independent MIR elements in the 3‟-UTR.  Mutations in 
SMC1A have been found in patients with the X-linked disorder Cornelia de Lange 
syndrome, which is characterised primarily by mental retardation (Deardorff et al., 
2007; Musio et al., 2006).  The SMC1A protein can be phosphorylated by ATM 
(Ataxia-telangiectasia mutated) kinase, the ATM transcript has recruited two MIR 
repeats also in the 3‟-UTR (Kim et al., 2002).  ATM is mutated in Ataxia telangiectasia; 
a neurodegenerative disease which affects the development of the cerebellum, causes 
immunodeficiency and a predisposition to malignant neoplasms (Mavrou et al., 2008).  
ATM is also linked to the development of ocular telangiectasia, a form of vascular 
disease of the retina (Mauget-Faÿsse et al., 2003). 
  
As previously discussed miRNAs are central in fine tuning protein expression in 
neurones, and thus may play a role in synaptic plasticity.  MiRNAs are also reported to 
be abundant in the cells of the retina, particularly photoreceptors.  For instance the 
miRNAs miR-96 and miR-183 are upregulated in P347S-Rhodopsin transgenic mice, a 
model for retinitis pigmentosa (Loscher et al., 2007; Loscher et al., 2008) and 
photoreceptor degeneration has been observed in retinal Dicer knockout mice (Damiani 
et al., 2008).  These observations confirm the significance of miRNAs in retinal 
function, and given the apparent significance of MIR elements in photoreceptors, it is 
possible these repeats are involved in the localisation of mRNAs, to the inner and/or 
outer photoreceptor segments.  The MIR elements may be acting as miRNA targets 
during photoreceptor plasticity, in a similar manner to that suggested for hippocampal 
neurones, leading to suppression of translation until there is a demand for protein 
expression upon phototransduction.  
 
4.5.4. MIR elements and human disease 
 
Several of the genes which have exaptated MIRs are known to be mutated in 
neurological disease and syndromic conditions, including Alzheimer‟s disease, 
schizophrenia and Joubert syndrome (JBTS).  Both kinesin light chain 1 (KLC1) and 
tissue transglutaminase (TGM2) are implicated in Alzheimer‟s disease, and encode 
several splicoforms due to the exonisation of MIR elements (discussed further in 
chapters 5 and 6).  KCL1 is responsible for anterograde transport of proteins such as the 
Chapter 4. Functional significance of the exaptation of an MIR element 
 
  
107 
 
  
microtubule-associated protein tau (Utton et al., 2005), and abnormal aggregations of 
tau are found in the neuronal cytoskeleton of Alzheimer‟s patients (Andersson et al., 
2007).  Tau has been shown to be an excellent substrate for TGM2, and lesions 
observed in Alzheimer‟s patients have been linked to abnormal tau cross-linking by 
TGM2 (Wang et al., 2008).   
 
KLC1 is also noted to associate with Huntington-associated protein 1 (HAP1; McGuire 
et al., 2006), which has exaptated an MIR element in the 3‟-UTR.  HAP1 binds to the 
Huntington gene (HTT) and is enriched in neurones, suggesting a link with the 
pathology of Huntington‟s disease (Wu and Zhou, 2009).  HAP1 is also known to 
interact with the MIR-containing gene AHI1 which is mutated in Joubert syndrome, and 
there is a significant reduction in AHI1 expression in a HAP1 knock-out strain of mice 
(Sheng et al., 2008).  Furthermore studies of TGM2 knock-out mice cross bred with 
Huntington‟s disease mouse models (R6/2 and R6/1), demonstrate a reduction in 
neuronal cell death, motor dysfunction and abnormal protein aggregates, implicating 
TGM2 in the pathology of Huntington‟s disease (Mastroberardino et al., 2002; Bailey 
and Johnson, 2005).    
 
At least 12 MIR-containing genes are mutated in distinct retinal disorders and 
associated syndromes (including the previously discussed JBTS, AH1I, NR3E2, NRL, 
RHO, RPGR and SAG.  JBTS is characterised by a malformed brain stem and the 
complete or partial absence of the cerebellar vermis.  These characteristics result in 
motor and mental retardation, accompanied by numerous physiological characteristics 
(Parisi et al., 2007). AHI1, also termed Jouberin, and NPHP1 (Nephronophthisis 1 
(juvenile)) are mutated in JBTS (Tory et al., 2007) and both genes have exaptated MIRs 
in the 3‟-UTR.  There are a number of splice variants of AHI1 which encode two 
protein products and the MIR element is providing an in-frame stop codon for the 
truncated AHI1 isoform (chapter 5).  In addition, AHI1 is a candidate for schizophrenia 
susceptibility (Amann-Zalcenstein et al., 2006).   
 
In the JBTS1 (Joubert syndrome 1) chromosomal region, 9q34, resides the MIR-
containing gene EHMT1 (Euchromatic histone-lysine N-methyltransferase 1).  This 
gene has not yet been associated with JBTS cases however EHMT1 is found to be 
involved in subtelomeric 9q34 deletion syndrome (Kleefstra et al., 2006), a region 
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associated with both mental retardation and JBTS.  Furthermore within the JBTS locus 
11p12-q13.3 defined by Valente et al., (2005) there are 24 genes which have recruited 
MIR elements (appendix 9.5).   
 
4.6. Conclusion 
 
Overall it appears that MIR elements may indeed be important multifunctional 
components in mammalian biological processes.  Given the sequence conservation and 
abundance of the MIR repeats in the human genome, it is possible that these elements 
may have been co-opted during evolution in the development and enhancement of 
mammalian neuronal function, specifically in synaptic plasticity and photoreceptor 
activity.  When taking together the functional enrichment data it becomes apparent that 
the MIR-containing genes are functionally significant in neuronal cells and possibly the 
adaptive immune system.  Furthermore MIR elements may be playing a role in 
translocating mRNA and regulating localised protein synthesis by the formation of 
dsRNAs, miRNA precursors or miRNAs binding sites.   
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5. MIR ELEMENTS MAY CONTRIBUTE TO THE TRANSCRIPTOME 
VIA EXONISATION 
 
5.1. Introduction 
 
The majority of the human genome is comprised of ncDNA (98.5%), of which at least 
45% is made up of TEs (Lander et al., 2001).  It has been estimated that 60% of TEs are 
located in introns in both human and mouse genomes, yet intronic sequences comprise 
<25% of the total human gDNA (Sela et al., 2007).  This abundance of TEs in introns 
compared to intergenic DNA suggests preferential insertion and/or retention within gene 
regions.  Most intronic TEs will not disrupt gene expression and as a consequence are 
less likely to be subject to natural selection than exonic TEs; however this would also be 
the case for intergenic TEs.  A collection of intronic TEs have been demonstrated to 
play a role in gene expression, for instance the insertion of Mu DNA transposons in 
maize intronic sequences have long been known to play a part in gene regulation and 
phenotypic variation (Greene et al., 1994; Luehrsen and Walbot, 1990; Bennetzen et al., 
1984).  In mammals intronic SINEs have also been reported to generate cryptic splice 
sites resulting in alternative splicing (Sela et al., 2007; Krull et al., 2005; Sorek et al., 
2002).   
 
TEs which have been recruited within intronic and exonic regions may provide spice 
sites and splice enhancers/silencers, thereby providing an assortment of gene products.  
Exonic TEs may contribute polyadenylation signals and peptide sequences including 
methionines and translational termination codons.  Exonic TEs are unlikely to be 
retained and most will be selected against, as newly integrated TEs are potentially 
insertional mutagens, disrupting reading frames (Sela et al., 2007); therefore most TEs 
within coding regions are most likely a direct result of the exonisation of intronic 
elements.  Novel exons arise through three mechanisms; gene duplication, tandem exon 
duplication and exonisation (Kondrashov and Koonin 2001; Corvelo and Eyras 2008).  
The latter process occurs when TE-derived intronic and/or genomic sequences are 
recognised by the spliceosome and are exonised, allowing for a gene to adopt additional 
mRNA sequences.   
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A number of studies investigate the exonisation potential of intronic TEs in primate and 
rodent genomes, including Alu repeats, MIR elements and LTRs (Piriyapongsa et al., 
2007; Sela et al., 2007; Krull et al., 2007; Sorek et al., 2002; Nekrutenko and Li, 2001).  
The most widely studied class of transposons are the Alu elements which appear to play 
a prominent role in the creation of de novo exons in primate species (Krull et al., 2005; 
Lev-Maor et al., 2003; Sorek et al., 2002; Makałowski 2000).  Alu repeats are 
frequently exonised when in the inverse orientation as the consensus sequences include 
motifs which resemble acceptor and donor splice sites.  Mutations or RNA editing of 
the Alu sequence may allow for the elements to be actively spliced and exonised (Lev-
Maor et al., 2003; Sorek et al., 2002; Singer et al., 2004).  95% of A-to-I editing is 
reported to occur within Alu sequences located within ncDNA, following the formation 
of dsRNAs (Levanon et al., 2004). 
 
Recent research has focussed on the exaptation and exonisation of MIR elements; 
Mersch et al., (2007) identified the exonisation of 86 MIR elements in the human 
genome; Sela et al., 2007 identified 181 MIRs exonisation events within the UTRs and 
CDS of human genes (78 within the CDS) and Krull et al., (2007) identified 107 MIR 
exonisation events.  As indicated in chapter 3.1, this study has identified a greater 
number of MIR elements located in protein-coding regions (176), however not all of 
these MIR elements are spliced, for instance many are providing initiating methionines 
and stop codons without splicing.  Furthermore it is possible that MIR elements may not 
only contribute to splicing in the CDS but exonised MIR elements may also be present 
in the UTRs.  This chapter will detail the investigation of the potential for MIRs to 
provide functional splice sites, transcriptional control codons and the role of MIRs in 
shaping the transcriptome during evolution will be discussed.   
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5.2. Exonised MIR elements in the human genome 
 
The integration of an MIR element into a gene region may have one of several 
consequences to the mRNA produced (figure 5.1).  In the majority of integration events 
the presence of the MIR will be of no consequence to the corresponding gene.  If an 
MIR element is retained within an intronic or coding sequence it may, following 
mutation, provide a functional splice site.  Intronic MIR elements may be exonised 
generating whole cassette exons, which may be alternatively or constitutively expressed, 
exon skipping may also occur.  If the MIR is retained or exonised within the coding and 
UTR exons it is possible over time that they may acquire transcriptional and/or 
translational signals such as initiating methionine codons, splice sites and 
polyadenylation signals (see chapter 3.2). 
 
The exonic arrangement of all mRNA transcripts which have recruited MIR elements 
was studied, and the positions of the repeat sequences determined. Those MIRs which 
contribute splice sites were noted, including CDS and UTR exons (table 5.1).  The 
exonised MIR sequences were collected and the corresponding pre-mRNA splice site 
sequences recorded (appendix 9.8).  The presence of initiating methionines and stop 
codons was noted and the orientation of the exonised MIR elements was determined.  
MIR element which have transposed in the middle of an exon, with no splice sites being 
provided were also included (table 5.1). 
 
Of the total MIR-containing genes none contained spliced MIR elements in the 3‟-UTR; 
however there are an equal number of MIR-mediated splicing events noted for CDS and 
5‟-UTR exons.  The majority of the splice sites produce alternative splice variants 
(62%), however 25 acceptor and 23 donor constitutive splice site sequences are 
provided by a recruited MIR element.  Likewise most of the exons containing the 
methionine and stop codons are alternatively expressed; 62% and 74% respectively.  A 
total of 65 termination codons were identified in exons derived from MIRs of which 20 
are alternative stop codons.  There are 26 examples of genes where whole cassette 
exons are spliced due to both the acceptor and donor splice sites being generated by a 
single exaptated MIR element (table 5.2).  A total of 73 EST sequences, assigned to 
known genes, were noted to contain spliced MIRs.  There are no corresponding full 
length cDNA clones detected to support the expression of the EST sequences and as 
such these examples were not included in the analysis (appendix 9.9). 
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Figure 5.1. Modes of exonisation following the integration of an MIR element within the 
coding sequence 
 
Coding exons are depicted by orange boxes, the MIR element is in blue and untranslated 
regions are green.  Acceptor (5’) and donor (3’) splice sites, initiating methionines (ATG) and 
stop codons (TAG) have been included.  A) Integration of an MIR in the middle of a coding exon 
can provide additional protein coding sequence and alter the reading frame.  B) Insertion into 
an intron can generate an internal cassette exon which may be alternatively spliced or 
constitutively expressed.  C) MIR can contribute an alternative 5’-splice site (ss).  D) The MIR 
element can provide a functional initiating methionine residue.  E) The MIR contributes an 
alternative 5’-ss.  F)  Reading through of 3’-ss into the consecutive intron and the MIR carries 
an in-frame stop codon, resulting in a truncated transcript. 
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A 
 
MIR Family 
Entire 
CDS 
CDS 
Acc SS 
CDS 
Only 
CDS 
Don SS 
5’-UTR 
Acc SS 
5’-UTR 
Don SS 
3’-UTR 
Acc SS 
3’-UTR 
Don SS 
+ - + - + - + - + - + - + - + - 
MIR 3 6 2 14 1 4 2 6 5 8 7 4 0 0 0 0 
MIRb 2 9 3 8 4 0 5 6 2 5 6 8 0 0 0 0 
MIRc 0 1 0 2 0 0 1 1 0 2 0 1 0 0 0 0 
MIRm 0 1 0 1 0 0 1 0 0 2 0 1 0 0 0 0 
MIR_mars 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 
MIR3 2 2 1 5 1 1 3 2 2 4 2 3 0 0 0 0 
THER1_MD 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
TOTAL  
7 19 6 30 8 5 12 15 9 21 15 17 0 0 0 0 
26 36 13 27 30 32 0 0 
 
 
B 
 
MIR Family 
Alt 
Acc Ss 
Alt  
Don Ss 
Con 
Acc SS 
Con 
Don SS 
Alt  
ATG 
Con 
ATG 
Alt  
TAG 
Con 
TAG 
+ - + - + - + - + - + - + - + - 
MIR 6 12 6 5 1 10 3 5 1 3 1 1 8 10 4 3 
MIRb 4 8 8 9 1 5 3 5 0 2 1 3 11 4 1 6 
MIRc 1 3 0 2 0 1 1 0 1 0 0 0 1 0 1 1 
MIRm 0 0 0 0 0 3 1 1 0 0 0 0 1 1 0 0 
MIR_mars 0 0 0 0 0 0 0 0 1 0 0 0 1 0 0 0 
MIR3 2 6 4 2 1 3 1 3 3 2 0 2 5 6 1 0 
THER1_MD 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
TOTAL  
13 29 18 18 3 22 9 14 6 7 2 6 27 21 7 10 
42 36 25 23 13 8 48 17 
 
 
Table 5.1.  Human genes which have exonised MIR elements within the coding sequence and 
untranslated regions 
 
The MIR elements have been grouped into family members, whether they are in the sense (+) 
or antisense (-) orientation, and the number of MIRs involved in each exonisation event 
recorded.  A) Acceptor (Acc) and donor (Don) splice sites (SS) have been noted for coding and 
UTR exons.  B) Whether the splice sites, methionines (ATG) and stop codons (TAG) are 
alternative (Alt) or constitutive (Con) has been determined. 
 
  
Symbol Gene name 
MIR 
type 
 
Gene 
Pos. 
Con 
Pos. 
Splice 
event 
Type of 
exonisation Sequence information 
ABHD2 alpha/beta hydrolase domain containing protein MIR + 5' Int 1 Alt 
Alternative 
5’-UTR 
tttcctcacctctaaaacagAAA 
AGGgtaagc 
ANKRD9 ankyrin repeat domain 9 MIR3 - 5' Ex 2 Con 
Constitutive 
5’-UTR 
acccctcccctttcttacagATA 
CAGgtaggt 
C11orf51 chromosome 11 orf 51 MIRb - 5' Ex 2 Con 
Constitutive 
5’-UTR 
ttattatccccattttacagATG 
CAGgtctgt 
C7orf65 chromosome 7 orf 65 MIRb - CDS Ex 2 Con 
Constitutive 
CDS 
tgcctgctcttattgtgcagGTA 
GAGgtaata 
CHRD chordin MIR - TAG Int 2 Alt 
Alternative 
CDS with TAG 
attattatccccattttccaGAC 
AGGgtaagtcttg 
CHRDL2 chordin-like 2 MIR - CDS Ex 10 Con 
Constitutive 
CDS 
ttattatccccattttacagATG 
CCAgtaagt 
CPA5 carboxypeptidase A5 MIRc - 5' Int 1 Alt 
Alternative 
5’-UTR 
taatacattgcattttgcagGCT 
GAGgtaggg 
CSF3R colony stimulating factor 3 receptor (granulocyte) MIR3 - 5’ Ex 2 Con 
Constitutive 
5’-UTR 
atgttatttctttcccacagATG 
CTGgtaagt 
DMWD dystrophia myotonica-containing WD repeat motif MIR - CDS Ex 4 Con 
Constitutive 
CDS 
agacccctctgtctccgtagTTC 
CAAgtcagt 
EIF4G3 eukaryotic translation initiation factor 4 gamma, 3 MIRb - 5’ Int 1 Alt 
Alternative 
5’-UTR 
attttgctaattctttccagCAA 
AAGgtaatc 
FXYD4 FXYD domain containing ion transport regulator 4 MIR - 5' Ex 2 Con 
Constitutive 
5’-UTR 
tgatgatcctccttttacagGAC 
TTGgtaagt 
GDPD5 
glycerophosphodiester phosphodiesterase 
domain 
MIR + 5' Int 2 Alt 
Alternative 
5’-UTR 
tgcaaatccttccttcctagGGC 
CAGgtttgt 
GIPC1 GIPC PDZ domain containing family, member 1 MIR - 5' Int 1 Alt 
Alternative 
5’-UTR 
gaattccacccatttttcagATG 
CTGgtaagt 
GSG1L germ cell associated 1-like MIR - CDS Int 4 Alt 
Alternative 
CDS 
ccaaagtgatgggattacagGTG 
CTGgtaagt 
1
1
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Symbol Gene name 
MIR 
type 
 
Gene 
Pos. 
Con 
Pos. 
Splice 
event 
Type of 
exonisation Sequence information 
IL6ST 
interleukin 6 signal transducer (gp130, oncostatin M 
receptor) 
MIRb + 5’ Ex 2 Con 
Constitutive 
5’-UTR 
agactctcctctctttacagTGA 
TGGgtaagt 
KLC1 kinesin light chain 1 MIRb - TAG Int 13 Alt 
Alternative 
CDS with TAG 
gtcctccccacattttaaagATG 
(AACTGACTT)ATGgtgagt 
LAS1L LAS1-like (S. cerevisiae) MIR3 - CDS Ex 9 Con 
Constitutive 
CDS 
ccaacatcctcatgttacagATG 
ACAgtgagt 
MORF4L2 mortality factor 4 like 2 MIR + 5' Int 2 Alt 
Alternative 
5’-UTR 
taatagttcctacttcatagGAT  
CATgtaagt 
MUC15 mucin 15 MIRb + 5' Int 1 Alt 
Alternative 
5’-UTR 
ttgcctcttccattttccagCTT 
GTTgtaagt 
NEK11 NIMA (never in mitosis gene a)- related kinase 11 MIR3 + 5’ Int 1 Alt 
Alternative 
5’-UTR 
attctgtccttctctaaaagGAA 
TCTgtaagt 
NUMB numb homolog isoform 1 MIRb - 5’ Ex 3 Con 
Constitutive 
5’-UTR 
ttattattctcattttacagATG 
CAGgtctgt 
PELI3 pellino homolog 3  MIRb - CDS Int 2 Alt 
Alternative 
CDS 
tcatttcaatcttcacaaagATG 
CTGgtaagt 
RHBDD3 rhomboid domain containing 3 MIRm - 5' Ex 2 Con 
Constitutive 
5’-UTR 
gatatccttggtttctacagAAG 
AAGgtaggc 
SGIP1 
SH3-domain GRB2-like (endophilin) interacting 
protein 1 
MIRb - CDS Int 15 Alt 
Alternative 
CDS 
ttatctttccctttttacagATG 
CAGgtctgt 
TP53I11 p53-inducible protein 11 MIRb - 5' Int 1 Alt 
Alternative 
5’-UTR 
ttttgccccgggctccctagGAA 
GAGgtaagg 
UBE2V1 ubiquitin-conjugating enzyme E2 variant 1 MIRb - ATG Int 1 Alt 
Alternative 
ATG with CDS 
ggaaagcattttatctccacAGC 
(AAGATGGCA)AAGgtgagt 
 
Table 5.2. Cassette exons with both the 3’ and 5’ splice sites provided by an MIR sequence 
MIR-mediated exonisation generating constitutive (Con) and alternative (Alt) cassette exons.  The MIR sub-type has been listed along with the orientation 
 (+, sense; -, antisense).  The gene symbol and full description has been provided and the constitutive position of the exon is noted as either exonic (Ex) or  
intronic (Int). The splice site sequence is included, exonic sequences are in capitals and intronic sequences lower case. 
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5.3.    Whole exons generated by MIR elements 
 
In the human genome twenty six exons have been generated by slicing both in and out 
of a recruited MIR element.  Eleven internal exons are constitutively spliced, of which 
four are protein-coding exons and the remaining seven within 5‟-UTRs.  Of the 
alternatively spliced exons, six are protein coding exons and nine are in 5‟-UTR exons 
(table 5.2).  The genes Kinesin light chain 1 (KLC1) and Chordin (CHRD) were 
selected for further sequence analysis, as these are the only examples where the MIR-
derived exon carries an alternative translational termination codon.  
 
Multiple alternate splicing event have been described for KLC1 resulting in nineteen 
mRNA transcript variants, encoding four different proteins of related function (McCart 
et al., 2003).  Five of the nineteen mRNA transcripts encode a truncated protein, due to 
splicing of the MIR-derived exon which carries an in-frame stop codon (figure 5.2).  
The full length CHRD protein contains four cys-rich repeats (CR1-4) which bind to 
bone morphogenetic proteins (BMP), and binding to any one of the four CRs is shown 
to significantly inhibit BMP signalling (Larrain et al., 2000).  Millet et al., (2001) 
studied the expression of six CHRD splice variants, two of which contain the MIR-
derived exon identified in table 5.2.  Millet et al., (2001) noted that the MIR-containing 
transcript lacks the CR2-4 binding regions and contains only a partion of CR1, they 
further demonstrated that this transcript was not a BMP antagonist.  The alternative 
CHRD mRNA transcript contains at least six downstream 3‟-UTR exons and as such is 
a candidate for nonsense-mediated decay (NMD), as NMD is a cellular surveillance 
mechanism which recognises and degrades mRNA with premature termination codons 
(Chang et al., 2007).  The splicing of the multiple 3‟-UTR exons of CHRD is supported 
by two cDNA clones and four ESTs in the sequence databases, with none containing a 
poly(A) tract (accessions; AF209930, AF209929, DA092462, DA096654, DA336666, 
DA106058).  Millet et al., (2001) successfully amplified the MIR-containing CHRD 
splicoforms by northern blot analysis and RT-PCR in foetal liver, but did not study the 
expression of the truncated protein.  Pairwise sequence alignments were generated of 
the alternative MIR-derived exons of KLC1 and CHRD, including the flanking intronic 
sequence and the MIR consensus sequence (figure 5.2).  This revealed that in both the 
KLC1 and CHRD exons the stop codon and the acceptor and donor splice sites are at 
the same position in the MIR core-SINE region (see section 5.4).  
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A Human KLC1 
 
 
 
 
 
 
 
55641    cattttaaagATGAGGAAAATGAAGCTCGGGCTGGTTAACTGACTTGCTCAGCGTCCCATGgtgagt           
         ||||||| ||||||||||| |||:||||:|:  |||||| ||||||||:||: ||| ||::|: ||| 
149      cattttacagATGAGGAAACTGAGGCTCAGAGAGGTTAAGTGACTTGCCCAAGGTCACACAgctagt [Help] 
 
 
B Human CHRD 
 
 
 
 
 
 
 
 
 
 
1004     cattttccagACAGGGACCTTGAGGCCCAGAGAGATGAAGTAGCTTGTCTAGGGTCACGCAGCTTgtaagtg   
           |||||| ||||:::|||  :|||||||||| |||:||||||::||||||:|:||||||:||||| ||||||| 
143      cattttacagATGAGGAAACTGAGGCCCAGAGAGGTGAAGTGACTTGCCCAAGGTCACACAGCKAgttagtg 
 
 
 
 
 
 
Figure 5.2.  Pairwise sequence alignments of whole cassette exons with alternative stop 
codons generated by the exonisation of an MIR element 
 
A) Alternative exon 14 of KLC1 is MIR-derived and will encode a truncated protein; the MIR 
sequence provides the translation termination codon (accession NM_005552.4). B) CHRD exon 
1b is derived from a MIRb element and contains numerous 3’-UTR exons.  Note that the stop 
codon and the acceptor and donor splice sites are at the same position for both MIR 
sequences (accession AF209930.1).  Sequence conservation was determined using the 
ClustalW2 alignment tool (http://www.ebi.ac.uk/Tools/clustalw2/index.html).  
Exon    1a                                 2        3                4    5         6           7                      25 
 
                          1b 
                  Exon 11    12                              15                                            16 17                             18 
 
                                                         13   14    
 KLC1 gDNA   
     
 
 
 
MIRb consensus 
  
  
  
  
      
 CHRD gDNA   
 
 
 
 
MIRb consensus 
  
  
  
 
      
Coding exon       Untranslated region                 MIR-derived exon 
Intronic sequence      Stop codon                                  
  
 
     KLC1 
 
Human          tatttttccattttaaagATGAGGAAAATGAAGCTCGGGCTGGTTAACTGACTTGCTCAGCGTCCCATGgtgagt 
Chimpanzee     tatttttccattttaaagATGAGAAAAATGAAGCTCGGGCTGGTTAAATGACTTGCTCAGCGTCCCATGgtgagt 
Horse          tatttttccattttaaagATGAGAAAAATGAAGCTCGGGCTGGTTAAATGACTTGCTCAGCGTTCCATGgtgagt 
Dog            tatttttccgttttaaagATGAGAAAAATGAAGCTCGGGCTGGTTAAATGACTTGCTGAGCGTCCCATGgtgagt 
Cow            tatttttccattttaaagATGAGAAAGACGAAGCTCGGGCTGGTTAAATGACTTGCTCAGCATCGCATGgtgagt 
Rat            tattttt-cgttttaaagATGAGAAAGATGAAGCTCGGGCTGGTTAAATGACTTGCTCAGCGTCC-ATGgtgagt 
Mouse          tattttt-cgttttaaagATGAGAAAGATGAAGCTCGGGCTGGTTAAATGACTTGCTCAGCGTCCCATGgtgagt 
Wallaby        tatttttccattttaaagATGAGGAAAATGAAGCTCGGGCTGGTTAAATGACTTGCTCAACGTTCCATGgtgagt 
Opossum        tatttttccattttaaagATGAGGAAAATGAAGCTCGGGCTGGTTAAATGACTTGCTCAACGTTCCATGgtgagt 
Platypus       tatttttccattttaaagATGAGGAAAATGAAGCT-GT-CTGGTTAAATGACCTGCTCAGCGTCCCACGgtgagt 
               ******* * ************* ** * ****** *  ******** **** **** ** *   * ******** 
 
     CHRD 
 
Human          ttttccattttccagACAGGGACCTTGAGGCCCAGAGAGATGAAGTAGCTTGTCTAGGGTCACGCAGCTTgtaagt 
Chimpanzee     ttttccattttccagACAGGGACCTTGAGGCCCAGAGAGATGAAGTAGCTTGTCTAGGGTCACGCAGCTTgtaagt 
Macaque        ttttccattttccagACAGGGACCTTGAGGCCCAGAGAGACGAAGTAGCTTGTCTAGGGTCACGCAGATTgtaagt 
Cow            ttttccgtttttcagATAGGGACCGCACAGCCCAGAGAGGTTAAGTAACTTGTCTAGAGTCGCGCAGCTTgtaggt 
Dog            ttttccattttccagATAGGGACCTTAAGGCCCAGAGAGGTTAAGTAGTTTGTCTAGGGTCACGCAGCTTgtaaga 
Mouse          tgctctactttgcagACAGGGACGCCGAGGCTCAGAGAAGTTAAGAAACTTTGGACGGGCCATGTAACTTgtaaat 
Rat            tgctctactttgcagACAGGGACGCCAACGCTCAGAGGAGTTAAGAAACTTGTCCAGGGCCATGTAACTTgtaaat 
            *  **   *** **** ******      ** *****     *** *  **     * * *  * *  ***** 
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Figure 5.3.  Multiple sequence alignment of the MIR elements for KLC1 and CHRD for a number of mammalian species 
Genomic DNA containing the exaptated MIR elements has been aligned from a number of species.   The exonic region is boxed green and the 
stop codon boxed red.  Intronic regions are in lower case and exonic sequence is capitalised. Sequence conservation was determined using the 
ClustalW2 alignment tool (http://www.ebi.ac.uk/Tools/clustalw2/index.html; accession numbers appendix 9.3).   
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KLC1 Acceptor SS Score Donor SS Score 
Human tccattttaaagA 4.2 ATGgtgagt 10.4 
Macaque tccattttaaagA 4.2 ATGgtgagt 10.4 
Chimpanzee tccattttaaagA 4.2 ATGgtgagt 10.4 
Cow tccattttaaagA 4.2 ATGgtgagt 10.4 
Dog tccgttttaaagA 5.0 ATGgtgagt 10.4 
Mouse ttcgttttaaagA 5.4 ATGgtgagt 10.4 
Rat ttcgttttaaagA 5.4 ATGgtgagt 10.4 
Wallaby tccattttaaagA 4.2 ATGgtgagt 10.4 
Opossum tccattttaaagA 4.2 ATGgtgagt 10.4 
Platypus tccattttaaagA 4.2 ATGgtgagt 10.4 
CHRD Acceptor SS Score Donor SS Score 
Human ttttccagacagG 8.3 CTTgtaagt 6.9 
Macaque ttttccagacagG 8.3 CTTgtaagt 6.9 
Chimpanzee ttttccagacagG 8.3 ATTgtaagt 6.9 
Cow tttttcagatagG 6.6 CTTgtaggt 3.9 
Dog ttttccagatagG 6.6 CTTgtaaga 5.6 
Mouse ctttgcagacagG 6.2 CTTgtaaat 3.5 
Rat ctttgcagacagG 6.2 CTTgtaaat 3.5 
 
Table 5.3. Acceptor and donor splice site strength for the MIR-derived exon of KLC1 and 
CHRD for a number of mammals 
 
The splice site strengths were scored using GENIE.  Intronic regions are in lowercase and exonic 
sequences capitalised.  
 
Multiple sequence alignments were generated with the gDNA of KLC1 and CHRD from 
a selection of species.  Conservation of the MIR-derived exon was determined by 
aligning the flanking constitutive exons with the intronic sequence to determine if the 
MIR element and splice sites are conserved in other mammals (figure 5.3).  Exon 14 of 
human KLC1 appears to be highly conserved in mammals including marsupials and 
monotremes.  The donor splice site of KLC1 was conserved in all species and scored 
highly at 10.4 using the GENIE program (Reese et al., 1997).  The acceptor splice site 
however scored lower, with a mean average of 4.5 suggesting minor splicing of this 
isoform.   
 
The CHRD isoform with multiple 3‟-UTR exons appears to be conserved in other 
mammalian species, there is a corresponding dog cDNA sequence in the GenBank 
database (accession number XM_854602) and sequence homology of the alternative 
MIR-derived for other primates and rodents (figure 5.3).  The splice donor site is 
completely conserved between primates and scores highly with GENIE (mean 6.4) in 
other mammals.  However the conservation observed may be a consequence of the 
exonic sequence and splice sites being derived from the core-SINE, which by default is 
highly conserved.  
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5.4.   Splice sites within MIR elements 
 
Analysis of the MIR-derived alternative exons of KLC1 and CHRD identified a specific 
region of the MIR element providing the acceptor and donor splice sites (figure 5.2).  
Subsequently all of the splice sites (including the exon/intron boundary) residing within 
MIR elements were aligned, and the co-ordinates in relation to the MIR consensus 
sequence were recorded to determine if the same MIR region was being exonised.  
Following which an mRNA consensus sequence for the acceptor and donor splice sites 
was determined; ttacagATG for the acceptor splice site and CAGgtaagt for the donor 
splice site (figure 5.4).  The acceptor and donor consensus sequences are highly 
conserved in the inverse orientation of the MIR sequence.  The acceptor and donor 
splice sites which are located in MIR elements in the direct orientation are distributed 
randomly across the consensus, being generated following multiple nucleotide changes.    
 
The putative acceptor splice site sequence has perfect sequence homology to the MIR 
consensus sequence at position 138-129nt (figure 5.4), these co-ordinates fall into the 
core-SINE region and the splice site is 100% conserved between all MIR sub-families.  
The strength of the acceptor splice site was calculated using GENIE and the consensus 
sequence gives a score of 8.4 (maximum possible of 14.2, average of 7.9 for constitutive 
exons; Zhang 1998; Reese et al., 1997).  The degree of conservation and the splice site 
strength suggests that no sequence changes are necessary from the original MIR 
sequence to provide a functional acceptor splice site for all sub-types, and subsequent 
sequence changes may merely strengthen or weaken the expression.   
 
A donor splice site was identified at position 80-71nt of the MIR inverse consensus 
sequence and is located just outside of the core-SINE region.  The putative donor splice 
site is predictably less conserved between the MIR elements, due to this MIR region 
demonstrating reduced conservation (see section 3.3).  The donor splice site consensus 
determined, following aligning the pre-mRNA sequences, scores exceptionally high at 
12.4, much higher than the average for constitutive exons (8.1).  However sequence 
changes at 78-79nt (T/A and A/G) from the MIR consensus are necessary to achieve this 
splicing strength, as the score for the homologous region in the MIR consensus is 
weaker at 7.4 for sub-types MIR, MIRb, THER1_MD and MIR_Mars; MIR3 gives a 
weaker score of 3.1 and MIRm is not recognisable as a functional splice site with a score 
of -9.0 (table 5.3).   
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It was noted that splicing predominantly occurs in MIR and MIRb elements and no 
splicing events were detected for THER1_MD (table 5.1).  Given that the acceptor splice 
site is completely conserved it would be anticipated that acceptor splice sites be 
observed for all of the MIR element sub-types; however when looking at the dataset as a 
whole (chapter 3) a very small proportion of the total MIRs are the older elements 
including THER1_MD, and those identified are predominantly in the 3‟-UTR.   
 
 
      ACCEPTOR 
        
      Antisense                                                        Sense 
                
 
     
      DONOR 
        
      Antisense                                                        Sense 
                
 
 
    
 
 
   
 
 
 
 
 
Figure 5.4. Putative splice site for the MIR consensus sequences 
A)  The MIR-derived splice site sequences were sorted according to whether the MIR was in the 
sense or antisense orientation.  The splice site consensus sequence was predicted using 
WebLogo.  The image demonstrates the probability of a nucleotide being present for each 
position with the height of the stacked letters signifying the frequency of each nucleotide.  The 
top letter in the alignment is most conserved (Crooks et al., 2004). B)  The co-ordinates of the 
acceptor and donor slice sites identified within the antisense MIR sequence.   
 
   ttacagATG                                                       CAGgtaagt    
    262        138-129          80-71   1 
        |             |                                                  |     | 
 3’-                                                            CORE-SINE                                                                             -5’ 
A    
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 MIR_Mars     TATTATTATCCCCATTTTACAGATGAGGAAA-CTGAGGCAGACAGAGGTTAAGTGACTTG 102 
 THERI_MD     TATTATTATCCCCATTTTACAGATGAGGAAA-CTGAGGCAAACAGAGGTTAAGTGACTTG 101 
 MIR          TATTATTATCCCCATTTTACAGATGAGGAAA-CTGAGGCACAGAGAGGTTAAGTAACTTG 95 
 MIRb         TATTATTATCCCCATTTTACAGATGAGGAAA-CTGAGGCTCAGAGAGGTTAAGTGACTTG 121 
 MIRm         AGTCTTAATCCCCATTTTACAGATGAGGTAA-CTGAGGCACAGAGAAGTTAAGTGACTTG 101 
 MIR3         T-CCAACCCNCTCATTTTACAGATGAGGAAAACTGAGGCCCAGAGAGGTGAAGTGACTTG 121 
                        * **************** ** *******  * *** ** **** ***** 
 
 
 
 
 MIR_Mars     CCCAGGGTCACACAGCTAGTAAGTGTCTGAGGCCGGATTTGAACTCAGGTCTTCCTGACT 42 
 THERI_MD     CCCAGGGTCACACAGCTAGTAAGTGTCTGAGGCTAGATTTGAACTCAGGTCTTCCTGACT 41 
 MIR          CCCAAGGTCACACAGCTAGTAAGTGGCAGAGCCGGGATTCGAACCCAGG-CAGTCTGGCT 46 
 MIRb         CCCAAGGTCACACAGCTAGTAAGTGGCAGAGCCAGGATTCGAACCCAGGTCTGCCTGACT 42 
 MIRm         CCCAAGGTCACACAGCAGACAAGTGGCAGAGCCNGGATTAGAACCCAGGTCCTTCTGACT 41 
 MIR3         CCCAAGGTCACACAGCTAGTTAGTGGCAGAGCTAGGACTAGAACCCAGGTC-TCCTGACT 44 
              **** ***********     **** * ***    ** * **** **** *   *** ** 
 
 
 
Figure 5.5. Putative splice site for the MIR consensus sequences 
The MIR consensus sequences have been aligned in the antisense orientation outlining the 
sequence conservation for each MIR sub-family.  The acceptor (red) and donor (blue) splice 
sites are boxed; the core-SINE is highlighted green and the stop codon observed with KLC1 and 
CHRD boxed orange.   Sequence conservation was determined using the ClustalW2 alignment 
tool (http://www.ebi.ac.uk/Tools/clustalw2/index.html).  MIR consensus sequences were 
obtained from RepBase, the primary reference database of prototypic repetitive DNA 
sequences.  The MIR sub-families are names according to the nomenclature provided by 
Repbase (table 2.1).   
 
 
 
Consensus sequence Nucleotide sequence Splice site strength 
Perfect AAGgtaagt 12.6 
Aligned mRNAs CAGgtaagt 12.4 
MIR CTAgtaagt 7.4 
MIRb CTAgtaagt 7.4 
THERI_MD CTAgtaagt 7.4 
MIR_Mars CTAgtaagt 7.4 
MIR3 CTAgttagt 3.1 
MIRm CAGacaagt -9.0 
 
Table 5.4. Putative splice site for the MIR consensus sequences 
The putative consensus donor splice site and the corresponding sequences of the MIR sub-
families are scored.  A ‘perfect’ donor splice site has been included as a reference.  The splice 
site strengths were scored using the GENIE program. 
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 5.5. Tissue specific expression of exonised MIR elements in the human genome 
 
Several of the human genes which have exaptated MIR elements in coding exons were 
chosen for further analysis.  It was not possible to investigate all of the genes in the 
dataset, therefore a sample set of the human genes which have recruited MIR elements 
were chosen.  Genes were selected that are within the three main function groups 
observed in chapter 4 (neuronal function, immune responses and mammalian 
reproduction).  The genes were further filtered if they demonstrated alternative splicing 
due to the presence of an MIR sequence.  Abelson helper integration site 1 (AHI1) is 
essential in brain development and was selected due to the MIR element carrying a stop 
codon within a novel exon, resulting in the synthesis of a truncated putative protein 
product.  An alternative transcript variant of the Class II, major histocompatibility 
complex, transactivator (CIITA) was also chosen, as it encodes a splice variant 
generated by the skipping of a donor splice site.  The incorporated intronic sequence has 
recruited an MIR element which carries an alternative stop codon.  Finally the gene 
Germ cell associated 1 like (GSG1L) was selected as a novel internal exon may be 
expressed due to splicing in and out of an intronic MIR element.  
 
5.5.1.   Expression profile of the splice variants of AHI1 
 
In humans there are four transcript variants for AHI1, three differ in the 5‟-UTR whereas 
the fourth is truncated at constitutive exon 25 (figure 5.6).  The fourth transcript is 
generated by splicing into intron 25 of the full length reference-sequence (RefSeq) 
resulting in an alternative terminal exon.  The novel region of the read-through exon 
contains an MIR element which is located 27bp downstream of the acceptor splice site 
and provides an in-frame stop codon (figure 5.6).  The splice site is strong (score 10.4) 
and is only conserved in primates, MIR elements could also not be detected using 
RepeatMasker.  Genomic sequences of AHI1 were aligned to detect the presence of the 
MIR repeats in other species.  Demonstrating the recruitment of the MIR element in 
chimp, macaque, dog and cattle sequences and could not be detected in rodent species, 
and is most likely lost by deletion.  The stop codon observed is only in-frame in the 
human splice variant due to indels; however translation terminates in an upstream stop 
codon within the MIR sequence for the other primates (figure 5.8).  The other 
mammalian species studied (cow, dog) have recruited an MIR element, however there 
are no detectable in-frame stop codons present in the intron, and as such similar 
translation to that of primates could not occur.  AHI1 is thought to be essential in brain 
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development, and mutations are associated with autism, schizophrenia and symptoms 
linked to JBST 3; such as retinal dystrophy and central nervous system abnormalities 
(Alvarez-Retuerto et al., 2008; Ingason et al., 2007; Valente et al., 2006).  Considering 
the pathology of AHI1, high levels of mRNA expression would be expected in the 
retina, kidney and brain.  RT-PCR was performed on human cDNA samples with 
isoform specific primers (figure 5.7) to determine if there is tissue specific expression of 
the AHI1 variants.  The full length transcript is ubiquitously expressed in all tissues 
analysed with low levels of expression detected in the kidney and placenta (figure 5.7a).  
There appears to be restricted expression of the truncated AHI1 human mRNA, with 
expression detected in the lung, pancreas and testes (figure 5.7b).   
 
 
 Human AHI1 
      
           
 
 
 
 
 
 
 3436   GTATATTATGGTGGAAAAAGCACTAGACTCAGGGTCAGCCAGCCAGAAGAACTGAGC-CGA--CCTGGGATCC 
    ||:|: |:::||||||||||||||:||||::|:|||||       ||||| |||:|: |||  |||||  :|| 
 8    GTGTGGTGCAGTGGAAAGAGCACTGGACTTGGAGTCAG-------GAAGACCTGGGTTCGAGTCCTGG--CTC   
 
 
 
 
 
 
 
Figure 5.6. Exonic organisation of Abelson helper integration site 1 (AHI1) 
Exonic organisation of AHI1 beginning at constitutive exon 24.  Coding sequences are in red and 
UTRs in blue.  The MIR element is integrated within an alternative terminal exon of the short 
variant (B) and carries an in-frame stop codon.  The region with the stop codon has been 
aligned with the MIRc sense consensus sequence.  The mRNA coordinates have been included 
and the MIR element spans the region 3436 – 3548bp.  Primer sequences are listed in table 2.3 
and the position of the forward (blue) and reverse (red) primers are indicated by arrows.  
Sequence conservation was determined using the ClustalW2 alignment tool 
(http://www.ebi.ac.uk/Tools/clustalw2/index.html; accession numbers appendix 9.3).   
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Coding exon               Untranslated region                Stop codon 
Intronic sequence                        MIR element                           /      Forward/reverse primer  
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Figure 5.7.  Amplified AHI1 fragments from a number of human tissues 
A) Amplification of the full length AHI1 transcript, 594 bp; B) MIR-containing short AHI1 variant 
670 bp; C) GAPDH positive control, 983 bp.  All fragments were analysed on a 2% agarose gel 
with 1X SybrSafe.  The fragments are of the anticipated size and were confirmed by sequencing.  
DNase and RNase-free water was used as a negative control.  Tissues are abbreviated as 
follows; Bm, bone marrow; Br, brain; Ht, heart; Kd, kidney; Lv, liver; Lg, lung; Pl, placenta; Pn, 
pancreas; Rt, retina; SM, skeletal muscle; TSp, spleen and Ts, testis.   
 
 
 
5.5.2.   Expression profile of the splice variants of CIITA 
 
CIITA is a transcriptional co-activator of major histocompatibility complex (MHC) class 
II gene transcription, and restores MHC class II gene expression in mutant cells.  CIITA 
mutations are associated with bare lymphocyte syndrome (BLS) type II (Steimle et al., 
2003), and a SNP within the promoter region results in susceptibility to rheumatoid 
arthritis, multiple sclerosis, myocardial infarction (Swanberg et al., 2005).   
 
A novel transcript was identified for CIITA which encodes a truncated protein.  The 
RefSeq is comprised of 18 exons (figure 5.9a), and the shorter transcript (figure 5.9b) is 
expressed as a result of skipping the donor splice site of constitutive exon 11 and the 
inclusion of the consecutive intron.  The novel read-through region contains an MIRb 
element which carries an in-frame stop codon is located at nt2796.  The MIR is located 
141bp downstream of the splice site and as such the transcript encodes a novel 47 amino 
acid residues.  The MIR-containing transcript also skips exon 6 of the RefSeq following 
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which the reading frame is maintained.  The first 11 exons of the mRNA of CIITA were 
aligned including the read-through sequence, for a number of mammals to determine if 
the transcript is conserved, and whether the MIR element has been exaptated in any 
other mammalian species (figure 5.8).  The MIR element was detected by RepeatMasker 
for all of the species including chimp, macaque, rodents and canine but the stop codon is 
only in-frame in primate species.  The skipped splice site is completely conserved 
(CAGgtgggg) in all animals and scores slightly lower than average at 7.7.     
 
RT-PCR was performed to determine if there is tissue-specific expression of the two 
CIITA isoforms.  The full length CIITA mRNA was found to be ubiquitously expressed 
(figure 5.10b), whereas the MIR-containing transcript demonstrates tissue-specific 
expression (figure 5.10a).  High levels of expression were noted in the retina, spleen and 
thymus and lower levels in the pancreas and testis.  The short form of CIITA was 
undetectable in bone marrow and skeletal muscle.  
 
     Human CIITA 
 
     
 
 
 
 
   
  2732      GGGTGGGGCAGAATGGATTCTCTCCATTTTTAAGATGAGGATGTTGAGGCTCAGAGAGGGGCAGCCACTTGCC  
              |:|:||:||:    ||| ||:|||||||  ||||||||| ::|||||||||||||||   ||:|||||||| 
  154       CTGCGAGGTAGGTATTATTATCCCCATTTTACAGATGAGGAAACTGAGGCTCAGAGAGGTTAAGTGACTTGCC 
 
 
 
 
 
Figure 5.8. Exonic organisation of CIITA 
Exonic composition of CIITA beginning at constitutive exon 3.  Coding sequences are in red and 
UTRs in blue.  The MIR element is integrated within the terminal exon of the short variant (B) 
and carries an in-frame stop codon.  The region with the stop codon has been aligned with the 
MIRb antisense consensus sequence.  The mRNA coordinates have been included and the MIR 
element spans the region 2648 – 2844bp.  Primer details are listed in table 2.3 and the position 
of the forward (blue) and reverse (red) primers are indicated by arrows.  Sequence 
conservation was determined using the ClustalW2 alignment tool 
(http://www.ebi.ac.uk/Tools/clustalw2/index.html; accession numbers appendix 9.3).  
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Figure 5.9.  Amplified CIITA fragments from a number of human tissues  
A) Amplification of a fragment of the truncated MIR-containing CIITA variant, 161 bp; B) the full 
length CIITA transcript, 303 bp.  All fragments were analysed on a 2% agarose gel with 1X 
SybrSafe.  The fragments are of the anticipated size and were confirmed by sequencing.  DNase 
and RNase-free water was used as a negative control.  Tissues are abbreviated as follows; Bm, 
bone marrow; Br, brain; Ht, heart; Kd, kidney; Lv, liver; Lg, lung; Pl, placenta; Pn, pancreas; Rt, 
retina; SM, skeletal muscle; Sp, spleen; Ts, testis and Thy, thymus.   
 
5.5.3.   Expression profile of the splice variants of GSG1L 
 
An alternative splice variant of GSG1L is generated by the inclusion of an alternative 
exon in intron 5; following which the reading frame is maintained for the remainder of 
the constitutive exons spliced (figure 5.11).  Both the acceptor and donor splice sites are 
derived from an MIR element in the antisense orientation.  The MIR element was 
aligned with the GSG1L gDNA sequence, revealing that the acceptor and donor splice 
sites are at the same region of the MIR consensus previously identified (section 5.4), and 
both the acceptor and donor splice site scored highly at 9.4 and 10.4 respectively.   In the 
MIR-derived exons of KLC1 and CHRD a specific region of the core-SINE (108-106nt) 
was noted to provide the stop codon sequence, for the alternative GSG1L exon the 
termination codon is neither conserved nor in-frame.  Multiple sequence alignments 
were generated to determine if the MIR is recruited in other species, and if there is 
conservation of the splice sites consistent with expression of the alternative exon (figure 
5.8).  RepeatMasker provided evidence of the retention of the MIR by chimpanzee, 
macaque, rat, mouse and dog; however the acceptor splice site is only sufficiently 
conserved in primates (humans, chimpanzee and macaque; table 5.5).  A weaker splice 
site is present for dog and the sequence in rodents has diverged from the original MIR 
consensus and is not longer recognisable as a splice site. 
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 Source Acceptor SS Score Donor SS Score 
 MIR consensus cccattttacagATG 8.4 CTAgtaagt 7.4 
 Human tccattttacagGTG 9.4 CTGgtaagt 7.4 
 Chimp tccattttacagATG 8.6 CTGgtaagt 7.4 
 Macaque cccattttacagATG 8.4 CTGgtaagt 7.4 
 Dog cccattttatagATG 6.8 CCGgtaaat 6.9 
 Rat cctactttacatATG -1.9 CTGgctagt -4.7 
 Mouse cctactttacatATG -1.9 CTGgctagt -4.7 
 
Table 5.5.  Acceptor and donor splice site strength for the MIR-derived exon of GSG1L for a 
number of mammals 
 
All mammalian sequences available in the nucleotide databases were included in the analysis.  
The splice site (SS) strengths were scored using the web base calculator GENIE.  Intronic regions 
are in lowercase and exonic sequences capitalised. As a reference the average score for human 
constitutive exons is 7.9 and 8.1 for acceptor and donor splice sites respectively (Reese et al., 
1997).  
 
 
   Human GSG1L 
      
       
 
 
 
239595      cattttacagGTG-GCAAATCGAGGCACAGAGAGGGAGGGCGACTTGCCCCAGGTCACACAGCTGgtaagtgcca 
      ||||||||||:|| | |||::|||||||||||:||  ::|::|||||||| |||||||||||||:||||||| || 
142         cattttacagATGAGGAAACTGAGGCACAGAGAGGTTAAGTAACTTGCCCAAGGTCACACAGCTAgtaagtggca 
 
 
 
 
 
 
Figure 5.10.  Exonic organisation of GSG1-like (GSG1L) 
Exonic composition of GSG1L beginning at constitutive exon 3.  Coding sequences are in red 
and UTRs in blue.  The MIR element is provided an internal cassette exon which is alternatively 
spliced.  The exon has been aligned with the MIR antisense consensus sequence.  The gDNA co-
ordinates have been included.  The intronic sequence including the splice sites is shown (lower 
case).  Primer details are listed in table 2.3 and the position of the forward (blue) and reverse 
(red) primers are indicated by arrows.  Sequence conservation was determined using the 
ClustalW2 alignment tool (http://www.ebi.ac.uk/Tools/clustalw2/index.html; accession 
numbers appendix 9.3).   
           Exon  3                                              4                           5    6                  7              8          
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Little is known regarding the molecular function of GSG1L, although expression 
appears to be restricted to the brain, eye and testis (UniGene cluster Hs.91910; 
http://www.ncbi.nlm.nih.gov/UniGene/clust.cgi?ORG=Hs&CID=91910).  RT-PCR was 
performed to confirm the presence of the exonised MIR and to determine if there is 
differential expression of the two variants (figure 5.12).  The RefSeq variant of GSG1L 
is ubiquitously expressed, with high levels of expression in the brain, heart and retina, 
with weak expression noted in bone marrow and liver.  The MIR-derived isoform 
displays a different expression pattern and was undetectable in bone marrow and liver, 
and expressed at low levels in the kidney, suggesting a potentially different function for 
this splicoform. 
 
 
 
 
                  
                      
 
Figure 5.11.  Amplified GSG1L fragments from a number of human tissues 
A) Amplification of the short MIR-containing GSG1L variant, 499 bp; B) the full length GSG1L 
transcript, 489 bp; C) GAPDH positive control, 983 bp.  All fragments were analysed on a 2% 
agarose gel with 1X SybrSafe.  The fragments are of the anticipated size and were confirmed by 
sequencing.  DNase and RNase-free water was used as a negative control  Tissues are 
abbreviated as follows; Bm, bone marrow; Br, brain; Ht, heart; Kd, kidney; Lv, liver; Lg, lung; Pn, 
pancreas; Rt, retina; SM, skeletal muscle; Sp, spleen and Ts, testis. 
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           AHI1 
 
 Human           GCCAGAAGAACTGAGCC-GACCTGGGATCCCACCACTTCCTAACTGTTTTGTTAGGTAGTTCA-CTTTCTC-------TCTT 
 Chimpanzee      GCCAGAAGAACTGAGCCTGACCTGGGATCCCACCACTTCCTAACTGTTTTGTTAGGTAGTTCA-CTTTCTC-------TCTT 
 Macaque         GCCAGAAGAAATGAGCCTGACCTGGGATCCCACCACTTCCTAACTGTTTTGTTAGGTAGTTCG-CTTTCTC-------TCTT 
 Horse           GCCAGGAGCGCTGG-CCAAACCCTA-A--CTGCCTC-TCCCTGCCCTTGTCTCGG-TAGCTGACCTTTCACAGGATCGTGTC 
 Cow             GCCAGAAGGGTTGGGCCTGACTCTA-ATTCTGCCCCGTCACAGCTGTTACCTTGGGTAGTTTCTCTCTCCCAGTATAATGTC 
                 ***** **   **  **  **     *  *  ** * **    *  **   *  * *** *   ** ****       * *             
    
           CIITA 
 
 Human           -CTTTTAGTATGCAGAGCAGCCGGGTGG-GGCAGAATGGATTCTCTCCATTTTTAAGATGAGGATGTTGAGGCTCAGAGAGGGGCA 
 Chimpanzee      TCTTTTAGTATGCAGAGCAGCCGGGTGG-GGCAGAATGGATTCTCTCCATTTTTAAGATGAGGATGTTGAGGCTCAGAGAGGGGCA 
 Macaque         TCTTTTAGTACTCAGGGCAGCCGGGTGG-GGCAGAATGGATTCTCTCCATTTTTAAGATGAGGATGTTGAGGCTCAGAGAGGGGCG 
 Horse           TCCTTGAGTGTGCACAGCAGCCAGCTGGAGGCAGAACTGATTCCTTCCATTCTTTAGATGAGGAACCCAAGGCTCAGAGAGGGACA 
 Mouse           CTATTCCATGGGTACAGCA-TTAGATGG-TACAGAATAC-CCCCCCCCCATTATAAGATGACAATACTGAGGGCCAGAGAAAGGTA 
 Rat             CCATTCCGTGGGTATAGCA-TTAGATGG-TACAGCATAG-TCCCCTCCAATAATAGGATGACAGT-CTGAGGGTCAGAGAAAGGTA 
               **   *    *  ***    * ***   *** *      *   **  *  *  *****        ***  ******  *     
 
           GSG1L 
 
 Human           tccattttacagGTGGCAAATCGAGGCACAGAGAGGGAGGGCGACTTGCCCCAGGTCACACAGCTGgtaagt  
 Chimpanzee      tccattttacagATGGCAAATCGAGGCACAGAGAGGGAGGGCGACTTGCCCCAGGTCACACAGCTGgtaagt 
 Macaque         cccattttacagATGGCAAATGGAGGCACATTTAGGGAGGGCAACTTGCCCCAGGTCACACAGCTGgtaagt 
 Dog             cccgtttcatagATGAGAAACCAAGGCACAGAGAGGTAAAGTAAATTGCCTAAAGTCCCACAGCCGgtaaat 
 Mouse           cctactttacatATGCCAAGTTGAGTCCCAGAGGGGTGCTGTGATTTGTCCAAGGCCACACAGCTGgctagt  
 Rat             cctactttacatATGCCAAGTTGAGTCCCAGAGGGGTGCTGTGATTTGTCCAAGGCCACACAGCTGgctagt  
                        *   ** * *  **  **    ** * **    **    *  * *** *  * * * ****** **  * * 
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Figure 5.12.  Multiple sequence alignment of the MIR elements identified for CIITA, GSG1L and AHI1 for a number of mammalian species 
The exonic region of GSG1L is boxed green, intronic regions are in lowercase and the exonic sequence is in capitals.  The human stop codon region is highlighted 
in red and the alternative primate in-frame primate stop codon for AHI1 is blue.  Sequence conservation was determined using the ClustalW2 alignment tool 
(http://www.ebi.ac.uk/Tools/clustalw2/index.html; accession numbers appendix 9.3).     
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5.6. Discussion 
 
The creation of de novo exons via exonisation provides a means of generating 
alternative splice variants, and subsequently a range of diverse gene products.  Nascent 
exons are most commonly expressed at lower levels than constitutive exons.  
Expressing new exons at low levels will allow for the adaptation and generation of 
novel functions, with minimal consequence to the existing gene function, as the original 
splicoform remains predominant (Nurtdinov et al., 2009; Kim et al., 2008).  Numerous 
examples exist where Alus are exonised thus increasing the transcriptome, however 
these examples are limited to primate genomes.  Furthermore Alus are relatively young 
retrotransposon (<120myr) compared to MIR elements and the inclusion of a de novo 
exon cannot be attributed to splice site strength but rather to exon age (Kim et al., 
2008).  Older exons are more strongly spliced due to having sufficient time to acquire 
regulatory sequences such as splice enhancers, allowing for a higher inclusion strength 
and greater establishment (Ast, 2004). 
 
In chapter 3 MIR elements were noted to be contributing protein coding sequences in 
117 transcripts and many are alternatively spliced.  There has been previous interest into 
the exonisation of TEs including Alus, MIRs and LTR elements (Krull et al., 2005; Sela 
et al., 2007; Krull et al., 2007; Lin et al., 2009; Piriyapongsa et al., 2007).  Therefore 
the dataset of genes identified in chapter 3 were screened for spliced MIR elements and 
translational control codons, not only to compare with other studies but to give a more 
complete picture of the distribution of these elements in human genes.   
 
5.6.1. Exaptated MIR elements may provide functional splice sites and contribute 
to alternative splicing 
 
Overall a total of 126 splicing events take place within an exaptated MIR element, of 
which 78 generate alternative transcripts whilst the remainder are constitutively spliced.  
Of the exonised MIR elements, there appears to be no obvious preference to exonise at 
either 3‟- or 5‟- splice sites and a similar number of acceptor and donor splice sites are 
located within MIR sequences (67 and 59 respectively).  There are also equal numbers 
of 5‟-UTR acceptor and donor splicing events observed (62 and 63 respectively).  There 
were no examples of MIRs recruited in the 3‟-UTRs providing functional splice sites.   
MIR elements were also noted to contribute initiating methionine codons and 
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translational termination codons (22 and 65 respectively).  The majority of splicing 
events occur primarily in the younger MIR elements, predominantly the MIR and MIRb 
sub-types, with no splicing noted in the retained sequence of the sub-family 
THER1_MD and few observed for MIRm and MIR_Mars.  However this can be 
partially explained by the data obtained in chapter 3, as the vast majority of the total 
MIR elements identified in human genes being the younger elements (MIR, MIRb and 
MIR3) with the older elements constituting only 9% of the total exaptated.  Furthermore 
the majority of the older MIR repeats are recruited in the 3‟-UTRs.  For example eight 
THER1_MD elements are found in 5‟-UTRs of human genes with the remainder in the 
3‟-UTR (note that MIRs in the 3‟-UTRs have not been exonised).     
 
EST sequences with exonised MIR elements corresponding to 73 different annotated 
genes were identified, making a total of 243 human genes which have exonised MIR 
elements and/or have the repeats contributing to protein coding sequences.  There were 
no corresponding full length cDNA clones detected to support the expression of the 
EST sequences, and as such the reading frames and complete exonic composition can 
not be predicted, therefore these examples were not included in the analysis (appendix 
9.9), however taking into account the annotated genes with exonised EST sequences, it 
is possible that almost 1% of the total human genes in the genome contain MIR-derived 
protein coding sequences, corresponding to 25% of the genes with TEs in protein-
coding regions (Nekrutenko and Li, 2001).  
 
The majority of the acceptor splice sites are present when the MIR element is in the 
inverse orientation (76%), but there is no apparent orientation preference for donor 
splicing, with 53% occurring when in the MIR has integrated in the inverse orientation.  
There were 26 distinct whole internal cassette exons which are derived from a single 
MIR element, of which 42% are constitutively spliced.  Of the MIR-derived exons, 12 
are protein-coding with the remainder being in the 5‟-UTR; with the majority of the 
MIR repeats in the inverse orientation (73%).  Putative acceptor and donor splice sites 
were apparent in the MIR inverse consensus sequence following the generation of 
multiple sequence alignments of all of the exonised nucleotide sequences.  The acceptor 
splice site is highly similar to the vertebrate splice consensus sequence  and a de novo 
MIR element theoretically could have been strongly spliced following integration.  
There would be no need for sequence changes from the consensus, as the putative splice 
sequence is completely conserved between MIR sub-families, with being in the core-
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SINE region.  The putative donor splice region is less conserved between the MIR 
elements and at least two base changes are necessary. Aligning the nucleotide sequences 
of these splice sites (including the intronic sequence) demonstrates the consensus 
sequence of all of the splice sites generated through MIR recruitment.  Both the 
acceptor and donor splice site consensus sequences generated score exceptionally high 
(8.4 and 12.4 respectively), much higher than average constitutive splice sites, 
demonstrating that following mutation an MIR could potentially generate a complete 
exon of ~50bp in all mammalian genomes.  However if this was the case most antisense 
MIR elements would be exonised, considering the degree of homology between 
different MIR elements, suggesting further regulatory sequences are necessary if the 
splice site is to be actively maintained.  As such most of the dormant putative splice 
sites of exaptated MIR elements in the inverse orientation have diverged and no longer 
resemble canonical splice sites.   
 
The majority of exonised MIR elements observed in this investigation are a direct result 
of splicing into intronic MIR repeats.  These elements may be actively spliced following 
mutation or the acquisition of further regulatory sequences, resulting in the spliceosome 
recognising the sequence motifs which resemble the splice sites consensus.  Essentially 
intronic MIR elements may have provided a way for genomes to „experiment‟ during 
evolution, by expressing novel alternative splice variants at low levels at no expense to 
normal gene function.   
 
5.6.2. Tissue specific expression of transcript variants which have exonised MIR 
elements and human disease 
 
171 human genes contain exonised MIR elements, of which many demonstrate 
alternative splicing.  A number of genes were therefore selected and analysed for tissue 
specificity and validated using RT-PCR.  AHI1 is critical for normal brain development 
and is mutated in neurodegenerative related disorders, learning difficulties and 
psychoses, including autism, Joubert syndrome and schizophrenia (Alvarez Retuerto et 
al., 2008; Tory et al., 2007; Valente et al., 2006; Amann-Zalcenstein et al., 2007).  The 
gene GSG1L was selected as there are two alternatively spliced transcripts, differing by 
the presence of an internal coding exon which is derived entirely from a single MIR 
element.  Little is known regarding the function of GSG1L however expression is 
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restricted to the brain, whole eye and testis (UniGene cluster Hs.91910) , presenting the 
gene as an interesting candidate for further analysis, due to the putative functional role 
of MIR elements in neuronal function discussed previously.  The final gene to be 
investigated was the MHC class II transactivator CIITA, which is mutated in 
immunodeficiency syndromes such as bare lymphocyte syndrome type II (BLS), 
leukaemias, multiple sclerosis and rheumatoid arthritis (Steimle et al., 1993; Swanberg 
et al., 2005). 
 
All three of these genes contain alternative splice variants as a direct consequence of the 
recruitment of an MIR element.  Both AHI1 and CIITA express a truncated protein 
product due to a stop codon in an MIR element in a read-through exon and GSG1L 
contains an internal MIR-derived coding exon.  Of these splice variants, all three 
demonstrate tissue-specific expression, compared to the the full length transcripts which 
have not recruited an MIR element.  The truncated AHI1 transcript, which appears to be 
conserved only in primate orders, displayed a restricted expression pattern and could be 
detected only in the lung, pancreas and testes.  This transcript is not expressed in the 
brain and retina; key tissues when considering the pathological role of this gene, such as 
in the development of Joubert syndrome, schizophrenia and kidney disease.  The tissue 
specificity of the shorter AHI1 mRNA transcript suggests that the splice variants may 
have distinctly different functional roles in these tissues.  It is possible that the read-
through transcript may be redundantly expressed and non-functional, the splice site 
being skipped due to the presence of weak splice signals; however this is unlikely 
considering the tissue-specific expression of the MIR-containing transcript.  
 
The MIR-derived splice variant of GSG1L displayed tissue specific expression with no 
detectable expression in bone marrow and liver, and low expression levels in the 
kidney.  The full length transcript is expressed in all of the tissues analysed, though 
detectable at low levels in the bone marrow, liver and spleen.  Both of the GSG1L 
isoforms are highly expressed in brain, heart and retina.  GSG1L encodes a protein of 
unknown function, when analysing the conserved domains listed in the Pfam database 
there is sequence similarity with a domain conserved in proteins specifically expressed 
in germ line testicular cells (Matsui et al., 1997).   A further conserved region is shared 
with the Claudin family of proteins, which are involved in the formation of tight 
junctions, and have been known to localise to the cilia of the retinal pigment epithelium 
(Rahner et al., 2004).  GSG1L is a recently annotated gene and these results 
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demonstrate differential expression and potentially different functional roles of the two 
splicoforms. 
 
The main area of discussion during chapter 3 primarily focussed on the role of MIR 
elements in neuronal gene function; however it is highly likely that MIRs may play a 
role in other biological processes.  For example aspects of the immune system such as 
cytokine function appeared to be significant when consulting the Gene Ontology.  The 
Joubert syndrome loci, AHI1 and NPHP1, are also associated with non-neurological 
disorders such as coeliac disease, leukaemia and kidney disease (Maiuri et al., 2005; 
Jiang et al., 2004; Ala-Mello et al., 1998).  Therefore a gene known to function in the 
immune system was selected.   
 
CIITA regulates MHC class II gene transcription and loss of CIITA expression has been 
associated with chronic myeloid leukaemia (CML) and bare lymphocyte syndrome, type 
II (Day et al., 2003; Dziembowska et al., 2002).  CIITA encodes several transcripts 
variants, of which one is truncated due to skipping a donor splice site resulting in the 
incorporation of an intronic MIR element.  The exaptated MIR carries the premature 
stop codon.  Following RT-PCR the full length sequence was detected in all tissues and 
the truncated MIR-containing isoform could not be detected in bone marrow or skeletal 
muscle.  The C-terminus of the full length CIITA transcript contains two leucine rich 
repeats (LRRs), which are essential for the interaction with MHC class II promoter-
binding proteins (Sisk et al., 2001).  The MIR-containing transcript lacks the LRRs and 
as such the truncated CIITA protein may be unable to revert MHC class II-negative 
cells to express class II antigens (Day et al., 2003).  A single nucleotide mutation in the 
C-terminal end of the full length CIITA isoform have been attributed to BLS, and it is 
possible that the CIITA isoform which has exaptated the MIR element may contribute 
to the progression of CML and BLS (Day et al., 2003; Dziembowska et al., 2002).  
Expression of the short form of CIITA was not detected in normal bone marrow by RT-
PCR, which is interesting as expression of the truncated CIITA protein has been 
detected in K-562 (myelogenous leukaemia) and Rajii (Burkitt's lymphoma-derived) 
cell lines (Day et al., 2003; Riley et al., 1995).  This further suggests that upregulation 
of the MIR-containing transcript may be involved in the progression of leukaemias and 
BLS. 
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5.7. Conclusion 
 
The exonisation of MIR elements in the human genome suggests that MIRs may play a 
significant role in mammalian genome evolution by shaping the transcriptome.  Overall 
it appears that 1% of the total human genes have MIR-derived splice sites or coding 
sequences.  Furthermore 38% of the splicing events observed generate constitutive 
exons, in contrast to the distribution of exonised Alu elements which are predominantly 
alternatively spliced (Sorek et al., 2002; Sela et al., 2007).  The MIR family are more 
ancient and sufficient time may have passed for the MIR elements to be accepted as 
fully functional and highly expressed exons, whereas the younger exonised Alus may 
still be in their infancy.    
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6. MIR ELEMENTS AND THE ALTERNATIVE SPLICING OF TISSUE  
 TRANSGLUTAMINASE (TGM2) 
 
6.1.      Introduction  
 
TGM2 is of particular interest to this study as all of the documented isoforms have 
recruited independent MIR elements. A further truncated transcript was identified 
following in silico analysis which has exaptated six MIRs, recruited in the coding 
sequencece and both the 5‟- and 3‟- UTRs (appendix 9.1).  Secondly, TGM2 
dysfunction is implicated in several of the key disorders discussed in chapter 5, such as 
the neurodegenerative conditions; schizophrenia, Alzheimer‟s disease and Huntington‟s 
disease and both Type-2 diabetes and MODY (maturity onset diabetes of the young; 
table 4.7).   
 
Tranglutaminases (TGases) comprise a large family of structurally similar enzymes, 
which catalyse protein cross-linking via specific ε-(γ-glutamyl) lysine isopeptide bonds 
in a Ca
2+
 dependent manner (Aeschlimann and Paulsson, 1991).  In humans there are 
seven distinct TGase genes, which all post-translationally modify proteins 
(Aeschlimann et al., 1998; Chen and Mehta, 1999).  TGases differ in their biological 
function and peptide sequence; however they share a common active site and all display 
transamidation activity.  Tissue transglutaminase (TGM2) is a multifunctional enzyme 
which differs from its relatives, as in addition to TGase activity and protein cross-
linking TGM2 has the ability to bind and hydrolyse GTP (Lee et al., 1989).  TGM2 
GTPase activity is similar to the α subunits of large heterotrimeric G proteins (Mhaouty-
Kodja, 2004).    
 
TGM2 is ubiquitously expressed and functions as a monomer (Lin and Ting, 2006).  In 
humans the full length RefSeq protein comprises 687 amino-acids (aa), the nucleotide 
sequence, including the UTRs, is ~4 kb in length and is composed of 13 coding exons.  
The full length TGM2 protein encompasses a number of binding sites and activity 
domains.  The N-terminus consists of a β-sandwich domain which contains fibronectin 
and integrin binding sites.  The catalytic core contains a triad of papain-like catalytic 
residues, calcium binding sites and a conserved tryptophan (Trp) residue (Murthy et al., 
2002).  The C-terminus is composed of two β-barrels, the first containing a collection of 
guanine binding sites and the second β-barrel interacts with phospholipase C-δ1 (PLC-
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δ1), α1-adrenergic receptors (α1-AR) and the G-protein coupled receptor GPR56 (Xu 
and Hynes, 2007).  The tertiary structure of the TGM2 protein varies; when bound to 
GTP, at normal cellular levels of free Ca
2+
, the TGase active sites are blocked and 
TGM2 functions as a guanine nucleotide-binding protein (G-protein) in receptor 
signalling, and is not involved in TGase activity.  When GTP is hydrolysed the three 
dimensional structure changes and binding to Ca
2+
 exposes two Trp residues, which 
control the access of the substrate to the active site (Fesus and Piacentini, 2002).  It is 
thought that GTP may act as a molecular „switch‟ between the two TGM2 activities 
(Monsonego et al., 1998; Festoff et al., 2002). 
 
TGM2 has been implicated in complex and diverse biological functions including cell 
differentiation and growth, active responses to injury, cell adhesion and protein 
aggregation (Collighan and Griffin, 2009; Verderio et al., 2005).  TGM2 disruption is 
implicated in the pathogenesis of numerous neurological conditions including 
Alzheimer Disease, Huntington‟s disease, Parkinson‟s disease and schizophrenia (Ikura 
et al., 1993; Lesort et al., 2002; Andringa et al., 2004; Bradford et al., 2009).  TGM2 
has also been implicated in inflammation, rheumatoid arthritis, diabetes (Type I, Type II 
and MODY) cystic fibrosis and has been identified as an autoantigen in coeliac disease 
(Kim, 2006; Maiuri et al., 2005; Dieterich et al., 1997; Hummel et al., 2007; Porzio et 
al., 2007; Bernassola et al., 2002; Maiuri et al., 2008).  
 
There are two widely documented TGM2 isoforms which differ not only in structure but 
also in their function.  The full length RefSeq transcript demonstrates protective activity 
against apoptotic events and subsequent cell death, whereas the short form is shown to 
be upregulated prior to cell death and has been suggested to promote apoptotic 
responses (Antonyak et al., 2006).  The shorter TGM2 peptide is 548aa in length and is 
encoded by a transcript of ~1.9 kb.  The truncated isoform lacks the C-terminal region 
which contains the guanine nucleotide binding sites and is unable to bind GTP 
(Antonyak et al., 2006).  A third protein product (TGM2_Vs) has also been reported of 
approximately 38.7 kDa, detected in the human erythroleukemia (HEL) cell line,  
induced by retinoic acid (Fraij and Gonzales, 1996).  Finally an aberrant splicing event 
has been reported at RefSeq exons 12 and 13, generating a transcript with a shorter UTR 
and lacking the terminal 63-residues (TGM2_dLg) (Lai et al., 2007).   
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6.2.        The identified TGM2 isoforms and the exaptation of MIR elements 
 
As MIR elements were actively transposing prior to the radiation of the placental 
mammals it is possible that the MIRs may have been recruited in TGM2 of other 
mammalian species.  Nucleotide databases were screened for trace nucleotide 
sequences, ESTs and cDNA clones which correspond to the genomic region of TGM2 
for a number of species.  ESTs and trace sequences were accepted if a splice site was 
present which conforms to the consensus sequences described by Zhang (1998), as any 
non-spliced ESTs could represent splicing errors, natural antisense transcripts or nRNA.  
Where necessery composite mRNA sequences were generated and all identified splice 
variants were screened for the presence of MIR elements.  
 
A total of five human TGM2 splice variants were identified (figure 6.1); four of which 
have been published (Lai et al., 2007; Antonyak et al., 2006; Festoff et al., 2002; Fraij 
and Gonzales, 1996) and a novel fifth transcript (TGM2_Tc).  All five isoforms have 
recruited MIR elements (table 6.2), the RefSeq transcript (TGM2_wLg) has recruited 
three MIR elements within the 3‟-UTR located 559, 670 and 885bp downstream of the 
termination codon; TGM2_Tc encodes the same three terminal exons (11-13) as 
TGM2_wLg and as such has recruited the same three MIR elements.  TGM2_Sh, shares 
the initial 538-residues with the RefSeq TGM2.  The protein is truncated at constitutive 
exon 10, due to reading through the donor splice site, resulting in the retention of 
intronic sequence encoding 10 novel residues and an alternative stop codon.  TGM2_Sh 
contains an unrelated MIR element in the 3‟-UTR sequence, 64bp downstream of the 
stop codon.  The third transcript, TGM2_Vs, is generated in a similar manner to 
TGM2_Sh, with skipping of the donor splice site occurring at RefSeq exon 6; a further 
independent MIR element is present in the 3‟-UTR, 91bp downstream of the 
termination codon.   
 
A further transcript designated TGM2_dLg is generated by a rare splicing event at the 
consensus CT/YCAC, which does not appear to conform to conventional splicing 
mechanisms, and is discussed in more detail in section 6.3 (Lai et al., 2007).  This 
transcript contains the same MIR elements noted in the 3‟-UTR of the full length 
transcript; however due to the altered reading frame an alternative stop codon is carried 
by the first of the three MIR elements.    
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The final transcript, TGM2_Tc, is the only one of the five isoforms regulated by an 
alternative promoter as the initiating methionine is located within RefSeq intron 10.  
The protein encodes 147 novel N-terminal residues followed by the common TGM2 C-
terminus.  TGM2_Tc has exaptated seven MIR elements, one in the 5‟-UTR, one which 
contains the methionine codon and contributes 51 residues of peptide sequence, one 
within the coding sequence and the remaining three within the 3‟-UTR, at the same 
positions seen with the full length transcript (table 6.1). 
 
 
  
        
 
 
 
 
Figure 6.1.  Exonic composition of the multiple splice variants of TGM2 
The exonic composition of the TGM2 isoforms begins at canonical exon 4. A) TGM2_Tc, the 
transcript start site is located within common intron 10 and the initiating methionine is within 
a recruited MIR element: B) TGM2_wLg is the full length RefSeq mRNA of 13 exons: C) 
TGM2_dLg demonstrates variation in splicing between canonical exons 11 and 12, an 
alternative reading frame is present and the in-frame stop codon is within an MIR element:  D) 
TGM2_Sh is truncated due to reading through the donor splice site at exon 10 and contains an 
MIR in the 3’-UTR:  E) TGM2_Vs is truncated at exon 6 and has recruited an MIR element in the 
3’-UTR.  The position of the last common residue V286 for TGM2_Vs and S538 for TGM2_Sh 
has been included as a reference.  S538 is also the first amino acid which is shared with 
TGM2_wLg. 
 
 
 
 
 
 
 
A 
             Exon 4                                                                                                                     
B 
 
C 
                                                                                              S538 
D 
                                                   V286 
E 
Coding exon      Intron 
UTR exon     MIR element  
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Since MIR elements are present in all mammalian genomes, the genomic sequences of a 
number of mammals were studied to determine if the TGM2 isoforms are conserved or 
expressed, and if the MIR elements have been recruited (table 6.1).  The TGM2 
isoforms were identified in all species studied with the exception of TGM2_Tc, which 
could only be predicted in primates, the initating methionine sequence is absent in other 
species due to the deletion of the MIR elements in the novel region.  TGM2_dLg could 
only be predicted for primates and rat due to either limited gDNA sequences in the 
databases or a lack of conservation of the cryptic splice site.  An MIR element could not 
be detected for the rodent full length TGM2 using RepeatMasker. 
 
 
SPECIES 
Isoform ID Human Chimp Macaque Dog Cow Rat Mouse 
TGM2_Vs 3’-UTR 3’-UTR 3’-UTR 3’-UTR 3’-UTR 3’-UTR 3’-UTR 
TGM2_Sh 3’-UTR 3’-UTR 3’-UTR 3’-UTR 3’-UTR 3’-UTR NM 
TGM2_dLg 
TAG, 
3’-UTR 
3’-UTR 
TAG, 
3’-UTR 
3’-UTR* 
TAG, 
3’-UTR 
3’-UTR* 
NE NE 
- 
3’-UTR 
3’-UTR* 
NE 
TGM2_wLg 
3’-UTR 
3’-UTR 
3’-UTR 
3’-UTR* 
3’-UTR 
3’-UTR 
3’-UTR* 
3’-UTR 
3’-UTR 
3’-UTR* 
3’-UTR* 
3’-UTR 
3’-UTR* 
3’-UTR* 
3’-UTR 
- 
3’-UTR * 
3’-UTR * 
- 
3’-UTR * 
3’-UTR * 
TGM2_Tc 
5’-UTR 
ATG 
CDS 
3’-UTR 
3’-UTR 
3’-UTR 
5’-UTR 
ATG 
CDS 
3’-UTR 
3’-UTR 
3’-UTR* 
5’-UTR 
ATG 
CDS 
3’-UTR 
3’-UTR 
3’-UTR* 
NE NE NE NE 
 
Table 6.1.  TGM2 splice variants and the presence of MIR elements for a number of 
mammalian species 
 
Abbreviation:  NE) No evidence of the isoform or limited sequence data available; NM) There is 
evidence for the transcript but no MIR element is detected; *) No MIR can be detected using 
RepeatMasker but there is evidence of an MIR element when aligning with the human mRNA.  
The gene region which the MIR element is detected has been included for all isoforms and 
species (ATG, methionine; TAG, stop codon; UTR, untranslated region).  
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6.3. The functional domains and binding sites of TGM2 varies between 
transcript variants 
 
The full length TGM2 protein contains a collection of documented binding sites and 
activity domains (Chen and Mehta, 1999; figure 6.2).  There is a β-sandwich domain at 
the N-terminus which contains fibronectin binding sites.  The catalytic core contains a 
triad of catalytic residues and calcium binding sites and the there are two β-barrels at the 
C-terminus which containing binding sequences for PLC-δ1 and α1-AR.  The TGM2 
isoforms identified differ in their peptide sequence and as such the presence of the 
described binding sites and domains was determined for each of the TGM2 isoforms.   
 
 
 
  
 
 
 
 
 
▲   Guanine nucleotide binding sites  A   Fibronectin binding domain 
▲   Catalytic residues    B   ATP/GTP binding and activity domain 
▲   Calcium binding site   C   TGase activity domain 
        α1B-adrenoreceptor binding domain       Phospholipase C-δ1 binding domain 
 
 
Figure 6.2. Schematic representation of the known catalytic sites and binding domains of the 
full length TGM2 protein 
 
The Guanine nucleotide binding sites are positioned as follows; K173, F174, R478, V479, M483, 
R580 and Y583.  Catalytic active sites are at C227, H335 and D358, the active site region 
common to all TGases is Y274-W278.  Calcium binding sites are N398, D400, E447 and E452.  
The α1B-adrenoreceptor binding domains are L547-I561, R564-D581, Q633-E646 and 
phospholipase C-δ1 binding domain V665-K672 (Chen and Mehta, 1999). The activity and 
binding domains are A) The fibronectin domain overlapping with the TGase activity site at 
amino-acid position 1-272; B) The ATPase/GTPase activity domain and ATP/GTP binding 
domain located at 138-471 and C) TGase activity domain positioned at 1-138. 
 
    A                                                  B  
                      C 
▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲  ▲ 
1                       124                             273           359                     473               573 587                     687 
N     β-sandwich                                           Core                                  β-barrel 1          β-barrel 2        C 
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Following the clarification of all known binding and activity domains, it was possible to 
determine the potential impact on the function of the splice variants of TGM2 (table 6.2; 
figure 6.3).  It appears that all of the transcripts, with the exception of TGM2_Tc may 
have the ability to bind fibronectin and possess varying levels of TGase activity due to 
the absence of catalytic residues and disruption of the GTP pocket.  Both TGM2_dLg 
and TGM2_Sh contain all of the catalytic active sites, TGM2_Vs however maintains 
only the active site common in all TGase genes at C227.  The transcripts will also have 
varying levels of G-protein activity as only TGM2_wLg and TGM2_dLg contain all of 
the known guanine-binding residues.  TGM2 has been reported to function as a protein 
kinase, with the activity modulated by ATP and Ca
2+ 
(Mishra et al., 2007).  The exact 
phosphorylation sites of TGM2 remain to be determined and the kinase activity of the 
TGM2 isoforms can not be predicted. 
 
Of the five TGM2 isoforms, only the RefSeq transcript (TGM2_wLg) and TGM2_Tc 
contain complete canonical binding domains for PLC-δ1 and α1-AR.  TGM2_dLG is 
similar to the full length TGM2 in composition, as it contains 13 exons; however due to 
atypical splicing at the junction of exons 12/13 it lacks the PLC-δ1-binding domains, 
and maintains only one of the three α1-AR-binding regions,  so may display a reduction 
in binding capacity or even fail to bind altogether.  Both of the truncated read-through 
transcripts, TGM2_Vs and TGM2_Sh will lack the capacity to interact with both PLC-
δ1 and α1-AR due to transcription terminating prior to reaching the known binding 
sequences.  TGM2 possesses a further known binding domain for GPR56 (Xu and 
Hynes, 2007).  The specific binding sequence is yet to be determined however the N-
terminal end of GPR56 has been shown to interact with the C-terminus of TGM2, via 
the β-barrel domains.  Xu and Hynes (2007) noted that TGM2 constructs containing just 
the β-barrels were sufficient to bind to GPR56, so it is likely that in addition to the full 
length peptide (TGM2_wLg ), the protein encoded by the TGM2_Tc isoform would 
also bind to GPR56 (Xu and Hynes, 2007).  The novel polypeptide sequence encoded 
by TGM2_Tc is 147aa in length.  When this novel protein sequence was screened 
against the Pfam database, no homology to known domains was detected.  It is possible 
that the sequence may contain yet unidentified motifs, though unlikely as the novel 
sequence is a result of exon skipping and not a separate exon. 
 
  
Transcript details MIR elements Activity and binding domains 
Transcript 
name 
Accession 
Size 
(bp) 
Size 
(aa) 
MIR 
type 
mRNA 
position 
MIR 
MIR 
position 
TGase 
Ca2+ 
Activity 
GTP/ 
ATPase 
FN1 α1-AR PLC-δ1 
TGM2_wLg NM_004613 3937 687 
MIRb 
MIRc 
MIR3 
2724  2859 
2835  2984 
3050  3222 
256  116 
137  6 
17  203 
3- UTR 
3- UTR 
3- UTR 
+ + + + + + 
TGM2_dLg Appendix* 2238* 674 
MIRc 
MIR3 
1975  2074 
2140  2312 
137  6 
17    203 
TAG 
3- UTR 
+ + + + 
Q633-E646 
only 
- 
TGM2_Sh NM_198951 1879 548 MIR 1812  1879 251  184 3- UTR + + 
Lacks R580 
and Y583 
+ - - 
TGM2_Vs CR604340 1476 349 MIR 1203  1333 47    180 3- UTR + 
C277 
only 
K173 and 
F174 only 
+ - - 
TGM2_Tc AK126508 3465 296 
MIR 
MIR 
MIRb 
MIR 
MIRb 
MIRc 
MIR3 
391   488 
614   832 
948  1087 
1099  1191 
2270  2405 
2381  2530 
2596  2768 
137  40 
28  261 
142  1 
28  121 
256  116 
137  6 
17  203 
5- UTR 
ATG 
CDS 
CDS 
3- UTR 
3- UTR 
3- UTR 
- - 
R580 and 
Y583 only 
- + + 
 
Table 6.2. Catalytic and binding domains for the human splicoforms of TGM2 
The transcript details including the accession numbers and transcript and peptide size have been supplied. * The transcript is a composite sequence predicted 
using previous publication data (Appendix 9.1; Lai et al., 2007), transcript sizes which are predicted as the nucleotide sequence may not be full length as 
commonly the tail ends of UTRs are lacking following cloning.  The MIR sub-family, position in the mRNA and the coordinated of the MIR consensus sequence 
has been included along with the region of the transcript which it resides.  The presence of the activity domains and binding domains are also indicated as 
present (+) or lacking (-).  Abbreviations as follows: ATG, initiating methionine; TAG, stop codon; UTR, untranslated region; CDS, protein coding sequence; FN1, 
fibronectin;  α1-AR, α1-adrenoreceptor binding; PLC- δ1, phospholipase C-δ1 interaction.  
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TGM2_ Tc ----------------------------------------------------------------------------------------------------------- 
TGM2_wLg MAEELVLERCDLELETNGRDHHTADLCREKLVVRRGQPFWLTLHFEGRNYEASVDSLTFSVVTGPAPSQEAGTKARFPLRDAVEEGDWTATVVDQQDCTLSLQLTTP 
TGM2_dLg MAEELVLERCDLELETNGRDHHTADLCREKLVVRRGQPFWLTLHFEGRNYEASVDSLTFSVVTGPAPSQEAGTKARFPLRDAVEEGDWTATVVDQQDCTLSLQLTTP 
TGM2_Sh MAEELVLERCDLELETNGRDHHTADLCREKLVVRRGQPFWLTLHFEGRNYEASVDSLTFSVVTGPAPSQEAGTKARFPLRDAVEEGDWTATVVDQQDCTLSLQLTTP 
TGM2_Vs MAEELVLERCDLELETNGRDHHTADLCREKLVVRRGQPFWLTLHFEGRNYEASVDSLTFSVVTGPAPSQEAGTKARFPLRDAVEEGDWTATVVDQQDCTLSLQLTTP 
 
                                                     TGase activity 
 
 
TGM2_ Tc ----------------------------------------------------------------------------------------------------------- 
TGM2_wLg ANAPIGLYRLSLEASTGYQGSSFVLGHFILLFNAWCPADAVYLDSEEERQEYVLTQQGFIYQGSAKFIKNIPWNFGQFEDGILDICLILLDVNPKFLKNAGRDCSRR 
TGM2_dLg ANAPIGLYRLSLEASTGYQGSSFVLGHFILLFNAWCPADAVYLDSEEERQEYVLTQQGFIYQGSAKFIKNIPWNFGQFEDGILDICLILLDVNPKFLKNAGRDCSRR 
TGM2_Sh ANAPIGLYRLSLEASTGYQGSSFVLGHFILLFNAWCPADAVYLDSEEERQEYVLTQQGFIYQGSAKFIKNIPWNFGQFEDGILDICLILLDVNPKFLKNAGRDCSRR 
TGM2_Vs ANAPIGLYRLSLEASTGYQGSSFVLGHFILLFNAWCPADAVYLDSEEERQEYVLTQQGFIYQGSAKFIKNIPWNFGQFEDGILDICLILLDVNPKFLKNAGRDCSRR  
 
 
 
 
TGM2_ Tc ----------------------------------------------------------------------------------------------------------- 
TGM2_wLg SSPVYVGRVVSGMVNCNDDQGVLLGRWDNNYGDGVSPMSWIGSVDILRRWKNHGCQRVKYGQCWVFAAVACTVLRCLGIPTRVVTNYNSAHDQNSNLLIEYFRNEFG 
TGM2_dLg SSPVYVGRVVSGMVNCNDDQGVLLGRWDNNYGDGVSPMSWIGSVDILRRWKNHGCQRVKYGQCWVFAAVACTVLRCLGIPTRVVTNYNSAHDQNSNLLIEYFRNEFG 
TGM2_Sh SSPVYVGRVVSGMVNCNDDQGVLLGRWDNNYGDGVSPMSWIGSVDILRRWKNHGCQRVKYGQCWVFAAVACTVLRCLGIPTRVVTNYNSAHDQNSNLLIEYFRNEFG 
TGM2_Vs SSPVYVGRVVSGMVNCNDDQGVLLGRWDNNYGDGVSPMSWIGSVDILRRWKNHGCQRVKYGQCWVFAAVACTgelhagmwvmspgrgheehwsrnqdipalvlppat 
 
 
 
TGM2_Tc ----------------------------------------------------------------------msalilprmkgprlthpesrahqalpghslsssshsl 
TGM2_wLg EIQGDKSEMIWNFHCWVESWMTRPDLQPGYEGWQALDPTPQEKSEGTYCCGPVPVRAIKEGDLSTKYDAPFVFAEVNADVVDWIQQDDGSVHKSINRSLIVGLKIST 
TGM2_dLg EIQGDKSEMIWNFHCWVESWMTRPDLQPGYEGWQALDPTPQEKSEGTYCCGPVPVRAIKEGDLSTKYDAPFVFAEVNADVVDWIQQDDGSVHKSINRSLIVGLKIST 
TGM2_Sh EIQGDKSEMIWNFHCWVESWMTRPDLQPGYEGWQALDPTPQEKSEGTYCCGPVPVRAIKEGDLSTKYDAPFVFAEVNADVVDWIQQDDGSVHKSINRSLIVGLKIST 
TGM2_Vs ntlnalcglepvttlsgplsnshpssgc* 349 ------------------------------------------------------------------------- 
 
1                                                                                                       107                     
|                                                                                                         | 
 
 
215                                                                                                     321                     
|                                                                                                         | 
 
 
108                                                                                                     214                     
|                                                                                                         | 
 
 
322                                                                                                     428                    
|                                                                                                         | 
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TGM2_Tc rsacatqiqtsrtwevewltrghpleeakagleprpvgvqvrplpaaqcplsssslgtlepqwgvqgsaqpfprcvtpstflplsvplgvarelggvilhhehppfs 
TGM2_wLg KSVGRDEREDITHTYKYPEGSSEEREAFTRANHLNKLAEKEETGMAMRIRVGQSMNMGSDFDVFAHITNNTAEEYVCRLLLCARTVSYNGILGPECGTKYLLNLNLE 
TGM2_dLg KSVGRDEREDITHTYKYPEGSSEEREAFTRANHLNKLAEKEETGMAMRIRVGQSMNMGSDFDVFAHITNNTAEEYVCRLLLCARTVSYNGILGPECGTKYLLNLNLE 
TGM2_Sh KSVGRDEREDITHTYKYPEGSSEEREAFTRANHLNKLAEKEETGMAMRIRVGQSMNMGSDFDVFAHITNNTAEEYVCRLLLCARTVSYNGILGPECGTKYLLNLNLE 
TGM2_Vs ----------------------------------------------------------------------------------------------------------- 
 
 
 
TGM2_Tc psaEKSVPLCILYEKYRDCLTESNLIKVRALLVEPVINSYLLAERDLYLENPEIKIRILGEPKQKRKLVAEVSLQNPLPVALEGCTFTVEGAGLTEEQKTVEIPDPV 
TGM2_wLg PFSEKSVPLCILYEKYRDCLTESNLIKVRALLVEPVINSYLLAERDLYLENPEIKIRILGEPKQKRKLVAEVSLQNPLPVALEGCTFTVEGAGLTEEQKTVEIPDPV 
TGM2_dLg PFSEKSVPLCILYEKYRDCLTESNLIKVRALLVEPVINSYLLAERDLYLENPEIKIRILGEPKQKRKLVAEVSLQNPLPVALEGCTFTqqpklnspppqphhceapt 
TGM2_Sh PFSgkalcswsic* 548 ----------------------------------------------------------------------------------------   
TGM2_Vs ----------------------------------------------------------------------------------------------------------- 
 
 
 
TGM2_Tc EAGEEVKVRMDLLPLHMGLHKLVVNFESDKLKAVKGFRNVIIGPA* 
TGM2_wLg EAGEEVKVRMDLLPLHMGLHKLVVNFESDKLKAVKGFRNVIIGPA* 
TGM2_dLg mcwvpptlagahgasnpfnhhgkllwallpg* 674 --------- 
TGM2_Sh --------------------------------------------- 
TGM2_Vs  --------------------------------------------- 
 
            
Calcium binding  KLV α1- AR binding domain 
Catalytic site   KLV PLC-δ1 binding domain 
          Guanine binding site  klv Novel peptide sequence 
428                                                                                                      535                    
|                                                                                                          | 
 
 
536                                                                                                      642                    
|                                                                                                          | 
 
 
643                                         687                                                              
|                                             |                                                                                                          
 
 
Figure 6.3.  Peptide sequences of the TGM2 isoforms 
The amino acid marker positions are included for each row as a reference 
when determining the positions of active sites and binding domains.  Novel 
peptide sequences which are generated by the incorporation of intronic 
sequences, as a result of donor splicing being skipped are in bold italics.  
Binding sites and catalytic sites have been outlined as noted in the legend.  
All transcripts with the exception of TGM2_Tc bind fibronectin and possess 
TGase activity.  TGM2_Tc contains only one of the GTP binding regions and 
has the ability to bind with PLC-δ1 and α1-AR.  TGM2_dLg contains all 
binding and activity domains with the exception of one α1-AR binding 
region and lacks PLC-δ1 binding capacity.  TGM2_Vs and TGM2_Sh both 
lack the PLC-δ1 and α1-AR binding domains and have restricted calcium 
binding and GTP/ATPase activity.  Sequence conservation was determined 
using the ClustalW2 alignment tool (accession numbers appendix 9.3).    
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6.4. Splicing and stop codons generated by MIR elements for TGM2 
 
Given that all of the TGM2 isoforms contain MIR elements the role of the repeats in the 
splicing and expression of the TGM2 transcripts was investigated.  Translation of both 
TGM2_dLg and TGM2_Tc terminates at a stop codon located within an exaptated MIR 
element. TGM2_Tc contains seven MIR elements in all, and in addition to the stop 
codon the initiating methionine codon is carried within an MIR sequence. The 
alternative methionine sequence is undiverged from the original MIR consensus. 
 
TGM2 genomic sequences were identified from a range of mammal to determine if 
TGM2_Tc is likely to be expressed in other species.  Multiple cross-species alignments 
revealed that TGM2_Tc may be primate specific and a low level of conservation 
between the corresponding human TGM2 genomic sequence and other non-primate 
mammals is apparent (figure 6.5).  However the information is limited to the sequence 
data available, and only rodents, dog, cow and opossum can be compared.  The novel 
nucleotide sequence of TGM2_Tc is 100% conserved between human and chimpanzee, 
which is to be expected, and the methionine sequence is conserved and in-frame for the 
other two primate species studied within the order hominidae; gorilla and orangu-tan 
(figure 6.6).  The complete conservation of TGM2_Tc does not extend to earlier primate 
orders such as the old world monkeys.  For example, when comparing the genomic 
sequence of the rheusus macaque the methionine codon is conserved but is no longer in-
frame, due to an indel generating a frame shift at position 997nt (figure 6.7b-c).  A 
similar TGM2_Tc transcript may be present in the macaque genome however, as there 
is an in-frame methionine sequence, which conforms to the vertebrate Kozak consensus, 
located 32bp upstream of the methionine observed in the great apes (figure 6.7a).   
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Comparison of the sequences flanking the initiating methionine codon for TGM2_Tc to 
that of the Kozak consensus sequence (ACCATGG) indicates that the initiation site may 
be weak; however this appears to be typical of methionines located within MIR 
elements (appendix 9.8).  To confirm this observation the MIR sequences containing the 
initiating methionine codons were aligned using WebLogo, revealing that overall the 
nucleotide sequence conforms to the Kozak consensus (figure 6.4) but it is not 
uncommon for the flanking 3bp upstream and downstream sequences to differ.  
 
    
 
 
 
 
 
 
 
Figure 6.4.  Consensus sequence surrounding initiating methionines provided by MIR 
elements 
 
The image demonstrated the probability of a nucleotide being present for each position 
between -3 to +6.  The image was created by aligning 21 MIR sequences which contain start 
codons using WebLogo.  The height of the stacked letters represents the frequency of each 
nucleotide.  The top letter in the alignment is most conserved (Crooks et al., 2004). 
 
 
 
 
1 
 
 
0.5 
 
 
0 
      -3      -2     -1                               +4     +5     +6 
 
                           Initiating methionine 
  
                 ATG  
 
 
                   
 
 
   
Coding exon    Untranslated region           Evolutionary conserved region  
  Intronic region     MIR 
                 
Figure 6.5.  Evolutionary conserved regions of a number of mammalian species for TGM2_Tc 
Image adapted from the ECR browser (http://ecrbrowser.dcode.org/) which displays evolutionary conserved genomic regions.  The RefSeq coding exons have 
been numbered, 11-13.  The exonic composition of TGM2_Tc is included as a reference.  The species included are dog, cow, rat, mouse and opossum. The 
position of the initiating methionine (in the human transcript) has been included.  The figure demonstrates the lack of conservation for the novel TGM2_Tc 
region for a number of mammals  
TGM2_Tc 
Exon 11                                         12                     13 
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      Human            GGGAAGTGCAGTGCCTGGTGCAGCAAGCAGATGTCGGCTCTGATCCTCCCCAGGATGAAGGG-CCCGCGGCTCACACACCCTGAGTC - 847 
      Gorilla          NNNNNNNNNNNNNNNNNNNNNNNNNNNNAGATGTCGGCTCTGATCCTCCCCAGGATGAAGGG-CCCGCGGCTCACACACCCTGAGTC 
      Chimpanzee       GGGAAGTGCAGTGCCTGGTGCAGCAAGCAGATGTCGGCTCTGATCCTCCCCAGGATGAAGGG-CCCGCGGCTCACACACCCTGAGTC 
      Orang-utan       NNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNCCTCCCCAGGATGAAGGG-CCGGCGGCTCACACACCCCGAGTC 
      Macaque          GGGAAGTGCAGTGCCTGATGCAGCA-GCAGATGTCGGCTCTGATCCTCCCCAGGATGAAGGGCCCCGCGGCTCACACACCCTGAGTC 
 
 
      Human            CCGAGCGCACCAGGCTCTTCCGGGACACTCGCTCAGCTCATCCTCCCACAGCCTTAGGAGTGCCTGTGCCACGCAGATCCAAACAT  - 963 
      Gorilla          CCGAGCGCACCAGGCTCTTCCGGGACACTCGCTCAGCTCATCCTCCCACAGCCTTAGGAGTGCCTGTGCCACGNNNNNNNNNNNNN 
      Chimpanzee       CCGAGCGCACCAGGCTCTTCCGGGACACTCGCTCAGCTCATCCTCCCACAGCCTTAGGAGTGCCTGTGCCACGCAGATCCAAACAT 
      Orang-utan       CCGAGCACACCAGGCTCTTCCGGGACACTCGCTCAGCTCATCCTCCCACAGCCTTAGGAGTGCCTGTGCCANNNNNNNNNNNNNNN 
      Macaque          TGGAGCGCACCAGGCTCTTCCGGGACACTCGCTCAGCTAATCCTCCCACAGCCTTAGGAGTGCCTGTGCCATGCAGATCCAAACAT 
                 
 
 
Figure 6.6.  Multiple sequence alignment of the methionine containing region of TGM2_Tc for a number of primates   
Completely conserved sequences are in green, identical residues in pink, similar residues in blue and different residues in black.  N signifies that the sequence was 
unobtainable in current databases.  The ATG sequence, boxed red, is conserved in all species however in the macaque the codon is not in frame and therefore 
non-functional.  Sequence conservation was determined using the ClustalW2 alignment tool (http://www.ebi.ac.uk/Tools/clustalw2/index.html; accession 
numbers appendix 9.3).   
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    Human        CCTTTATAGGGTTGTCATGTAGGTGAAGT-GGAGCCCGCCGTGGGAAGTGCAGTGCCTGGTGCAGCAAGCAGATGTCGGCTCTGATCCTC  - 836   
    Macaque      CCTTT-TAGGGTTGTTATGAAGGTGAAGTAGGAGCTCGCCATGGGAAGTGCAGTGCCTGATGCAGCA-GCAGATGTCGGCTCTGATCCTC   
 
 
 
    Human       MSALI----------LPRMKGPRLTHPESRAHQALPGHSLSS---SSHSLRSACATQIQTSRTWEVEWLTRGHPLEEAKAGLEPRPVGVQVRPLPAAQCPLF 
    Macaque     MGSAVPDAAADVGSDPPQDEGPRGSHTLSLERTRLFRDTRSANPPTALGVPVPCRSKRQGPGRWSGSCGVN--PLEEAKAGLEPRPVGVQVCPLPAVLCPLF 
 
 
    Human       SSSSLGTLEPQWGVQGSAQPFPRCVTPSTFLPLSVPLGVAR-ELGGVILHHEHPPFSPSAEKSVPLCILYEKYRDCLTESNLIKVRALLVEPVINSYLLAER 
    Macaque     SSSSLGTLEPQWGVLGSAQPFPCCVTPSTFLPLSVPLGVARGELGGVILHHEHPPFSPSAEKSVPLCILYEKYRDCLTESNLIKVRALLVEPVINSYLLAER 
 
 
 
 
                                                                            P   L   E   E   A   K 
    Human         ACA TCG AGG ACC TGG GAG GTG GAG TGG CTC ACG CGG GGT CA-C CCA TTA GAA GAG GCA AGG  - 1016 
    Macaque        CGT CAA GGA CCT GGG AGG TGG AGT GGC TCA TGT GGG GTC AAC CCA TTA GAG GAG GCA AGG 
 
 
 
 
Figure 6.7.  Multiple sequence alignment of TGM2_Tc for human and macaque 
Completely conserved amino acids are in green, identical residues in pink, similar residues in blue and different residues in black.  A) Alternative putative 
initiating methionine (boxed red) for the macaque which is not conserved in the human sequence.  B) The peptide sequence is conserved until residue P61; the 
region where canonical exon 11 begins has been provided.  C) Nucleotide triplet sequences for human and macaque outlining the region at nucleotide 997 where 
the frameshift occurs.  Sequence conservation was determined using the ClustalW2 alignment tool (http://www.ebi.ac.uk/Tools/clustalw2/index.html; accession 
numbers appendix 9.3).   
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The termination codon of the TGM2_dLg transcript is situated within an MIR element 
(table 6.2).  The same MIR is within the 3‟-UTR of TGM2_wLg, but following the 
altered splicing an alternative reading frame is in use, allowing for translation to 
continue into the MIR sequence which contains the stop codon.  The alternative C-
terminal is made up of 51 novel amino acids.  TGM2_dLg is generated through the use 
of atypical alternative acceptor and donor splice sites located in RefSeq exons 12 and 
13.  There are two known modes of splicing occurring in vertebrates which differ in the 
splice site consensus sequence, with the major spliceosome splicing at AG-GT.  
Splicing of TGM2_dLg occurs at the consensus CTYCAC, which is not a conventional 
major or minor splice site (figure 6.8).  Previous studies have confirmed the expression 
of the isoform in human and rat tissues (Lai et al., 2007; Tolentino et al., 2004; 
Monsonego et al., 1997).  Both the acceptor and donor splicing occurs within a 
CTYCAC motif and as such it is not possible to distinguish the exact position where 
splicing occurs, although a putative sequence can be determined.  Multiple sequence 
alignments were generated with the region containing both the atypical acceptor and 
donor splice sites for a number of mammalian species, to reveal the conservation of the 
atypical splicing (figure 6.9).  The donor splice site was determined as (CUucacugug) 
and shown to be conserved in all mammals studied, with complete identity of the 
subsequent nine intronic nucleotides.  The acceptor splice site described in human 
(ctCCAC) was only detected in primate species with a different 3‟ region noted in rats, 
both of which are noted to be proceeded by three cytosine nucleotides (figure 6.8 and 
6.9).  Surprisingly no similar sequence was detected in mice. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.8.  Comparison of major splicing, minor splicing and the CTYCAC motif of TGM2_dLg 
The putative non-canonical splice site of TGM2_dLg has been determined for primate and rat.  
Crucial exonic sequences are boxed blue and conserved intronic sequence outside the box.  
Major (U12 type intron) and minor (U2 type intron) splice site sequences have been included 
as a reference (Will and Lührmann, 2005).  Fasta code Y = T / C; R = A / G; S = C / G. 
TGM2_dLg 
 
 
Major  
 
 
Minor  
 
 
 
Donor                                                             Acceptor 
 
5’ -           AG  GURAGU                               YAG  G               -3’ 
5’ -                  RUAUCCUUU                        YAS                   -3’ 
 
5’-            CU  UCACUGUG                      CCCCT  YCAC        -3’ 
 
  
 
 
 
 Human           GCAAGCTGGTGGCTGAGGTGTCCCTGCAGAACCCGCTCCCTGTGGCCCTAGAAGGCTGCACCTTCACTGTGGAGGGGGCCGGCCTGACTGAG 
 Chimpanzee      GCAAGCTGGTGGCTGAGGTGTCCCTGCAGAACCCGCTCCCTGTGGCCCTGGAAGGCTGCACCTTCACTGTGGAGGGGGCCGGCCTGACTGAG 
 Macaque         GCAAGCTGGTGGCCGAAGTGTCCCTGCAGAACCCGCTCCCTGTGGCCCTGGAAGGCTGCACCTTCACTGTGGAGGGGGCCGGGCTAACCGAG 
 Cow             GCAAGCTGGTGGCTGAGATATCTCTGCAGAACCCGCTCACTGTGGCGCTGTCGGGCTGCACCTTCACTGTGGAGGGAGCAGGCCTGATTGAG 
 Rat             GCAAACTGGTGGCTGAGGTGTCCCTGAAGAACCCACTTTCTGATTCCCTGTATGACTGTGTCTTCACTGTGGAGGGGGCTGGCCTGACCAAG 
 Mouse           GCAAACTGGTGGCTGAGGTGTCCCTGAAGAACCCACTTTCCGATCCCCTGTATGACTGCATCTTCACTGTGGAGGGGGCTGGCCTGACCAAG 
              
 
 
 Human           GAGCTGAAGGCTGTGAAGGGCTTCCGGAATGTCATCATTGGCCCCGCCTAAGGGACCCCTGC-------TCCCAGC----CTGCTGAGAGCC 
 Chimpanzee      GAGCTGAAGGCTGTGAAGGGCTTCCGGAATGTCATCATTGGCCCCGCCTAAGGGACCCCTGC-------TCCCAGC----CTGCTGAGAGCC 
 Macaque         GAGCTGAAGGCTGTGAAGGGCTTCCGGAATGTCATCATTGGCCCCGCCTAAGGGACCCCTGC-------TCCCAGC----CTGCTGAGGGCC 
 Cow             GAGCTGAAGGCCGTGAAGGGCTTTAGGAACGTCATCGTTGGCCCCTCCTAAGGGGTCCCCGTG--CCAGCCCCACCTCAGCCACTGAGGGCC 
 Rat             GAACTGAAGTCGGTCAAGGGTTACCGGAATATCATCATCGGCCCGGCCTAAGGGACCCCCTTCACCCAGACTCAGCCC-ATCACTTGCCAGC 
 Mouse           GAGCTGAAGTCGGTGAAGGGTTACCGGAATGTTATCATCGGCCCGGCCTAAGGGACCCCTT---CCCAGACTCAACCCCACCACTTGCCAAC 
                 
 
 
 Human           CCAGAGCTGGGTGGGGACAGTGATAGGCCCAAGGTC----------------CCCTCCACATCCCAGCAGCCCAAGCTTAATAGCCCTTCCC 
 Chimpanzee      CCAGAGCTGGGTGGGGACAGTGATAGGCCCAAGGTC----------------CCCTCCACATCCCAGCAGCCCAAGCTTAATAGCCCTCCCC 
 Macaque         CCAGAGCTGGGTGAGGACAGTGATAGGCCCAAGGTC----------------CCCTCCACATCCCAGCAGCCCAAGCTTAATAGCCCTTCCC 
 Cow             CCTGAGC-AGGTGCAGATGGGGAGGGTCCCAGGAACAGACCACACCCCAAATCCCCTCACATCCCAGCAGCCCTGACCCAATA--CTTCCCC 
 Rat             CGCACCTCGAGTTCTAACAGGGACAGCAACCTGTTGG-----------ATGTCCATGAGAAACTTCAGGGTGGGAACTGAGGCTGCCCGTGC 
 Mouse           CGCACCTTAAGTTCTCACAGGGACACCAGCCTGCTGA-----------ACATCCATGAGAAACTTCAGGGTACAAACTGAGGCTGCT-GTGC 
 
Figure 6.9.  Multiple sequence alignment of the CTYCAC motif of TGM2_dLg 
Completely conserved sequences are in green, identical residues in pink, similar residues in blue and different residues in black.  The ‘CTTCAC’ acceptor  
Splice region is boxed blue and the donor splice sites red.  The human mRNA co-ordinates are included as a reference.  Sequence conservation was determined 
using the ClustalW2 alignment tool (http://www.ebi.ac.uk/Tools/clustalw2/index.html; accession numbers appendix 9.3).   
A 
 
 
 
 
 
C 
B 
 
 
 
 
 
C 
C 
 
 
 
 
 
C 
1901                                                                                         1994                    
|                                                                                               | 
 
 
2113                                                                                         2193                    
|                                                                                               | 
 
 
2638                                                                                         2714                    
|                                                                                               | 
 
 
C
h
ap
ter 6
. M
IR
 elem
en
ts an
d
 altern
ativ
e sp
licin
g
 o
f tissu
e tran
sg
lu
tam
in
ase (T
G
M
2
) 
1
5
3
 
Chapter 6. MIR elements and alternative splicing of tissue transglutaminase (TGM2)  
 
  
154 
 
  
It is possible that the TGM2 isoforms which were detected in silico are artefactual and 
represent errors in splicing; specifically TGM2_dLg and TGM2_Tc, as there are no 
ESTs in the available databases which support the expression of these transcripts.  The 
mRNA from human and rat tissues were analysed by RT-PCR to confirm the expression 
of the discussed TGM2 isoforms.  Primers were used to amplify TGM2 (figure 6.10), 
and amplicons were purified, cloned and sequenced.  All five TGM2 transcript variants 
were expressed in all tissues analysed (figure 6.11).   
 
 
        
 
 
 
 
 
Figure 6.10.  Positions of the primers used in the RT-PCR experiments 
Exonic composition of the splice variants of TGM2 generated using the NCBI sequence 
alignment tool Spidey (http://www.ncbi.nlm.nih.gov/spidey/). Schematics begin at constitutive 
exon 4; displaying the MIR positions, and coding and non-coding exons.  Primer details are 
listed in table 2.3 and the position of the forward (blue) and reverse (red) primers are 
indicated by arrows.  The primers of TGM2_dLg and TGM2_wLg contain the splice site at the 
boundary of exon 12/13 to distinguish between the two splice variants.  Transcripts TGM2_Tc, 
TGM2_wLg and TGM2_dLg use the same reverse primer annealing to the terminal exon.  
 
 
 
 
 
 
 
 
 
 
 
Tc 
                Exon 4                                                                                                                     
wLg 
 
dLg 
                                                                                               
Sh 
                                                    
Vs 
Coding exon    Intron          Forward primer  
UTR exon   MIR element   Reverse primer 
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Figure 6.11.  Amplification of the TGM2 isoforms in multiple tissue types 
 
Amplified fragments of the TGM2 isoforms were analysed on a 2% agarose gel with 1X 
SybrSafe.  Tissues are abbreviated as follows: Br, brain; Ht, heart; Kd, kidney; Li, liver; Lu, lung; 
Pc, pancreas; Sp, spleen and Ts, testis.  TGM2_wLg (514 bp) and TGM2_dLg (414 bp) were 
amplified from rat cDNA normalised with GAPDH (figure 2.2), using primers designed 
elsewhere (Tolentino et al., 2002).  Published primers were used to ensure that only the 
targets were amplified, as the primer sequence must contain the CTTCAC motif of TGM2_dLg 
(figure 6.8) in order to differentiate between the two isoforms.  TGM2_Vs (323 bp), TGM2_Sh 
(481 bp) and TGM2_Tc (482 bp) were amplified from a pre-synthesised human cDNA panel 
(Clontech; primer details table 2.1).  All TGM2 fragments were confirmed by sequencing, 
DNase and RNase-free water was used as a template in the negative controls.    
 
 
 
 
 
 
 
       Br         Ht       Kd         Li         Lu         Pc         Sp         Ts      -ve 
TGM2_Vs 
TGM2_Sh 
TGM2_dLg 
TGM2_wLg 
TGM2_Tc 
500 bp 
300 bp 
1 kb 
500 bp 
1 kb 
500 bp 
500 bp 
1 kb 
1 kb 
300 bp 
300 bp 
700 bp 
500 bp 
1 kb 
700 bp 
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TGM2 has been implicated in neurodegenerative disease and diabetes (Ruan and 
Johnson, 2007; Porzio et al., 2007; Bernassola et al., 2002; Mastroberardino et al., 
2002), so to further expand the expression profile of TGM2, two rat cell lines were 
selected for RT-PCR analysis.  C6 cells are derived from rat glioma cells (Brenda et al., 
1968) and BRIN-BD11 cells are glucosensitive insulin-secreting clonal pancreatic β-
cells (Rasschaert et al 1996).  cDNA was synthesised from C6 cells which were either 
differentiated or in the mitotic phase.  Normal rat pancreatic islet cDNA was used as a 
comparison to the expression of the insulinoma BRIN-BD11 cells.   
 
Fragments of all known rat TGM2 isoforms were amplified in both mitotic and 
differentiated C6 cells, BRIN-BD11 cells and rat islets (figure 6.12). Similar 
concentrations of the TGM2 isoforms were amplified from both mitotic and 
differentiated C6 cells compared to normal brain tissue (figure 6.11), however with 
higher levels of TGM2_wLg appearing to be amplified.  The BRIN-BD11 cells and rat 
islets displayed lower levels of TGM2_wLg than expected with TGM2-Sh appearing to 
be preferentially expressed.  This data however is not quantitative and real-time qRT- 
PCR would need to be performed to confirm these observations. 
 
 
 
                      
 
 
                      
       
Figure 6.12.  Expression of TGM2 isoforms amplified from rat islets, C6 and BRIN-BD11 cells 
Amplified fragments of the TGM2 isoforms were analysed on a 2% agarose gel with 1X 
SybrSafe.  Abbreviations: Diff, differentiated C6 cells; Mit, C6 cells in mitotic phase; Brin, BRIN-
BD11 cells; Islets, normal rat islet of Langerhans.  TGM2_wLg (514bp) and TGM2_dLg (414bp) 
were amplified from rat cDNA using primers designed elsewhere (Tolentino et al., 2002).  
Primer details and cycling condition for TGM2_Vs (488bp) and TGM2_Sh (544bp) are in table 
2.3.  All TGM2 fragments were confirmed by sequencing, DNase and RNase-free water was 
used as a negative control and GAPDH (738bp) as a positive control. 
Vs                    Sh                   dLg                wLg                              +ve 
   Brin     Islets      Brin     Islets      Brin     Islets     Brin     Islets                     Brin     Islets                       
-ve 
 Diff       Mit        Diff       Mit        Diff       Mit        Diff      Mit                       Diff       Mit    
Vs                    Sh                   dLg                wLg                              +ve 
-ve 
300 bp 
500 bp 
1 kb 
C6 cell line 
 
1 kb 
300 bp 
500 bp 
Pancreatic cells  
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6.5.   In situ expression of the TGM2 isoforms in the adult rat brain 
 
The TGM2 isoforms were successfully detected in the rat brain using RT-PCR; however 
the spatial distribution of these transcripts cannot be determined by PCR alone.  
Radioactive in situ hybridisation was performed on five adult Wistar rat brains to 
investigate the distribution of the TGM2 mRNA transcripts.   
 
All four TGM2 isoforms were highly expressed in the corpus callosum and anterior 
commissure (figure 6.13); white matter regions connecting the left and right cerebral 
hemispheres, which consist of bundled axonal projections and facilitates communication 
between the two hemispheres.  High levels of TGM2 expression was also detected in 
the limbic region; specifically the olfactory tract, which is important in odour perception 
and the hippocampus, including the dendrate gyrus and fimbria; areas fundamental in 
long-term learning and spatial awareness.  TGM2_wLg appears to be expressed at lower 
levels in the olfactory tract than the other TGM2 isoforms.  Finally high levels of 
expression was visualised in cells of the optic nerve, optic chiasma and optic tract for all 
four isoforms, consistent with a role in visual perception and memory.  There appears to 
be little or no expression of the four TGM2 splice variants in the hypothalamus, the 
thalamus, the amygdala and the cuadate putamen.  The spatial distribution of the 
primate-specific TGM2_Tc in the brain is unknown and cannot be compared to the rat 
in situ hybridisation data.  
 
The four rat TGM2 isoforms are expressed at similar levels in the same brain regions, 
suggesting that expression all of transcripts variants is required for normal brain 
function.  The transcription of these isoforms will be facilitated by a single promoter as 
these isoforms share the start exon and inititating methionine (figure 6.1).  Any 
variation in protein expression levels may be due to differences in mRNA half-lives and 
stability.  The expression of these spliceoforms may also be regulated by the MIR-
derived putative miRNA target sites and precursors discussed in section 6.6.   
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Figure 6.13.  Distribution of TGM2 mRNA expressing cells in the normal rat brain 
A) TGM2_Vs; B) TGM2_Sh; C) TGM2_dLg; D) TGM2_wLg.  Coronal sections of the normal adult Wistar rat brain hybridised with 35S-labeled antisense RNA probes.  
Cells expressing TGM2 mRNA are visualised as light areas.  High levels of TGM2 mRNA were detected within the white matter areas; (CC) corpus callosum and 
(AC) anterior commissure.  High levels are also detected in sensory regions; optic nerve/chiasm/tract (OT) and the limbic region; (Hp) hippocampus and (Of) 
olfactory tract and (ML) media lemniscus.  Low levels were detected in the (T) thalamus, (Hy) hypothalamus, (FC) frontal cortex and (CP) caudate putamen.  
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6.6.     The role of MIR elements in the function of the TGM2 isoforms 
 
Multiple TGM2 splice variants have been identified and subsequently the expression 
confirmed in a number of tissues; however the role of the MIR elements in regulating 
the function of these TGM2 isoforms was to be determined.  It is clear that the MIRs are 
critical for the functional expression of TGM2_Tc and TGM2_dLg by providing 
methionine and/or stop codons.   
 
In previous chapters the role of MIRs in post-transcriptional control of gene expression 
has been discussed, for example by the formation of dsRNA, precursor miRNAs and 
miRNA targets.  TGM2 splice variants were screened for the presence of such 
sequences (table 6.3).  There is sequence similarity between three known pre-miRNA 
stem-loop structures and the TGM2_Tc mRNA sequence (figure 6.14); two in the 5‟-
UTR and the third within the coding sequence.  There is a further potential pre-miRNA 
stem-loop sequence within the 3‟-UTR of TGM2_Vs which resides within the exaptated 
MIR element (figure 6.14).  No evidence of similar structures was found in the other 
TGM2 isoforms (TGM2_Sh, TGM2_dLg and TGM2_wLg).  
  
 
MicroRNA 
name 
Transcript 
name 
mRNA 
location 
Gene 
region 
MIR Strand 
BLAST 
Score 
E-value 
hsa-mir-1285 TGM2_Tc 83  1 5’-UTR N - 288 2.20E-08 
hsa-mir-619 TGM2_Tc 63  141 5’-UTR N + 188 9.60E-04 
hsa-mir-220c TGM2_Tc 876  949 CDS N + 137 2.70E-01 
hsa-mir-640           TGM2_Vs 1240  1327 3’-UTR Y + 143 1.20E-01 
NH TGM2_Sh . . . . . . 
NH TGM2_dLg . . . . . . 
NH TGM2_wLg . . . . . . 
 
Table 6.3.  Predicted MiRNA precursor stem -loop sequences  
MiRNA precursor sequences have been predicted using the miRBase search engine.  The gene 
region and co-ordinates which the hairpin is situated has been provided. Abbreviations: Y, the 
stem-loop sequence it within an exaptated MIR sequence; N, the predicted stem-loop is not 
located at the MIR region; NH, no hairpin structure detected.  The miRNA name and the strand 
which it is located has been included (+, sense; -, antisense).  The BLAST score and the 
expectation (E-) value has been included; the lower the E-value the more significant the score 
(Altschul et al., 1990). 
  
 
  TGM2_Tc 
 
    TGM2_Tc           83   UUUGGGAGGCUGAGGCAGGAGGAUUGCUUGAGCCCAGGAGUUUGAGACCAGCCUGAGCAACAUAGUGAGACC-CCGUCUCUAUA   1    
                           |||||||||| ||||| || | ||  ||||||||||| | ||||||||||  ||| |||||| ||||||||| ||||||||| | 
    hsa-mir-1285       1   UUUGGGAGGCCGAGGCUGGUGCAUCACUUGAGCCCAGCAAUUUGAGACCAAUCUGGGCAACAAAGUGAGACCUCCGUCUCUACA   84   
 
 
 
    TGM2_Tc           63   CUCCUGCCUCAGCCUCCCAAAGUGCUGGGAUUACAGGCGCGAGCCACUACACCCAAC--U-ACUUGUAUUUAUUUACUGCUC   141  
                           | ||  ||||||||||||||| ||||||||||||||||  |||||||| |   | ||  | || || |  | |||  ||| | 
   hsa-mir-619         1   CGCCCACCUCAGCCUCCCAAAAUGCUGGGAUUACAGGCAUGAGCCACUGCGGUCGACCAUGACCUGGACAUGUUUG-UGCCC   81   
 
 
    TGM2_Tc          876   GAGCGCACCAGGCUCUUCCGGGACACUCGCUCAGCUCAUCCUCCCACAGCCUU-AGGA--GUGCCUGUGC-CACG-CAG   949  
                           || | |||  |||| ||  |  | ||||  | ||||||||| | ||||||||| || |  | ||||| || || | ||| 
    hsa-mir-220c       7   GACCACACAGGGCUGUUGUGA-AGACUCAGUGAGCUCAUCCCCACACAGCCUUCAGCACAGGGCCUG-GCUCAGGGCAG   83   
 
 
  TGM2_Vs 
 
    TGM2_Vs    1240  GUGACCUUGAGCAAAUGACUUCUU-UCUGA-ACCUCAGUUUCCUCGUCUGGAAAAUGGGGACAACAUCAAG-A-CCUUCCUCCUAGAGUGG  1327  
               |||||| || |||| |  ||     || || || |||| | |||  |||| ||||||||  ||  ||| || | ||| |||| ||  || | 
    hsa-mir-640   1  GUGACCCUGGGCAAGUUCCUGAAGAUCAGACACAUCAGAUCCCUUAUCUGUAAAAUGGG--CAUGAUCCAGGAACCUGCCUC-UACGGUUG  88   
 
 
 
Figure 6.14.  Putative pre-miRNA stem-loop structures identified in the human mRNA sequences of TGM2_Vs and TGM2_Tc 
 
Sequence alignments identified using MiRBase demonstrating sequence homology between TGM2 mRNA and known human pre-miRNA stem-loops; mir-1285, 
mir-619, mir-220c and mir-640.   
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A further mechanism for the regulation of gene expression is via siRNAs derived from 
dsRNA structures (Ying et al., 2008).  These siRNA may then be involved in the RNAi 
pathway, and subsequently mRNA degradation, mRNA stability and suppressing 
translation.  Two of the MIR elements within the 3‟-UTR of the full length TGM2 are in 
opposite orientations (direct/inverse) and may potentially form dsRNAs (figure 6.15).  
These MIR elements are present in TGM2_dLg and TGM2_Tc, and may provide a 
means of regulating transcription and/or translation of all three isoforms.  Likewise 
dsRNAs may form following the hybrisiation of an MIR element in the 5‟-UTR and the 
MIR containing the methionine of the transcript TGM2_Tc.  
 
 
 
 
     TGM2_Tc (77% sequence identity) 
 
413 acagagaggggaggtcatctccccgggctcacacagccagtgagtggc 460 
|||||||||||| |  || | |  ||| |||||||||  | || |||| 
1186 tgtctctccccttccttacacgaaccccagtgtgtcgcccccttaccg 1139 
 
 
 
     TGM2_dLg (84% sequence identity) 
 
2428 agtgg-cctcgtggttattagcaaggctgggtaatgtgaaggc 2469 
||||| ||| |||||||||  ||||||||||  || | || || 
2803 tcacctggaacaccaataaatgttccgacccggtatattttcg 2761 
 
 
 
 
Figure 6.15. Putative dsRNA structure formed by adjacent MIR sequences in opposite 
orientations 
 
There is 77% sequence homology for a potential dsRNA formed between an MIR located 
within the 5’-UTR and the protein-coding sequence of TGM2_Tc.  Likewise there is 84% 
sequence homology between adjacent MIR elements which have been recruited in the 
following isoforms: TGM2_Lg, TGM2_dLg and TGM2_Tc.  The mRNA coordinates for TGM2_Tc 
and TGM2_dLg have been provided as a reference. 
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6.6.1. Splice signals and termination codons 
 
A potential role of the MIR elements in the expression of all of the transcripts has been 
proposed with the exception of TGM2_Sh.  One observation with both TGM2_Sh and 
TGM2_Vs is the occurrence of read-through exons where the donor splice sites are 
skipped and the intron contains an MIR element.  It could be that the MIRs are 
providing a splicing signal which silences the skipped splice site; therefore the read-
through TGM2 isoform sequences were screened for possible exon splice silencer (ESS) 
sequences (table 6.4).  ESSs were identified using the RegRNA web server and were 
considered authentic if previously demonstrated to be functional.   
 
Putative ESS sequences were located within the MIRs of both TGM2_Sh and 
TGM2_Vs (table 6.4).  It is worth noting that ESS sequences are small and may be 
abundant in both mRNAs; therefore they may represent artefacts, and cannot be 
confirmed as functional ESSs with these findings alone.  However the possibility 
remains that the MIRs may be involved in the splicing of these transcripts via one or 
more of these ESS sequences.  
 
 
Transcript 
name 
MIR 
position 
ESS 
position 
ESS 
sequence 
Reference 
TGM2_Vs 1203  1333 
1203  1206 
1219  1226 
1223  1230 
1233  1236 
1245  1249 
1246  1249 
1259  1266 
1306  1309 
1312  1316 
1318  1321 
CAAG 
GAGGGAGG 
GTGGGAGG 
CAAG 
CAAGG 
CAAG 
GAAAGAAG 
CAAG 
GGAAG 
TAGG 
Caputi et al., 1995 
Mandal et al., 2004 
Mandal et al., 2004 
Caputi et al., 1995 
Staffa et al., 1997 
Caputi et al., 1995 
Mandal et al., 2004 
Caputi et al., 1995 
Sun et al., 1993 
Del Gatto-Konczak et al., 1999 
TGM2_Sh 1812  1879 
1819  1823 
1849  1852 
1814  1817 
1855  1858 
1874  1877 
1848  1851 
1849  1852 
CATGG 
TTAG 
AAGT  
AAGT  
AAGT 
TAGG 
TTAG 
Uporova et al., 1999 
Si et al., 1998 
Mayeda et al., 1999 
Staffa and Cochrane, 1995 
Del Gatto and Breathnach, 1995 
Del Gatto-Konczak et al., 1999 
Tomonaga et al., 2000 
 
Table 6.4. Exonic splice silencing sequences identified in the recruited MIR elements 
 
The mRNA co-ordinates for the recruited MIR elements and the predicted ESS have been 
supplied.  References which report the sequences as being functional ESS in other genes have 
been listed.  
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6.7.      Discussion  
 
There are a number of reported alternative TGM2 transcripts which when screening 
with RepeatMakser were noted to contain MIR elements (Atonyak et al., 2006; Fraij 
and Gonzales, 1996; Lai et al., 2007).  A further novel isoform was identified which has 
recruited seven MIR elements.  TGM2 is also mutated in a number of human 
neurological disorders including Alzheimer‟s disease, schizophrenia and Huntington‟s 
disease.  TGM2 was therefore selected for further analysis and discussion, to determine 
if the MIR elements and isoforms are conserved between mammals, and if the elements 
are playing a role in regulating the expression of the TGM2 transcript variants.   
 
6.7.1.   Alternative splicing of TGM2 and the exaptation of MIR elements 
 
A total of five human TGM2 transcript variants were identified, four published and one 
novel (TGM2_Tc).  Intriguingly all of the isoforms have recruited MIRs, with a total of 
nine independent exaptated MIR elements identified.  The wild-type full length 
transcript (TGM2_wLg) has recruited three MIR elements within the 3‟-UTR.  Two of 
the TGM2 isoforms (TGM2_Sh and TGM2_Vs) encode truncated proteins due to 
skipping the donor splice site of exons 6 and 10 respectively. The shorter forms of 
TGM2 contain different MIR elements also in the 3‟-UTR.  A further TGM2 isoform 
(TGM2_dLg) is encoded following an atypical splicing event occurring in exons 12 and 
13 of the full length transcript.  Both the acceptor and donor splicing takes place within 
the consensus sequence CTYCAC, which is not a recognised classic splice site; 
however a similar atypical splicing event, containing a CTTC motif, has been reported 
for the G protein, beta-3 subunit (GNB3; Rosskopf et al., 2003).  TGM2_dLg shares the 
three MIR elements identified in the full length transcript, however the irregular 
splicing encodes a peptide from an alternative reading frame, with the stop codon 
located within the first of the recruited MIR.  A fifth novel protein (TGM2_Tc) is 
truncated at the N-terminus, and is translated from an initiating methionine located 
within RefSeq intron 10, and as such will be regulated by an alternative promoter.  
TGM2_Tc has recruited seven MIR elements in total, two of which are contributing to 
the coding sequence, including the alternative initiating methionine codon, three are in 
the 3‟-UTR and are at the same position observed with the full length isoform.  The 
TGM2_Tc transcript shares the last three exons at the C-terminal of the wild-type 
TGM2 with a maintained reading frame.   
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Multiple cross-species sequence alignments revealed conservation of TGM2_Vs and 
TGM2_Sh with other primates, rodents, dog and cow.  However conservation of 
TGM2_Tc could only be detected in primates, and there is no evidence of the 
integration of the MIRs in the genomic region.  Given the age of the MIR elements all 
mammals should have integrated, and the repeats have been deleted in dog, cow and 
rodents, suggesting that TGM2_Tc may be involved in a recently developed function, 
possibly related to the known TGM2 dual-activities.  TGM2_dLg is encoded following 
an atypical splicing event, and the splice site including the flanking intronic sequences 
are conserved in primates; with an alternative acceptor splice site being reported at a 
different position in rats (Monsonego et al., 1997).  Neither of the splicing motifs 
appears to be conserved in mouse, dog or cow, however the MIR elements have been 
exaptated but without the necessary sequence changes required to generate the splice 
motif.  It appears therefore that the different TGM2 isoforms may have arisen at 
different times during evolution, possibly to modify the diverse enzyme activity of the 
TGM2 enzyme. 
 
6.7.2.   Expression analysis and conservation of the TGM2 splice variants 
 
Expression analysis of the TGM2 isoforms revealed ubiquitous expression of the 
mRNA, with all five transcripts being expressed in a number of tissues, including the rat 
clonal beta cell line (BRIN-BD11) and the glioma (C6) rat cell line.  The expression of 
the rat isoforms were observed in rat brain by radioactive in situ hybridisation, and all 
transcripts studied display similar spatial staining patterns.  All TGM2 rat isoforms were 
expressed in the hippocampus, including the dendrate gyrus and fimbria; areas 
fundamental in long-term learning and spatial awareness.  Memory loss is the earliest 
clinical observation in Alzheimer‟s disease patients, and upregulation of TGM2_Sh has 
been observed in the hippocampal regions of such individuals.  High levels of TGM2 
expression was visualised in cells of the optic nerve, optic chiasma and optic tract for all 
four isoforms, consistent with a role in visual perception and memory.  TGM2 has 
previously been linked to retinal dystrophy and apoptosis during photoreceptor 
degeneration in rats (Zhang et al., 1996), but the role of TGM2 in visual pathways or 
the visual system of the brain has not previously been studied.   
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A high level of TGM2 mRNA staining was noted in the olfactory tract and olfactory 
bulb, which contains the sensory neurons responsible for processing and perceiving 
odours.  Olfactory dysfunction is associated with early Parkinson‟s disease, and patients 
frequently experience odour hallucinations and anosmia (absence of smell sensation) 
(Diederich et al., 2009; Wszolek et al., 1998).  Neurodegenerative anosmia is an early 
indicator of dementia and Alzheimer‟s disease, with all patients displaying olfactory 
impairment (Wilson et al., 2009).  Furthermore >70% of individuals over 80 years of 
age are reported to have a significant loss in odour sensation (Lafreniere et al., 2009).   
 
A strong signal for TGM2 mRNA was detected in the corpus callosum and anterior 
commissure, which are white matter regions connecting the left and right cerebral 
hemispheres; facilitating communication between the two hemispheres.  The corpus 
callosum (CC) has been suggested to be involved in processing emotions and social 
interaction and as such is implicated in autism, with a reduction in the total CC size 
being observed in autistic individuals (Vidal et al., 2006).  Agenesis and/or atrophy or 
the CC has also been noted in Alzheimer‟s disease, Parkinson‟s disease, schizophrenia 
patients and established bipolar disorder cases (Serra et al., 2009; Wszolek et al., 1998; 
Walterfang et al., 2009; Davis, 1994).  TGM2 has not previously been implicated in 
autism or bipolar affective disorder; however TGM2 has been implicated in the 
development of schizophrenia following the identification of several TGM2 SNPs in 
schizophrenia cases and their parents (Bradford et al., 2009).   Furthermore abnormal 
protein cross-linking and amyloid plaques have been linked to TGM2 in the pathology 
of Alzheimer‟s disease and TGM2 has also been shown to be responsible for the 
formation of Lewy bodies in the hippocampus of Parkinson‟s disease patients (Andringa 
et al., 2004). 
 
6.7.3.     The TGM2 isoforms will display differences in transamidation and GTP- 
               binding activity 
 
TGM2 is a multifunctional calcium-dependant enzyme which catalyses both 
intracellular and extracellular protein cross-linking, and functions as a G-protein when 
bound to GTP.  TGM2 is composed of distinct activity and binding domains, the full 
length isoform contains several calcium binding sites within a catalytic core region, 
with the TGase function attributed to the core and N-terminus, and the C-terminus 
essential for G-protein activity.   
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There are numerous guanine binding sites positioned predominantly in the β-barrels at 
the C-terminal end, which are known to interact with α1-AR, PLC-δ1 and GPR56.  
There is a distinct relationship between the dual activities of TGM2.  When bound to 
GTP the TGase activity is downregulated, whereas GTPase activity is inhibited by Ca
2+
 
binding.  The two activities are known to possess different functional roles.  When 
TGM2 is functioning as a TGase it has been shown to be involved in apoptosis, cell 
adhesion and protein cross-linking (Collighan and Griffin, 2009; Malion and Piacentini, 
1998), whereas when TGM2 is acting as a G-protein it stimulates PLC-δ1 activity and 
regulates receptor-mediated signalling by coupling ligand-bound GPCRs to PLC-δ1, 
mainly α1-AR, thromboxane and oxytocin (Park et al., 1998; Kang et al., 2002).  GTP-
binding and subsequent PLC-δ1 stimulation has been implicated in anti-apoptotic cell 
survival (Citron et al., 2002).  Moreover there is a strong relationship between the 
interaction and stimulation of PLC-δ1 by TGM2 and the regulation of intercellular 
calcium levels.  PLC-δ1 is stimulated upon binding to the GTP-bound TGM2 protein, 
thus inducing capacitative calcium entry, following which a constant level of 
intracellular Ca
2+
 is maintained until the GTP is hydrolysed resulting in the inhibition of 
PLC-δ1 activity (Kang et al., 2002).  Overall the dual-function of TGM2 offers a means 
of switching between different enzyme activities, and alternative splicing of TGM2 may 
provide further regulation and control of the diverse protein function, allowing for 
TGM2 to adapt to different environmental conditions.   
 
6.7.3.1.   Protein activity of TGM2_Sh and TGM2_Vs 
 
Differential expression of the TGM2_Sh, TGM2_dLg and full length TGM2 has been 
previously demonstrated.  Antonyak et al., (2006) studied TGM2 mutants lacking 30aa 
at the C-terminal end which were unable to bind GTP, or to stimulate and/or interact 
with PLC-δ1, and displayed weak transamidation activity; possibly a consequence of 
failed TGM2-mediated receptor signalling and associated Ca
2+
 entry. Antonyak et al., 
(2006) further demonstrated a lack of GTP-binding and weak TGase activity of 
TGM2_Sh expressed in HeLa cells, and suggested that the full length isoform protects 
against apoptotic events and cell death, whereas the short isoform induces apoptotic 
responses.  The apoptotic effect of TGM2 is suggested to be due to abnormal protein 
aggregations of TGM2, with TGM2_Sh forming large oligomers in cells, which is not 
attributed to TGase cross-linking but through an undetermined mechanism (Antonyak et 
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al., 2006).  It is most likely that TGM2_Vs is also GTP-independent and may behave in 
a similar manner to that observed for TGM2_Sh due to the transcript encoding a peptide 
which lacks the C-terminal 149 residues.  Furthermore it can be assumed that both the 
short isoforms will not interact with α1-AR, PLC-δ1 and the G-protein coupled receptor 
GPR56, due to the absence of G-protein function. 
 
6.7.3.2.   Protein activity of TGM2_dLG  
 
TGM2_dLg is composed of 13 exons and is highly similar to the RefSeq, however the 
C-terminus differs due to atypical splicing, encoding a protein which contains all the 
guanine nucleotide binding sites but lacks the interaction sites for PLC-δ1 and α1-AR.  
Festoff et al., (2002) studied the expression of TGM2_dLG and TGM2_wLg following 
spinal cord injury (SCI) in rats.  Prior to SCI they detected the full length TGM2, 
however 24 hrs post-SCI, both transcripts were detected with TGM2_dLg being 
upregulated.  As such they proposed that following SCI, there is a switch in GTP-
dependency of TGM2 with a preference for the GTP-independent isoform.  Tolentino et 
al., (2004) studied the expression of TGM2_dLg following cerebral ischemic attack 
(stroke), focussing particularly on the fluctuation of cytosolic Ca
2+
.  TGM2_dLg was 
noted to be upregulated and expressed at higher levels than TGM2_wLg at low calcium 
concentrations.  Finally TGM2_dLg has been shown to have an altered affinity for Ca
2+
 
at normal calcium levels, TGase activity is less than 10% that observed in the full length 
form.  Furthermore TGM2_dLg has also been demonstrated to enhance GTP hydrolysis 
and is insensitive to GTP inhibition when Ca
2+
 levels increase (Lai et al., 2007).  
 
Expression of TGM2_dLg may allow for an enhanced response to subtle changes in 
calcium levels, whereas the full length transcript may not be receptive to such changes.  
It is possible that TGM2_dLg may be rapidly expressed following splicing of the full 
length mRNA transcript.  For example, once TGM2_wLg has been exported to the 
cytoplasm, post-transcriptional splicing may occur, deleting the sequence flanked by the 
CTYCAC motif; resulting in nucleus-independent control of gene expression.  A two 
step splicing event would allow for a rapid switch to the TGM2_dLg GTP-independent 
isoform, and downregulation of the full length transcript in response to environmental 
changes, such as following injury or ischemia.  A similar means of post-transcriptional 
regulation has been suggested for the minor spliceosome, and it is thought that minor 
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splicing (U12-type) may take place in the cytosol following nuclear export of partially 
spliced pre-mRNA, supported by the detection of the associated minor-class of small-
nuclear-RNAs enriched in the cytoplasm (König et al., 2007).     
 
6.7.3.3.   Protein activity of TGM2_Tc 
 
The final transcript identified (TGM2_Tc) is the only transcript that lacks the 
fibronectin domain and as such would not be involved in FN1-associated functions 
including wound healing, cell adhesion and blood plasma development (Akimov and 
Belkin, 2001; Telci and Griffin, 2006).  TGM2_Tc shares the last three exons at the C-
terminal end with the full length transcript and has intact binding sites for PLC-δ1 and 
α1-AR; however only four of the five guanine binding residues are encoded and as such 
the protein will not form a complete GTP-binding pocket.  Consequently TGM2_Tc 
may have weak or null GTPase activity and as a result, limited PLC-δ1 and α1-AR 
interaction and stimulation.   
 
TGM2_Tc is intriguing as it is the only isoform which will be regulated by an 
alternative promoter sequence.  Furthermore the putative protein will most likely be 
calcium independent and will not exhibit TGase activity or the „normal‟ GTP activity 
associated with the wild-type TGM2.  The only common feature shared with the full 
length protein is the presence of the PLδ-C1, α1-AR and GPR56 interaction sites.  It is 
possible that the previously discussed kinase activity of TGM2 may be attributed to the 
novel N-terminal polypeptide sequence or that the truncated protein functions solely as 
a G-protein.  Alternatively the predicted dsRNAs formed by the hybridisation of 
adjacent MIR elements present both in the 5‟-UTR and 3‟-UTR may be a source of 
siRNAs that regulate the expression levels of the other isoforms, encoded from a single 
promoter.  These suggestions however are speculative and require further investigation 
and experimental validation.  Finally given that MIRs were active prior to the 
mammalian radiation, the MIR elements recruited by TGM2_Tc should be present in 
non-primate mammals, yet the repeats cannot be detected and have either integrated late 
in mammalian evolution or have been deleted.  These finding suggesting that TGM2_Tc 
may have a recently adapted function, possibly involved in the known TGM2 dual-
activities or an increase in cognitive ability, such as learning and memory.   
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Taking into account the potential variations in enzyme activity of the TGM2 isoforms, it 
appears that there is a necessity for „finely tuned‟ gene expression in situations where 
there are fluctuations in intracellular [Ca
2+
], for example when there is a reduction in 
free Ca
2+
 following ischemia, as discussed previously.  In addition, there may be a 
requirement for TGM2 to function as a G-protein in a Ca
2+
-independent manner when 
there is a high level of Ca
2+
 entry from intracellular stores.  One such example being at 
the onset of and during parturition, as the primary trigger for human myometrial 
contractions is an increase in intracellular calcium (Tribe et al., 2001).  In such 
instances TGM2 may need to function solely as a G-protein to couple with α1-AR and 
oxytocin, the neurotransmitter responsible for contractions of the myometrium during 
labour and mammary tissue during lactation (Lee et al., 2009).  One study monitored 
TGM2 expression levels in rats during pregnancy (Dupuis et al., 2004), and GTP-bound 
TGM2 was predominantly localised to the plasma membrane and upregulated during 
pregnancy.  Furthermore myometrial α1-AR is known to participate in the initiation of 
uterine contractions (Limon-Boulez et al., 1997), possibly through TGM2-mediated 
signalling with PLC-δ1.     
 
6.7.4.     The role of MIR elements in the differential expression and activity of  
       TGM2  
 
During previous chapters the primary observation has been that MIR elements may be a 
source of cis-acting regulatory sequences, such as miRNA, dsRNAs, cryptic splice sites 
and initiation and termination codons.  The abundance of MIR elements recruited by 
TGM2 isoforms suggests that these elements may play a role in TGM2 function.  
Therefore the exaptated MIR sequences of TGM2 were studied to determine if the 
repeats are contributing to the expression of the TGM2 isoforms by the previously 
described mechanism, such as post-transcriptional control of gene expression via the 
formation of dsRNAs or by providing translational control codons. 
 
The role of MIR elements in the protein expression of TGM2_Tc and TGM2_dLg is 
easily determined, as a repeat is providing an initiating methionine and a stop codon.  
However the role of the MIR elements in the expression of TGM2_Vs and TGM2_Sh is 
less clear and required further investigation.  A putative miRNA precursor stem-loop 
structure was noted in the MIR sequence of TGM2_Vs, which could regulate expression 
by blocking translation of this protein product.  TGM2_Vs and TGM2_Sh are both 
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read-through transcripts where donor splicing is skipped and a truncated protein 
produced.  It is possible that the MIR elements may be a source of splicing signals 
which may silence the skipped splice site, and several exonic splice silencer sequences 
were identified within the recruited MIRs of TGM2_Vs and TGM2_Sh, however these 
sequences have not been confirmed experimentally.   
 
Finally three predicted pre-miRNA sequences were noted in the 5‟-UTR and coding-
sequence of TGM2_Tc.  The stem-loops are not located within the MIR element, but 
may regulate the expression of the TGM2_Tc isoform, which is encoded from an MIR-
derived methionine.  Moreover a putative dsRNA structure was identified for 
TGM2_Tc, formed by the hybridisation of an MIR element in the 5‟-UTR and a second 
inverted MIR element in the coding sequence.  A second predicted dsRNA may also be 
generated between adjacent MIR elements present in the 3‟-UTR of TGM2_wLg, 
TGM2_dLg and TGM2_Tc.  The role of MIR elements in the localisation of mRNA in 
polarised cells, via the formation of dsRNA and miRNAs has previously been discussed 
(section 4.4).  TGM2 is expressed in a number of polarised cells such as photoreceptors, 
neurones and epithelial cells (Zhang et al., 1996; Festoff et al., 2001; Treharne et al., 
2009).  Furthermore TGM2 is known to be expressed in distinct cell compartments, for 
example G-protein activity occurs at the cell membrane and in the cytosol, yet when 
TGM2 is acting as TGase, protein activity takes place in the nucleus, extracellular space 
and cytosol (Fesus and Piacentini, 2002).  Therefore MIR-mediated mRNA localisation 
and RNAi may play a role in regulating spatial protein expression of TGM2 in polarised 
cells. 
 
 
 
 
6.8.        Future investigations 
 
To determine if the loss of the C-terminal residues has an effect on the overall activity 
of TGM2 a number of well documented protein and functional assays could be 
performed.  TGase activity can be measured directly from cell lysates (Gnaccarini et al., 
2009; Slaughter et al., 1992).  Fibronectin binding, GTP binding and inhibition could 
also be measured by well established protocols (McEwen et al., 2002; Datta et al., 2006; 
Achyuthan et al., 1996).   
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Determining the protein activity of the individual TGM2 isoforms would require the 
optimisation of several experiments in order to differentiate between the various splice 
variants and protein products.  For example, the full length isoforms could be cloned 
into mammalian expression vectors, allowing for the transient transfection of 
mammalian cell lines.  Isoform specific monoclonal antibodies may also be designed, 
specific to the novel peptide sequence of each protein product.  These antibodies could 
then be used to measure protein levels by western blotting.  Individual isoforms could 
also be knocked down in cultured cells by siRNAs.   
 
The expression of the isoforms in transfected cells (plasmid or siRNA) could be 
measured by real-time qRT-PCR following exposure to cytotoxic or neuroprotective 
compounds modelling specific neurological conditions.  For example treating with 
amyloid β-peptides that are known to accumulate and damage neurons in the brain of 
patients with Alzheimer disease (Wilhelmus et al., 2009).  Likewise the glucose 
responsiveness of transfected pancreatic β-cells could be studied and the isoform 
expression recorded in hyperglycaemic and/or lipotoxic conditions (Ball et al., 2000). 
 
Chapter 6. MIR elements and alternative splicing of tissue transglutaminase (TGM2)  
 
  
172 
 
  
6.9.        Conclusion 
 
It appears that MIR elements are involved in regulating the expression of TGM2 
isoforms and may have provided a means of enhancing the multifunctional enzyme 
properties.  There are five human TGM2 splice variants, all of which have recruited at 
least one MIR element.  The isoforms appear to be conserved in other mammals with 
the exception of the primate specific TGM2_Tc and there are no TGM2 transcript 
variants identified for chicken and zebrafish.  It appears that the MIR elements may play 
an important role in regulating the expression of the multiple transcript variants by 
providing cis-acting regulatory sequences such as stop codons, initiating methionines 
and miRNA target sites.  And as such the repeats elements may be regulating the rate of 
protein expression, or mRNA stability by forming dsRNA and binding miRNA.   
 
Overall it is possible that the transposition of MIR elements may have provided a pool 
of new genomic material that was utilised by the TGM2 gene to generate multiple 
protein products.  This multitude of TGM2 proteins may have assisted in the adaptation 
of TGM2 function during mammalian evolution, producing the complexly regulated 
multi-activity of TGM2.  
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7.       GENERAL DISCUSSION AND FURTHER STUDIES 
 
7.1. MIR elements recruited in the 3’-UTRs may be involved in the post-
transcriptional control of gene expression 
 
The transcription of mature mRNA is a multi-factorial process involving a number of 
elements including RNA polymerase, promoters, transcription factors, enhancers and 
splice sites.  UTRs have also been shown to play a role in post-transcriptional control of 
gene expression by a number of mechanisms including; mRNA transport and sub-
cellular localisation, repression of translation and mRNA stability (Mignone et al., 
2003; Guhaniyogi and Brewer, 2001).  The significance of the 3‟-UTR in gene 
expression has previously been suggested, for example mutations and polymorphisms in 
the 3‟-UTRs has been attributed to disease, such as bipolar disorder, retinal 
degeneration and systemic lupus erythematosus (Verardo et al., 2009; Pickard et al., 
2008; Citores et al., 2004; Conne et al., 2000). 
 
In chapter 3 it was noted that 75% (1395) of the total MIR elements identified have 
been recruited in the 3‟-UTRs of human genes, with a high level of sequence 
conservation of the core-SINE, as such these genes share a common feature and may 
contain sequence homology of ~70bp.  The highly conserved property of the core-SINE 
suggests that maintaining the repeat sequence may be fortuitous.  The abundance of 
MIR in the 3‟-UTR may merely reflect the lack of selective pressure as these repeats are 
less likely to disrupt protein expression.  Nonetheless it is conceivable to assume that 
some MIR elements may become domesticated, and that this tolerance of recruiting TEs 
in the 3‟-UTR may provide sufficient time for the MIR to adopt a functional role 
without affecting the viability of the existing gene expression.   
 
Sub-cellular localisation of mRNA is a means of targeting protein expression to a 
specific, usually distal intracellular region, and RNA is transported in the majority and 
possibly all polarised cell types (Mohr and Richter, 2001; Palacios and St Johnston, 
2001).  The translocation of mRNA in hippocampal neurones is regulated by miRNAs 
and has been implicated in learning and memory (Costa-Mattioli et al., 2009).  A 
number of putative miRNA target sites, precursor miRNA stem-loops and dsRNA 
structures were noted to reside within exaptated MIR elements in 3‟-UTRs.  Four of 
which the mRNA has previously been reported to be localised to the dendritic 
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compartment of hippocampal neurones (CD59, CAMK2A, DDN and NEURL).  Two of 
these genes, DDN and CAMK2A, are both suggested to be involved in synaptic 
plasticity, and learning and memory (Pinkstaff et al., 2001; Kremerskothen et al., 2006).  
Furthermore both DDN and CAMK2A contain regulatory sequences of ~1kb in the 3‟-
UTR, dendritic-targeting-elements (DTEs), which include recruited MIR elements.  
MiRNA target sites were also identified within exaptated 3‟-UTR MIR elements of 
AHI1, NRL, RHO and RPGR; genes which are expressed in photoreceptor rod cells and 
have been implicated in retinal degenerative conditions.  
 
7.2. MIR elements provide cryptic splice sites and many have been exonised 
 
In chapter 4 it was noted that MIR elements are associated with 5% (1359) of the genes 
in the human genome, with 117 of these genes containing protein-coding sequences 
partly derived from MIRs.  There are 26 distinct exons comprised entirely of an MIR 
element including both the 3‟ and 5‟ splice sites, further supporting the hypothesis that 
MIR elements are providing cis-regulatory sequences.  A total of 126 splice sites were 
identified with a large proportion being alternative acceptor splice sites, when the MIR 
element is recruited in the antisense orientation.  Two sequence motifs were identified 
in the MIR consensus sequences which resemble strong splice sites.  The acceptor splice 
site could potentially be active immediately following integration without the need for 
change from the original MIR consensus, and all of the MIR sub-types contain an 
almost perfect canonical acceptor splice site in the consensus sequence.  This degree of 
conservation suggests that further enhancer sequences are necessary if the splice site is 
to be maintained, otherwise most antisense MIR elements would be exonised.   
 
The majority of MIR elements will have originated from intronic MIR elements, with 
most intact intronic MIRs behaving as pseudo-exons. As such any intronic MIR element 
could potentially be accessed by a gene during mammalian evolution when developing 
new phenotypes.  A large number of MIR elements are regulating the expression of 
spliceoforms by providing alternative initiating methionines and stop codon sequences.  
MIR elements have provided a resource of raw genomic material that could be utilised 
by mammalian genes to fine tune gene function and to adapt or „experiment‟ with a 
repertoire of protein products.   
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7.3. Further investigations  
 
Many of the proposed functions of the MIR elements described in this study require 
experimental analysis.  Validating predicted miRNA target sites and precursors is 
challenging and labour intensive, as miRNAs are small sequences (~22 nucleotides) and 
are usually expressed at low levels.  The most effective method would be to use a 
transfection approach with recombinant clones.  Firstly the miRNA precursor sequence 
will have to be cloned (from genomic DNA) into an expression vector and transfected in 
a chosen cell line, following which an increase in miRNA expression should be noted 
compared to the endogenous levels by real-time qRT-PCR.  Secondly, constructs of the 
3‟-UTRs of the gene of interest, which harbours the MIR and predicted miRNA target, 
will have to be cloned into a luciferase reporter.  A further construct of the 3‟-UTR 
sequence could be generated which lacks the MIR element.  The miRNA precursor 
expression vector and the 3‟-UTR/luciferase reporter will then both have to be 
transfected in cultured cells.  Following which the gene expression will be measured by 
real-time qRT-PC and/or western blotting, to validate the MIR-derived miRNA target 
sequence is regulating gene expression.   
 
A similar approach could be used to determine if the MIR elements are involved in 
mRNA stability and degradation.  The expression of the 3‟-UTR/luceferase reporter 
with the MIR element could be compared to that which has the MIR element excised.  
The role of the MIR elements in translocating mRNA to the dendritic comapartment of 
neurones can be determined by cloning chosen full length mRNA contructs which either 
contain or lack the MIR element into mammalian expression vectors, tagged with green 
fluorescent protein (GFP).  The recombinant clones will then have to be transfected into 
a neuronal cell line, and the spatial expression of the protein visualised with a 
fluorescent microscope to determine if the MIR is involved in regulating localised 
protein synthesis in specific cell compartments.  Localisation of mRNA could also be 
detected by non-radiaoactive in situ hybridisation.  Finally the tissue-specific expression 
of the MIR-containing spliceoforms will also have to be confirmed by quantitative real-
time qRT-PCR.   
 
One obvious constraint during these investigations is that the results presented are 
confined to the current annotated sequence databases, which are consistently updated 
with the verification of additional ESTs and cDNA clones daily.  Likewise a large 
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portion of mammalian genomic sequence data is incomplete.  As such revisiting the 
databases at a later date could reveal further MIR-containing genes and provide 
additional insight in to the role of MIR elements is mammalian genomes.  It is also 
possible that MIR elements may have other functional roles, for example mammalian 
imprinting, as a number of imprinted genes have recruited MIR elements.  Evidence 
(chapter 4) suggests that MIR elements may be involved in immunological processes, 
both areas are of interest which may be investigated further. 
 
Only exonic MIR elements were collected and analysed, corresponding to ~0.4% of the 
total MIR elements in the human genome.  It is possible that intronic MIR elements 
may take part in controlling gene expression via undetermined mechanisms, and 
intronic mutations and SNPs have previously been attributed to disease.  Likewise 
intergenic MIR elements may be involved in enhancing gene expression or contribute to 
promoter regions. For example a preliminary analysis using TranspoGene 
(http://transpogene.tau.ac.il/; Levy et al., 2008) identified 489 annotated human genes 
which have putative promoters which contain MIR-derived sequences, these results are 
raw and are not included in this study, however the data may be revisited in the future.  
Furthermore it would be interesting to screen the complete dataset of MIR-containing 
genes for miRNA targets and dsRNA structures to determine if a particular miRNA 
family are prevalent.  MIR elements actively accumulated prior to the radiation of 
mammals, and whilst this study has focussed on human genes specifically, it would be 
interesting to study the full global exaptation of the MIR elements across a large number 
of mammals, including the more distant relatives, monotremes and marsupials.  All of 
these topics mentioned warrant further investigation and any one would provide a solid 
foundation for subsequent research projects. 
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7.4. Conclusion  
 
In conclusion, MIR elements have the potential to provide a series of cis-regulatory 
sequences.  Elements detected in 5‟-UTRs and coding sequences are contributing to 
alternative splicing by carrying stop codons, translation initiation codons and motifs 
which resemble known splice sites.  MIR elements recruited in the 3‟-UTR appear to be 
playing a different but equally significant role in gene expression, and may be involved 
in post-transcriptional control by generating dsRNA structures, precursor miRNAs and 
providing miRNAs target sites.  MIR elements may be involved in the regulation of 
expression in neuronal cells by localising mRNAs to distinct cellular compartments and 
by suppressing translation during transport until there is a need for rapid protein 
expression.  It can also be considered that MIR elements may regulate RNA 
translocation in other polarised cell types, such as epithelial cells, cilia and fibroblasts; 
or may be involved in oogenesis.  Noteworthy, it is possible that MIR elements may be 
a source of miRNA target sites when exaptated in the 5‟-UTR or the coding sequence, 
though less common miRNAs have been reported to regulate gene expression and block 
translation and/or transcription when bound to these regions (Zhou et al., 2009). 
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9.1.     MIR-containing genes which are known and validated 
 
All genes are human with the exception of Arhgef17, Arrb1, Cacna1d and Plxnb2 which are 
noted in rodent genes only.  Abbreviations: 5’, 5’-untranslated region; 3’, 3’-untranslated 
region; CDS, coding sequence; ATG, initiating methionine codon; TAG, stop codon. 
 
Gene Name 
Accession 
Number 
Genomic  
Location 
MIR  
Location 
MIR 
Type 
Loc. 
A4GALT  
NM_017436  
BC055286 
 
- 
7 121 
186 317 
- 
112 228  
154   17 
- 
MIR 
MIR3 
- 
5’ 
5’ 
AAA1 
NM_207285  
NM_207286  
NM_207287  
NM_207288  
NM_207289  
NM_207290  
NM_207283  
43  195  
43  195 
43  195 
- 
43  195 
- 
- 
261   112 
261   112 
261   112 
- 
261    112 
- 
- 
MIR  
MIR 
MIR 
- 
MIR 
- 
-  
ATG 
ATG 
- 
- 
ATG 
- 
- 
AADACL1 NM_020792 3310 3415  74 180  MIR3 3’ 
ABCC13 
NM_138726  
NM_172024  
NM_172026  
NM_172025  
1444 1640 
- 
- 
- 
201      6 
- 
- 
- 
MIR   
- 
- 
- 
3’ 
- 
- 
- 
ABCC3 NM_003786  4758 4926   198     14  MIR3  3’ 
ABCG2 NM_004827 2755 2852 95 207  MIR3  3’ 
ABHD2 
NM_152924  
NM_007011  
 
2447 2604   
171 259  
2845 3002 
45 197   
143 230  
45 197  
MIR3  
MIR  
MIR3  
3’ 
5’ 
3’ 
ABHD4 NM_022060 1610 1783 188     21 MIR3  3’ 
ACADSB NM_001609 5246 5384 202     42  MIR3 3’ 
ACAN 
NM_001135  
NM_013227  
BC036445 
 
- 
- 
2624 2790  
3984 4167 
- 
- 
47  265  
13  206 
- 
- 
MIRb 
MIR 
- 
- 
3’ 
3’ 
ACAT1  
NM_000019 
BC063853 
- 
1672 1799   
- 
1  126  
- 
MIRb  
- 
3’ 
ACBD5 NM_145698 
4192  4298  
6459  6581  
8746  8847 
12866 12956  
52  176 
207     91 
112  216   
223    127  
MIRm   
THER1_MD  
MIR  
MIR  
3’ 
3’ 
3’ 
3’ 
ACCN4 
NM_018674  
NM_182847  
BC031812 
- 
- 
2425 2544 
- 
- 
4  124 
- 
- 
MIR3  
- 
- 
3’ 
ACE2 NM_021804 3334 3381 206  254  MIR  3’ 
ACSS1 NM_032501 4   54 129     79  MIR  5’ 
ACVR1C NM_145259 2364 2465 148     40 MIR  3’ 
ADAM19 
NM_023038  
NM_033274  
2989 3127 
- 
49 193 
- 
MIR 
- 
3’ 
- 
ADAMTS4 NM_005099 4224 4324   109  222  MIRb  3’ 
ADAMTS7 
NM_014272 
AF140675 
 
- 
2502 2562 
2843 3013 
- 
93  150 
30  207 
- 
MIR_Mars 
MIRb  
- 
CDS 
TAG 
ADAMTS9 
NM_182920 
AB037733.1 
- 
4447  4637 
- 
2    200  
- 
MIR3 
- 
3’ 
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ADAMTSL1 
NM_139238 
NM_052866 
NM_139264 
2116 2271 
- 
- 
35  201 
- 
- 
MIR3 
- 
- 
TAG 
- 
- 
ADAMTSL5 NM_213604 129  314  186      5  MIRb  5’ 
ADC NM_052998 360  481 172     29 MIR3  5’ 
ADCK4 NM_024876 13  112 36  138 MIRb  5’ 
ADCY1 NM_021116 10178 10428  258      1  MIRb 3’ 
ADCY2 NM_020546 
4766 4881 
5765 5876 
22  188  
153     46 
MIR  
MIR_Mars 
3’ 
3’ 
ADCY6 
NM_015270  
NM_020983  
469  594  
- 
91  214 
- 
MIR 
- 
5’ 
- 
ADD2  
NM_001617  
NM_017482  
NM_017483  
NM_017484  
NM_017488  
2766 2930 
2193 2251 
1848 2012 
1275 1333 
2852 3016 
179      3 
140  206  
179      3 
140  206 
179      3 
MIR3 
MIRb  
MIR3 
MIRb  
MIR3 
3’ 
3’ 
3’ 
3’ 
3’ 
ADIPOQ NM_004797 1075 1258 202     21  MIRb   3’ 
ADRA1A 
NM_000680 
NM_033302 
NM_033303 
NM_033304 
AY491781 
- 
- 
- 
- 
1302  1404  
- 
- 
- 
- 
159  55   
- 
- 
- 
- 
MIR 
- 
- 
- 
- 
CDS 
AGGF1 NM_018046 4289 4417 119  258  MIR_Mars 3’ 
AGPAT6 
  
NM_178819 
AY358670 
- 
2033 2215 
- 
2  195  
- 
MIR    
- 
3’ 
AGXT2L2 NM_153373  1592 1737 227     78 MIR 3’ 
AHCYL1  
NM_006621 
AF090905 
- 
910 1095 
- 
24  225 
- 
MIRb  
- 
3’ 
AHI1 
NM_01765 
NM_001134832 
- 
3436  3548  
- 
8  118 
- 
MIRc 
- 
TAG 
AIF1L 
NM_031426  
 
NM_001002260 
 
1686 1805  
2175 2215 
1708 1827 
2197 2237 
205     87 
276    234 
205     87 
276    234 
MIR3 
MIRm 
MIR3 
MIRm 
3’ 
3’ 
3’ 
3’ 
AIPL1 
NM_001033054 
NM_001033055 
NM_014336 
BC007994 
- 
- 
- 
1403  1466   
- 
- 
- 
157    103 
- 
- 
- 
MIR 
- 
- 
- 
3’ 
AK2 
NM_001625  
NM_013411  
 
 
 
- 
1870 2087 
2727 2778 
2783 3004  
3250 3324  
- 
3  263   
115  161  
258     26 
19  112  
- 
THER1_MD  
MIRm  
MIRb 
MIR  
- 
3’ 
3’ 
3’ 
3’ 
AKAP13 
NM_006738  
NM_007200  
NM_144767  
BC050312 
- 
- 
- 
2869 2919 
- 
- 
- 
103  153  
- 
- 
- 
MIR 
- 
- 
- 
3’ 
AKAP14 
NM_178813  
NM_001008534 
NM_001008535 
BC066357 
- 
- 
- 
1   76  
- 
- 
- 
174  249  
- 
- 
- 
MIR 
- 
- 
- 
5’ 
AKAP5 NM_004857 
109  282 
496  657  
89  272  
35  195 
MIRb 
MIR3 
5’ 
5’ 
ALAD 
NM_001003945 
 
NM_000031 
 
2820 2907 
2913 2987 
2654 2741 
2747 2821 
143     53   
78      4   
143     53   
78      4  
MIR 
MIR 
MIR 
MIR 
5’ 
5’ 
5’ 
5’ 
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ALDH3B1 
NM_000694 
 
NM_001030010  
 
1800 1936 
2239 2268 
1689 1825 
2128 2157  
30  164 
165  191 
30  164 
165  191 
MIR 
MIR 
MIR 
MIR 
3’ 
3’ 
3’ 
3’ 
ALDH3B2 
NM_000695  
NM_001031615 
2148 2236  
1992 2080  
48  138  
48  138 
MIRb 
MIRb 
3’ 
3’ 
ALG2 NM_033087  2416 2588  74  272  THER1_MD 3’ 
AMACR 
NM_014324  
NM_203382  
2274 2363  
2113 2202 
203    115 
203    115  
MIRb 
MIRb 
3’ 
3’ 
AMIGO2 NM_181847 
3212 3301 
3415 3525  
90  179  
196     82  
MIR3 
MIR3 
3’ 
3’ 
AMOT NM_133265 4331 4445 206     81 MIR3 3’ 
AMOTL1 NM_130847 4535 4688 214     35  MIRb 3’ 
AMPD3 
NM_000480  
 
 
NM_001025389  
 
 
NM_001025390  
 
 
3262 3349 
3487 3534 
3540 3666  
3225 3312  
3450 3497  
3503 3629  
3364 3451  
3589 3636  
3642 3768 
99  201  
152  202 
157     14  
99  201  
152  202 
157     14 
99  201  
152  202 
157     14 
MIR3 
MIR3  
MIRb 
MIR3 
MIR3  
MIRb 
MIR3 
MIR3  
MIRb 
3’ 
3’ 
3’ 
3’ 
3’ 
3’ 
3’ 
3’ 
3’ 
ANKRD34C 
XM_930512 
AK127037  
- 
3024  3274 
- 
6    260   
- 
MIRb 
- 
5’ 
ANKRD42 NM_182603 
1460 1628 
1659 1669  
5  193 
194  205 
MIR 
MIR 
3’ 
3’ 
ANKRD43 NM_175873 2833 2957  81  207  MIRm      3’ 
ANKRD49 
NM_017704 
AL833977 
 
- 
467  551  
655  862  
- 
164  258  
260     17  
- 
MIR_Mars 
MIRb 
- 
TAG 
3’ 
ANKRD5 
NM_022096  
NM_198798  
281  345 
- 
176    112 
- 
MIR 
- 
5’ 
- 
ANKS6 
NM_173551 
 
 
BC012981 
 
3419 3512 
4362 4586  
6376 6510   
845  954  
979 1188  
93  188 
251      5   
74  235 
5  115 
262     44 
MIR3 
MIR 
MIRb 
MIRb 
MIR 
3’ 
3’ 
3’ 
5’ 
5’ 
ANRIL  NR_003529 
3480  3581   
3820  4033    
137     38    
241      5    
MIR 
MIR 
ncRNA 
AP2B1 
NM_001030006  
NM_001282  
3953 4093 
3911 4051 
187     27  
187     27 
MIR3 
MIR3 
3’ 
3’ 
APBA2BP 
NM_031231  
NM_031232  
1433 1518  
1535 1620 
40  124   
40  124   
MIR 
MIR 
3’ 
3’ 
APLN NM_017413 1342 1505 201     19  MIR3 3’ 
APOF NM_001638 1162 1359   34  228 MIRb 3’ 
APOLD1 NM_030817 
1513 1681 
1868 1879 
23  231  
232  245  
MIRb 
MIRb 
3’ 
3’ 
APTX 
NM_175073  
NM_175069  
NM_175072  
NM_017692  
NM_175071  
- 
- 
- 
1  110 
- 
- 
- 
- 
184     68  
- 
- 
- 
- 
MIR 
- 
- 
- 
- 
5’ 
AQP1 NM_198098  2424 2484  151     97 MIRm 3’ 
AQP2 NM_000486 
2201 2294  
3340 3410 
3434 3680 
124     15 
254    183  
261      9  
MIR3 
MIRb 
MIRb 
3’ 
3’ 
3’ 
AQP9 NM_020980 2136 2285   240     90 MIRb 3’ 
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ARHGAP24 
NM_001025616 
NM_031305  
- 
4465 4574  
- 
41  168   
- 
MIR 
- 
3’ 
ARHGAP27 NM_199282 
2793 2863 
3316 3394  
150     77 
271    181 
MIR 
THER1_MD  
3’ 
3’ 
Arhgef17  
(mus) 
NM_001081116 
8002  8091 
8447  8506 
9072  9168 
82    184 
6     65 
15    120 
MIR3 
MIR 
MIRb 
3’ 
3’ 
3’ 
ARHGEF6  
 
NM_004840 
BC043505 
- 
1   86  
- 
59  158  
- 
MIR3 
- 
5’ 
ARL1 NM_001177 
1267 500 
2907 2980  
246      5   
123  208  
MIR  
MIR3  
3’ 
3’ 
ARL10 
NM_173664  
 
BC059361 
 
1277 1366 
2087 2206 
872  904 
1208 1344  
55  151 
73  201 
251    217    
216     73  
MIR   
MIR3 
MIRb 
MIRb 
3’ 
3’ 
CDS 
3’ 
ARL11 NM_138450 2855 3091  255     11  MIRb 3’ 
ARMCX3 
NM_016607  
NM_177947  
NM_177948  
3145 3261 
3117 3233   
3068 3184  
122  248  
122  248 
122  248   
MIR 
MIR 
MIR 
3’ 
3’ 
3’ 
ARNT2 NM_014862 
3490 3577 
4707 4779 
3   84 
248    172 
MIRm 
MIRm 
3’ 
3’ 
ARNTL2  
NM_020183 
AF256215 
- 
5144 5312 
- 
202      6  
- 
MIR3 
- 
3’ 
Arrb1 (mus) 
NM_177231 
NM_178220 
2740  2841 
2716  2817  
74    177  
74    177  
MIR3 
MIR3 
3’ 
3’ 
ARSG NM_014960 1820 2011 7  268 MIRb 3’ 
ART1 NM_004314 48  114 141     74 MIR ATG 
ARTN 
NM_003976  
NM_057091  
NM_057160  
NM_057090 
3  100  
- 
- 
- 
110  222   
- 
- 
- 
MIRb 
- 
- 
- 
5’ 
- 
- 
- 
ASL 
NM_001024943 
NM_000048  
NM_001024944 
NM_001024946 
AY203938 
- 
- 
- 
- 
635  765  
- 
- 
- 
- 
262    136   
- 
- 
- 
- 
MIR 
- 
- 
- 
- 
5’ 
ASTN1 
 
NM_004319  
NM_207108  
5568 5812 
- 
252      4  
- 
MIR 
- 
3’ 
- 
ASTN2 
NM_014010  
NM_198186  
NM_198187  
NM_198188  
- 
- 
- 
74  185 
- 
- 
- 
175     61  
- 
- 
- 
MIR3 
- 
- 
- 
5’ 
ATM 
NM_000051  
NM_138292  
BC061584 
12439 12598 
8269 8428 
6   61 
257     79 
257     79 
8   63 
MIRb 
MIRb 
MIR 
3’ 
3’ 
5’ 
ATP2B1 
NM_001001323 
NM_001682  
5933 6089  
5779 5935   
2  187  
2  187  
MIR3 
MIR3 
3’ 
3’ 
ATP6V0E2 
NM_001100592 
NM_145230 
169   256 
169   256 
224    130    
224    130    
MIRb 
MIRb 
5’ 
5’ 
ATP6V1B1   
NM_001692 
BC035978 
- 
965 1003  
- 
147   109 
- 
MIR       
- 
3’ 
ATP6V1E2 NM_080653 194  421 267     30  MIRb 5’ 
ATP6V1G2 
NM_130463  
NM_138282  
918 1162  
764 1008 
21  267   
21  267   
MIRb      
MIRb      
3’ 
3’ 
ATP7B 
NM_000053  
NM_001005918 
5867 6048  
5246 5427 
272     83 
272     83 
MIRb      
MIRb      
3’ 
3’ 
ATPAF1 NM_001042546 3116  3301 10  193 MIRb 3’ 
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NM_022745 
AF111705 
3320  3505 
700  885  
10  193   
10  193  
MIRb 
MIRb 
3’ 
   5’ 
ATPIF1 
NM_016311  
NM_178190  
NM_178191  
- 
- 
1068 1125  
- 
- 
169   113 
- 
- 
MIR3 
- 
- 
3’ 
ATXN7L1 
NM_152749 
BC003517 
1398 1470 
1748 1896    
51  123 
255     99  
MIRb 
MIR       
3’ 
3’ 
AVPR1A NM_000706 128   227 237   142  MIRc 5’ 
AVPR2 NM_000054 1482 1545  82  148  MIR       3’ 
AXL 
NM_021913  
NM_001699  
3309 3409 
3282 3382 
99  202 
99  202   
MIR3  
MIR3  
3’ 
3’ 
B3GNT1 
NM_006057  
NM_033170  
NM_033171  
NM_033172  
NM_033173  
1575 1806  
1490 1673 
1684 1915  
1524 1755  
2270 2453  
220      2  
176      2 
220      2  
220      2 
176      2  
MIRb 
MIRb 
MIRb 
MIRb 
MIRb 
3’ 
3’ 
3’ 
3’ 
3’ 
B3GNT6 NM_006876 1421 1664 2  263    MIRb 3’ 
B4GALT2 
NM_003780  
NM_001005417 
1751 1839  
1537 1625  
43  135  
43  135  
MIR 
MIR 
3’ 
3’ 
B9D2 NM_030578 759   928 3  181 MIR 3’ 
BATF2 NM_138456 1100 1250  238     88  MIRb 3’ 
BBS7 
NM_176824  
NM_018190  
2663 2872 
- 
252      2 
- 
MIRb 
-  
3’ 
- 
BCAS2 NM_005872 1200 1265  238    191 THER1_MD 3’ 
BDKRB2 NM_000623 
2100 2261 
2358 2394 
43  259 
205  247  
MIR_Mars  
MIRb 
3’ 
3’ 
BEND6 
NM_152731 
BC022988 
- 
91  229 
- 
23  160 
- 
MIR 
- 
5’ 
BEST2 NM_017682 1716 1839 124  262 MIRb      3’ 
BEST3 
NM_152439 
NM_032735 
1885 1947 
- 
208    144 
- 
MIR3 
- 
3’ 
- 
BHLHB9 NM_030639 2842 3083  247      4 MIRb 3’ 
BIRC4 NM_001167 
5397 5487 
6290 6439 
128  225 
206     49 
MIRb  
MIR3 
3’ 
3’ 
BMP1 
NM_006132  
NM_001199  
NM_006128  
NM_006129  
NM_006130  
1374 1455 
- 
- 
- 
- 
22   97 
- 
- 
- 
- 
MIR 
- 
- 
- 
- 
3’ 
- 
- 
- 
- 
BMPR2  NM_001204  6577 6796  228      7  MIRb 3’ 
BNIPL 
NM_138278  
NM_138279  
2019 2112 
- 
44  147   
- 
MIR 
- 
3’ 
- 
BPA-1 
XM_001726020 
AB088847 
- 
787   959   
- 
267    81  
- 
MIRb 
- 
3’ 
BPESC1 NM_021812 
49  206  
1323 1490 
1854 1898  
2845 3081  
195     21  
44  229 
233  276  
1  261 
THER1_MD 
MIRb 
MIRm 
MIR 
5’ 
3’ 
3’ 
3’ 
BRF1 
NM_001519  
NM_145696  
 
NM_145685  
- 
304  442 
532  673 
19  127  
- 
165     22 
180     19  
146     19 
- 
MIR   
MIR_Mars  
MIR_Mars 
- 
5’ 
5’ 
5’ 
BRWD1 
NM_018963  
NM_033656  
NM_001007246 
- 
- 
2143 2360 
- 
- 
35  258  
- 
- 
MIR_Mars 
- 
- 
3’ 
BSDC1 NM_018045 
1800 2010 
2108 2203 
51  258   
113     19  
MIR 
MIR 
3’ 
3’ 
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2680 2758 120     41  THER1_MD  3’ 
BSND NM_057176 1257 1302  112  158  MIRb 3’ 
BTC NM_001729 1164 1271  268    149 MIRb 3’ 
BTN3A1 
NM_007048 
 
NM_194441  
2085 2252  
2250 2481 
- 
225     52  
272     21  
- 
MIR 
MIR 
- 
3’ 
3’ 
- 
BTN3A2 
NM_007047 
 
2778 2949   
2950 3177  
225     52  
268     22  
MIR 
MIR 
3’ 
3’ 
BTN3A3 
NM_006994 
 
NM_197974 
 
1913 2084   
2088 2312  
1823 1994  
1998 2222 
225     52  
260     22  
225     52  
260     22 
MIR 
MIR 
MIR 
MIR 
TAG 
3 
TAG 
3’ 
BTNL3 
NM_197975 
NM_006707 
1822 1980 
1720 1878 
84  263  
84  263     
MIRb 
MIRb 
3’ 
3’ 
BUD31 NM_003910 256  334   132     45 MIR 5’ 
BZRAP1 NM_004758 6112 6324 208      2 MIR3 3’ 
C10orf10 NM_007021 1041 1169   42  170 MIR 3’ 
C10orf105 XM_001715769 4253  4335   229     61    MIR 3’ 
C10orf111 NM_153244 1478 1647 48  249   MIR 3’ 
C10orf25 NM_001039380 
259  337 
1131 1344  
1436 1527 
2041 2098 
2527 2577 
191    115 
245     25 
173  273    
262    205 
196    144 
MIRb 
MIR_Mars 
MIRb 
MIR 
MIR 
3’ 
3’ 
3’ 
3’ 
3’ 
C10orf54 NM_022153 4616  4771     229     61 MIRc 3’ 
C11orf44 
NM_173580 
 
933 1156 
2487 2667 
10  262 
37  216 
MIRb 
MIRb 
ncRNA 
ncRNA 
C11orf51 NM_014042 131  216 140     55 MIRb 5’ 
C11orf57 NM_018195 2717 2826 43  156    MIR 3’ 
C11orf68  
NM_031450 
BC010512 
- 
2   75 
- 
160     84 
- 
MIR 
- 
5’ 
C11orf86 NM_001136485 1000  1095  198    101  MIRc 3’ 
C11orf92 NM_207429 
3032  3171 
3464  3494 
160     27  
32       1 
MIRb 
MIRb 
3’ 
3’ 
C12orf47 NM_016534 1116 1331 263     50 MIRb ncRNA 
C12orf52 NM_032848 281  400 90  220 MIRb 5’ 
C12orf76 NM_207435 446   556  29    145 MIR CDS 
C13orf1 NM_020456 
1737 1933 
2249 2273 
4  232 
233  260 
MIRb 
MIRb 
3’ 
3’ 
C14orf126 NM_080664 691  784 38  136 MIRb 3’ 
C14orf132 NM_020215 
1177 1348 
2955 3173 
5012 5088 
175      1 
236      1 
193    117 
MIR3 
MIRb 
MIR3 
ncRNA 
ncRNA 
ncRNA 
C14orf139 NM_024633 826  936  127     22  MIR ncRNA 
C14orf178 NM_174943 
721  789 
793  890 
37  108 
163  272 
MIR_Mars 
MIRb 
3’ 
3’ 
C14orf33 XM_375081 1757  1949 234  3 MIRb 3’ 
C14orf91 AF113687 1241 1410 22  200 MIRb ncRNA 
C15orf33 
NM_152647 
BC048125 
- 
1208 1359  
- 
33  186  
- 
MIR3  
- 
TAG 
C15orf39 NM_015492 3567 3725 24  188 MIRb 3’ 
C15orf5 NM_030944 157  285 1  141 MIR ncRNA 
C15orf52 NM_207380 4926  5116 3  200 MIRb 3’ 
C16orf47 NM_207385 252  310  82     24  MIR  CDS 
C16orf88 NM_001012991 1782  1950  252     74   MIR 3’ 
C17orf102 NM_207454 
1614  1702 
1875  2119  
206    117 
260     16 
MIR3 
MIRb 
3’ 
3’ 
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3250  3454 65    268 MIRb 3’ 
C17orf65 NM_178542 1616 1770 208     50 MIR3 3’ 
C17orf66  
NM_152781 
BC033734 
 
- 
973 1206 
1224 1321 
- 
258      6 
93  206      
- 
MIRb 
MIR3 
- 
3’ 
3’ 
C17orf67 XM_378687 727  812 107     26 MIRb 5’ 
C18orf12 AB027121 38  205   3  171  MIR ncRNA 
C18orf21 NM_031446 929  961 156  188 MIR 3’ 
C18orf49 
AK000229 
BC047606 
1292 1411 
1455 1633 
126  253 
203     22 
MIRb 
MIR 
ncRNA 
ncRNA 
C19orf20 NM_033513 1319 1359 109  149 MIR 3’ 
C19orf54 NM_198476 1051 1156 174     68 MIR 3’  
C1orf116 NM_023938 5278 5490 40  262   MIRb 3’ 
C1orf167 XM_209234  
2864 2957  
3643 3720  
136     48  
58  145 
MIR 
MIR 
CDS 
3’ 
C1orf187 NM_198545 1577 1738 250     91 MIRb 3’ 
C1orf2 
NM_006589 
NM_198264 
BC008854 
2991 3094  
2703 2806  
1192 1296 
7  127 
7  127 
7  127 
MIR 
MIR 
MIR 
3’ 
3’ 
TAG 
C1orf213 
NM_001008896 
NM_138479 
- 
1427 1614 
- 
4  226 
- 
MIRb 
- 
3’ 
C1orf220 NM_207467 342   446  196     91 MIRb 5’ 
C1QTNF3 
NM_030945 
NM_181435  
- 
2024 2079 
- 
95     38  
- 
MIR 
- 
3’ 
C1RL NM_016546 2009 2230 222      3 MIRb 3’ 
C20orf160 NM_080625 2358 2513 94  259 MIR 3’ 
C20orf54 NM_033409 
87  169 
1967 2094 
88  168 
74  197 
MIR3 
MIRb 
5’ 
3’ 
C21orf24 NM_001001789 2905 2998 123     29    MIR 3’ 
C21orf87 XR_040389 22   196 194     27 MIR       ncRNA 
C21orf88 NM_153754 34  156 182     56  THER1_MD ncRNA 
C21orf96 XR_040896 291   369 17     36  MIR ncRNA 
C22orf24 NM_015372 1061  1231  19  197   MIRb 3’ 
C22orf26 NM_018280 973 1084 100  212 MIRb 3’ 
C2orf18  
NM_017877 
BC016389 
 
- 
326  364 
549  730 
-  
150    112 
258     31 
- 
MIR 
MIRb 
- 
3’ 
3’ 
C2orf73 NM_001100396 1218  1368  36    188  MIRb    3’ 
C3orf19 NM_016474 2632 2769 154     10 MIRb 3’ 
C3orf27 NM_007354 
1622 1726 
2073 2307 
178     74 
260      6   
MIRb 
MIRb 
3’ 
3’ 
C3orf35 
NM_178339  
NM_178341  
NM_178342  
1205 1317  
833  925 
952 1069 
141     21  
144     43  
160     40 
MIR 
MIR 
MIRb 
CDS 
CDS 
3’ 
C3orf51 U88965 
1476 1625 
1930 1960   
255    103 
102     72 
MIRb 
MIRb 
ncRNA 
ncRNA 
C3orf57 
NM_145035 
BC071875 
1445 1536 
61  152 
135     42  
135     42 
MIR 
MIR  
3’ 
5’ 
C4orf6 NM_005750 702  870 221     43 MIRb 3’ 
C5orf20 NM_130848 1067 1293 31  260 MIR 3’ 
C5orf3 NM_018691 378  563 232      2 MIR 5’ 
C6orf105 NM_032744 1074 1246 197     30 MIR3 3’ 
C6orf114 NM_033069 
 883 1034 
1186 1277 
260    109  
100      8  
MIRb 
MIRb 
TAG 
3’ 
C6orf12 
XM_379403  
 
 
1131 1182 
1846 2052 
3544 3684 
270    213 
254     27 
43  187   
MIRm 
MIRb 
MIR 
ncRNA 
ncRNA 
ncRNA 
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XM_945157  9056 9185 22  171 MIR ncRNA 
C6orf155 
NM_024882 
 
1356 1448 
1950 2074 
236    147 
70  193   
MIR 
MIR3 
ncRNA 
ncRNA 
C6orf195 NM_152554 41  184 190     40 MIRb 5’ 
C6orf227 NM_207497 
956  1128 
1875  2067   
201     31  
18    251  
MIR 
MIR3 
3’ 
3’ 
C6orf99 XM_374188 148  215 123  199 MIR3 CDS 
C7 NM_000587 2866 2995 66  195 MIR3 3’ 
C7orf13 NM_032625 1233 1350 35  158 MIRb ncRNA 
C7orf65 NM_001123065 105   157 140     85 MIRb CDS 
C8orf14 NM_054029 476  609 50  184    MIR       5’ 
C8orf17 NM_020237 
90  157 
328  383 
2628 2680 
190    123 
173    112 
56  109 
MIRb   
MIR3 
MIR 
5’ 
5’ 
3’ 
C8orf43 NM_052958 1348 1539 57  262 MIR ncRNA 
C8orf44 NM_019607 897 1119 23  248 MIRb        3’ 
C8orf46 NM_152765 
1396 1538 
1934 2110 
258    112 
258     54 
MIR_Mars 
MIR 
3’ 
3’ 
C8orf55 NM_016647 1863 1968 158     22 MIR 3’ 
C9orf100 
NM_001031728 
NM_032818   
- 
2669 2755 
- 
23  115 
- 
MIR 
- 
3’ 
C9orf109 XM_379665 
5005 5221 
5303 5432 
245      1 
179     59 
MIR 
MIRm 
3’ 
3’ 
C9orf110 XM_379664 
5005 5221 
5363 5429 
245      1 
135     74 
MIR 
MIRb 
3’ 
3’ 
C9orf130 
NR_023389 
AF170307  
- 
502   543  
- 
139     97   
- 
MIRb 
- 
ncRNA 
C9orf156  
NM_016481 
AY189280 
- 
1245 1403 
- 
252     84   
- 
MIRb 
- 
5’ 
C9orf25 NM_147202 
1927 2100 
3100 3169 
3  177 
60  130 
MIR3 
MIRb 
3’ 
3’ 
C9orf27 NM_021208 616  762 39  193 MIRb 3’ 
C9orf31 XR_040686 154   266 144     29  MIRc ncRNA 
C9orf5 NM_032012 
3658 3856 
6554 6729 
7351 7509 
260     41 
202     23 
180     25 
MIR_Mars 
MIR3 
MIRb 
3’ 
3’ 
3’ 
C9orf72 
NM_018325  
NM_145005  
 
 
- 
1157 1382 
1423 1491 
1730 1805 
- 
2  247 
259    188 
87  162    
- 
MIR 
MIR 
MIRb 
- 
3’ 
3’ 
3’ 
C9orf84 NM_173521  1614 1727 59  195 MIR3 3’ 
C9orf91 NM_153045 
1687 1758 
2687 2796 
3097 3145 
3250 3389 
181    109 
46  154 
155  202   
22  159 
MIR3 
MIR3 
MIR3 
MIRb 
3’ 
3’ 
3’ 
3’ 
C9orf97 
NM_139246 
AF258575 
- 
1109 1181 
- 
16   90 
- 
MIRb 
- 
3’ 
C9orf98 NM_152572 135  184 161    109   MIR 5’ 
CA8 NM_004056 2096 2165 191  268   MIRb 3’ 
CACHD1 NM_020925 
396  479 
491  626 
266    172 
250    107 
MIRb 
MIRb 
5’ 
5’ 
Cacna1d (rat) 
NM_017298 
M57682 
- 
6343  6522 
- 
2    193 
- 
MIRc 
- 
 
CACNA1G NM_018896 
NM_198376 
NM_198377 
NM_198378 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
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NM_198379 
NM_198380 
NM_198382 
NM_198383 
NM_198384 
NM_198385 
NM_198386 
NM_198387 
NM_198388 
NM_198396 
NM_198397  
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
5006 5081 
5061 5236 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
145     66   
6  174  
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
MIRb  
MIRb  
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
TAG 
3’ 
CACNA2D4 
NM_172364  
 
 
NM_001005737  
 
 
NM_001005766  
 
 
4984 5090 
5093 5217 
5250 5343   
4913 5019 
5022 5146 
5179 5272 
4939 5045 
5048 5172 
5205 5298 
212    106 
272    113 
176  273 
212    106 
272    113 
176  273 
212    106 
272    113 
176  273 
MIRb 
MIR 
MIR 
MIRb 
MIR 
MIR 
MIRb 
MIR 
MIR 
3’ 
3’ 
3’ 
3’ 
3’ 
3’ 
3’ 
3’ 
3’ 
CACNG3 
NM_006539 
AF114832 
- 
1751 1899   
- 
60  210 
- 
MIRb 
- 
3’ 
CALML4 
NM_001031733   
NM_033429 
 
 
- 
224  364 
1206 1375 
3020 3099 
- 
149      5 
20  196 
102     18 
- 
MIR 
MIRb 
MIR 
- 
5’ 
3’ 
3’ 
CAMK2A 
NM_015981  
NM_171825   
 3768 3833 
4020 4183 
3735 3800 
3987 4150   
85  151 
8  180 
85  151   
8  180 
MIRm 
MIR3 
MIRm 
MIR3 
3’ 
3’ 
3’ 
3’ 
CAPN5 NM_004055 
2171 2274 
3692 3765  
24  129 
81  153  
MIR 
MIR 
3’ 
3’ 
CASC2 
NM_178816  
NM_201377  
- 
542  616 
- 
20  106 
- 
MIRm 
- 
ncRNA 
CASP10 
NM_001230 
NM_032974 
NM_032976 
NM_032977 
3266 3375 
- 
3303 3412 
3395 3504 
200     88   
- 
200     88   
200     88 
MIR3 
- 
MIR3 
MIR3 
3’ 
- 
3’ 
3’ 
CASR NM_000388 4669 4913 33  267 MIRb 3’ 
CATSPER2 
NM_054020 
NM_172095 
NM_172096 
NM_172097 
- 
- 
- 
1000 1149 
- 
- 
- 
247     97 
- 
- 
- 
MIR 
- 
- 
- 
3’ 
CATSPER2P1 NR_002318  971  1120   247     97 MIR ncRNA 
CCBL2 
NM_001008661  
NM_001008662  
1870 2009  
1770 1909   
95  243  
95  243  
MIR 
MIR 
3’ 
3’ 
CCDC113 NM_014157 2701 2856 63  267 MIRb 3’ 
CCDC26 NM_145050 853 1095 37  267 MIRb 3’ 
CCDC52 NM_144718 
4302 4451 
4512 4740 
4785 5000 
182     23 
268     60 
3  247 
MIR 
MIRb 
MIR 
3’ 
3’ 
3’ 
CCDC64B 
NM_001103175  
XM_085463 
- 
1086  1225 
- 
72    229 
- 
MIRb 
- 
5’ 
CCDC68 NM_025214 2552 2728  252     51   MIR 3’ 
CCDC76 NM_019083 2616 2842 38  260 MIR 3’ 
CCDC82 NM_024725 78  152 26   99 MIR 5’ 
CCDC95 NM_173618 - - - - 
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AY189289 
 
1025 1193  
2139 2226 
1  161 
36  124 
MIR3 
MIR 
3’ 
3’ 
CCNF NM_001761 4128 4222 88  197   MIRb 3’ 
CCNO 
NM_021147  
NM_001024592 
 
29  159 
613  730 
735  789 
94  230  
152     35 
94  150 
MIRb 
MIRb 
MIRb 
ATG 
3’ 
3’ 
CCR5 NM_000579 2781 2881 153  259 MIR 3’ 
CCRL2 NM_003965 1439 1660  261     23 MIRb 3’ 
CD28 NM_006139 2645 2767 21  157 MIRb 3’ 
CD300A NM_007261 1692 1818 175     51   MIR_Mars 3’ 
CD300LG 
NM_145273 
AF427619 
- 
691  761 
895  987   
- 
200 138 
141 49 
- 
MIR3 
MIR 
- 
CDS 
CDS 
CD33 NM_001772 1255 1433 29  210 MIR 3’ 
CD4 NM_000616 
1901 2028 
2126 2332  
147      6 
212     17 
MIRb 
MIRb 
3’ 
3’ 
CD48 
NM_001778 
BC030224 
 
- 
915 1009 
1483 1576 
- 
30  126 
122  216 
- 
MIRb 
MIRb 
- 
3’ 
3’ 
CD59 
NM_000611 
 
 
 
 
NM_203329  
 
 
 
 
NM_203330  
 
 
 
 
NM_203331  
 
 
 
 
3585 3709 
3967 4153 
5456 5560 
5900 6098 
6252 6429 
3634 3758 
4016 4202 
5505 5609 
5949 6147 
6301 6478 
3746 3870 
4128 4314 
5617 5721 
6061 6259 
6413 6590 
3630 3754 
4012 4198 
5501 5605 
5945 6143 
6297 6474 
152     20 
2  211 
99      1 
28  261   
268     67 
152     20 
2  211 
99      1 
28  261 
268     67 
152     20 
2  211 
99      1 
28  261 
268     67 
152     20 
2  211   
99      1 
28  261 
268     67 
MIRb 
MIRb 
MIR3 
MIR 
MIRb 
MIRb 
MIRb 
MIR3 
MIR 
MIRb 
MIRb 
MIRb 
MIR3 
MIR 
MIRb  
MIRb 
MIRb 
MIR3 
MIR 
MIRb 
3’ 
3’ 
3’ 
3’ 
3’ 
3’ 
3’ 
3’ 
3’ 
3’ 
3’ 
3’ 
3’ 
3’ 
3’ 
3’ 
3’ 
3’ 
3’ 
3’ 
CD80 NM_005191 1457 1591 193     20 MIR3 3’ 
CD84 
NM_003874 
U96627 
- 
1057 1193 
- 
47  195   
- 
MIR3 
- 
3’ 
CD8A 
NM_001768   
NM_171827   
1108 1290 
997 1179 
201      9 
201      9     
MIR3 
MIR3 
3’ 
3’ 
CDC14B 
NM_003671   
NM_033331   
NM_033332   
- 
- 
3922 4028 
- 
- 
1  116   
- 
- 
MIR       
- 
- 
3’ 
CDC20B NM_152623 
1625 1829 
2174 2234 
2559 2644 
1  199 
259    197 
29  119  
MIR  
THER1_MD  
MIR 
TAG 
3’ 
3’ 
CDC25B 
NM_021873  
NM_004358   
NM_021872   
33  141 
33  141 
33  141 
44  152 
44  152 
44  152 
MIRm 
MIRm 
MIRm 
5’ 
5’ 
5’ 
CDH22  NM_021248 
3285 3457 
3457 3651     
265     70 
65  262   
MIRb 
MIR 
3’ 
3’ 
CDK5RAP3 NM_176095  838 1023 268     66 MIRb 3’ 
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NM_025197   
NM_176096   
838 1023  
- 
268     66 
- 
MIRb 
- 
3’ 
- 
CDKN2A 
NM_000077   
NM_058197  
NM_058195   
1045 1128 
1319 1402 
1036 1119 
149     60 
149     60 
149     60 
MIRb 
MIRb 
MIRb 
3’ 
3’ 
3’ 
CDKN2B 
NM_004936   
NM_078487   
2606 2743 
2729 2866 
252     91 
252     91 
MIRb 
MIRb 
3’ 
3’ 
CECR6 NM_031890 3350 3513 41  208   MIR3 3’ 
CENPC1 
NM_001812 
BC030695 
- 
1918 2005 
- 
180     94 
- 
MIR3 
- 
3’ 
CENTB2 NM_012287 6167 6219 82     31 MIR 3’ 
CENTD3 NM_022481 4862 4967 81  201   MIR3 3’ 
CES4 NM_016280 958 1158 208      1 MIR3 3’ 
CFP NM_002621 12  148 193     69 MIRb  5’ 
CGNL1 NM_032866 6680 6860   3  207 MIR3 3’ 
CGREF1 NM_006569 1653 1852 274     60 MIRb 3’ 
CHL1 NM_006614 6582 6726 26  171 THER1_MD 3’ 
CHRD 
NM_003741 
NM_177978  
NM_177979  
- 
498  551  
- 
- 
134     81 
- 
- 
MIR 
- 
- 
TAG 
- 
CHRDL2 NM_015424 1372 1429  135     78   MIR CDS 
CHST5 
NM_012126   
NM_024533   
- 
849 1020 
-  
207     39   
- 
MIR 
- 
5’ 
CHURC1 NM_145165 
1612 1804 
2019 2114 
2204 2247 
2566 2604 
28  216   
261    151 
140     97 
114     76   
MIRb 
MIR 
MIR 
MIR 
3’ 
3’ 
3’ 
3’ 
CIITA 
NM_000246 
AF410154 
- 
769  862   
- 
174     76  
- 
MIR    
- 
TAG 
CLDN1 NM_021101 
1894 2048  
2432 2669 
22  191 
6  240 
MIRb 
MIRb 
3’ 
3’ 
CLDN10 
NM_182848   
NM_006984  
2267 2435 
2091 2259 
221     39 
221     39 
MIR 
MIR 
3’ 
3’ 
CLEC12B NM_205852 1081 1252 173      7   MIR 3’ 
CLEC4M 
NM_014257  
NM_214675   
NM_214676  
NM_214677  
NM_214678 
NM_214679 
-  
- 
-  
885  972 
885  972  
822  909   
 - 
- 
- 
69  155 
69  155 
69  155 
- 
- 
- 
MIRb 
MIRb 
MIRb 
- 
- 
- 
3’ 
3’ 
3’ 
CLEC5A NM_013252 
2780 2972 
3083 3133 
8  198 
93  145 
MIRb 
MIR 
3’ 
3’ 
CLIP4 NM_024692 2901 3066 191     16  MIR3 3’ 
CLN5 NM_006493 3705 3881 225     43 MIRb 3’ 
CLN8 NM_018941 4233 4440 234     14 MIR 3’ 
CLYBL 
NM_138280 
NM_206808  
2392 2546 
- 
79  251  
-  
MIR 
- 
3’ 
- 
CNOT7 
NM_013354  
NM_054026  
- 
1234 1399 
- 
206     17 
- 
MIR3 
- 
3’ 
CNTF NM_000614 1139 1367 268     20   MIRb 3’ 
CNTN2 NM_005076 4602 4792 199     13   MIR3 3’ 
CNTN3 NM_020872 3675 3814 19   164 MIRc 3’ 
COBLL1 NM_014900 2188 2347 27  198  MIRb 5’ 
COL28A1 
NM_001037763 
XM_209824   
- 
1438 1652 
- 
225      8 
- 
MIRb 
- 
3’ 
COL4A6 
NM_001847   
NM_033641   
- 
- 
- 
- 
- 
- 
- 
- 
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BC005305 876 1105 7  268   MIRb 3’ 
COL8A1 
NM_001850  
NM_020351  
AF170702 
- 
- 
1966 2090 
- 
- 
66  194 
- 
- 
MIR3 
- 
- 
3’ 
CORO2B NM_006091 
2095 2305 
2651 2788  
223      7 
261     86 
MIRb 
MIR_Mars 
3’ 
3’ 
COX15 
NM_078470   
NM_004376  
3618 3672 
2379 2433 
151  205 
151  205 
MIR3 
MIR3 
3’ 
3’ 
CPLX3 NM_001030005 1020 1177 19  188 MIR3 3’ 
CPM 
NM_001874 
NM_198320 
NM_001005502 
5342 5368 
5328 5354 
5310 5336 
127  153 
127  153 
127  153 
THER1_MD 
THER1_MD 
THER1_MD 
3’ 
3’ 
3’ 
CPNE5 NM_020939 2720 2880 31  193 MIR3 3’ 
CRB1 
NM_201253 
BX640729 
- 
3555 3702 
- 
257     94 
- 
MIRb 
- 
3’ 
CRB2 NM_173689 4729 4837   136  243   MIR_Mars 3’ 
CREBL2 NM_001310 3588 3693   81  197 MIRb 3’ 
CREG2 NM_153836 1867 2008 255    109 MIRb 3’ 
CRELD1 
NM_001031717 
NM_015513 
BC008720 
- 
- 
1127 1305   
- 
- 
216     38 
- 
- 
MIR   
- 
- 
CDS 
CRHR2 NM_001883 1530 1587 125     67 MIR 3’ 
CRNKL1 NM_016652 2931 3103 37  256 MIRb 3’ 
CRSP2 NM_004229 7622 7855 262     13 MIR 3’ 
CRTAC1 NM_018058 2616 2854   1  252   MIRb    3’ 
CRYZL1 
NM_145858 
AK057604  
1029 1201 
1608  1780  
218     35 
218     35  
MIR 
MIR 
3’ 
3’ 
CSF3R 
NM_000760  
NM_156038  
NM_156039  
NM_172313  
99  179 
99  179 
99  179 
99  179 
133     57 
133     57 
133     57 
133     57 
MIR 
MIR 
MIR 
MIR 
TAG 
TAG 
TAG 
TAG 
CSMD2 NM_052896 11451 11656 235      7 MIRb    3’ 
CUL1 
NM_003592 
BC034318 
- 
61  170 
- 
49  179    
- 
THER1_MD 
- 
5’ 
CUL3 NM_003590  
5849 5970 
5971 6049 
268    143 
111     29 
MIR 
MIRb 
3’ 
3’ 
CX3CR1 NM_001337 
2146 2228 
2198 2248 
 43  154 
117  171 
MIRm 
MIR 
3’ 
3’ 
CXorf52 
NM_173168 
AY168775 
266  307 
266  307  
110  151 
110  151 
MIRb  
MIRb  
TAG 
TAG 
CXorf9 NM_018990 1816 1938 65  202   MIR3 3’ 
CYB561D1 NM_182580 1090 1257 2  190   MIR3 3’ 
CYB5D1 NM_144607 1639 1792 182     24 MIRb 3’ 
CYB5RL NM_001031672 
1319  1464 
2025  2082 
2301  2482 
2938  3059  
20    170   
28     84 
190      6  
1    122   
MIRc 
MIR3 
MIR3 
MIRc 
3’ 
3’ 
3’ 
3’ 
CYBB NM_000397 1877 2123 262      1    MIR_Mars 3’ 
CYBRD1 NM_024843 1773 2012 241      1 MIR 3’ 
CYLD NM_015247  4808 4883  118  194 MIR3 3’ 
CYorf15B NM_032576 2336 2517 262     77 MIR 3’ 
CYP2U1 
NM_183075 
 
2000 2104 
3050 3248 
99  197 
261     37 
THER1_MD 
MIRb 
3’ 
3’ 
CYP4F3 NM_000896 2758 2844 111     20   MIR 3’ 
CYP4V2 NM_207352 3257 3378 184     57 MIR3 3’ 
CYSLTR2 NM_020377 2135 2298 253     73 MIRb 3’ 
DAAM2 NM_015345 - - - - 
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BC047575 1409 1570 190     41 MIR3 3’ 
DAB2IP 
NM_032552   
NM_138709  
- 
41  137 
- 
128  226 
- 
THER1_MD 
- 
5’ 
DACT3 NM_145056 1832 1938 30  145 MIR 3’ 
DARS2 NM_018122 2904 3100 89  263 MIR_Mars 3’ 
DBF4B 
NM_145663   
NM_025104  
2936 3068 
765  887 
64  199   
184     61 
MIR3 
MIRb 
3’ 
3’ 
DBH NM_000787 2574 2718 12  175   MIRb 3’ 
DCDC1 
NM_198462  
NM_181807 
4281 4423 
- 
147      4 
-   
MIRb 
- 
3’   
- 
DCLRE1B NM_022836 3106 3260 89  263 MIR_Mars 3’ 
DCLRE1C 
NM_001033855   
NM_022487  
NM_001033858   
NM_001033857 
- 
- 
242  329 
242  329 
- 
- 
137     51 
137     51 
- 
- 
MIR   
MIR   
- 
- 
5’ 
5’ 
DCX 
NM_000555  
 
NM_178152  
 
NM_178153   
 
NM_178151   
 
3674 3737 
4465 4680 
3337 3400 
4128 4343 
3322 3385 
4113 4328 
3390 3453 
4181 4396 
172    110 
203      3 
172    110 
203      3 
172    110 
203      3 
172    110 
203      3 
MIR3 
MIR3 
MIR3 
MIR3 
MIR3 
MIR3 
MIR3 
MIR3 
3’ 
3’ 
3’ 
3’ 
3’ 
3’ 
3’ 
3’ 
DDN NM_015086 
2616 2792 
3548 3730 
16  201 
73  253 
MIR3 
MIRb 
3’ 
3’ 
DDR1 
NM_013993   
NM_001954 
NM_013994 
- 
- 
3  165 
- 
- 
90  258   
- 
- 
MIR 
- 
- 
5’ 
DDX52 NM_007010 3265 3357 77  170 MIRb 3’ 
DDX58 NM_014314 4164 4304 95  260  MIRb 3’ 
DEC1 NM_017418 91  161 42  111 MIR 5’ 
DEF8 
NM_017702 
NM_207514 
- 
3082  3180 
- 
70    166   
- 
MIR 
- 
3’ 
DENND1B NM_144977 2116 2174 253    193 MIR 3’ 
DENND2C NM_198459 3845 3975 261    126 MIRb 3’ 
DENND5B NM_144973 6214  6328  161     45 MIR3  3’ 
DGKA 
NM_201444   
NM_201445    
NM_001345   
NM_201554   
- 
87  208 
- 
- 
- 
124      1 
- 
- 
- 
MIRb 
- 
- 
- 
5’ 
- 
- 
DHCR24 NM_014762 
1820 2045 
2980 3108 
5  262 
34  168 
MIRb 
MIR 
3’ 
3’ 
DHCR7 NM_001360 1699 1742 104  153 MIRb 3’ 
DHRS12 
NM_001031719 
NM_024705 
912 1040  
- 
229    103  
- 
MIR 
- 
3’  
- 
DHX33 NM_020162 2332 2495 64  235 MIRb 3’ 
DIS3 NM_014953 5683 5792 233   121 MIRb 3’  
DISC1 
NM_001012957 
NM_001012958 
NM_001012959  
NM_018662  
6120 6332 
- 
2049 2165 
6186 6398 
252     15 
- 
133     11 
252     15 
MIRb 
- 
MIR 
MIRb 
3’ 
- 
TAG 
3’ 
CTXN2 NM_001145668 
1181 1293 
1408 1635 
1687 1807 
1935 2134 
9  131 
29  261     
87  200   
196      8 
MIRm 
MIR 
MIR3 
MIR 
3’ 
3’ 
3’ 
3’ 
DKK3 
NM_015881  
NM_013253  
1831 2060 
1817 2046 
251      4 
251      4 
MIRb 
MIRb 
3’ 
3’ 
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NM_001018057 1649 1878  251      4 MIRb 3’ 
DLEU1 
NR_002605 
AF490255 
223  280  
64  121 
219    167  
219    167 
MIRb  
MIRb 
ncRNA 
DLGAP4 
NM_014902 
NM_183006  
4835 5007   
3622 3794 
44  204 
44  204 
MIR 
MIR 
3’ 
3’ 
DMBT1 
NM_004406   
NM_007329   
NM_017579   
5693 5799 
7577 7683 
7547 7653 
109  215 
109  215 
109  215   
MIRb   
MIRb   
MIRb   
3’ 
3’ 
3’ 
DMRTC2 NM_033052 1449 1558 136     33 MIRb   3’ 
DMWD NM_004943 
1949 2056 
2700 2770 
140     30 
154     77 
MIR 
MIR3 
CDS 
3’ 
DNAJB13 
NM_153614 
AF516185 
- 
1233 1299 
- 
144     73  
- 
THER1_MD 
- 
TAG 
DNAJB14 
NM_001031723   
NM_024920  
- 
1507 1640 
- 
73  224    
- 
MIRb   
- 
3’ 
DNAJB8 NM_153330 845  911 48  121   MIR 5’ 
DNAJC18 NM_152686 2080 2246 254     68 MIRb   3’ 
DNASE2 NM_001375 1836 1995   34  195 MIRb   3’ 
DOCK2 
NM_004946 
BC016996 
- 
1498 1589 
- 
91  190 
- 
MIRb 
- 
3’ 
DOCK5 NM_024940 6830 6911 204    118 MIR3 3’ 
DOCK8 
NM_203447 
BC045629 
- 
1592 1722 
- 
192     31 
- 
MIR   
- 
TAG 
DPM2 
NM_152690  
NM_003863 
BC015374 
183  341 
- 
153   311 
246     91 
- 
246     91  
MIRb 
- 
MIRb 
TAG 
- 
TAG 
DPP4 NM_001935 19  155 43  183 MIR3 5’ 
DPP6 
NM_130797  
NM_001936  
NM_001039350 
BC035912 
- 
- 
- 
1039 1123  
- 
- 
- 
133     49  
- 
- 
- 
MIRb   
- 
- 
- 
ATG 
DPP8 
NM_130434   
NM_017743   
NM_197960  
NM_197961  
BC040203 
- 
- 
- 
- 
13  252 
- 
- 
- 
- 
260     10 
- 
- 
- 
- 
MIR3 
- 
- 
- 
- 
5’ 
DPYSL2 NM_001386 3290  3378 109     22 MIRc 3’ 
DSC2 
NM_024422   
NM_004949   
4987 5123 
5033 5169 
87  215 
87  215    
THER1_MD 
THER1_MD 
3’ 
3’ 
DUOX1 
NM_017434   
NM_175940  
109  239 
- 
134      4 
- 
MIR3 
- 
5’ 
- 
DUSP18 NM_152511 2128 2327 35  267   MIRb   3’ 
DUSP3 
NM_004090 
 
BC008286 
2563 2748  
3486 3535 
1199 1367 
2122 2171 
198     24 
139  187 
198     24 
139  187 
MIRb 
MIR3 
MIRb 
MIR3 
3’ 
3’ 
ATG 
3’ 
DVL3 NM_004423 4906 5060   28  189   MIRb   3’ 
DYNC2LI1  
NM_016008   
NM_015522   
NM_001012665   
BC040558 
- 
- 
- 
1671 1743 
- 
- 
- 
119  191 
- 
- 
- 
MIRb   
- 
- 
- 
3’ 
DYNLRB1 
NM_014183   
NM_177954  
 
- 
557  718 
813  963 
- 
6  171 
207     61 
- 
MIR 
MIRb   
- 
3’ 
3’ 
DZIP1 
NM_014934  
 
NM_198968   
4958 5103 
6076 6244 
5015 5160 
203     47 
39  221 
203     47 
MIR 
MIR 
MIR 
3’ 
3’ 
3’ 
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 6133 6301 39  221 MIR 3’ 
E2F6 
NM_001952   
NM_198256  
NM_198325  
NM_198258  
NM_198257  
NM_212540  
2120 2312   
2191 2383 
2253 2445 
2324 2516 
2065 2257 
2044 2236 
53  264 
59  264 
53  264 
53  264 
59  264 
59  264 
MIRm 
MIRm 
MIRm 
MIRm 
MIRm 
MIRm 
3’ 
3’ 
3’ 
3’ 
3’ 
3’ 
EBF2 
NM_02265 
AK001144 
 
- 
1714  1837 
2059  2218 
- 
1    131  
204     34 
- 
MIRb 
MIR3 
- 
3’ 
3’ 
EBI3 NM_005755 776  892 40  154 MIRb 3’ 
EDA 
NM_001399  
 
NM_001005609 
 
NM_001005610 
NM_001005611 
NM_001005612 
NM_001005613 
NM_001005614 
NM_001005615 
3344 3445 
4568 4688 
3338 3439 
4562 4682 
- 
- 
- 
- 
- 
- 
129     13 
203     89 
129     13 
203     89 
- 
- 
- 
- 
- 
- 
MIRb 
MIR3 
MIRb 
MIR3 
- 
- 
- 
- 
- 
- 
3’ 
3’ 
3’ 
3’ 
- 
- 
- 
- 
- 
- 
EDG6 NM_003775 1452 1495 82  125 MIR 3’ 
EEPD1 NM_030636 3477  3597 182     51  MIRb 3’ 
EFEMP2 NM_016938 1829 1935 39  156 MIR3 3’ 
EGLN2 
NM_053046 
NM_017555 
 
NM_080732 
- 
1325 1560 
1775 1887 
- 
- 
159     37 
159     37 
- 
- 
MIR 
THER1_MD 
- 
- 
5’ 
5’ 
- 
EHD3 NM_014600 2678 2881 254     54 MIRb 3’ 
EHD4 NM_139265 1689 1869 25  205    MIR3 3’ 
EHMT1 
NM_024757 
AF461894 
- 
760  928 
- 
214     35 
- 
MIR 
- 
5’ 
EIF1AX NM_001412 3733 3967 5  229   MIRb 3’ 
EIF4G3 NM_003760 18   88 140     66 MIRb 5’ 
ELF1 NM_172373 2687 2816 65  202 MIR3 3’ 
ELF3 NM_004433 
849  866 
1162 1299 
1480 1703 
204    185 
184     37 
16  220   
MIR3 
MIR3 
MIRb 
5’ 
5’ 
5’ 
ELK4 
NM_001973 
NM_021795 
140  374 
132  374 
253      7 
262      7 
MIRb 
MIRb 
5’ 
5’ 
EMR2 
NM_013447 
 
NM_152916 
 
NM_152917  
 
NM_152918   
 
NM_152919   
 
NM_152920  
 
NM_152921   
 
4582 4635 
4933 5078 
4435 4488 
4786 4931 
4303 4356 
4654 4799 
4156 4209 
4507 4652 
4549 4602 
4900 5045 
4402 4455 
4753 4898 
4270 4323 
4621 4766 
 209    155 
154      7 
209    155 
154      7 
209    155 
154      7 
209    155 
154      7 
209    155 
154      7 
209    155 
154      7 
209    155 
154      7 
MIRb 
MIRb 
MIRb 
MIRb 
MIRb 
MIRb 
MIRb 
MIRb 
MIRb 
MIRb 
MIRb 
MIRb 
MIRb 
MIRb 
3’ 
3’ 
3’ 
3’ 
3’ 
3’ 
3’ 
3’ 
3’ 
3’ 
3’ 
3’ 
3’ 
3’ 
ENAM NM_031889 
5241 5368 
5491 5558 
137  270   
198    135 
MIRm 
MIR3 
3’ 
3’ 
ENSA 
NM_207042  
NM_207043  
- 
1216 1395 
- 
6  187 
- 
MIRm 
- 
3’ 
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NM_004436  
NM_207044  
NM_207045  
NM_207046  
NM_207047  
NM_207168  
- 
1168 1347 
- 
- 
1032 1211 
- 
- 
6  187 
- 
- 
6  187 
-  
- 
MIRm 
- 
- 
MIRm 
- 
- 
3’ 
- 
- 
3’ 
- 
EPB41L1 
NM_012156  
NM_177996  
5754 5953 
5347 5540 
3  201 
9  201   
MIR3 
MIR3 
3’ 
3’ 
EPB41L4B 
NM_018424  
NM_019114 
2251 2364 
- 
84  199    
- 
MIR3 
- 
3’ 
- 
EPHA10 
NM_001004338 
NM_173641  
 
- 
1137 1198 
1505 1626 
- 
218    156 
168     42 
- 
MIR 
MIRb 
- 
3’ 
3’ 
EPHA8 
NM_020526  
NM_001006943 
4135 4294 
1699 1839 
181     13 
109  254 
MIR3 
MIRb 
3’ 
3’ 
EPHB2 
NM_017449   
NM_004442   
BC067861 
- 
- 
1565 1690   
- 
- 
132      5 
- 
- 
MIR 
- 
- 
TAG 
EPM2A 
NM_005670  
 
NM_001018041 
2058 2179 
2645 2868 
- 
133      5 
252      8 
- 
MIRb 
MIRb 
- 
3’ 
3’ 
- 
ERBB3 
NM_001982  
 
NM_001005915 
4724 4854 
5152 5230 
- 
258    113 
112     26   
- 
MIRb 
MIRb 
- 
3’ 
3’ 
- 
ERGIC1 
NM_001031711 
NM_020462  
- 
708  881 
1254 1362 
- 
22  204 
203     85 
- 
MIRb 
MIRb 
- 
3’ 
3’ 
ERLIN2 
NM_007175  
NM_001003790  
BC067765 
- 
- 
1095 1230 
- 
- 
181     37 
- 
- 
MIR3 
- 
- 
3’ 
ERMAP 
NM_001017922 
NM_018538  
BX537371 
- 
- 
236  433 
- 
- 
254     36 
- 
- 
MIRb 
- 
- 
5’ 
ESR1 
NM_000125 
BX640939 
 
 
- 
1247 1306 
1695 1804 
3029 3227 
- 
86  145 
207     93 
8  254 
- 
MIRb 
MIR3 
MIRb 
- 
3’ 
3’ 
3’ 
ETV6 NM_001987 5309 5409 151     49 MIR 3’ 
ETV7 NM_016135 1507 1544 115  151   MIRb 3’ 
EVI5 NM_005665 
4367 4416 
4547 4592 
116     72 
71     31 
MIRb 
MIRb 
3’ 
3’ 
EXOC5 NM_006544 5800 6040 267     10 MIRb 3’ 
EXOSC1 NM_016046 988 1049 251    189 MIRb 3’ 
EXTL1 NM_004455 613  786 3  186 MIR3 5’ 
F2RL1 NM_005242 1713 1845 198     55 MIR3 3’ 
FABP2 NM_000134 1846 1907 268    208   THER1_MD 3’ 
FADD NM_003824 1309 1371 75     10 MIR 3’ 
FAIM2 NM_012306 
2814 2968 
3159 3275 
197     47 
27  143 
MIRb 
MIR 
3’ 
3’ 
FAM100A 
NM_145253 
AF447881 
 
- 
299  434 
483  574 
- 
208     61 
147     40    
- 
MIR3 
MIR 
- 
5’ 
5’ 
FAM109A NM_144671 110  195 134     48 MIR 5’ 
FAM110A 
NM_207121 
NM_031424 
1   49 
- 
207    156 
-    
MIR 
- 
5’ 
- 
FAM111A 
NM_022074  
NM_198847  
2157 2247 
2118 2218 
262    152 
262    141  
MIR 
MIR  
3’ 
3’ 
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FAM139A NM_173678 2829  2916 3     94   MIR 3’ 
FAM163A NM_173509 2602 2713 25  152 MIRb 3’ 
FAM167A NM_053279 2388 2486 173     74 MIR3 3’ 
FAM168A 
NM_015159  
D87470 
 
 
 
- 
2031  2152 
3206  3335 
3507  3663 
4532  4637  
- 
197     74  
259    112  
238     43   
180     72 
- 
MIR3 
MIRc 
MIRc 
MIRc 
- 
3’ 
3’ 
3’ 
3’ 
FAM179B 
NM_015091 
BC057255 
-  
4604  4849  
-  
240      4 
-  
MIRc 
- 
3’ 
FAM184A 
NM_024581 
NM_001100411 
BX640728 
- 
- 
2285 2493 
- 
- 
27  253 
- 
- 
MIRb 
- 
- 
3’ 
FAM26C NM_001001412 
2073 2292  
2385 2422 
2726 2879 
2  223 
143    106  
2  171 
MIRb 
MIR 
MIRb 
3’ 
3’ 
3’ 
FAM26D NM_153036 831 1017 40  257    MIRb 3’ 
FAM40A NM_033088 
2530 2645 
4323 4360 
151     34 
113  153 
MIR 
MIRb 
3’ 
3’ 
FAM49B 
NM_016623 
BC016345 
- 
34  154 
- 
136     16   
- 
MIR 
- 
5’ 
FAM50B NM_012135 1390 1618 12  262   MIR 3’ 
FAM53B 
NM_014661 
BC031654 
- 
1333 1397  
- 
179    111 
- 
MIR 
- 
TAG 
FAM62C NM_031913 2140 2231 157     65   MIRm 3’ 
FAM79B NM_198485 3505 3615   87  191    MIR 3’ 
FAM92B NM_198491 
1339 1532 
1706 1884   
70  261 
43  254 
MIR 
MIRb 
3’ 
3’ 
FAM98B NM_173611 1250 1382 14  142 MIRb 3’ 
FANCF NM_022725 2147 226 42 177 MIR3 3’ 
FAT3 
XM_926199 
XM_936538 
16562 16728 
16561 16727 
185      6 
185      6   
MIR3 
MIR3 
3’ 
3’ 
FBLIM1 
NM_017556 
NM_001024215 
NM_001024216 
77  212 
- 
- 
178     33 
- 
- 
MIRb 
- 
- 
5’ 
- 
- 
FBXL12 NM_017703 1337 1475 21  173   MIRb   3’ 
FBXL7 NM_012304 2543 2624 48  135 MIR 3’ 
FBXO18 
NM_032807  
NM_178150  
31  156  
- 
6 125 
- 
MIR3 
- 
ATG 
- 
FBXO31 NM_024735 2177 2309 13  152  MIR 3’ 
FBXO44 
NM_033182  
NM_183412  
NM_183413  
NM_001014765 
 
2270 2305 
2256 2291 
2145 2180 
277  373 
2642 2677 
205  240 
205  240 
205  240 
14  119 
205  240  
MIR 
MIR 
MIR 
MIRm 
MIR 
3’ 
3’ 
3’ 
5’ 
3’ 
FCMD NM_006731 
4375 4414 
5634 5764 
67     30   
116  254 
MIR 
MIRb 
3’ 
3’ 
FEZ2 
NM_005102 
L17328  
- 
114  276 
- 
72  235 
- 
MIR 
- 
5’ 
FGD1 NM_004463 3960 4111  37  194 MIR3 3’ 
FGD2 
NM_173558 
BC062363 
 
- 
699  768 
955 1084 
- 
147     75 
30  157 
- 
MIR 
MIR 
- 
3’ 
3’ 
FGD3 NM_033086 4453 4551 129     31   MIR 3’ 
FGF7 NM_002009 3385 3517 202     46 MIR3 3’ 
FGR  NM_005248 1832 1924 204    112 MIR3 3’ 
FHAD1 XM_934878  - - - - 
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XM_934883  
XM_934889  
XM_934892  
XM_934885  
XM_057107   
XM_934887  
XM_934881  
XM_934876  
XM_934890  
- 
3227 3343 
- 
- 
3786 3994   
1026 1205 
- 
- 
20  130 
- 
141     22 
- 
- 
231     22 
78  256 
- 
- 
140     37 
- 
MIRb   
- 
- 
MIRb   
MIR 
- 
- 
MIRb   
- 
3’ 
- 
- 
3’ 
3’ 
- 
- 
CDS 
FIBIN NM_203371 2635  2706 170     93 MIRc 3’ 
FIGNL1 NM_022116 
48  160 
225  3178 
135     17 
4   98 
MIR 
MIR 
5' 
5’ 
FILIP1 NM_015687 4224 4369 33  199 MIR3 3’ 
FKRP 
 
NM_001039885 
 
NM_024301 
 
2376 2503 
3088 3344 
2157 2284 
2869 3125 
4  137 
262      9 
4  137 
262      9 
MIR 
MIR 
MIR 
MIR 
3’ 
3’ 
3’ 
3’ 
FLT3LG 
NM_001459  
U03858 
- 
818  915 
- 
186     87 
- 
MIRb 
- 
3’ 
FMNL3 
NM_175736  
 
 
 
NM_198900   
 
 
 
7401  7646 
7772  7866 
8187  8376 
10124 10264 
7248  7493 
7619  7713 
8034  8223 
9971 10111 
255     11 
127     26 
256     15 
146      1 
255     11 
127     26 
256     15 
146      1 
MIRb 
MIR 
MIRb 
MIR  
MIRb 
MIR 
MIRb 
MIR 
3’ 
3’ 
3’ 
3’ 
3’ 
3’ 
3’ 
3’ 
FNDC3B NM_022763 4804 4965 3  165 MIR 3’ 
FOXD2 NM_004474 
135  241 
351  496 
472  622 
51  157 
166      9 
138  58 
MIR3 
MIR 
MIRb 
5’ 
5’ 
5’ 
FOXI1 
NM_012188  
NM_144769  
1411 1609 
1126 1326 
245     37  
245     37 
MIRb 
MIRb 
3’ 
3’ 
FRAG1 NM_014489 1558 1690 53  181   MIR3 3’ 
FREQ NM_014286 2112 2271 30  202 MIR3 3’ 
FRMPD2L1 
NM_001042524 
NM_001042525  
1512  1675 
1498  1661 
254     94 
254     94 
MIRb 
MIRb 
3’ 
3’ 
FRMPD2L2 
NM_001042515 
NM_001042516 
1512 1675  
1498 1661 
254     94 
254     94 
MIRb 
MIRb 
3’ 
3’ 
FRRS1 NM_001013660 509   571 118     53 MIRb 5’ 
FSTL1 NM_007085 2113 2171 73  132 MIR 3’ 
FTO 
XM_051200 
 
 
XM_931743 
 
XM_931747 
 
 
XM_931752 
 
 
2499 2623  
2561 2778 
3155 3278 
1253 1470 
1847 1970 
1448 1572 
1510 1727 
2104 2227 
1424 1548 
1486 1703 
2080 2203 
143     25 
42  261 
87  219   
42  261   
87  219   
143     25 
42  261 
87  219 
143     25 
42  261 
87  219 
MIR3 
MIRm 
MIRb 
MIRm 
MIRb 
MIR3 
MIRm 
MIRb 
MIR3 
MIRm 
MIRb 
3’ 
3’ 
3’ 
3’ 
3’ 
3’ 
3’ 
3’ 
3’ 
3’ 
3’ 
FUT10 NM_032664 3146 3273 49  179 MIR3 3’ 
FUT8 
NM_178155 
NM_178154 
NM_178156 
NM_004480 
NM_178157 
101  193 
- 
101  193 
- 
- 
64  161 
- 
64  161 
- 
- 
MIRb 
- 
MIRb 
- 
- 
5’ 
- 
5’ 
- 
- 
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FXC1 NM_012192 746  817 188    116 MIRb 3’ 
FXN 
NM_000144 
NM_181425 
1838 2008 
1846 2016 
44  208 
44  208 
MIR3 
MIR3 
3’ 
3’ 
FYB 
NM_001465 
NM_199335 
3803 3916 
3665 3778 
57  185 
57  185    
MIRb 
MIRb 
3’ 
3’ 
GAB2 
NM_080491 
NM_012296 
5118 5186 
5164 5232 
110  180 
110  180 
MIR3 
MIR3 
3’ 
3’ 
GAB3 NM_080612 2370 2630 249      4 MIRb   3’ 
GABBR2 NM_005458 4457 4675 19  221   MIRb   3’ 
GABRA4 NM_000809 
3608 3703  
5071 5220 
204    114 
51  201   
MIR3 
MIR3 
3’ 
3’ 
GABRE NM_004961 2637 2770 245    117 MIR_Mars 3’ 
GAFA2 XM_001725248 27    78  91    147  MIR CDS 
GALNT10 
NM_198321 
NM_017540 
- 
1  157 
- 
96  262 
- 
MIRb 
- 
3’ 
GALNT11 NM_022087 1740 1953   242      8 MIRb 3’ 
GALNT4  NM_003774 
3003 3042 
3073 3199 
29   71 
72  202 
THER1_MD 
MIR3 
3’ 
3’ 
GAS2L3 NM_174942 75  153 140     58 MIRb 5’ 
GAS7 
NM_003644 
 
NM_201432   
 
NM_201433   
 
5945 6028 
7079 7167 
6353 6436 
7487 7575 
6383 6466 
7517 7605 
90  173 
61  147 
90  173 
61  147   
90  173 
61  147   
MIR3 
MIR 
MIR3 
MIR 
MIR3 
MIR 
3’ 
3’ 
3’ 
3’ 
3’ 
3’ 
GCET2 
NM_152785 
 
 
NM_001008756  
 
 
657  704 
1335 1501  
2551 2694   
824  871  
1502 1668 
2718 2861  
109  158  
207     20  
4  156  
109  158  
207     20  
4  156 
MIR3 
MIR3  
MIRm  
MIR3 
MIR3 
MIRm 
TAG 
3’ 
3’ 
TAG 
3’ 
3’ 
GCLC 
NM_001498 
BC022487 
- 
1738 1907 
- 
5  194 
- 
MIR3 
- 
3’ 
GCNT2 
NM_145649   
NM_001491   
NM_145655  
 
2932 3068 
3200 3336 
2464 2509 
2728 2864  
246    111 
246    111 
256    210   
246    111 
MIRb 
MIRb 
MIR 
MIRb 
3’ 
3’ 
3’ 
3’ 
GDAP2 NM_017686 2659 2762 108  221   MIRb 3’ 
GFI1B NM_004188 1277 1354 72  149   MIR 3’ 
GGCX NM_000821 
2913 2982 
2954 3088 
260    191 
166     20 
MIRb 
MIR_Mars 
3’ 
3’ 
GGTA1 NR_003191 1258  1377 127    251 MIR ncRNA 
GHDC NM_032484 295  438 179     46   MIRb 5’ 
GIPC1 
NM_005716 
NM_202467 
NM_202468 
NM_202469 
NM_202470 
NM_202494 
94  153 
94  153 
- 
- 
- 
- 
136     78 
136     78 
- 
- 
- 
- 
MIR 
MIR 
- 
- 
- 
- 
5’ 
5’ 
- 
- 
- 
- 
GJB3 
NM_024009   
NM_001005752   
268  384 
- 
236    118 
- 
MIR_Mars 
- 
5’ 
- 
GLB1L3 NM_001080407 1687 1879 48  250 MIRb CDS 
GLDN NM_181789 1474 1608 12  163 MIR3 3’ 
GNA12 NM_007353 3597 3715 90  199   MIR3 3’ 
GOLGA8A 
NM_181077 
AF163441 
- 
11  199 
- 
48  246 
- 
MIRb 
- 
5’ 
GOLGA8B NM_001023567 54  144 159  235 MIR 5’ 
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385  560 48  233 MIRb 5’ 
GOLPH2 
NM_016548  
NM_177937   
- 
2590 2674 
- 
201    113   
- 
MIR3 
- 
3’ 
GP5 NM_004488 3276 3527 18  268 MIRb 3’ 
GPI 
NM_000175 
AB209575 
- 
1757  1869 
- 
163     47 
MIRb 
- 
3’ 
GPR114 NM_153837 
247  421  
2362 2504  
3561 3761 
46  182 
23  147   
24  248 
MIRm 
MIRb 
MIR 
5’ 
3’ 
3’ 
GPR132 NM_013345 2902 3024 55  191 MIRb   3’ 
GPR135 NM_022571 1846 1908 83     23 MIR 3’ 
GPR155 
NM_001033045 
NM_152529 
3038 3198 
2889 3049 
60  216   
60  216 
MIRb 
MIRb 
3’ 
3’ 
GPR171 NM_013308 98  178 13 94 MIR  5’ 
GPR26 NM_153442 5610 5702 187    106 MIR   3’ 
GPR44 NM_004778 1832 1987   213     57 MIRb   3’ 
GPR78 NM_080819 1722 1775 81  134 MIR 3’ 
GPR81 NM_032554 
3179 3276 
3365 3425 
100  201  
182  246   
MIR 
MIRb 
3’ 
3’ 
GPR97 NM_170776 1731 1927 27  208 MIR3 3’ 
GPX7 NM_015696 912 1024 132  252 MIR 3’ 
GRAMD1B XM_370660  5729 5896  23  190  MIR3 3’ 
GREB1 
NM_014668   
NM_033090   
NM_148903   
7521 7732 
- 
1896 1985 
223      4   
- 
140     50 
MIRb   
- 
MIRb 
3’ 
- 
3’ 
GRIP2 
XM_042936   
XM_940982   
XM_944910   
 
 
- 
- 
1176 1348 
1927 2064 
2594 2626 
- 
- 
181      8 
61  201 
91  125   
- 
- 
MIRb 
MIR3 
MIRm 
- 
- 
3’ 
3’ 
3’ 
GRPEL2 NM_152407 3363 3518   51  224 MIRb 3’ 
GSG1L 
NM_144675 
 
NM_001109763 
 
AY302134 
1582  1715 
3151  3334 
1966  2099 
3535  3718 
371   420 
151     19  
46    241  
151     19  
46    241  
126     77  
MIRc 
MIR 
MIRc 
MIR 
MIR 
3’ 
3’ 
3’ 
3’ 
CDS 
GTPBP1 
NM_004286 
 
AF077204 
 
3794 3931 
4091 4148 
4454 4495 
92  125 
5  147 
220    158 
157    114 
147    114  
MIRb   
MIRb 
MIRb 
MIRb 
3’ 
3’ 
3’ 
5’ 
GUCA1B NM_002098 1839 1974 26  162   MIR3 3’ 
H2AFJ 
NM_018267   
NM_177925   
1952 2070   
- 
143  268 
- 
MIRb 
- 
3’ 
- 
HAP1 
NM_003949   
NM_177977   
2729 2910 
2573 2754 
207      2 
207      2 
MIRb   
MIRb   
3’ 
3’ 
HAPLN3 
NM_178232 
BC062320 
- 
139  274 
- 
140     18 
- 
MIR 
- 
5’ 
HAPLN4 NM_023002 
2790 2848 
3220 3347 
179    123 
34  175 
MIRb   
MIRb   
3’ 
3’ 
HAS1 NM_001523 1861 1908 111  157 MIR3 3’ 
HBS1L NM_006620 6683 6892 236      3 MIRb   3’ 
HCK NM_002110 
1849 1896 
1869 1951 
105  151 
118  193 
MIRb   
MIR3 
3’ 
3’ 
HDAC6 
NM_006044 
BC011498 
- 
653  805 
-  
96  274 
- 
MIRb 
- 
3’ 
HDAC8 
NM_018486 
AF212246 
- 
575  695 
- 
16  144 
- 
MIR 
- 
3’ 
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HDHD3 NM_031219  
8  142 
366  443 
533  610 
19  150 
191    115 
18   96 
MIR   
MIRb   
MIR 
5’ 
5’ 
5’ 
HEMK1 NM_016173 
2507 2611 
3288 3482 
4031 4071 
159     46 
28  232   
157    117 
MIRm  
MIRb   
MIR3 
3’ 
3’ 
3’ 
HFE 
NM_000410  
NM_139002   
NM_139003  
NM_139004  
NM_139005  
NM_139006  
NM_139007   
NM_139008  
NM_139009  
NM_139010  
NM_139011   
2122 2215 
- 
- 
1785 1910 
- 
- 
- 
- 
- 
- 
- 
241    149 
 
- 
245    125 
- 
- 
- 
- 
- 
- 
- 
MIR 
- 
- 
MIRb   
- 
- 
- 
- 
- 
- 
- 
3’ 
- 
- 
3’ 
- 
- 
- 
- 
- 
- 
- 
HHAT NM_018194 1861 2009 175     1 MIR3 3’ 
HIF3A 
NM_152794 
NM_022462 
NM_152795  
NM_152796  
- 
- 
1903 2008  
- 
- 
- 
151     36 
- 
- 
- 
MIR3 
- 
- 
- 
TAG 
- 
HIST1H2AC 
NM_003512 
U90551 
- 
1350 1466 
- 
80  210 
- 
MIRb 
- 
3’ 
HK1 
NM_000188  
NM_033496  
NM_033497  
NM_033498  
NM_033500  
- 
3  128 
- 
- 
- 
- 
20  153 
- 
- 
- 
- 
MIR 
- 
- 
- 
- 
5’ 
- 
- 
- 
HK2 NM_000189 
476  581 
869  942 
2  112 
113  188 
MIRb 
MIRb 
5’ 
5’ 
HKR1 
NM_181786  
BC053845 
- 
1  108 
- 
125     12 
- 
MIR 
- 
5’ 
HM13 
NM_030789  
NM_178580  
NM_178581  
NM_178582  
 
 
- 
- 
- 
540  691 
877 1107 
1110 1293 
- 
- 
- 
22  154 
8  262 
202     18 
- 
- 
- 
MIRb 
MIR 
MIRb 
- 
- 
- 
3’ 
3’ 
3’ 
HNF4A 
NM_178849 
 
NM_000457.3  
 
NM_178850  
NM_175914  
NM_001030003  
NM_001030004  
2692 2819   
2876 2997 
2722 2849 
2906 3027  
1285 1385   
- 
- 
- 
265    136   
145     26  
265    136   
145     26 
49  149 
- 
- 
- 
MIRb   
MIRb   
MIRb  
MIRb  
MIRb  
- 
- 
-  
3’ 
3’ 
3’ 
3’ 
TAG 
- 
- 
- 
HNF4G NM_004133 2285 2442 196     39 MIRb 3’ 
HOP 
NM_032495  
NM_139211  
NM_139212  
AF492678 
- 
- 
- 
83  197 
- 
- 
- 
77  196   
- 
- 
- 
MIR3 
- 
- 
- 
5’ 
HPCAL4 NM_016257 2796 2992 253     54    MIRb   3’ 
HPS1 
NM_000195  
NM_182637  
NM_182639  
NM_182638  
2731 2883  
2684 2836 
- 
2337 2489 
45  262  
45  262 
- 
45  262 
MIR 
MIR 
- 
MIR 
3’ 
3’ 
- 
3’ 
HRH1 NM_000861 2477 2637 217     57 MIRb   3’ 
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HRH2 NM_022304 1669 1842 266     84 MIRb   3’ 
HS1BP3 
NM_022460 
BC027947 
- 
1086 1211 
- 
69  206   
- 
MIR 
- 
3’ 
HS2ST1 NM_012262 
2585 2839 
6464 6510 
1  257 
8   55 
MIR_Mars 
MIR3 
3’ 
3’ 
HS6ST3 NM_153456 
3163 3361 
5549 5749 
251     13 
210      6 
MIRb 
MIRb 
3’ 
3’ 
HSD11B1L 
NM_198705  
NM_198706   
NM_198707  
NM_198708  
NM_198533  
NM_198704  
1145 1180  
1348 1383 
1308 1343  
1236 1271 
1213 1248  
1050 1085  
150    115   
150    115   
150    115   
150    115   
150    115   
150    115   
MIRb  
MIRb  
MIRb  
MIRb  
MIRb  
MIRb  
3’ 
3’ 
3’ 
3’ 
3’ 
3’ 
HSDL2 NM_032303 2725 2810 169     80 MIRm 3’ 
HSH2D NM_032855 1806 1988 246     53 MIRb 3’ 
HSPA12B NM_052970 2887 3022   10  143 MIR3 3’ 
HSPA14 
NM_016299  
NM_001037538 
 
 
 
- 
1831 2027 
3193 3287 
3567 3646 
4265 4439 
- 
39  256 
5  113 
103  187 
63  239 
- 
MIR 
MIR 
MIR3 
MIR 
- 
3’ 
3’ 
3’ 
3’ 
HSPB8 NM_014365 434  515 56  145 MIR 5’ 
HTR3E NM_182589  5  209 57  262 MIR  ATG 
HTR4 
NM_000870  
NM_199453  
2371 2519   
- 
32  183   
- 
MIR3 
- 
3’ 
- 
HUNK NM_014586 6257 6394 201     62 MIR3 3’ 
HVCN1 
NM_001040107 
NM_032369 
87  174  
60  149 
140     52  
142     52 
MIRb 
MIRb 
5’ 
5’ 
HYAL1 
 
NM_007312  
NM_153282 
NM_153283  
NM_153284   
NM_153285  
NM_153286   
NM_033159   
NM_153281   
2214 2436 
1649 1861 
1382 1594 
1402 1614 
964 1176 
815 1027 
1729 1951 
2024 2246 
268     19 
259     19 
259     19 
259     19 
259     19 
259     19 
268     19 
268     19 
MIRb 
MIRb 
MIRb 
MIRb 
MIRb 
MIRb 
MIRb 
MIRb 
3’ 
3’ 
3’ 
3’ 
3’ 
3’ 
3’ 
3’ 
HYDIN 
NM_017558  
BC028351  
- 
2684 2754 
 - 
38  110 
- 
MIRb 
- 
3’ 
IBRDC1 NM_152553 1044 1120  80      2 MIR CDS 
ICMT NM_012405  2258 2371  98  218  MIRb 3’ 
IFIT5 NM_012420 1656 1726 267    197 MIRb 3’ 
IFT122 
NM_052985 
NM_018262 
NM_052989 
NM_052990 
AK024435 
 
AK096891 
AK124140 
- 
- 
- 
- 
3427  3491  
3519  3614  
100   138 
291   412 
- 
- 
- 
- 
27     93 
158    259  
86    125 
135      7  
- 
- 
- 
- 
MIRb 
MIR 
MIR 
MIR 
- 
- 
- 
- 
3’ 
3’ 
5’ 
5’ 
IFT81 
NM_014055   
NM_031473   
- 
1863 1991 
- 
153     29 
- 
MIR 
- 
3’ 
IGF1 NM_000618 1745 1974 1  200 MIRb 3’ 
IGF2BP2 
NM_006548  
NM_001007225   
AF057352 
- 
- 
284  372 
- 
- 
26  115 
- 
- 
MIR 
- 
- 
5’ 
IGSF1 NM_001555  - - - - 
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NM_205833   1496 1659 
1651 1813 
5  168 
78  259 
MIRb 
MIR 
3’ 
3’ 
IKBKG 
NM_003639 
AY114157 
- 
1   68 
- 
171    104 
- 
MIR3 
- 
ATG 
IL10RA NM_001558 
2757 2884 
3379 3627 
6  153 
3  268 
MIR 
MIRb 
3’ 
3’ 
IL12RB1 
NM_005535  
NM_153701 
2046 2100 
1777 1842 
141     87 
191  255 
MIRb 
MIRb 
3’ 
3’ 
IL12RB2 NM_001559 
135  267 
3582 3626  
196     63  
275    231 
MIR 
MIRm 
5’ 
3’ 
IL16 
NM_004513   
 
NM_172217   
 
3151 3255 
4677 4890  
5573 5677 
7099 7312 
268    152 
225     22   
268    152 
225     22   
MIRb 
MIR_Mars 
MIRb 
MIR_Mars 
3’ 
3’ 
3’ 
3’ 
IL17RE 
NM_153480   
NM_153481   
NM_144640  
NM_153482   
NM_153483 
BC063110 
- 
- 
- 
- 
- 
1227 1362 
- 
- 
- 
- 
- 
108  259   
- 
- 
- 
- 
- 
MIRb 
- 
- 
- 
- 
- 
3’ 
IL18BP 
NM_173042 
NM_001039659 
NM_001039660 
579  671 
- 
- 
72  162 
- 
- 
MIR3 
- 
- 
5’ 
- 
- 
IL18R1 NM_003855 2529 2768 2  253   MIR 3’ 
IL1A NM_000575 
1944 2153 
2121 2334 
268     57 
18  219 
MIR 
MIRb 
3’ 
3’ 
IL1RAP 
NM_002182 
NM_134470 
2790 2957 
- 
21  197 
- 
MIR3 
- 
3’ 
- 
IL20RB NM_144717 1338 1485 3  151    MIR3 3’ 
IL21R 
NM_021798 
 
NM_181078 
 
NM_181079 
 
2343 2526 
2735 2780 
2456 2639 
2848 2893 
2358 2541 
2750 2795 
58  265 
276    231 
58  265 
276    231 
58  265   
276    231   
MIRb 
MIRm 
MIRb 
MIRm 
MIRb 
MIRm 
3’ 
3’ 
3’ 
3’ 
3’ 
3’ 
IL22RA1 NM_021258 2573 2794 36  260   MIRb 3’ 
IL22RA2 
NM_052962 
NM_181309 
NM_181310 
1  191  
1  191 
1  191 
68  261   
68  261 
68  261 
MIRb 
MIRb 
MIRb 
5’ 
5’ 
5’ 
IL23R NM_144701 2281 2342 146     83 MIR 3’ 
IL27RA NM_004843 2347 2501 237     57 MIRb 3’ 
IL28RA 
NM_170743 
 
NM_173064 
 
NM_173065 
 
2160 2357 
3252 3322 
2073 2270 
3165 3235 
2029 2226 
3121 3191 
35  259  
152  81 
35  259  
152  81 
35  259  
152  81 
MIRb 
MIR 
MIRb 
MIR 
MIRb  
MIR 
3’ 
3’ 
3’ 
3’ 
3’ 
3’ 
IL2RB NM_000878 3683 3782 63  166   MIR3 3’ 
IL6ST 
NM_002184 
NM_175767 
148  240  
- 
9  101  
- 
MIRb 
- 
5’ 
- 
IL8 NM_000584 907  984 113  183 MIR 3’ 
IMP3 NM_018285 668  692 141    117 MIR 3’ 
INOC1 
NM_017553 
BX640651 
- 
5252 5334 
- 
114  212 
- 
MIRb 
- 
3’ 
INPP5D 
NM_001017915 
NM_005541 
4089 4144 
4086 4141 
254    199  
254    199 
MIRb 
MIRb 
3’ 
3’ 
INTS2 NM_020748 5264 5329  119  194 MIR 3’ 
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INTU 
NM_015693 
BC051698 
- 
3231 3466  
- 
251      7 
- 
MIRb 
- 
3’ 
IREB2 
NM_004136 
BC017880 
 - 
1278 1481 
 - 
206      3 
- 
MIR 
- 
3’ 
IRF6 NM_006147 1894 2051 16  185     MIR3 3 
ISCA1 NM_030940 1166 1292 183     58 MIR3 3’ 
ISG20 
NM_002201 
BC016341 
 
 
 
- 
566  645 
1365 1444 
1924 2020 
2084 2180 
- 
9   96 
85  165 
166  262 
168     75 
- 
MIRb 
MIR 
MIR 
MIR3 
- 
3’ 
3’ 
3’ 
3’ 
ISG20L1 NM_022767 2183 2422 14  262 MIRb 3’ 
ITGA2 NM_002203 5153 5302 47  198    MIR3 3’ 
ITGAL NM_002209 3612 3793 16  196 MIRb 3’ 
ITGB3 NM_000212 4000 4163 41  207 MIR3 3’ 
ITGB7 NM_000889 26  135 133     10 MIR 5’ 
ITIH4 NM_002218 3075 3141 186    120   MIR3 3’ 
ITIH5 
NM_030569 
NM_032817 
NM_001001851 
5054 5132 
4394 4472 
- 
140     64 
140     64 
- 
MIR 
MIR 
- 
3’ 
3’ 
- 
ITK NM_005546 3130 3360 248     25 MIRb 3’ 
ITPK1 NM_014216 2297 2400 91  195 MIRm 3’ 
JAK3 NM_000215 3444 3527 49  139 MIR 3’ 
JARID1B NM_006618  418  597  65  262 MIR 5’ 
JHDM1D NM_030647  6188  6302 25    140 MIR 3’ 
KCNA6 NM_002235 4039 4170 42  171    MIR 3’ 
KCNA7 NM_031886 
4037 4105 
4161 4284 
152     83 
191     56 
MIRb 
MIRm 
3’ 
3’ 
KCNE3 NM_005472 1725 1860  58  200   MIR3 3’ 
KCNG3 
NM_133329 
NM_172344 
3333 3398 
3300 3365 
177    110 
177    110 
MIR3 
MIR3 
3’ 
3’ 
KCNG4 
NM_172347   
NM_133490 
- 
1174 1276 
1287 1422 
- 
60  180 
270    113 
- 
MIRb 
MIRm 
- 
3’ 
3’ 
KCNH5 
NM_139318 
NM_172376 
NM_172375 
- 
2152 2288 
- 
- 
2  151 
- 
- 
MIR 
- 
- 
3’ 
- 
KCNJ13 NM_002242 2262 2330 124  197   MIR3 3’ 
KCNK3 NM_002246 2102 2267 261     99 MIRb 3’ 
KCNK6 
NM_004823 
 
 
1421 1553 
2066 2206 
2525 2555 
29  165 
31  176 
177  207 
MIR 
MIR 
MIR 
3’ 
3’ 
3’ 
KCNS1 
NM_005552 
NM_002251 
 
- 
232  394 
2315 2417 
- 
261     85   
157     15   
- 
MIRb 
MIRb 
- 
5’ 
3’ 
KCTD17 NM_024681 1398 1425 161  188   MIRb 3’ 
KHK 
NM_000221 
NM_006488 
1727 1880 
1727 1880   
34  192 
34  192 
MIRb 
MIRb 
3’ 
3’ 
KIF1A 
 
NM_004321 
 
7821 7982 
 
5  166 
    
MIR3 
 
3’ 
 
KLC1 
NM_005552  
NM_182923  
1958 2011   
- 
137     84  
- 
MIRb 
- 
TAG 
- 
KLF12 
NM_007249 
NM_016285 
7815 8049 
- 
267      8  
- 
MIRb 
- 
3’ 
- 
KLF17 NM_173484 2541 2627  37  121  MIRb 3’ 
KLF3 
NM_016531 
BC051687 
- 
1639 1707 
- 
63  134 
- 
MIRb 
- 
3’ 
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KLHDC6 NM_207335 2614 2832 36  261 MIRb 3’ 
KLHL23 
NM_144711 
BC016950 
- 
1358 1481 
- 
4  130   
- 
MIR3 
- 
3’ 
KLHL32 NM_052904 2778 2916  52  186 MIR 3’ 
KLHL6 NM_130446 2056 2305 272      2 MIRb 3’ 
KLK10 
NM_002776 
NM_145888 
1328 1543 
1191 1406 
22  255 
22  255 
MIRb 
MIRb 
3’ 
3’ 
KLK15 
NM_023006 
NM_138563 
NM_138564 
NM_017509 
1036 1188 
1017 1169 
899 1051   
1154 1306 
76  229 
76  229   
76  229 
76  229 
MIR 
MIR 
MIR 
MIR 
3’ 
3’ 
3’ 
3’ 
KLK6 
NM_002774 
NM_001012964 
NM_001012965 
NM_001012966 
1306 1508   
1322 1524 
1274 1476 
1165 1367 
56  262     
56  262     
56  262     
56  262     
MIR 
MIR 
MIR 
MIR 
3’ 
3’ 
3’ 
3’ 
KRI1 NM_023008 2551  2579 148    120  MIRc 3’ 
KRT4 NM_002272 2   77  100     25 MIR 5’ 
KRT74 NM_175053 2257 2490 268      2 MIRb 3’ 
L3MBTL 
NM_015478 
NM_032107 
2546 2760 
- 
4  224 
- 
MIRb 
- 
3’ 
- 
LAMP3 NM_014398 2417 2640 274      7 MIRb 3’ 
LAS1L NM_031206  1116 1231 135      4 MIR3 CDS 
LDLRAP1 NM_015627 1903 2010 164     18   MIRb 3’ 
LENG4 
NM_024298 
BC006309 
 
- 
1544 1591   
1626 1799 
- 
98  145 
28  216 
- 
MIR 
MIR 
- 
3’ 
3’ 
LEP NM_000230 2458 2595 177     33    MIR3 3’ 
LHFPL5 NM_182548 1341 1429 96  186 MIR3 3’ 
LIG4 
NM_002312 
NM_206937 
109  244 
66  123 
230     93   
145     87 
MIRb 
MIR 
5’ 
5’ 
LILRB2 
NM_005874 
BC025766 
 
- 
1586 1728 
1905 2122 
- 
35  188 
14  247 
- 
MIR3 
MIRb 
- 
3’ 
3’ 
LINGO1 NM_032808 2681 2931 3  258 MIRb 3’ 
LINS1 
NM_018148 
NM_001040614  
NM_001040615  
NM_001040616  
AK001445 
2384 2466  
- 
- 
- 
2397  2466   
69  154  
- 
- 
- 
85    154 
MIRb 
MIRb  - 
- 
- 
MIRb 
CDS 
- 
- 
- 
 
LIPG NM_006033 3014 3144 167     27 MIRb 3’ 
LMBR1L NM_018113 273  401  120  249 MIR_Mars CDS 
LMOD1 NM_012134 3685 3850   244     66   MIRb 3’ 
LPPR2 NM_022737 190  274 104  188 MIRb 5’ 
LRAT NM_004744 4040 4084 188  233 MIR 3’ 
LRFN1 XM_290842  98  156 141     83 MIRb 5’ 
LRRC15 NM_130830 4913 5009 263    162   MIRb 3’ 
LRRC21 NM_015613 2045 2100 262    207 MIR 3’ 
LRRC25 NM_145256 
430  477 
1552 1754 
161    116 
28  236  
MIR 
MIR3 
3’ 
3’ 
LRRC32 
NM_005512 
 
 
 
 
 
7   90 
2107 2232 
2940 3158 
3388 3488 
3511 3580 
3841 3924 
14  101 
142      1 
232     13 
186     82 
128  198 
152     47 
MIRb 
MIR 
MIRb 
MIR3 
MIR3 
MIRm 
5’ 
3’ 
3’ 
3’ 
3’ 
3’ 
LRRC48 
NM_031294 
AL136926 
- 
1001 1084 
- 
219    129 
- 
MIRb 
- 
3’ 
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1385 1468 
3823 4028 
128     40 
246     36 
MIRb 
MIR 
3’ 
3’ 
LRRC59 NM_018509 1600 1748 196     35 MIR3 3’ 
LTBP2 
NM_000428 
AF113211 
7283 7435 
1  149 
249     87 
245     87  
MIR 
MIR 
3’ 
5’ 
LUZP1 
NM_033631 
 
4932 5110 
5263 5330 
20  201   
110  177 
MIR3 
MIR3 
3’ 
3’ 
LVRN 
NM_173800  
BC070028 
- 
134   186  
- 
142     90  
- 
MIR 
- 
5’ 
LYPD5 
 
NM_001031749 
 
 
NM_182573 
 
 
1219 1323 
1326 1405   
1408 1613 
1183 1287 
1290 1369 
1372 1600 
2  107 
27  107 
27  218 
2  107 
27  107 
27  255 
MIR 
MIR 
MIR 
MIR 
MIR 
MIR 
3’ 
3’ 
3’ 
3’ 
3’ 
3’ 
LYPD6 NM_194317 2512 2645  254    119 MIRb 3’  
LZIC NM_032368 1148 1292 197     32 MIR3 3’ 
MACF1 
NM_012090 
NM_033044 
98   147 
- 
134     85  
-  
MIR 
- 
5’ 
- 
MAFF 
NM_012323 
NM_152878 
1248 1349 
1198 1299 
134     38 
134     38 
MIR 
MIR 
3’ 
3’ 
MAGIX 
NM_001099680  
NM_001099681  
NM_001099682  
NM_024859 
- 
- 
- 
2409  2531   
- 
- 
- 
155     17 
- 
- 
- 
MIRb 
- 
- 
- 
TAG 
MALT1 
NM_006785 
NM_173844 
4201 4347 
4168 4314 
152      4 
152      4 
MIRb 
MIRb 
3’ 
3’ 
MAN2A2 NM_006122 6056 6130 193  268 THER1_MD 3’ 
MAOB NM_000898 2103 2257  202     46 MIR3 3’ 
MAP2K3 
NM_002756 
NM_145109 
NM_145110 
- 
- 
105  140 
- 
- 
143    108    
- 
- 
MIR 
- 
- 
5’ 
MAP3K14 NM_003954 3861 3984 109  229 MIR 3’ 
MAP3K8 NM_005204 578  673 263    163 MIR       5’ 
MAP4K5 
NM_006575 
NM_198794 
4164 4332 
4212 4380  
199     11  
199     11   
MIRb 
MIRb 
3’ 
3’ 
MAPK4 NM_002747 3097 3256 176     17 MIR3 3’ 
MAPKAPK2 
NM_004759 
NM_032960 
1472 1629 
- 
175     16 
- 
MIR3      
- 
3’ 
- 
MARCH5 NM_017824 3261 3438 25  197 MIRb 3’ 
MARCH8 
NM_001002265 
NM_145021 
NM_001002266 
511  622 
511  622 
- 
74  190 
74  190 
- 
MIR3 
MIR3 
- 
5’ 
5’ 
- 
MARCH9 
NM_138396 
BC009489 
- 
48  224 
- 
200     22 
- 
MIR 
- 
5’ 
MARK4 NM_031417 3060 3132 84  153 MIRb 3’ 
MASP1 
NM_001879  
 
 
NM_139125 
 
NM_001031849 
2599 2825  
3111 3244 
3970 4042 
2721 2791 
3657 3821 
- 
14  254 
2  138 
92  165 
87  157 
37  207   
-  
MIRb 
MIR3 
MIR 
MIR3 
MIR3 
- 
3’ 
3’ 
3’ 
3’ 
3’ 
- 
MAST3 
XM_038150 
 
XM_938007 
 
5331 5414 
5429 5603 
5328 5411 
5426 5600 
46  140 
256     71 
46  140 
256     71 
MIR 
MIRb 
MIR 
MIRb 
3’ 
3’ 
3’ 
3’ 
MAT1A NM_000429 1944 2187 255      1 MIR 3’ 
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MATN1 
NM_002379 
M55683 
- 
1579 1780 
- 
258     38 
- 
MIRb 
- 
3’ 
MB 
NM_005368 
NM_203377 
NM_203378 
- 
93  166 
- 
- 
23   96 
- 
- 
MIR 
- 
- 
5’ 
- 
MBL2 NM_000242 3241 3423 37  226 MIR 3’ 
MC1R NM_002386 1661 1737 82  172 MIR3 3’ 
MCCC2 NM_022132 1987 2034   106  153 MIR 3’ 
MCM10 
NM_182751 
NM_018518 
3130 3235 
3127 3232 
89  194 
89  194 
MIR3 
MIR3 
3’ 
3’ 
MDGA1 
NM_153487 
 
7447 7567 
8274 8356 
193     62 
187     93 
MIR3 
MIR3 
3’ 
3’ 
MED25 
NM_030973 
AF447873   
 
- 
586  676  
1436 1479 
- 
240    158  
136     93  
- 
MIRb 
MIRm 
- 
5’ 
5’ 
MED8 
NM_201542 
NM_052877 
NM_001001651 
NM_001001653 
NM_001001654 
982 1208 
- 
- 
982 1208 
939 1165 
15  260 
- 
- 
15  260 
15  260 
MIRb 
- 
- 
MIRb 
MIRb 
3’ 
- 
- 
3’ 
3’ 
MEG3 AF447875 4756 4882 121  254 MIRb 3’ 
MEGF11 NM_032445 5149 5276 84  205 MIR3 3’ 
MEGF9 
XM_929502  
XM_933704  
XM_941600  
XM_945294  
- 
1597 1806 
- 
1597 1806 
- 
4  256 
- 
4  256 
- 
MIR 
- 
MIR 
- 
3’ 
- 
3’ 
MESDC2 
NM_015154 
BC009210 
 
 
 
- 
1813 1912 
1854 2012 
2389 2558 
2678 2795 
- 
96  202 
187     22 
93  272 
38  178 
- 
MIR3 
MIR3 
MIRb 
MIRm 
- 
3’ 
3’ 
3’ 
3’ 
METTL13 
NM_001007239 
NM_014955 
NM_015935 
2746  2830  
2889  2973 
3214  3298 
262    182 
262    182 
262    182 
MIRb 
MIRb 
MIRb 
3’ 
3’ 
3’ 
MFAP3 NM_005927 1900 1968 111  185 MIR3 3’ 
MFAP5 NM_003480 1744 1880 20  156 MIR3 3’ 
MFSD2 
NM_032793 
AF370364 
- 
145  273 
- 
134      8 
- 
MIR 
- 
5’ 
MFSD4 
NM_181644 
AY358107 
- 
2853 3106 
- 
7  262 
- 
MIR 
- 
3’ 
MGAT5 
NM_002410 
 
1245 1458 
 
9  233 MIR 5’ 
MICA NM_000247 1186 1360 24  223  MIR TAG 
MICAL2 
NM_014632 
BX538021 
- 
1  187  
- 
36  262 
- 
MIRb 
- 
5’ 
MIF4GD NM_020679 1136 1205 70 145  MIR  3’ 
MIPOL1 
NM_138731 
 
4121 4203 
4277 4387 
261    177 
165     26 
MIR_Mars 
MIRb 
3’ 
3’ 
MIR16 
NM_016641 
 
1854 1966 
2257 2506 
198     85   
258      4 
MIR3 
MIRb 
3’ 
3’ 
MLLT6 
NM_005937 
BC064612 
- 
2072 2269 
- 
197      1  
- 
MIR 
- 
3’ 
MLXIPL 
NM_032951 
NM_032952 
NM_032953 
NM_032954 
2767 2938  
2710 2881 
2761 2932 
2704 2875 
33  191 
33  191 
33  191 
33  191 
MIRm 
MIRm  
MIRm 
MIRm 
3’ 
3’ 
3’ 
3’ 
MMP19 NM_002429 2019 2250 1  264   MIRb 3’ 
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NM_001032360 1672 1903 1  264   MIRb 3’ 
MMRN1 NM_007351 4538 4776 266      3 MIRb 3’ 
MOBKL2C 
NM_145279 
NM_201403 
2171 2322 
2123 2283 
193     39 
202     39 
MIR3 
MIR3 
3’ 
3’ 
MON1B NM_014940 2649 2740 108  197 MIRb 3’ 
MORF4L2 
NM_012286 
BC056899 
- 
110  164 
- 
164  231 
- 
MIR 
- 
5’ 
MPL NM_005373 3082 3305   12  249 MIR 3’ 
MPO NM_000250 2693 2901 2  228 MIR 3’ 
MPP3 
NM_001932 
 
10  147 
2099 2203 
124  265 
198     93 
MIRb 
MIR3 
5’ 
3’ 
MRAP2 NM_138409 1348 1485 53  207 MIR3 3’ 
MRI1 
NM_001031727 
 
NM_032285 
 
1310  1441 
1770  1804 
1169  1300 
1629  1663 
21    151 
138    172 
21    151 
138    172 
MIR 
MIR 
MIR 
MIR 
3’ 
3’ 
3’ 
3’ 
MRM1 NM_024864 1776 1816 162  202 THER1_MD 3’ 
MRO NM_031939 1629 1877 262      2   MIR 3’ 
MRPL10 
NM_145255 
NM_148887 
1218 1406  
1316 1504  
247     27 
247     27  
MIRb 
MIRb 
3’ 
3’ 
MRPL27 
NM_016504 
NM_148571 
 
 
NM_148570 
- 
340  445  
1059 1287 
1401 1503 
- 
- 
266    161  
262     15  
104  213   
- 
- 
MIRb 
MIR 
MIR 
- 
- 
3’ 
3’ 
3’ 
- 
MRPL42 
NM_014050 
NM_172177 
NM_172178 
1279 1438 
1282 1441  
1302 1461 
220      9  
220      9  
220      9  
MIRb 
MIRb 
MIRb 
3’ 
3’ 
3’ 
MRPL49 NM_004927 1727 1841  30  155 MIRb 3’ 
MRRF 
NM_138777 
NM_199177 
BC002814 
- 
- 
677   798 
- 
- 
26  145 
- 
- 
MIR 
- 
- 
3’ 
MRS2L 
NM_020662 
BC069009 
- 
1337 1545 
- 
2  230   
- 
MIR 
- 
3’ 
MS4A10 NM_206893 
817  894  
2097 2241  
128     49 
6  145  
MIRb 
MIR3 
TAG 
3’ 
MS4A3 
NM_006138 
NM_001031809 
NM_001031666 
1440 1653  
1302 1515 
1131 1344  
1  219  
1  219  
1  219  
MIRb  
MIRb   
MIRb 
3’ 
3’ 
3’ 
MS4A6A 
NM_152851 
NM_022349 
NM_152852 
- 
1109 1240  
- 
- 
167     35 
- 
- 
MIR3 
- 
- 
3’ 
- 
MSR1 
NM_138715 
NM_002445 
NM_138716 
2910 2973 
- 
2721 2784 
2   66  
- 
2   66  
MIR 
- 
MIR  
3’ 
- 
3’ 
MST150 NM_032947 
 5  142 
180  340 
946 1127   
191     38 
183     22  
34  212 
THER1_MD  
MIR3  
MIRb   
5’ 
ATG 
3’ 
MSX1 NM_002448 1319 1466 182     41 MIR3  3’ 
MTIF2 
NM_001005369 
NM_002453  
375  529 
92  246 
3  160  
3  160 
MIR3  
MIR3 
5’ 
5’ 
MUC15 NM_145650 199  283 99  178 MIRb 3’ 
MUC3B 
XM_168578  
XM_374502  
XM_940796  
2233 2367  
1114 1242 
- 
43  193 
43  187  
- 
MIRb  
MIRb  
- 
3’ 
3’ 
- 
MYCBP NM_012333   1387 1551  78  241 MIRb 3’ 
MYEOV NM_138768 1372 1532 261     87  MIR   CDS 
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 1926 2022 230    110  MIRb 3’ 
MYO15A NM_016239 
7364  7465 
10947 11025   
188     82  
55  139 
MIR   
MIR 
CDS 
3’ 
MYO5A NM_000259 
7666  7742   
9821  9950   
115 193  
221     84      
MIR3 
MIRc 
3’ 
3’ 
MYO7A 
NM_000260 
HSU55209 
- 
3829 3958 
- 
29  159 
- 
MIRb 
- 
CDS 
MYOZ3 
NM_133371 
 
2394 2564  
2661 2866 
250     73  
28  262  
MIRb  
MIRb 
3’ 
3’ 
MYRIP NM_015460 3996 4165 197      2  MIRb  3’ 
MYSM1 
XM_055481  
XM_941796  
BX537912 
 
- 
- 
2208 2361  
2517 2713 
- 
- 
20  200 
7  205 
- 
- 
MIR3 
MIR3 
- 
- 
3’ 
3’ 
MYT1L NM_015025 666  798  144      5  MIRm  5’ 
NAALAD2 
NM_005467 
BC038840 
- 
1333 1503 
- 
70  251  
- 
MIR   
- 
3’ 
NAIF1 
NM_197956 
BC021580 
 - 
1077 1329 
 - 
2  261 
- 
MIRb 
- 
3’ 
NAPE-PLD 
NM_198990 
BC071604 
- 
2881 3003  
- 
82  216  
- 
MIR 
- 
3’ 
NAT9 NM_015654 1725 1786  149     86 MIRm  3’ 
NCAN NM_004386 5366 5620 262      3 MIRb    3’ 
NCOA6 
NM_014071 
AF208227 
- 
1740 1909 
- 
64  258  
- 
MIR 
- 
5’ 
NCR2 NM_004828 798  914  95  219 MIRb  TAG 
NDST1 NM_001543 
4712 4858 
7175 7293 
144      3 
23  153 
MIR3  
MIR 
3’ 
3’ 
NDST2 NM_003635 121  219 5  102  MIR 5’ 
NDUFAF1 
NM_016013 
BC000780  
- 
166  313 
- 
66  235  
- 
MIR 
- 
5’ 
NDUFB2 
NM_004546 
BC063026 
- 
135  181  
- 
126     83  
- 
MIR 
- 
5’ 
NDUFS1 NM_005006.5 2781 3023  262      5 MIRb 3’ 
NEDD4 
NM_006154 
NM_198400 
4603 4810  
5864 6008  
32  243  
32  186  
MIRb 
MIRb 
3’ 
3’ 
NEK3 
NM_002498 
NM_152720 
2040 2211  
1963 2134  
15  181   
15  181   
MIRb 
MIRb 
3’ 
3’ 
NEK6 
NM_014397 
BC012761 
- 
1874 2071 
- 
62  259  
- 
MIRb 
- 
3’ 
NETO1 
NM_138999 
NM_153181 
NM_138966 
BC050329 
 
- 
- 
- 
1901 1977 
2103 2172  
- 
- 
- 
141     56  
130  195 
- 
- 
- 
MIRm 
MIRb 
- 
- 
- 
3’ 
3’ 
NEU3 NM_006656 2 2478 2627  16  167  MIR3 3’ 
NEURL NM_004210 3520 3639 18  150 MIRb 3’ 
NEUROD2  
NM_006160 
AB021742 
- 
1  117 
- 
51  184  
- 
MIR3 
- 
5’ 
NEUROD4 
NM_021191   
BC040961 
- 
1109 1295 
- 
41  199 
- 
MIR3 
- 
3’ 
NFATC4 NM_004554 3702 3841  156      5  MIR 3' 
NFXL1 
NM_152995 
BC051193 
- 
2106 2220 
- 
135     14 
- 
MIR3  
- 
CDS 
NGFR NM_002507 1915 2061 201     52 MIR3 3’ 
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NHLRC1 NM_198586 
1202 1285 
1352 1452 
1721 1856  
28  118  
264    168   
167     38  
MIRb 
MIRb 
MIRb 
3’ 
3’ 
3’ 
NHP2L1 
NM_005008 
NM_001003796 
860  934  
779  853  
17   85 
17   85  
MIR 
MIR 
3’ 
3’ 
NIP30 
NM_024946 
BC063409 
- 
1927 2073 
- 
201     52  
- 
MIR3  
- 
5’ 
NIP7 NM_016101 
1210 1390   
1673 1746  
47  206  
207  271  
MIRb 
THER1_MD 
3’ 
3’ 
NIPA1 
NM_144599 
BX537997 
- 
5479 5616 
- 
4  152 
- 
MIR 
- 
3’ 
NIPSNAP1 NM_003634 1   98  154     44 MIR3 5’ 
NIT1 
NM_005600 
BC046149 
- 
1742 1887  
- 
59  201  
- 
MIRb 
- 
3’ 
NKIRAS2 
NM_001001349 
NM_017595 
2189 2301 
1713 1825  
70  185 
70  185  
MIR3 
MIR3 
3’ 
3’ 
NMNAT2 
NM_015039 
NM_170706 
3198 3395  
2983 3180  
200      6 
200      6 
MIR3 
MIR3 
3’ 
3’ 
NMUR1 NM_006056 
1817 1894  
2192 2287 
35  112  
113  207  
MIR 
MIR3 
3’ 
3’ 
NOD2 NM_022162 4277  4336 191    251 MIRc 3’ 
NOTCH2NL 
NM_203458 
BX537434 
 
- 
2854 3100  
3672 3773 
- 
262      8 
202     97  
- 
MIRb 
MIRb 
- 
3’ 
3’ 
NOV NM_002514 1947 1990 151    112  MIR 3’ 
NPAL3 
NM_020448 
BX640883 
- 
444  561 
- 
183     54 
- 
MIR 
- 
3’ 
NPCDR1 
 
XR_001027 
AF134979 
 
1416 1566  
1644 1794 
  
199     36 
199     36 
 
MIR   
MIR 
 
ATG 
ATG 
 
NPHP1 
NM_000272 
NM_207181 
2962 3144  
- 
262     56 
- 
MIR 
- 
3’ 
- 
NPTXR 
NM_014293 
 
 
 
NM_058178 
 
 
 
2581 2720 
3427 3550  
4550 4764 
5220 5359  
2578 2717 
3424 3547  
4547 4761 
5217 5356  
3  152   
141      6  
232     14  
179     19  
3  152   
141      6  
232     14  
179     19  
MIR3 
MIRm 
MIRb 
MIR3 
MIR3 
MIRm 
MIRb 
MIR3 
3’ 
3’ 
3’ 
3’ 
3’ 
3’ 
3’ 
3’ 
NR2E3 
NM_016346 
NM_014249 
BC041421 
- 
- 
273  373  
- 
- 
141     25  
- 
- 
MIRb 
- 
- 
5’ 
NR4A3 
NM_006981 
NM_173198 
NM_173200 
NM_173199 
4596 4774   
5343 5521 
3944 4122 
2437 2527  
208     19 
208     19 
208     19 
14   98  
MIR3 
MIR3 
MIR3 
MIRb 
3’ 
3’ 
3’ 
3’ 
NRIP3 NM_020645 1300 1443  176      5  MIR3  3‘ 
NRL 
NM_006177 
BC012395 
1629 1791 
- 
20  190   
- 
MIR3 
- 
3’ 
- 
NRSN1 NM_080723 1770 1924 37  195   MIR 3’ 
NRSN2 NM_024958 
11  148 
1019 1096 
1244 1417 
141      8 
82  160   
210     29 
MIR 
MIR3 
MIR_Mars 
5’ 
3’ 
3’ 
NSAP11 
XM_001722999  
AY176665 
 - 
1799  2009  
- 
17    242 
- 
MIRc 
- 
3’ 
NT5E NM_002526 2093 2329 255      8 MIRb 3’ 
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NTRK3 
NM_001012338  
NM_002530  
NM_001007156  
BT007291 
- 
- 
1758 1883 
1596 1721 
- 
- 
207     82 
207     82 
- 
- 
MIR3 
MIR3 
- 
- 
CDS 
CDS 
NTSR1 
NM_002531 
 
3061 3147  
3528 3660  
86  162 
24  173   
MIR 
MIRb 
3’ 
3’ 
NTSR2 NM_012344 1550 1694   101  263   THER1_MD 3’ 
NUBPL NM_025152 1579 1745 162      8   MIR 3’ 
NUCB2 NM_005013 114  211 58  168 MIRb 5’ 
NUDT12 NM_031438 2657 2780 190     75  MIR3  3’ 
NUMA1 NM_006185 
184  329  
1294 1467  
2  172   
175      2   
MIR 
MIRb 
CDS 
3’ 
NUMB 
NM_001005743 
NM_001005744 
NM_003744  
NM_001005745 
206  306  
206  306  
206  306  
206  306  
146     48  
146     48  
146     48  
146     48  
MIRb 
MIRb 
MIRb 
MIRb 
5’ 
5’ 
5’ 
5’ 
NUP133 NM_018230 3831 3941 49  176  MIR3  3’ 
NXF4 NR_002216 2140  2326 17    222  MIR ncRNA 
OAS1 
NM_016816 
NM_002534 
NM_001032409 
1328 1471   
1388 1470 
1230 1373  
179     21  
256    176  
179     21  
MIR3 
MIRb 
MIR3 
3’ 
3’ 
3’ 
OCLN NM_002538 2340 2430 210    122   MIRb 3’ 
OLFML2A 
NM_182487 
 
 
 
 
 
 
1655 1857  
2888 2999 
3998 4019  
4333 4426 
4441 4581 
5348 5460   
5526 5676  
249     38   
187     63  
168    146  
153     53 
246     87  
2  118   
203     47   
MIRb 
MIR3 
MIR 
MIRb 
THER1_MD 
MIR3 
MIRb 
3’ 
3’ 
3’ 
3’ 
3’ 
3’ 
3’ 
OPHN1 NM_002547 
4206 4352 
5827 5962  
180     10   
145      5  
MIR3 
MIR3 
3’ 
3’ 
OR4D2 NM_001004707 1550 1665  22  137  MIRb 3’ 
OR51E2 NM_030774 2189 2434  262      2  MIR 3’ 
ORAOV1 NM_153451 999 1194 257     43 MIRb 3’ 
ORC2L 
NM_006190 
AF315716 
- 
115  233  
- 
189     58 
- 
MIR3 
- 
ATG 
OSCAR 
NM_206818 
NM_206817 
NM_130771 
NM_133169 
NM_133168 
1580 1646   
1544 1610  
1066 1132 
1054 1120   
1021 1087  
12   84 
12   84 
12   84 
12   84 
12   84 
MIR 
MIR 
MIR 
MIR 
MIR 
3’ 
3’ 
3’ 
3’ 
3’ 
OSM NM_020530 1321 1464 3  154  MIR3 3’ 
OTUB2 
NM_023112 
 
AF318378 
1090 1172 
3361 3557  
2025 2221 
61  150 
34  235 
34  235 
MIRb 
MIR  
MIRb  
3’ 
3’ 
TAG 
P2RX7 
NM_002562 
NM_177427 
2360 2564 
2263 2467  
27  263 
27  263  
MIR 
MIR 
3’ 
3’ 
P2RY2 
NM_176072 
NM_002564 
NM_176071 
1918 2005  
1784 1871   
1850 1937 
156     64 
156     64 
156     64  
MIR3 
MIR3 
MIR3 
3’ 
3’ 
3’ 
P2RY6 
NM_176797 
NM_176798 
NM_176796 
NM_004154 
- 
- 
- 
21  126  
- 
- 
- 
33  142  
- 
- 
- 
MIRb 
- 
- 
- 
5’ 
P53AIP1 NM_022112 1833 2077  9  262  MIR 3’ 
PALM2 
NM_053016 
NM_001037293 
6011 6071 
- 
184    124  
- 
MIR3 
- 
3’ 
- 
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PAPLN NM_173462 5376 5473  104  201  MIR3 3’ 
PAPPA 
NM_002581 
AY189937 
9499  9598 
74   173  
83  169  
83  169  
MIR   
MIR 
3’ 
TAG 
PAPSS2 
NM_004670  
 
NM_001015880   
 
2988 3051  
3126 3184  
3003 3066  
3141 3199  
185    122   
78     17  
185    122   
78     17  
MIR3 
MIR 
MIR3 
MIR 
3’ 
3’ 
3’ 
3’ 
PAQR3 
NM_001040202 
BC031256 
- 
1040 1126 
- 
15  112 
- 
MIR 
- 
TAG 
PAQR5 
NM_017705 
 AY424283 
- 
10   94 
- 
45  136  
- 
MIR 
- 
5’ 
PARD3B 
NM_205863  
NM_152526  
NM_057177  
AB053321 
- 
- 
- 
936 1189  
- 
- 
- 
271      1 
- 
- 
- 
MIR 
- 
- 
- 
3’ 
PARS2 NM_152268 
1773 1893  
1981 2127  
31  169   
7  173   
MIR 
MIR3 
3’ 
3’ 
PARVA NM_018222 1541 1707  260     95    MIRb 3’ 
PAX5 NM_016734 
2470 2515  
3233 3366  
192    147  
2  130   
MIR3 
MIR3 
3’ 
3’ 
PAX7 
NM_002584  
NM_013945  
2105 2214 
2099 2208 
155     29  
155     29  
MIR  
MIR 
TAG 
TAG 
PBOV1 NM_021635   123  245  168      5  MIR  CDS 
PCBP4 
NM_020418  
NM_033009   
NM_033008   
NM_033010   
32  171 
32  171 
- 
- 
219     80 
219     80 
- 
- 
MIRb 
MIRb 
- 
- 
5’ 
5’ 
- 
- 
PCDH12 NM_016580 197  421 234     14  MIR 5’ 
PCDH21 NM_033100 
3404 3657 
3867 3955 
2  258   
154     66   
MIRb 
MIR3 
3’ 
3’ 
PCDHB12 NM_018932 2994 3188  206      4 MIRb 3’ 
PCDHB7  NM_018940 2949 3150 216      1  MIR  3’ 
PCGF3 
NM_006315 
BX640894 
- 
646  866  
889 1042 
- 
254      7  
21  177 
- 
MIRb 
MIR 
- 
5’ 
5’ 
PCTK3 
NM_212503  
NM_212502  
NM_002596  
BC040529 
- 
- 
- 
1046 1252   
- 
- 
- 
31  258 
- 
- 
- 
MIR 
- 
- 
- 
TAG 
PDCD2 
NM_002598   
NM_144781  
- 
1204 1367  
- 
261     72 
- 
MIR 
- 
3’ 
PDE11A NM_016953 4250 4374 25  158 MIRb  3’ 
PDE2A NM_002599 
3071 3201 
3601 3802 
51  204  
3  208    
MIRb 
MIR3 
3’ 
3’ 
PDE4A 
NM_006202 
U18088 
- 
50  251 
- 
7  262 
- 
MIR3 
- 
5’ 
PDE4C 
NM_000923 
U66347 
- 
1091 1216  
- 
182     41  
- 
MIR 
- 
5’ 
PDGFRB 
NM_002609 
 
3955 4120  
4657 4792  
30  189 
57  194 
MIR3 
MIR3 
3’ 
3’ 
PDLIM2 
NM_176871  
 
NM_021630  
NM_198042  
3234 3327 
3329 3533 
- 
- 
187     73 
261     43  
- 
- 
MIR3 
MIR 
- 
- 
3’ 
3’ 
- 
- 
PDSS2 NM_020381 3400 3476  80  159  MIRm 3’ 
PELI3 
NM_145065 
AF487456 
270  335  
168  233 
141     77  
141     77 
MIRb   
MIRb 
CDS 
CDS 
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PGGT1B 
NM_005023 
L25441 
 
- 
145  207 
211  328 
- 
195  261 
57  171  
- 
MIR  
MIR3 
- 
5’ 
ATG 
PHF12 
NM_001033561   
NM_020889   
- 
2728 2928  
- 
211      3  
- 
MIR3 
- 
3’ 
PHF19 
NM_015651  
NM_001009936  
BC022374 
- 
825  922    
685  782  
- 
34  154 
34  154 
- 
MIRb   
MIRb 
- 
TAG 
TAG 
PHLDB3 NM_198850 1304 1512 262     59  MIR 3’ 
PIGL NM_004278 979 1074   151  233  THER1_MD 3’ 
PIGS NM_033198 2277 2499  25  260  MIRb 3’ 
PIGZ NM_025163 2339 2562  5  230 MIR3 3’ 
PIK3AP1 NM_152309 3065 3205 183     31 MIR3  3’ 
PIK3IP1 NM_052880 1986  2100  132      7 MIR 3’ 
PIP5KL1 NM_173492 84  167 100     17  MIRb 3’ 
PKD1L1 NM_138295 8524 8760 261     11   MIRb   3’ 
PLA2G3 
NM_015715 
 
2240 2404  
2421 2571   
51  231  
62  209  
MIR 
MIR 
3’ 
3’ 
PLA2G4B 
NM_005090 
BC025290 
- 
1203 1374  
- 
77  260    
- 
MIRb   
- 
3’ 
PLAGL1 
NM_002656 
NM_006718 
BX537397 
- 
- 
1228 1410  
- 
- 
186      2  
- 
- 
MIRb   
- 
- 
5’ 
PLAUR 
NM_002659  
NM_001005376  
NM_001005377  
1295 1417 
- 
1160 1282  
61  203  
- 
61  203  
MIRb   
- 
MIRb   
3’ 
- 
3’ 
PLCB2 NM_004573 3984 4105 15  168 MIR3 3’ 
PLCB4 
NM_000933   
NM_182797   
5404 5459  
- 
111  167  
- 
MIR3 
- 
3’ 
- 
PLD1 NM_002662 5088 5204  171     56 MIR3 3’ 
PLEK NM_002664 1338 1442 75  183  MIR3 3’ 
PLSCR1 
NM_021105 
BC017901 
- 
670  823 
- 
259     93    
- 
MIR 
- 
3’ 
PLXNA2 
NM_025179 
AY358496 
- 
361  465  
- 
13  118  
- 
MIR3 
- 
5’ 
Plxnb2 (mouse) XM_484491 125  228 161     59 MIR  
PML 
NM_033238  
 
NM_033240  
NM_033242  
NM_033244  
NM_002675  
NM_033246  
NM_033247  
NM_033239  
NM_033249  
NM_033250 
NM_033245 
3800 3945  
5318 5542 
- 
- 
- 
- 
- 
1729 1775 
- 
- 
- 
- 
58  205 
33  261 
- 
- 
- 
- 
- 
221  268 
- 
- 
- 
- 
MIR3 
MIR_Mars 
- 
- 
- 
- 
- 
MIRm 
- 
- 
- 
- 
3’ 
3’ 
- 
- 
- 
- 
- 
3’ 
- 
- 
- 
- 
PNKD 
NM_015488 
NM_022572 
BC036457 
- 
- 
2947 2993 
- 
- 
20 253 
- 
- 
MIR 
- 
- 
3’ 
PNMA2 NM_007257 
3206  3440 
4162  4332  
261      3  
85    262  
MIRb 
MIRb 
3’ 
3’ 
PNPLA1 
NM_173676 
NM_001039725 
1578 1810  
- 
5  255   
- 
MIRb 
- 
3’ 
- 
PODXL 
NM_001018111 
 
2187 2354  
5212 5372  
177     15   
195     38   
MIR3 
MIR3 
3’ 
3’ 
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NM_005397 
 
2091 2258 
5116 5276  
177     15   
195     38   
MIR3 
MIR3 
3’ 
3’ 
POFUT1 
NM_015352   
 
NM_172236   
3124 3260 
3323 3535  
1321 1465 
86  233  
232     27  
209     67 
MIR_Mars 
MIRb 
MIRb 
3’ 
3’ 
3’ 
POLG NM_002693 133  299  172      1  MIR3 5’ 
POLH NM_006502 2617 2796  2  210  MIRb  3’ 
POLQ 
NM_199420 
AF090919 
- 
1961 2125  
- 
5  174   
- 
MIR 
- 
3’ 
POLR3D NM_001722 1682 1910 13  254  MIRb 3’ 
POPDC2 NM_022135 1459 1634  70  253  MIRb 3’ 
PPA2 
NM_176869  
NM_006903  
NM_176866 
NM_176867 
NM_001034191  
NM_001034192  
NM_001034193  
BC008246 
- 
- 
- 
- 
- 
- 
- 
993 1172  
- 
- 
- 
- 
- 
- 
- 
28  236   
- 
- 
- 
- 
- 
- 
- 
MIRb 
- 
- 
- 
- 
- 
- 
- 
3’ 
PPBPL2 XM_926381 823  942 246    126    MIRb   TAG 
PPP1R12B 
NM_002481  
NM_032105  
NM_032103  
NM_032104  
7940 8086  
8121 8267 
- 
- 
33  207    
33  207    
- 
- 
MIR3 
MIR3 
- 
- 
3’ 
3’ 
- 
- 
PPP1R3E 
AK024489 
 
BX248758 
 
1908  2082 
3579  3746 
432   556 
1385  1559  
184      3  
197     30 
70    198 
184      3 
MIR 
MIR3 
MIR3 
MIR 
3’ 
3’ 
5’ 
3’ 
PRCD 
- 
AK054729 
AK125617 
 
- 
560   638  
1078  1314  
2261  2477 
- 
20     96  
6    256 
266     31  
- 
MIR      MIR 
MIRb 
- 
U 
U 
U 
PRELID2 
NM_182960 
 
NM_138492 
 
NM_205846 
 
 
1309  1437 
1441  1679  
1508  1636 
1640  1878 
1273  1401 
1405  1643 
72    201 
30    267 
72    201 
30    267 
72    201 
30    267 
MIRb 
MIRb 
MIRb 
MIRb 
MIRb 
MIRb 
 
3’ 
3’ 
3’ 
3’ 
3’ 
3’ 
PRELP 
NM_002725  
 
NM_201348  
 
2656 2701  
3005 3039 
2646 2691  
2995 3029 
120  161  
162  192  
120  161  
162  192  
MIR3 
MIR3 
MIR3 
MIR3 
3’ 
3’ 
3’ 
3’ 
PRKACB 
NM_182948  
 
NM_002731  
 
NM_207578  
3846 3930  
4266 4319  
3876 3960   
4296 4349  
- 
113  197  
179  231  
113  197  
179  231  
- 
MIR3 
MIR_Mars 
MIR3 
MIR_Mars 
- 
3’ 
3’ 
3’ 
3’ 
- 
PRRX1 
NM_006902  
NM_022716   
2391 2503  
2319 2431  
66  182  
66  182  
MIR 
MIR 
3’ 
3’ 
PRX 
NM_020956  
NM_181882  
42  167  
- 
37  153 
 - 
MIR       
- 
3’ 
- 
PSD4 NM_012455 
1267 1374  
4781 4841  
7  124  
202  260  
MIRm   
MIRm 
CDS 
3’ 
PSEN2 
NM_000447  
NM_012486  
55  165  
- 
189     78 
- 
MIR3 
- 
5’ 
- 
PSMD12 
NM_002816  
NM_174871  
- 
- 
- 
- 
- 
- 
- 
- 
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BC065826 143  292 207     47 MIR       5’ 
PSMD6 
NM_014814 
AY359879 
- 
8  126 
- 
50  169 
- 
MIR       
- 
5’ 
PSMF1 
NM_006814  
NM_178578  
NM_178579  
1717 1831 
1680 1794 
1634 1748 
6  127 
6  127 
6  127 
MIR    
MIR    
MIR    
3’ 
3’ 
3’ 
PSTPIP2 NM_024430 1432 1566  182     46  MIR3 3’ 
PTCD2 NM_024754 
1719 1788  
1844 1985  
80      2 
88  252 
MIRm 
MIRb 
3’ 
3’ 
PTGIS NM_000961 
3168 3341  
5362 5454  
264     71  
184     93  
MIRb 
MIRm 
3’ 
3’ 
PTHLH 
NM_198965  
NM_002820  
NM_198964  
NM_198966  
- 
1659 1867 
1640 1848   
- 
- 
35  259 
35  259 
- 
- 
MIRb 
MIRb 
- 
- 
3’ 
3’ 
- 
PTHR1 NM_000316 94  156 138     78  MIR 5’ 
PTK7 
NM_002821  
NM_152880 
NM_152881 
NM_152882 
NM_152883 
BC046109 
- 
- 
- 
- 
- 
1623 1813  
- 
- 
- 
- 
- 
15  210  
- 
- 
- 
- 
- 
MIRb 
- 
- 
- 
- 
- 
3’ 
PTPN3 
NM_002829 
BC063287 
- 
2433 2634  
- 
37  258 
- 
MIR_Mars 
- 
3’ 
PTPRT 
NM_133170 
 
 
NM_007050   
 
 
5811 5964 
7701 7791 
8241 8445 
5868 6021  
7758 7848 
8298 8502  
256    115  
150     61 
229     21  
256    115 
150     61 
229     21 
MIR 
MIRm 
MIRb 
MIR 
MIRm 
MIRb 
3’ 
3’ 
3’ 
3’ 
3’ 
3’ 
PTPRU 
NM_133178   
NM_133177   
NM_005704   
5440 5586   
5451 5597  
5470 5616  
100  249 
100  249 
100  249 
MIR_Mars 
MIR_Mars 
MIR_Mars 
3’ 
3’ 
3’ 
PUS7L NM_031292 
2233 2401 
2832 2916 
3563 3806 
254     25  
32  122  
7  251  
MIRb  
MIRb 
MIR 
3’ 
3’ 
3’ 
PVRL1 
NM_002855   
NM_203285   
NM_203286  
- 
- 
1311 1394  
- 
- 
137  223 
- 
- 
MIRb 
- 
- 
3’ 
PVT1 XM_928984 716  850 155     21 MIRb 3’ 
PXMP4 
NM_007238   
NM_183397   
928 1006 
729  807  
42  124 
42  124 
MIR  
MIR 
3’ 
3’ 
PXN 
NM_002859 
BC052611 
- 
1166 1411  
- 
13  268 
- 
MIRb 
- 
3’ 
QPRT NM_014298 1053 1222 13  192  MIR 3’ 
RAB39B NM_171998 1812 1946  231     93  MIRb  3’ 
RAB4B  NM_016154 
161  375  
778  835 
10  226 
221  273 
MIR 
THER1_MD 
5’ 
5’ 
RAB7B NM_177403 1462 1620  24  192  MIRb 3’ 
RAE1 
NM_003610  
NM_001015885   
- 
10   90  
- 
188    109 
- 
MIR3 
- 
5’ 
RAG1 NM_000448 4389 4598 262     17 MIRb 3’ 
RALGPS1 
NM_014636 
BC032372 
- 
1616 1662  
- 
120  169  
- 
MIRb 
- 
3’ 
RANBP10 NM_020850 
2751 2799 
3969 4111 
126     72 
202     57   
MIRm 
MIR3 
3’ 
3’ 
RAP1GAP NM_002885 202     57   19  200 MIR3 3’ 
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RAPGEF3 
NM_006105 
U78169 
- 
3955 4092  
- 
24  166 
- 
MIR 
- 
3’ 
RASD2 NM_014310 
1953 2099  
2084 2140   
2426 2542  
154      8  
272    220  
194     67   
MIR3 
MIRm 
MIRb 
3’ 
3’ 
3’ 
RASGRF1  
NM_002891   
NM_153815   
- 
676  821  
- 
68  195  
- 
MIRb 
- 
5’ 
RASL10B NM_033315 2563 2679 3  128 MIRm 5’ 
RASL12 NM_016563 2333 2460  162     20  MIR 3’ 
RBBP9 NM_006606   905  943  68     30  MIR 3’ 
RBM19 NM_016196 
3343 3523  
3933 4124   
37  231  
21  216  
MIRb 
MIR 
3’ 
3’ 
RBM43 NM_198557 1250 1458  251     37 MIRb 3’ 
RCHY1 
NM_015436  
NM_001008925   
NM_001009922   
2863 3042  
2861 3040 
2836 3015  
223     21 
223     21 
223     21 
MIRb 
MIRb 
MIRb 
3’ 
3’ 
3’ 
RD3 NM_183059 2241 2336 204    109 MIR3 3’ 
RECQL5 
NM_004259  
NM_001003715   
NM_001003716   
- 
- 
2053 2144 
- 
- 
139     32   
- 
- 
MIR 
- 
- 
3’ 
RELB  NM_006509 2033 2080 145     97 MIR 3’ 
REXO1L1 NM_172239 
2003 2143  
5984 6137  
4  149  
40  208 
MIRb 
MIRb 
3’ 
3’ 
REXO1L6P XM_376784 
2447 2587  
6431 6584 
 4  149  
40  208 
MIRb 
MIR 
3’ 
3’ 
RFESD NM_173362 
453  631 
919 1006 
243     36 
144  236  
MIR 
MIR 
5’ 
5’ 
RFX3 
NM_002919   
NM_134428   
2724 2970   
- 
261     12 
- 
MIR 
- 
3’ 
- 
RGPD4 BX537861 1877 1958 187  274    THER1_MD    3’ 
RGS6 NM_004296 2849 2927  193  267  MIRb 3’ 
RGS9BP NM_207391 163  304  27  175    MIR3 5’ 
RHBDD2 
NM_001040456 
NM_001040457 
1244  1386 
1366  1508 
262    124 
262    124 
MIRb 
MIRb 
TAG 
TAG 
RHBDD3 NM_012265 181  232 137     84    MIRm 5’ 
RHO NM_000539 
1469 1529 
1601 1797 
216  276 
79  260 
MIRm 
MIRb 
3’ 
3’ 
RIC3 
NM_024557 
AF040723 
- 
2572 2753 
- 
207      2 
- 
MIRb 
- 
3’ 
RIG 
XM_932493 
U32331 
- 
1804 1949   
- 
111  268  
- 
MIRb 
- 
3’ 
RILP NM_031430 1677 1774  115  215 MIRb 3’ 
RIMS1 
NM_014989 
AB045726 
 
- 
5520 5691  
6009 6158  
- 
245     45  
179     23  
- 
MIRb 
MIRb 
- 
3’ 
3’ 
RIMS3 NM_014747 
2524 2620  
6170 6352 
28  128 
8  206    
MIRb 
MIR3 
3’ 
3’ 
RIMS4 NM_182970 
3499 3620  
3766 3862 
4243 4490  
190     69 
145     43   
258     15 
MIR3 
MIR 
MIR_Mars  
3’ 
3’ 
3’ 
RMND5B 
NM_022762 
AY359092 
- 
1006 1159 
- 
148      6 
- 
MIRb 
- 
3’ 
RNASE4 
NM_194430   
NM_002937   
NM_194431   
1485 1592 
- 
- 
122 9 
- 
- 
MIR3 
- 
- 
3’ 
- 
- 
RNASE7 NM_032572 1186 1341  167      8 MIRb 3’ 
RNASEL NM_021133 2683 2814 209     75 MIRb 3’ 
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3634 3867  263     22  MIRb 3’ 
RNF213 NM_020914 10721 10818 91  199   MIR3 3’ 
RNF7 
NM_014245  
NM_183237  
AF312226 
- 
175   289 
- 
- 
140     13 
- 
- 
MIR  
- 
- 
CDS 
- 
RNF8 
NM_003958   
NM_183078  
4015 4122  
3810 3917  
37  138  
37  138  
MIR 
MIR 
3’ 
3’ 
RNMT NM_003799 5208 5360   260     96 MIRb 3’ 
RNPS1 
NM_006711   
NM_080594   
L37368 
- 
- 
2298 2400   
- 
- 
172     72 
- 
- 
MIR 
- 
- 
3’ 
RP1-21O18.1 
NM_001017999 
NM_001018000 
NM_001018001 
NM_015209 
NM_201628 
30   235 
- 
- 
- 
3674  3824  
246   17   
- 
- 
- 
63  231 
MIR 
- 
- 
- 
MIRc 
5’ 
- 
- 
- 
3’ 
RPE 
NM_199229   
 
NM_006916  
 
1397 1587   
1694 1748 
1400 1590  
1697 1751  
49  246   
168    114   
49  246   
168    114   
MIR 
MIRb 
MIR 
MIRb 
3’ 
3’ 
3’ 
3’ 
RPGR 
NM_001034853 
NM_000328 
4351  4435 
- 
110   193  
-  
MIR3 
- 
3’ 
- 
RPL28 NM_000991 
3337 3561  
3699 3824  
12  249   
63  190 
MIR 
MIR 
3’ 
3’ 
RPL32P3 XM_379215 278  375   182     90 MIRc  5’ 
RPL7AL2 XM_066102  104  168  165    100 MIR CDS 
RPRD1B NM_021215 3918 4158 266     11 MIR_Mars 3’ 
RPUSD3 NM_173659 1075 1201   19  166  MIRb  3’ 
RRAS NM_006270 762  809 78  136 MIRb 3’ 
RRM2B NM_015713   
1516 1710 
3005 3178 
11  209  
260     74  
MIR 
MIRb 
3’ 
3’ 
RTP2 NM_001004312 1127 1269 20  163  MIR3 3’ 
RUFY4 NM_198483 
200  282  
1232 1399 
3209 3344  
187    102 
205     31 
57  199 
MIR3 
MIR3 
MIR3 
5’ 
5’ 
3’ 
RUNX1 
NM_001754   
NM_001001890 
D43967 
D10570 
- 
- 
2471 2603 
1661 1793 
- 
- 
105  241 
105  241 
- 
- 
MIR 
MIR 
- 
- 
3’ 
3’ 
SAG 
NM_000541 
BX647827 
- 
5307  5419 
- 
133   244    
- 
MIRb 
- 
3’ 
SAP18 NM_005870 1449 1530   163  259  MIR 3’ 
SAPS3 NM_018312 95  151 142     86 MIR 5’ 
SARM1 NM_015077 
3237 3399 
4669 4709  
6603 6801   
218     41  
102     62  
37  266    
MIRb  
MIR  
MIRb 
3’ 
3’ 
3’ 
SART3 
NM_014706  
BC041638 
704  903 
1026 1179  
248     26 
20  184   
MIRb  
MIRb  
3’ 
3’ 
SCAND2 
NM_022050  
NM_033633  
NM_033634   
NM_033635  
NM_033636  
NM_033640   
- 
- 
- 
2821 2976 
2863 3018   
- 
- 
- 
- 
67  230  
67  230  
- 
- 
- 
- 
MIR_Mars   
MIR_Mars   
- 
- 
- 
- 
3’ 
3’ 
- 
SCARB2 NM_005506 429 2 4357  163     96  MIRb 3’ 
SCD NM_005063 4937 5093 65  229  MIR 3’ 
SCD5 NM_001037582  - - - - 
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NM_024906 1231 1323  110  206  MIR 3’ 
SCEL 
NM_003843 
NM_144777 
BC047536 
- 
- 
2756 2860 
- 
- 
98  202 
- 
- 
MIR3 
- 
- 
3’ 
SCMH1 
NM_001031694 
NM_012236  
- 
56  184 
- 
142      6 
- 
MIRm 
- 
5’ 
SCML4 NM_198081 1822 2038  5  251    MIR 3’ 
SCN1B 
NM_001037  
NM_199037  
- 
860  936 
- 
50  126  
- 
MIRm 
- 
TAG 
SCN4B NM_174934 2928 3029  93  189  MIRb 3’ 
SCN8A 
NM_014191 
XM_001141985 
- 
10744 10948 
- 
2    216 
- 
MIRb 
- 
3’ 
SCNN1D NM_002978 8   89 99      7  MIRb 5’ 
SCNN1G   NM_001039 2748 2914 177     10  MIR 3’ 
SCYL1BP1 
NM_152281 
BC064945 
- 
792  892  
- 
249    137  
- 
MIR 
- 
3’ 
SEC23B 
NM_006363  
NM_032985  
NM_032986  
BC005404 
- 
- 
- 
152  243 
- 
- 
- 
153     42 
- 
- 
- 
MIR 
- 
- 
- 
5’ 
SEC61A1 NM_013336 3103 3232  136      4  MIR 3’ 
SEMA4F NM_004263 4095 4249  54  210 MIRb 3’ 
SEPN1 
NM_020451  
NM_206926  
3662 3820 
3560 3718  
209     33   
209     33   
MIRb   
MIRb   
3’ 
3’ 
SEPT6 
NM_145799  
NM_015129  
NM_145800  
NM_145802  
3857 3960  
2548 2651 
- 
- 
131     28 
131     28 
- 
- 
MIR 
MIR 
- 
- 
3’ 
3’ 
- 
- 
SERINC1 NM_020755 2553 2601   160    113  MIR3 3’ 
SERPINA13 NM_207378 23  161  237     95   MIRb 5’ 
SERPINA5 NM_000624 
1543 1688 
1798 1933  
168     26 
22  165   
MIR3 
MIR 
3’ 
3’ 
SERTAD3 
NM_013368  
 
NM_203344   
14  149 
219  281 
- 
136      3   
154     91  
- 
MIR3 
MIRb 
- 
5’ 
5’ 
- 
SFTPA2 NM_006926 
1095 1193 
1739 1827   
1883 2127 
184     82  
92  190  
255      4  
MIR3 
MIRb 
MIRb 
3’ 
3’ 
3’ 
SFXN5 NM_144579   2212 2332 59  182  MIR3 3’ 
SGCB NM_000232 1631 1904  268      2 MIRb 3’ 
SGCD 
NM_000337   
NM_172244  
7560 7785 
- 
262      5  
- 
MIR 
- 
3’ 
- 
SGIP1 
NM_032291 
BC040516 
- 
1465  1548 
- 
140     53 
- 
MIRb 
- 
CDS 
SH2B NM_015503 
683  853 
847 1098  
1571 1601 
2  188  
262      2  
113  143 
MIR 
MIRb 
MIRm 
5’ 
5’ 
5’ 
SH2D1B NM_053282 846  992  1  163 MIRb 3’ 
SH2D4B NM_207372 
2480 2580  
3380 3552 
1  100  
37  215  
MIRb 
MIRm 
3’ 
3’ 
SH3BP2 NM_003023 
2539 2635  
4489 4610  
4607 4680  
4918 4982  
106      2  
263    115   
44  121  
156     99 
MIR 
MIRb 
MIR 
MIRb 
3’ 
3’ 
3’ 
3’ 
SH3TC2 
NM_024577 
AF370410 
- 
2728 2862  
- 
180     38  
- 
MIR3 
- 
3’ 
SHC3 NM_016848 - - -  - 
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BX641139 2431 2469 
3140 3300 
9   48 
49  212 
MIR 
MIR 
5’ 
5’ 
SHC4 NM_203349 3465 3595   73  205  MIR3 3’ 
SHF NM_138356 1247 1402 84  268  MIRb 3’ 
SHOX2 
NM_006884  
NM_003030   
2383 2450  
2029 2096 
190  261  
190  261  
MIRb 
MIRb   
3’ 
3’ 
SHPRH NM_173082 6530 6748  252     20  MIRb   3’ 
SIAE 
NM_170601 
BC040966 
- 
617  710 
- 
249    147 
- 
MIR 
- 
TAG 
SIAH3 NM_198849 3422  3548  157     23  MIRc  3’ 
SIGLEC15 
NM_213602 
AK095432 
- 
1192  1404 
- 
16    237  
- 
MIRc 
- 
CDS 
SIGLEC5 NM_003830 1938 2113 20  210  MIRb   3’ 
SIL1 
NM_001037633   
NM_022464   
1838 1953   
1750 1865  
32  143   
32  143   
MIRb 
MIRb   
3’ 
3’ 
SIM1 NM_005068 3690 3816 11  145   MIRb 3’ 
SIM2 
NM_005069  
NM_009586  
-  
2113 2210  
- 
75  178   
- 
MIRm 
- 
3’ 
SIRPA 
NM_001040022  
NM_001040023  
NM_080792   
3088 3140  
2996 3048 
2755 2807 
123  174  
123  174  
123  174 
THER1_MD  
THER1_MD  
THER1_MD  
3’ 
3’ 
3’ 
SLAMF1 
NM_003037 
BC067847 
- 
1641 1814  
- 
24  202   
- 
MIRb 
- 
3’ 
SLC11A1 NM_000578 1903 2087  7  222  MIR 3’ 
SLC16A12 NM_213606 2499 2554 208    154  MIR3 3’ 
SLC16A14 NM_152527 1930 2009 153  233  MIRb 3’ 
SLC16A4 
NM_004696 
BC021664 
- 
1276 1637 
- 
131 193     
- 
MIR3 
- 
3’ 
SLC16A9 NM_194298 3177 3224   212    156  MIR   3’ 
SLC17A8 NM_139319 
2369 2525  
3621 3699 
228     57  
184  261  
THER1_MD  
MIR   
3’ 
3’ 
SLC18A1 
NM_003053 
BC006317 
- 
120  263 
- 
5  151   
- 
MIR3 
- 
5’ 
SLC1A2 NM_004171 
3330 3404 
6674 6845  
178  253   
2  185  
MIRb 
MIR3 
3’ 
3’ 
SLC1A3 NM_004172 2431 2552 82  205  MIR3 3’ 
SLC1A4 NM_003038 3037 3165  117  241   MIRb 3’ 
SLC1A7 NM_006671 
2082 2211 
2407 2491   
168     26 
189    102  
MIRb 
MIR3 
3’ 
3’ 
SLC22A16 
NM_033125 
AB055798 
- 
169  266  
- 
259    162  
- 
MIRb 
- 
5’ 
SLC22A7 
NM_153320 
NM_006672   
2004 2230  
1998 2224 
5  216 
5  216 
MIR  
MIR  
3’ 
3’ 
SLC23A1 
NM_005847   
NM_152685   
1883 2046  
1871 2034  
3  153  
3  153  
MIR  
MIR 
3’ 
3’ 
SLC25A29 
NM_152333   
 
NM_001039355   
1256 1430  
1888 1952 
1300 1426  
33  231  
94  162  
33  176   
MIRb 
MIRb 
MIRb 
3’ 
3’ 
3’ 
SLC25A34 NM_207348 1379 1578 235     26  MIRb  3’ 
SLC26A5 
NM_198999   
NM_206883   
NM_206884   
NM_206885   
- 
2313 2474 
1786 1947  
1243 1404  
- 
4  166   
4  166   
4  166   
- 
MIRb 
MIRb 
MIRb 
- 
3’ 
3’ 
3’ 
SLC29A2 NM_001532 2174 2412 260      2 MIR_Mars 3’ 
SLC2A10 
NM_030777 
 
2532 2676   
2706 2925 
41  202 
5  241  
MIR3 
MIRb 
3’ 
3’ 
SLC2A5 NM_003039 - - - - 
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BC035878 
 
968 1105 
1356 1572  
237    100  
245     13   
MIRb 
MIR 
3’ 
3’ 
SLC30A6 
NM_017964 
BC032525 
- 
3421 3591 
- 
5  172  
- 
MIR3 
- 
3’ 
SLC30A7 NM_133496 4859 5052  196      3  MIR3 3’ 
SLC35A5 NM_017945 2644 2750 143     37  THER1_MD 3’ 
SLC35C2 
NM_173179   
NM_015945   
NM_173073   
2294 2427  
- 
2036 2169  
43  189  
- 
43  189  
MIR  
- 
MIR 
3’ 
- 
3’ 
SLC36A3 NM_181774 2259 2418    19  193 MIR3 3’ 
SLC36A4 NM_152313 2272 2432 177     12  MIR3 3’ 
SLC43A3 
NM_014096 
NM_199329 
NM_017611 
2369 2484  
2264 2379  
2242 2357 
41  157  
41  157  
41  157  
MIRm  
MIRm  
MIRm  
3’ 
3’ 
3’ 
SLC45A2 
NM_016180   
NM_001012509  
 
- 
1689 1797  
2461 2578 
- 
173     51 
12  132  
- 
MIRb 
MIRb 
- 
3’ 
3’ 
SLC4A1 NM_000342 
3206 3383  
3393 3488  
82  258   
107     19    
MIRb   
MIRb   
3’ 
3’ 
SLC6A12 NM_003044 
72  189 
390  535 
3221 3382  
144     20  
12  164  
159      3  
MIR 
MIRm 
MIR3 
5’ 
3’ 
3’ 
SLC6A13 
NM_016615 
BC020867 
 
- 
343  443 
457  665  
- 
204     90 
10  220  
- 
MIR3 
MIRb 
- 
TAG 
3’ 
SLC6A15 
NM_182767  
NM_018057   
 
- 
2217 2464  
3994 4153  
- 
256     13 
224     59   
- 
MIRb 
MIRb 
- 
3’ 
3’ 
SLC6A6 
NM_003043 
BC006252 
- 
999 1128  
- 
37  163  
- 
MIRb 
- 
3’ 
SLC6A7 NM_014228 2513 2649  157      8  MIR3 3’ 
SLC9A1 
NM_003047 
BC012121 
- 
1840 1988  
- 
52  203  
- 
MIR 
- 
TAG 
SLCO2B1 NM_007256 2464 2581 31  152 MIR 3’ 
SLIC1 
NM_182854 
BC027944 
- 
404  510 
- 
140     27 
- 
MIR 
- 
TAG 
SMAD6 
NM_005585 
BC052569 
 
 
- 
2675 2721 
3085 3152 
3813 3927  
- 
273    108 
46  114  
33  154  
- 
MIRm  
MIR 
MIR3 
- 
3’ 
3’ 
3’ 
SMC1A NM_006306 
4571 4723 
5971 6160  
6154 6248  
6221 6283 
6525 6599 
6636 6739 
8429 8550  
22  173  
14  237  
197     97  
76     16 
152  240   
124     20  
193     42 
MIR  
MIRb  
MIR3  
MIR_Mars 
MIRb  
MIR  
MIR3 
3’ 
3’ 
3’ 
3’ 
3’ 
3’ 
3’ 
SMCR5 
NM_144774 
AF467442   
 
948 1168 
1727 1817 
1966 2172  
22  259    
81  166  
270     31    
MIRb  
MIR3  
MIR 
3’ 
3’ 
3’ 
SNHG3 
AJ006834 
AJ006835 
- 
1878 1907  
1934 1999 
- 
240    210 
142     68   
- 
MIR 
MIR 
- 
ncRNA 
ncRNA 
SNPH 
NM_014723 
AF187733 
- 
333  528  
- 
4  202    
- 
MIR3 
- 
5’ 
SNX21 
NM_033421 
 
2535 2688 
3086 3164 
211     37 
157     77 
MIR   
MIRm 
3’ 
3’ 
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NM_152897 
 
1298 1436 
1834 1906 
196     37 
157     83 
MIR   
MIR3  
3’ 
3’ 
SNX27 NM_030918 2050 2232 16  202  MIR3 3’ 
SNX6 
NM_021249 
NM_152233   
2898 3057  
2793 2952  
19  194 
19  194 
MIRb 
MIRb 
3’ 
3’ 
SORBS2 
NM_003603  
NM_021069   
AF090937 
- 
- 
866  929  
- 
- 
178    118  
- 
- 
MIR3 
- 
- 
3’ 
SORCS2 NM_020777 4356 4509 193     17    MIR3 3’ 
SOST NM_025237 1102 1273 5  170 MIR3 3’ 
SOX12 NM_006943 
3224 3271 
3594 3759 
3765 3869 
81  128   
11  230  
158     46 
MIR 
MIR 
MIR_Mars 
3’ 
3’ 
3’ 
SP2 
NM_003110 
BC005914 
- 
863 1009  
- 
174     24  
- 
MIRb 
- 
3’ 
SPAG8 
NM_001039592 
NM_172312 
- 
1865 1981 
- 
158     37  
- 
MIRb 
- 
3’ 
SPAR L10123   30  207 65  262   MIR 5’ 
SPATA12 NM_181727 
1029 1150 
1377 1481 
92  219 
193     89 
MIR 
MIRb 
CDS 
3’ 
SPEF2 
NM_024867 
NM_144722 
- 
2153  2291 
- 
37    169  
- 
MIRb 
- 
3’ 
SPRY3 NM_005840 
2449 2654  
4530 4761 
5305 5452 
8033 8180  
8196 8247  
204      5 
258     22  
177     33 
152      4  
115  165  
MIR3 
MIR 
MIR3 
MIRb 
MIRb 
3’ 
3’ 
3’ 
3’ 
3’ 
SPRY4 
NM_030964 
NM_001127496 
4372  4474  
4321  4423 
129     24 
129     24 
MIRc 
MIRc 
3’ 
3’ 
SPTBN4 
NM_020971  
NM_025213  
- 
2160 2229  
- 
272    195  
- 
MIR  
- 
TAG 
SRC 
NM_005417  
 
 
NM_198291  
 
 
187  279  
275  412 
2674 2828 
100  178 
174  311  
2573 2727 
156     53  
142      3 
187     37   
142     53  
142      3 
187     37 
MIRb 
MIR 
MIR3 
MIRb 
MIR 
MIR3 
5’ 
5’ 
3’ 
5’ 
5’ 
3’ 
SRGAP3 
NM_014850   
 
NM_001033117  
 
NM_001033116  
 
5608 5729 
6231 6324 
5536 5657 
6159 6252 
5505 5626 
6128 6221 
38  159  
155     66 
38  159  
155     66 
38  159  
155     66 
MIRb 
MIR 
MIRb 
MIR 
MIRb 
MIR 
3’ 
3’ 
3’ 
3’ 
3’ 
3’ 
SRI 
NM_003130   
NM_198901   
1650 1811 
1632 1793 
45  215  
45  215  
MIRb 
MIRb 
3’ 
3’ 
SS18L1  
NM_198935   
NM_015558   
3005 3126  
2193 2314 
216     94  
216     94  
MIR 
MIR 
3’ 
3’ 
SSPO 
NM_198455  
XM_376720 
- 
4470 4588 
- 
16  143  
- 
MIR 
- 
3’ 
ST3GAL1 
NM_003033   
NM_173344   
379  433 
379  433 
141     87  
141     87  
MIRb 
MIRb 
5’ 
5’ 
ST6GAL1 
NM_173216   
 
NM_003032   
 
NM_173217  
 
3173 3272 
3361 3571 
3051 3150 
3239 3449  
2516 2615 
2704 2914  
120     14  
34  260  
120     14  
34  260 
120     14  
34  260 
MIRb 
MIRb  
MIRb 
MIRb  
MIRb 
MIRb 
3’ 
3’ 
3’ 
3’ 
3’ 
3’ 
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ST6GALNAC6 NM_013443   89  147 141     83 MIRb ATG 
ST7L 
NM_017744  
NM_138727  
NM_138728  
NM_138729  
1982 2190  
1931 2139 
1889 2097  
- 
23  255   
23  255   
23  255   
- 
MIRb 
MIRb 
MIRb 
- 
TAG 
TAG 
TAG 
- 
STAB1 
NM_015136 
AB052957 
- 
2351 2443  
- 
70  167 
- 
MIR3 
- 
CDS 
STARD10 NM_006645 12  119  153     38 MIR 5’ 
STAT5A NM_003152 111  188  188    114 MIR3 5’ 
STEAP2 NM_152999 2765 3007  255      5 MIR 3’ 
STK32B 
NM_018401 
 
1415 1621 
2363 2568  
15  216   
1  209  
MIR3 
MIRb 
3’ 
3’ 
STK4 NM_006282 
2633 2793  
3345 3534 
5646 5823  
196     30  
268     63  
180      4  
MIR3 
MIRb 
MIRb 
3’ 
3’ 
3’ 
STK40 NM_032017 3099 3184  71  152  MIR 3’ 
STRA6 
NM_022369 
BC015881 
 
 
- 
599   687 
1468  1516 
1701  1870 
- 
141     49  
30     80 
96    252 
- 
MIRm 
MIRb 
MIRb 
- 
TAG 
3’ 
3’ 
STYK1 NM_018423 2621 2730 132  254   MIRb 3’ 
SUHW4 
NM_017661   
NM_001002843   
NM_001002844   
- 
- 
1072 1284  
- 
- 
260     48 
- 
- 
MIR 
- 
- 
3’ 
SUMF1 NM_182760 1402 1566  15  184    MIR3 3’ 
SUOX 
NM_000456   
NM_001032386   
NM_001032387   
138 271 
- 
- 
142 16 
- 
- 
MIR 
- 
- 
5’ 
- 
- 
SV2C 
NM_014979 
XM_043493 
- 
5375 5551 
- 
23  186 
- 
MIR3 
- 
3’ 
SYDE2 
NM_032184 
AL834286 
- 
2587  2697 
- 
32  141  
- 
MIR 
- 
3’ 
SYNGR1 
NM_004711 
 
 
NM_145731 
NM_145738 
1293 1442 
1807 1891 
2632 2706 
1116 1323  
- 
153      2  
121     33 
170    103  
35  268   
- 
MIRb 
MIR   
MIRb 
MIRb 
- 
3’ 
3’ 
3’ 
3’ 
- 
SYNPO NM_007286 3323 3488 7  164    MIR3 3’ 
SYT11 NM_152280 3192 3223 65     34  MIR 3’ 
SYT7 NM_004200 3699 3859 15  182 MIR 3’ 
TACR1 
NM_001058  
NM_015727  
1549 1726   
- 
2  186  
- 
MIRm 
- 
3’ 
- 
TADA3L 
NM_006354 
NM_133480 
NM_133481 
456  521  
456  521 
456  521  
234    167 
234    167 
234    167 
MIRb 
MIRb 
MIRb 
5’ 
5’ 
5’ 
TAF9B NM_015975 2451 2654 43  258  MIRb 3’ 
TAP2 
NM_000544 
NM_018833 
2822 3041 
5111 5316  
260     27  
254     41  
MIRb 
MIRb 
3’ 
3’ 
TAPBP 
NM_003190 
NM_172208 
NM_172209 
- 
2144 2256   
- 
- 
2  117  
- 
- 
MIRb 
- 
- 
3’ 
- 
TBC1D2 NM_018421 2898 3005  32  142 MIR 5’ 
TBC1D24 NM_020705 3431 3540 81  182 MIR  3’ 
TBC1D30 XM_037557 3830  3926  176     86  MIR 3’ 
TBC1D5 NM_014744 497  548 253    202   MIR 5’ 
TBN NM_138572 1681 1750  262    190  THER1_MD 3’ 
TBRG1 NM_032811 -  - - - 
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BC032312 
 
 
452  611 
638  767 
1136 1210  
68  262 
192     41 
271    196  
MIR 
MIRb   
MIRm  
TAG 
3’ 
3’ 
TCF2 
NM_000458 
NM_006481 
 
- 
2981 3108 
3632 3748 
- 
140      9  
91  211  
- 
MIR 
MIRb 
- 
3’ 
3’ 
TCL1B 
NM_199206 
NM_004918 
672  813  
- 
198     52  
- 
MIRb 
- 
3’ 
- 
TCL6 
NM_020553  
NM_020554  
NM_014418  
 
 
NM_020550  
 
 
NM_020552  
 
NM_012468  
 
 
2372 2484 
1393 1567  
113  287 
1723 1755 
2312 2431 
113  287 
1723 1755 
113  287 
1723 1755  
2728 2840  
113  287 
1723 1755 
2312 2431 
138     25   
197      2    
197      2  
69     38 
124      2 
197      2  
69     38 
197      2   
69     38   
138     25 
197      2  
69     38 
124      2 
MIRb 
MIR3 
MIR3 
MIRb 
MIRc 
MIR3 
MIRb 
MIR3   
MIRb   
MIRb   
MIR3 
MIRb 
MIRc 
3‘ 
ATG 
5’ 
ATG 
3’ 
5’ 
ATG 
3’ 
ATG 
3’ 
5’ 
ATG 
3’ 
TDP1 
NM_018319 
NM_001008744 
3224 3338  
3001 3115   
179     64  
179     64  
MIR3 
MIR3 
3’ 
3’ 
TFCP2L1 
NM_014553 
 
2826 2900  
4606 4791 
145     68  
183      1  
MIR 
MIR3 
3’ 
3’ 
TFEB NM_007162 196  273  126  206   MIR 5’ 
TFIP11 
NM_001008697 
NM_012143  
AF070662 
- 
- 
1  121  
- 
- 
229    108 
- 
- 
MIRb 
- 
- 
5’ 
TGFB1 
NM_000660 
X02812 
- 
2324 2462  
- 
249    103  
- 
MIR 
- 
3’ 
TGFBR2 
NM_001024847 
NM_003242 
474   519 
- 
136     91  
- 
MIR 
- 
CDS 
- 
TGM2 
NM_004613  
 
 
NM_198951  
CR604340 
AK126508 
 
 
 
 
2724  2859 
2835  2984 
3050  3222 
1812  1879 
1203  1333 
391   488 
614   832 
948  1087 
1099  1191 
2270  2405 
2381  2530 
2596  2768 
256  116 
137  6 
17  203 
251  184 
47    180 
137  40 
28  261 
142  1 
28  121 
256  116 
137  6 
17  203 
MIRb 
MIRc 
MIR3 
MIR 
MIR 
MIR 
MIR 
MIRb 
MIR 
MIRb 
MIRc 
MIR3 
3' 
3' 
3' 
3' 
3' 
5' 
ATG 
CDS 
CDS  
3' 
3' 
3' 
THAP5 NM_182529 
1743  1894 
2967  3126 
21    179   
91    262 
MIR3       
MIRb 
3’ 
3’ 
THRSP NM_003251 753  955  9  220 MIRb 3’ 
TICAM2 NM_021649 2643 2801   6  177  MIR3 3’ 
TK2 NM_004614 1445 1666  246      3  MIRb 3’ 
TLL1 NM_012464 5803 5989   222     21   MIRb 3’ 
TLOC1 NM_003262  23  148 26  143 MIR 5’ 
TMC1 NM_138691 262  337 11  108  MIRb 3’ 
TMEM10 
NM_033207   
NM_020847 
 
1407 1607  
3225 3378  
-  
18  256 
67  209  
-   
MIRb 
MIRb 
- 
3’ 
3’ 
- 
TMEM106B NM_018374 4043 4170  153     24 MIRm 3’ 
TMEM118 NM_032814 1517 1622   4  126   MIRb TAG 
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TMEM126B 
NM_018480 
BC017574 
 
- 
660  802 
831 1054 
- 
262    123 
22  249 
- 
MIR_Mars 
MIRb 
- 
3’ 
3’ 
TMEM132B 
NM_052907 
AB058689 
- 
5285  5377  
- 
65    160 
- 
MIRb 
- 
3’ 
TMEM139 NM_153345 1526 1641   141     22    MIRb 3’ 
TMEM144 NM_018342 2553 2783  30  262    MIR 3’ 
TMEM16C NM_031418 22  127 89  196  MIRb 5’ 
TMEM173 NM_198282 1547 1683  93  242 MIRc 3’ 
TMEM186 NM_015421 978 1139 2  191 MIRb 3’ 
TMEM215 NM_212558 2665  2791 83    204   MIR3 3’ 
TMEM29 NM_014138 6   96  74  167 MIRb 5’ 
TMEM50A NM_014313 1796 1911 196     76 MIR3 3’ 
TMEM68 NM_152417 1363 1419  73  129  MIRm 3’ 
TMEM72 
NM_001123376 
BX538120 
- 
1717 1941 
- 
248     13 
- 
MIRb 
- 
3’ 
TMPRSS11B NM_182502 2163 2284  205     86  MIR3 3’ 
TMUB2 
NM_024107 
NM_177441 
- 
259  482 
433  539 
- 
21  229 
268    166 
- 
MIR 
MIRb 
- 
5’ 
5’ 
TNFAIP8L3 NM_207381 1374 1421  160  207   MIRb 3’ 
TNFSF12 
BC071837 
NM_003809 
447  522 
- 
120  44 
- 
MIR 
- 
TAG 
- 
TNFSF4 NM_003326  
2362 2432 
2929 3086  
274    204 
2  165  
THER1_MD  
MIR3 
3’ 
3’ 
TNFSF8 NM_001244 1097 1193  1  100  MIRm 3’ 
TNNI1 NM_003281 
3320 3557 
3556 3758  
4679 4759  
262      7  
260     37  
121     29  
MIR 
MIRb 
MIR 
3’ 
3’ 
3’ 
TNRC6A 
NM_014494  
NM_020847  
80  190 
- 
116      3 
- 
MIRb 
- 
5’ 
- 
TOMM20 
NM_014765 
 
1936 2009  
2976 3035 
42  121   
200  256  
MIR 
MIR 
3’ 
3’ 
TOMM40 BC047528 2230 2313 180     85 MIR3 3’ 
TOR1A 
NM_000113 
BC014484   
- 
1468 1578 
- 
29  149 
- 
MIRb 
 
3’ 
TOR2A NM_130459 
875 1120  
1516 1592   
19  239  
52  129  
MIRm 
MIRb 
3’ 
3’ 
TP53 NM_000546 1801 1903   110  217 MIRb 3’ 
TP53I11 
NM_006034 
AK056379 
- 
164  263 
- 
170     61   
- 
MIRb 
- 
5’ 
TP53INP1 NM_033285 2200 2296 86  185 MIR 3’ 
TP53RK NM_033550 2639 2828 249     19 MIRb 3’ 
TP73L 
NM_003722 
AF061512 
- 
264  331 
- 
238    160 
- 
MIR 
- 
5’ 
TPK1 NM_022445 1751 1842 105  194  MIR3 3’ 
TPP1 NM_000391 3067 3288  14  252 MIRb 3’ 
TRAF1 NM_005658 151  343 203     17  MIR3 3’ 
TRAF3 
NM_145725  
NM_145726  
NM_003300  
196  308 
196  308 
- 
135     23  
135     23  
- 
MIR 
MIR 
- 
5’ 
5’ 
- 
TREML1 
NM_178174 
AY358357 
- 
1007 1108 
- 
202 97           
- 
MIR3 
- 
3’ 
TREML2 NM_024807 2881 3071  7  216    THER1_MD 3’ 
TRIAD3 
NM_207111  
NM_207116  
AY177398 
- 
- 
988 1049 
- 
- 
132  196 
- 
- 
MIR3 
- 
- 
5’ 
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TRIM10 
NM_006778  
NM_052828  
1779 1907  
1243 1372  
2  131 
2  131 
MIR3 
MIR3 
3’ 
TAG 
TRIM14 
NM_014788  
 
NM_033219  
NM_033220  
NM_033221  
 
3327 3545 
3813 3941  
- 
- 
2566 2784 
3052 3180 
241      2  
68  213 
- 
- 
241      2  
68  213 
MIR 
THER1_MD 
- 
- 
MIR 
THER1_MD 
3’ 
3’ 
- 
- 
3’ 
3’ 
TRIM16 
NM_006470 
AK056026 
 
AB209899 
- 
557   727  
763   872  
4628  4800 
- 
91    266  
130      4 
183      6  
- 
MIRb 
MIR3 
MIR 
- 
5’ 
5’ 
3’ 
TRIM22 NM_006074 2498 2667 40  212   MIR 3’ 
TRIM35 
NM_171982 
BC018337 
- 
512  619  
- 
139     30 
- 
MIR 
- 
CDS 
TRIM38 
NM_006355 
BX640949 
- 
1585 1743 
- 
53  231   
- 
MIR 
- 
3’ 
TRIM4 
NM_033017 
NM_033091  
2394 2580  
2316 2513  
250     51  
250     40  
MIRb 
MIRb 
3’ 
3’ 
TRIM5 
NM_033034  
NM_033092  
NM_033093  
2208 2315  
- 
- 
18  129  
- 
- 
MIR 
- 
- 
3’ 
TRIM62 NM_018207 1710 1866 23  201 MIR3 3’ 
TRIOBP NM_138632 1202 1330 160     31 MIRb   TAG 
TRPS1 NM_014112 9232 9407  91  260   MIR_Mars 3’ 
TRPV3 
NM_145068 
AF514998   
- 
2455 2570   
- 
82  202  
- 
MIR3 
- 
3’ 
TRSPAP1 
NM_017846 
BC039879 
- 
277  386 
- 
197     90  
- 
MIR3 
- 
5’ 
TSGA14 
NM_018718 
AY186739 
- 
2   99 
- 
124  226  
- 
MIRb 
- 
5’ 
TSKU NM_015516 
1727 1906 
2010 2070   
194      2 
70  128 
MIR3 
MIRb 
3’ 
3’ 
TSPAN2 NM_005725 2497 2625 85  202     MIR3 3’ 
TTC12 
NM_017868  
BC032355 
- 
2341  2392 
- 
138     87  
- 
MIR  
- 
3’ 
TTC21A 
NM_145755 
BC062621 
 
- 
1107 1318 
2055 2142 
- 
36  260     
33  119 
- 
MIRb 
THER1_MD 
- 
3’ 
3’ 
TTC3 
NM_003316  
NM_001001894  
98  296 
- 
27  239 
- 
MIRb 
- 
5’ 
- 
TTC31 NM_022492 2718 2891  73  252 MIRb 3’ 
TTC39A 
NM_001080494 
AB007921 
 
 
 
- 
94   241 
1491 1612 
3199 3410 
3795 3962 
- 
5  140 
154     33 
229     15 
36  192 
- 
MIRb 
MIR3 
MIRb 
MIR3 
- 
ATG 
3’ 
3’ 
3’ 
TTC9 
XM_027236 
XM_938197 
2816 3059  
2816 3059  
261      1 
261      1 
MIRb 
MIRb 
3’ 
3’ 
TTL NM_153712 3356 3496 57  191  MIRm 3’ 
TTN 
NM_003319  
NM_133378  
NM_133379  
NM_133432  
NM_133437 
BC013396 
 
- 
- 
- 
- 
- 
1790 1953 
1948 2079  
- 
- 
- 
- 
- 
268     91   
124  260  
- 
- 
- 
- 
- 
MIRb 
MIR_Mars 
- 
- 
- 
- 
- 
3’ 
3’ 
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TTPAL NM_024331 1982 2063 115  199 MIR3 3’ 
TUB 
NM_003320   
 
NM_177972  
 
3028 3177 
5861 5935 
2771 2920 
5604 5678  
202     36  
78  154  
202     36  
78  154  
MIR3 
MIRb 
MIR3 
MIRb 
3’ 
3’ 
3’ 
3’ 
TUBGCP3 
NM_006322 
BC007763 
- 
1854 1976  
- 
66  201  
- 
THER1_MD  
- 
3’ 
TUFT1 NM_020127 2980 3047  123  191  MIR3 3’ 
TULP4 
NM_020245   
NM_001007466   
- 
7122 7269 
- 
38  185 
- 
MIR3 
- 
3’ 
TXNDC2 NM_032243 18  107 23  117  MIR 5’ 
TYK2 NM_003331 151  298 228     81  MIR 5’ 
U2AF1 
NM_006758   
NM_001025203   
NM_001025204  
AF370386 
- 
- 
- 
306  450 
- 
- 
- 
226     57 
- 
- 
- 
MIRb 
- 
- 
- 
5’ 
UBE1L2 
NM_018227 
BC031637 
- 
1218 1423 
- 
60  274   
- 
MIR 
- 
3’ 
UBE2V1 
U39360 
NM_021988  
 
NM_199144  
 
NM_022442  
8  160 
165  260  
321  473  
165  258  
260  396 
124  262 
194     31  
111  214  
194     31  
111  212  
178     31 
180     31  
MIRb   
MIR   
MIRb   
MIR   
MIRb   
MIRb   
ATG 
5’ 
ATG 
5’ 
ATG 
ATG 
UBE3B 
NM_130466  
NM_183415  
397  498 
- 
14  123 
- 
MIRb 
- 
5’ 
- 
UBL7 
NM_032907   
NM_201265  
BC007913 
- 
- 
92  226 
- 
- 
74  213  
- 
- 
MIRb 
- 
- 
5’ 
UBXD5 
NM_145345   
NM_183008   
NM_145346  
BC038106 
- 
- 
- 
1768 1861 
- 
- 
- 
110  207   
- 
- 
- 
MIR3 
- 
- 
- 
3’ 
UCN2 NM_033199 1276 1376 40  139 MIR 3’ 
ULK2 NM_014683 5511 5602 154     62   MIRb 3’ 
ULK3 NM_001099436 2265 2500 10   229 MIR 3’ 
UNC13A 
XM_038604 
XM_937931 
5820 5916 
- 
187     85 
- 
MIR3 
- 
3’ 
- 
UNC50 NM_014044 815  907 8  119 MIR 5’ 
UNQ9370 NM_207447 1215 1417 1  205 MIRb 3’ 
USH2A 
NM_007123  
NM_206933  
- 
13178 13219 
- 
168  208 
- 
MIR3 
- 
CDS 
USP12 
NM_182488  
AF022789  
- 
4091 4330 
- 
25  262     
- 
MIRb 
- 
3’ 
USP45 XM_371838 366  517 8  170    MIR 3’ 
USP49 NM_018561 2572 2654 141  217 MIR 3’ 
VAPA 
NM_003574  
 
NM_194434  
 
3046 3206 
5963 6113   
2911 3071 
5828 5978 
179     21 
204     33 
179     21 
204     33 
MIR3 
MIRb 
MIR3 
MIRb 
3’ 
3’ 
3’ 
3’ 
VASH1 
NM_014909 
BC009031 
- 
1058 1129  
- 
109  180 
- 
MIR3 
- 
TAG 
VASN NM_138440 2295 2405 81  197    MIR3 3’ 
VDR 
NM_000376  
 
NM_001017535 
3337 3417 
4576 4643 
3459 3539 
4698 4765 
152     59 
273    210 
152     59 
273    210 
MIR 
THER1_MD 
MIR 
THER1_MD 
3’ 
3’ 
3’ 
3’ 
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VISA 
NM_020746 
 
2505 2684 
2745 2936 
45  247 
9  204   
MIRb 
MIR 
3’ 
3’ 
VPREB3 NM_013378 464  529 93  161 MIRb 3’ 
VPS24 
NM_016079  
NM_001005753 
1782 1843 
1721 1782 
75     15 
75     15 
MIR 
MIR 
3’ 
3’ 
VTA1 NM_016485 2760 2893 127  266     MIR 3’ 
VTN NM_000638 53  172 220     98  MIRb 5’ 
WARS2 
NM_015836  
NM_201263  
1790 1947  
1819 1976 
217     57 
217     57 
MIRb 
MIRb 
3’ 
3’ 
WASF2 NM_006990 2547 2696  186     21 MIR3 3’ 
WDR25 NM_024515 1832 1985  85  268  MIRb 3’ 
WDR31 
NM_001012361 
NM_001006615  
NM_145241  
BC012352 
- 
- 
- 
2586 2768 
- 
- 
- 
204     12 
- 
- 
- 
MIRb 
- 
- 
- 
3’ 
WDR73 NM_032856 1182 1360   7  206 MIRb 3’ 
WDR82 NM_025222 2168 2238  138     66 MIR 3’ 
WFDC1 NM_021197 941 1097   12  175  MIR3 3’ 
WISP1 
NM_003882  
NM_080838  
2494 2735 
- 
263     19 
- 
MIRb 
- 
3’ 
- 
WIT1  NM_015855 
340  387  
404  589 
643  708 
151    104 
8  192    
98     32    
MIR 
MIR 
MIR 
5’ 
5’ 
5’ 
WNT8A NM_058244  1211 1281 103     34    MIR       3’ 
XK NM_021083 4372 4522 109  263  MIR_Mars 3’ 
XKR5 NM_207411 2282 2388  58  174 MIR3  3’ 
XPNPEP2 NM_003399 2934 3139 250     65 MIR_Mars 3’ 
XTP3TPA NM_024096 980 1117  19  163  MIR 3’ 
YIPF1 NM_018982 67  183 134      2  MIR 5’ 
YWHAZ 
NM_003406  
NM_145690  
2750 2789  
2792 2831  
219  258   
219  258   
MIR 
MIR 
3’ 
3’ 
ZAK 
NM_016653 
NM_133646 
- 
3252 3489  
- 
7  261   
- 
MIR 
- 
3’ 
ZBTB44 NM_014155 1640 1721 23  109 MIR   TAG 
ZBTB7B NM_015872 3  137  107  257  MIR 5’ 
ZC3H12C 
XM_370654 
XM_931631 
496  678  
- 
3  186   
- 
MIRb 
- 
5’ 
- 
ZC3H13 NM_015070 
5333 5561 
6056 6181 
7  262 
73  205 
MIR 
MIRm 
3’ 
3’ 
ZC3H7B 
NM_017590 
 
3660 3763  
3799 3937  
100  202  
195     45 
MIR3 
MIR3 
3’ 
3’ 
ZCCHC24 NM_153367 
1736 1933 
2207 2260 
5  200 
123  189 
MIR3 
THER1_MD 
3’ 
3’ 
ZCCHC3 NM_033089 1922 2110 208     16 MIR3 3’ 
ZCCHC4 NM_024936 2652 2792 66  197 MIRb 3’ 
ZFAND5 
NM_006007 
BC027707 
- 
506  639 
- 
181     33 
- 
MIR3 
- 
5’ 
ZFAT1 
NM_001029939 
 
 
 
 
NM_020863 
2907 3017  
3423 3536 
4061 4169 
4161 4249 
4729 4863  
- 
143  255  
11  124 
47  156  
185  274  
191     56  
- 
MIR 
MIRb 
MIRb 
THER1_MD  
MIRb 
- 
3’ 
3’ 
3’ 
3’ 
3’ 
- 
ZFP2 NM_030613 2227 2388 32  205    MIR3  3’ 
ZFP28 NM_020828 2827 2891  188  252  MIRb 3’ 
ZFP82 NM_133466 2050 2142  65  162   MIRm 3’ 
ZFP90 NM_133458 2682 2831  165     19  MIR3 3’ 
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ZFP91-CNTF 
NM_053023  
NM_170768  
- 
2726 2954  
- 
268     20  
- 
MIRb 
- 
3’ 
ZNF10 
NM_015394 
 
2973 3211  
3976 4121  
12  262   
113  262   
MIR  
MIR 
3’ 
3’ 
ZNF142 
NM_001105537 
NM_005081 
169   225 
265   414  
135     84 
237     83 
MIR 
MIR 
5’ 
5’ 
ZNF184 NM_007149 2667 2782  50  172   MIR3 3’ 
ZNF185 NM_007150 
2216 2348 
2408 2452 
260    114  
262    218  
MIRb 
MIRb 
3’ 
3’ 
ZNF192 NM_006298 
4850  4897  
5289  5360  
262    215 
165     92 
MIR 
MIRb 
3’ 
3’ 
ZNF193 
NM_006299 
AY261373 
 
- 
938 1075  
1450 1541 
- 
27  171 
172  267  
- 
MIRb 
MIRb 
- 
3’ 
3’ 
ZNF195 
 
NM_007152 
BX537525 
 
 
- 
3514 3646  
3706 37 
  
- 
260    114   
262    218 
 
- 
MIRb 
MIRb 
 
- 
3’ 
3’ 
 
ZNF197 
NM_006991  
NM_001024855 
4120 4301  
- 
25  216  
- 
MIRb 
- 
3’ 
- 
ZNF2 
NM_021088  
NM_001017396 
2212 2460  
2140 2388 
260      8  
260      8  
MIR  
MIR 
3’ 
3’ 
ZNF248 NM_021045 18   80 126  188  THER1_MD  5’ 
ZNF25 NM_145011 2769 2993 2  261 MIR 3’ 
ZNF275 NM_001080485 
2625  2781 
2814  2877 
107  268 
82     19 
MIR 
MIR 
3’ 
3’ 
ZNF300 NM_052860 2713 2827 26  145  MIRb 3’ 
ZNF323 
NM_030899  
NM_145909  
2421 2585 
2784 2996 
16  193   
16  262   
MIR  
MIR  
3’ 
3’ 
ZNF324 NM_014347 2368 2495  270    114  MIR 3’ 
ZNF333 NM_032433  3796 3987  262     67  MIR 3’ 
ZNF341 NM_032819 3055 3302   2  259  MIRb 3’ 
ZNF354C 
NM_014594 
BC063312 
- 
2870 2905  
- 
77     43  
- 
MIR 
- 
3’ 
ZNF365 
NM_014951  
NM_199450  
NM_199451  
 
NM_199452 
 
- 
- 
2168 2377  
2937 3166  
1487 1696   
2256 2485  
- 
- 
230     14   
272      7  
230     14   
272      7 
- 
- 
MIRb 
MIRb 
MIRb 
MIRb 
- 
- 
3’ 
3’ 
3’ 
3’ 
ZNF398 
NM_170686 
NM_020781 
3531 3617 
3210 3296  
67  154  
67  154  
MIR3 
MIR3 
3’ 
3’ 
ZNF409 XM_375065 2902 2975 133  201 MIR3 TAG 
ZNF420 NM_144689 2548 2744  58  262 MIR 3’ 
ZNF445 NM_181489 
5462 5650  
7920 8099  
8409 8489  
1  172  
81  274  
72  153 
MIRb 
MIR 
MIRb 
3’ 
3’ 
3’ 
ZNF45 NM_003425 
165  212 
262  306  
110  157   
120     75  
MIRb   
MIR 
5’ 
5’ 
ZNF470 NM_001001668 
515   607 
3044  3125  
136     29  
176    259  
MIR       
MIRb 
5’ 
3’ 
ZNF471 NM_020813 4308 4381  184  258   MIRb   3’ 
ZNF473 
NM_015428 
NM_001006656 
3145 3378 
3023 3256 
4  251   
4  251   
MIR 
MIR 
3’ 
3’ 
ZNF483 
NM_133464  
NM_001007169 
2698 2842   
1057 1233  
5  189  
20  167  
MIRb   
MIR3 
3’ 
3’ 
ZNF488 NM_153034 1457 1672  31  252  MIRb   3’ 
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2821 2965  271    128  THER1_MD  3’ 
ZNF498 
NM_145115 
BX640720 
- 
1998 2074 
- 
167     91  
- 
MIRb   
- 
3’ 
ZNF501 NM_145044 
1364 1489  
2272 2437  
55  196 
223     51  
MIRb   
MIRb   
3’ 
3’ 
ZNF514 NM_032788 2605 2677 163     88 MIR3 3’ 
ZNF526 NM_133444 3738 3905  70  256   MIR 3’ 
ZNF540 NM_152606 2542 2644   65  182 MIR 3’ 
ZNF544 NM_014480 79  201  180     71  MIR 5’ 
ZNF546 NM_178544 
2262 2447  
3109 3216  
244     43  
249    131  
MIRb 
MIR 
TAG 
3’ 
ZNF566 NM_032838 2248 2378 134  262 MIR 3’ 
ZNF580 
NM_016202 
NM_207115 
1190 1280   
903  993  
34  136  
34  136  
MIRm 
MIRm 
3’ 
3’ 
ZNF583 NM_152478 2272 2470 42  248   MIRb 3’ 
ZNF597 NM_152457 1517 1636  245    133 MIRb 3’ 
ZNF606 NM_025027 3930 4135  232      2 MIR 3’ 
ZNF607 NM_032689 3159 3272 66  195  MIR 3’ 
ZNF639 
NM_016331 
AB097862 
613  745 
613  745  
141      2 
141      2 
MIRm  
MIRm 
CDS 
CDS 
ZNF660 NM_173658 1874 2004  18  148  MIRb 3’ 
ZNF662 NM_207404 1812 2039 266     25 MIRb   3’ 
ZNF663 NM_173643  604  738 118  253  MIR 5’ 
ZNF664 NM_152437 
4545 4684 
4763 4948 
47  207  
19  202  
MIR3 
MIR3 
3’ 
3’ 
ZNF689 NM_138447 1821 1981  180      1 MIR3 3’ 
ZNF70 NM_021916 2684 2915 6  221   MIRb   3’ 
ZNF75D NM_007131 1044 1302 2  266  MIRb   5’ 
ZNF767 NM_024910 574   657 162     83 MIRc TAG 
ZNF781 NM_152605 3040 3074 166  200 MIR 3’ 
ZNRF1 NM_032268 3265 3400  39  169  MIRm  3’ 
ZSCAN2 
NM_181877  
NM_017894  
NM_001007072 
2263 2382 
- 
- 
23  152  
- 
- 
MIR 
- 
- 
3’ 
- 
- 
ZSCAN20 NM_145238 3610 3845  259      2  MIR 3’ 
ZSCAN22 NM_181846  
4061 4212 
4424 4580 
9  170  
253     61  
MIRb 
MIRb 
3’ 
3’ 
ZSCAN23 NM_001012455 2393 2567   194    8 MIR3 3’ 
ZXDA NM_007156 2716 2859   17  154   MIR3 3’ 
ZYG11A NM_001004339 3570 3681  241    131  THER1_MD 3’ 
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9.2.     Hypothetical or unknown genes which have recruited MIR elements. 
 
The gene symbol and accession numbers are listed, 216 hypothetical proteins in total. 
 
 
Gene Name Accession Number Gene Name Accession Number 
FLJ42957  NM_207436 LOC388823 XM_373931 
FLJ90680 NM_207475 LOC388890 XM_373953 
KIAA0467 NM_015284 LOC388893 XM_373954 
LOC143188 
 
XM_378251 
NM_001025447 
LOC389025 XM_374004 
LOC146795 XM_378701 LOC389147 XM_371663 
LOC199800 XM_373810 LOC389149 XM_374051 
LOC219908  XM_169057 LOC389150 XM_374052 
LOC285422 XM_379280 LOC389237 XM_374094 
LOC285711  XM_211988 LOC389345 XM_374150 
LOC286208 XM_379668 LOC389683 XM_374277 
LOC387940  XM_373571 LOC390217 XM_372420 
LOC388276 XM_373685 LOC399715 XM_374766 
LOC389166  XM_374060 LOC399786 XM_378236 
LOC389791 
 
XM_372142 
NM_001013652 
LOC399875 XM_378279 
LOC400551  XM_378621 LOC399919 XM_378299 
LOC400605  XM_378685 LOC399959 XM_378316 
LOC400614  XM_378693 LOC400004 XM_378340 
LOC400651  XM_378747 LOC400084 XM_378389 
LOC401057  XM_379181 LOC400144 XM_378421 
LOC401280  
 
XM_376549 
NM_001013682 
LOC400320 XM_375163 
LOC401280  XM_376560 LOC400400 XM_378529 
LOC401553  XM_379671 LOC400496  XM_378562 
LOC441242  BC066990 LOC400552 XM_378623 
MGC15885  XM_378517 LOC400553 XM_378625 
PRO0195  AF090901 LOC400572 XM_378648 
FLJ10489 XM_379597 LOC400577 XM_378653 
FLJ13439 XM_378280 LOC400581 XM_375418 
FLJ20674 BC034471 LOC400586 XM_375424 
FLJ21408 XM_378573 LOC400655 XM_378753 
FLJ25076 XM_059689 LOC400743 XM_378843 
FLJ26484 XM_378703 LOC400756 XM_378865 
FLJ27365 NM_207477 LOC400796 XM_378917 
FLJ31183 XM_379381 LOC400813 XM_378947 
FLJ34048 XM_379510 LOC400831 XM_378956 
Chapter 9. Appendices 
 
  
255 
 
  
FLJ34515 XM_378620 LOC400847   XM_378982 
FLJ35700 NM_205851 LOC400880  XM_379030 
FLJ39051 XM_378321 LOC400942 XM_379075 
FLJ40852 NM_173677 LOC400960 XM_379102 
FLJ41046 NM_207479 LOC400964 XM_379106 
FLJ41278 XM_378362 LOC401005 XM_379135 
FLJ41350 XM_378247 LOC401006 XM_379136 
FLJ41481 XM_379078 LOC401032 XM_379156 
FLJ41562 XM_376320 LOC401062 XM_379190 
FLJ42280 NM_207503 LOC401165 XM_379299 
FLJ43903 XM_379595 LOC401212  XM_379363 
FLJ43963 XM_376334 LOC401234  XM_379395 
FLJ44076  NM_207486 LOC401256  XM_379409 
FLJ44255 XM_378741 LOC401324    XM_380100 
FLJ44385 NM_207478 LOC401456 XM_379562 
FLJ44674 NM_207449 LOC401477 XM_379605 
FLJ44817 XM_375090 LOC401480 XM_379608 
FLJ45248 NM_207505 LOC401490 XM_379619 
FLJ45721 NM_207490 LOC401530 XM_379643 
FLJ45872 XM_376795 LOC439951 XM_374769 
FLJ46320 XM_498649 LOC440791 XM_498870 
FLJ46836 NM_207509 LOC440894 XM_379121 
KIAA0040 NM_014656 LOC441046 BC025996 
KIAA0087 XM_376586 LOC51145 AF159054 
KIAA0125 NM_014792 LOC51215 AF113674 
KIAA0141 BC007855 LOC51216 AF113685 
KIAA0317 AB002315 LOC642863 AY358216 
KIAA0319L AF275679 LOC643738 AY358772 
KIAA0492 XM_378914 LOC645200 AB088847 
KIAA0748 XM_374983 LOC645238 AY358248 
KIAA1199 NM_018689 LOC87600 AF251048 
KIAA1239 XM_049078 LOC87623 XM_039762 
KIAA1257  XM_371664 MGC21881 NM_203448 
KIAA1274 NM_014431 PRO0386 AF116603 
KIAA1305 XM_370756 PRO0514 AF090933 
KIAA1644 XM_376018 PRO0767 AF113012 
KIAA1715 NM_030650 PRO0902 AF305821 
KIAA1853 NM_194286 PRO0943 AF116611 
KIAA1881 XM_375558 PRO1097  AF119844 
LOC114137 AF305822 PRO1386  AF118062 
LOC119893 AF227517 PRO1483 AF116635 
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LOC142937   BC008131 PRO1496 AF116665 
LOC144678 XM_378390 PRO1808 AF118077 
LOC145216 XM_378487 PRO2832 AF119902 
LOC147977 AF187554 PRO2949 AF119907 
LOC149134 NM_207326 PRO3073 AF119912 
LOC150568 XM_379117 LOC387943 XM_373574 
LOC150577 XM_379114 LOC388073 XM_373616 
LOC155036 XM_376722 LOC388418 XM_373748 
LOC170425 XM_378240 LOC388641 XM_373848 
LOC199899 XM_378866 LOC388813 XM_373925 
LOC201229 XM_375430 LOC339022 XM_294775 
LOC220799 AF320070 LOC339442 XM_378855 
LOC221140 XM_167908 LOC339468 XM_373847 
LOC222701 XM_167152 LOC339524 NM_207357 
LOC254808 XM_374069 LOC339807 XM_379099 
LOC255177 XM_378516 LOC339809 XM_291020 
LOC256176 XM_172889 LOC339902 XM_295097 
LOC283034 XM_210860 LOC347475 XM_298045 
LOC283143 XM_378312 LOC387647 XM_373451 
LOC283177 XM_378327 LOC387693 BC071736 
LOC283214 XM_378303 LOC387824 XM_373520 
LOC283332 XM_378355 LOC387826 XM_373521 
LOC283403 XM_211028 LOC387888 XM_373550 
LOC283432 XM_378379 LOC387927 XM_370726 
LOC283663 XM_378514 LOC284688 XM_378912 
LOC283682 XM_378544 LOC284798 XM_378971 
LOC283761 XM_378542 LOC284898 XM_379044 
LOC283854 XM_378599 LOC284931 XM_211694 
LOC284100 XM_375443 LOC285045 XM_379086 
LOC284551 XM_375713 LOC285418 AF318325 
LOC285547 XM_379258 LOC285484 XM_376303 
LOC286149 XM_379594   
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9.3.     Conservation of human MIR elements   
 
The number of MIR elements which corresponds to each nucleotide of the generic consensus 
sequence has been plotted for all of the MIR sub-families located within the 3’-UTR (A) coding 
sequence (B) and 3’-UTR (C).  MIR elements in the direct orientation are blue and inverse pink. 
 
A) 5’-UTR 
 
B) CDS 
 
C) 3’-UTR 
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9.4. Accession numbers for DNA sequences included in multiple sequence 
alignments 
 
All accession numbers are obtainable for the sequence database at NCBI.  Accession numbers 
for sequence data included in multiple sequence alignments.  The sequence types are obtained 
following BLASTn searches of sequence databases (Db) of either genomic DNA (gDNA; wgs, 
ggs, refseq_genomic), mRNA (refsq_rna, nr/nt) or expressed sequence tags (est).  Query 
sequences (source) were the generic MIR consensus sequence or from specific MIR-containing 
genes.  Source gene HGNC symbols have been listed. 
 
Fig. Page 
Query 
Source 
Accession No. Db 
Sequence 
Type 
Species 
3.3 50 
MIR 
consensus 
AC013758 
167249-135967 
wgs gDNA H.sapiens 
3.3 50 
MIR 
consensus 
NC_006479 
37834932-37834867 
wgs gDNA P.troglodytes 
3.3 50 
MIR 
consensus 
DAAA02013700 
17640-17575 
wgs gDNA B.taurus 
3.3 50 
MIR 
consensus 
AAEX02022366 
135713-135776 
wgs gDNA C.familiaris 
3.3 50 
MIR 
consensus 
NC_010459 
34977720-34977655 
wgs gDNA S.scrofa 
3.3 50 
MIR 
consensus 
AAHY01125103 
21760-21695 
wgs gDNA M.musculus 
3.3 50 
MIR 
consensus 
ABQO010260434 
319-254 
wgs gDNA M.eugenii 
3.3 50 
MIR 
consensus 
AC234489 
37870-37935 
ggs gDNA T. aculeatus 
3.3 50 
MIR 
consensus 
AAPN01000352 
15020-14955 
wgs gDNA O.anatinus 
3.3 50 
MIR 
consensus 
NM_000618 
1910-1975 
refseq_ 
rna 
mRNA H.sapiens 
3.3 50 
MIR 
consensus 
XM_001141985 
10817-10882 
refseq_ 
rna 
mRNA P.troglodytes 
3.3 50 
MIR 
consensus 
BC148869 
3541-3605 
nr/nt mRNA B.taurus 
3.3 50 
MIR 
consensus 
DT537928 
73-138 
est mRNA C.familiaris 
3.3 50 
MIR 
consensus 
DN106777 
155-218 
est mRNA S.scrofa 
3.3 50 
MIR 
consensus 
AK160844 
2516-2581 
nr/nt mRNA M.musculus 
3.3 50 
MIR 
consensus 
EC321646 
319-383 
est mRNA T.vulpecula 
3.3 50 
MIR 
consensus 
EH002999 
160-125 
est mRNA O.anatinus 
5.2 108 KLC1 
NC_000014.8 
104095525-104167888 
refseq_ 
genomic 
gDNA H.sapiens 
5.2 108 CHRD 
NC_000003.11 
184097861-184107617 
refseq_ 
genomic 
gDNA H.sapiens 
5.3 109 KLC1 
NT_026437.12 
85151305-85151379 
refseq_ 
genomic 
gDNA H.sapiens 
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Fig. Page 
Query 
Source 
Accession No. Db 
Sequence 
Type 
Species 
5.3 109 KLC1 
NC_006481.2 
104177189-104177263 
refseq_ 
genomic 
gDNA P.troglodytes 
5.3 109 KLC1 
NC_009167.2 
45145894-45145954 
refseq_ 
genomic 
gDNA E. caballus 
5.3 109 KLC1 
NC_006590.2 
74478371-74478445 
refseq_ 
genomic 
gDNA C.familiaris 
5.3 109 KLC1 
NC_007319.3 
68615799-68615873 
refseq_ 
genomic 
gDNA B.taurus 
5.3 109 KLC1 
NC_005105.2 
136585194-136585266 
refseq_ 
genomic 
gDNA R.norvegicus 
5.3 109 KLC1 
NT_166318.1 
23984950-23985010 
refseq_ 
genomic 
gDNA M.musculus 
5.3 109 KLC1 
NC_008801.1 
312097480-312097406 
refseq_ 
genomic 
gDNA M.domestica 
5.3 109 KLC1 
ABQO010977032.1 
2115-2041 
wgs gDNA M.eugenii 
5.3 109 KLC1 
NC_009094.1 
22698893-22698965 
refseq_ 
genomic 
gDNA O.anatinus 
5.3 109 CHRD 
NC_000003.11 
184098853-184098913 
refseq_ 
genomic 
gDNA H.sapiens 
5.3 109 CHRD 
NC_006490.2 
189910344-189910420 
refseq_ 
genomic 
gDNA P. troglodytes 
5.3 109 CHRD 
NC_007859.1 
102282539-102282464 
refseq_ 
genomic 
gDNA M.mulatta 
5.3 109 CHRD 
NC_007299.3 
84687537-84687462 
refseq_ 
genomic 
gDNA B.taurus 
5.3 109 CHRD 
NC_006616.2 
20263690-20263765 
refseq_ 
genomic 
gDNA C.familiaris 
5.3 109 CHRD 
NC_000082.5 
20733929-20734004 
refseq_ 
genomic 
gDNA M.musculus 
5.3 109 CHRD 
AC_000079.1 
79019711-79019636 
refseq_ 
genomic 
gDNA R.norvegicus 
5.8 116 AHI1 
NT_025741.15 
39878560-39878488 
refseq_ 
genomic 
gDNA H.sapiens 
5.8 116 AHI1 
NC_006473.2 
137724940-137724867 
refseq_ 
genomic 
gDNA P. troglodytes 
5.8 116 AHI1 
NC_007861.1 
128447624-128447697 
refseq_ 
genomic 
gDNA M.mulatta 
5.8 116 AHI1 
NC_009153.2 
81120331-81120256 
refseq_ 
genomic 
gDNA E. caballus 
5.8 116 AHI1 
NC_007307.3 
75649837-75649757 
refseq_ 
genomic 
gDNA B.taurus 
5.8 116 CIITA 
NG_009628.1 
36039-36122 
refseq_ 
genomic 
gDNA H.sapiens 
5.8 116 CIITA 
NC_006483.2 
11232769-11232829 
refseq_ 
genomic 
gDNA P. troglodytes 
5.8 116 CIITA 
NC_007877.1 
10978663-10978747 
refseq_ 
genomic 
gDNA M.mulatta 
5.8 116 CIITA 
NC_009156.2 
33510196-33510136 
refseq_ 
genomic 
gDNA E. caballus 
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Fig. Page 
Query 
Source 
Accession No. Db 
Sequence 
Type 
Species 
5.8 116 CIITA 
NC_000082.5 
10512495-10512557 
refseq_ 
genomic 
gDNA M.musculus 
5.8 116 CIITA 
NC_005109.2 
5101848-5101788 
refseq_ 
genomic 
gDNA R.norvegicus 
5.8 116 GSG1L 
NC_000016.9 
27835248-27835188 
refseq_ 
genomic 
gDNA H.sapiens 
5.8 116 GSG1L 
NC_006483.2 
28256956-28256896 
refseq_ 
genomic 
gDNA P. troglodytes 
5.8 116 GSG1L 
NC_007877.1 
26274918-26274858 
refseq_ 
genomic 
gDNA M.mulatta 
5.8 116 GSG1L 
NC_006588.2 
21891470-21891541 
refseq_ 
genomic 
gDNA C.familiaris 
5.8 116 GSG1L 
NC_000073.5 
133043735-133043664 
refseq_ 
genomic 
gDNA M.musculus 
5.8 116 GSG1L 
AC_000069.1 
178131185-178131115 
wgs gDNA R.norvegicus 
6.7 141 TGM2 
NC_000020.10 
36761415-36761327 
refseq_ 
genomic 
gDNA H.sapiens 
6.7 141 TGM2 
NC_007867.1 
26327686-26327773 
refseq_ 
genomic 
gDNA M.mulatta 
6.9 143 TGM2 
NC_000020.10 
36759606-36758589 
refseq_ 
genomic 
gDNA H.sapiens 
6.9 143 TGM2 
NC_006487.2 
35312705-35311170 
refseq_ 
genomic 
gDNA P. troglodytes 
6.9 143 TGM2 
NC_007867.1 
26329975-26328958 
refseq_ 
genomic 
gDNA M.mulatta 
6.9 143 TGM2 
NC_007311.3 
67599512-67598021 
refseq_ 
genomic 
gDNA B.taurus 
6.9 143 TGM2 
NC_005102.2 
148835362-148833769 
refseq_ 
genomic 
gDNA R.norvegicus 
6.9 143 TGM2 
NC_000068.6 
157944694-157943047 
refseq_ 
genomic 
gDNA M.musculus 
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9.5.     MIR-containing genes clustered on chromosomes 11 and 9. 
 
Gene symbol Position Gene symbol Position 
SLC1A2 11p13-p12  C9orf58 9q34.13-q34.3 
RAG1 11p12 C9orf90 9q34.11 
TP53I11 11p11.2  C9orf98 9q34.13 
SLC43A3 11q12.1 DBH 9q34.2 
ZFP91 11q12.1 DPM2 9q34.11-13 
CNTF 11q12.1 EHMT1 9q34.3 
FAM111A 11q12.1 FREQ 9q34.11 
MS4A3 11q12.1 GFI1B 9q34.2-13 
MS4A6A 11q12.1 NEK6 9q33.3-q34.11 
MS4A10 11q12.2 PIP5KL1 9q34.11 
GPR44 11q12.2 ST6GALNAC6 9q34.11 
SYT7 11q12.2 TOR1A 9q34.11 
BATF2 11q13.1 TOR2A 9q34.11 
MRPL49 11q13.1   
DKFZp761E198 11q13.1   
C11orf68 11q13.1   
SLC29A2 11q13.2   
PELI3 11q13.2   
ALDH3B2 11q13.2    
ALDH3B1 11q13.2    
SAPS3 11q13.2    
MYEOV 11q13.3   
ORAOV1 11q13.3   
FADD 11q13.3   
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9.6.     MIR-containing genes involved in regulatory pathways 
 
The pathway name and MIR-containing gene symbol is listed.  The total number of genes 
known to participate in each pathway is noted including the frequency (Freq) of MIR-
containing genes involved in each pathway. 
  
Pathway name MIR-containing gene Total Freq. 
Glycolysis / Gluconeogenesis 
ACAS2L, ACSS1,  ALDH3B1, ALDH3B2, 
AMPD3, DLD, HK1, HK2, IL21R 
65 0.138 
Inositol phosphate metabolism 
BDKRB2, CASR, CCR5, INPP5D, PIP5KL1, 
PLCB2, PLCB4 
52 0.135 
Propanoate metabolism ACADSB, ACAS2L, ACAT1, ACSS1, DHCR24 39 0.128 
Stilbene, coumarine and lignin 
biosynthesis 
MPO 8 0.125 
Pyruvate metabolism ACAS2L, ACAT1, ACSS1, DLD, IL21R 43 0.116 
Galactose metabolism B4GALT2, HK1, HK2 32 0.094 
Fructose and mannose 
metabolism 
B4GALT2, HK1, HK2, KHK 48 0.083 
Citrate cycle DLD, CLYBL 28 0.071 
Aminosugar metabolism HK1, HK2 30 0.067 
Starch and sucrose metabolism DDX52, FBXO18, HK1, HK2 78 0.051 
Pentose and glucuronate 
interconversions 
RPE 24 0.042 
Pentose phosphate pathway RPE 27 0.037 
Butanoate metabolism ACAT1 44 0.023 
Sulfur metabolism PAPSS2, SUOX 14 0.143 
ATP synthesis 
ATP6V1G2 ATP6V1B1, ATP6V1E2, 
ATP6VOE2L 
40 0.1 
Methane metabolism MPO 10 0.1 
Reductive carboxylate cycle CO2 
fixation) 
ACSS1 11 0.091 
Oxidative phosphorylation 
ATP6V0E2L, ATP6V1B1, ATP6V1E2, 
ATP6V1G2, ATP7B, COX15, MEGF11, 
NDUFB2, NDUFS1, PPA2 
130 0.077 
Nitrogen metabolism CA8 24 0.042 
Carbon fixation RPE 25 0.04 
Fatty acid biosynthesis (path 1) MCCC2 8 0.125 
Synthesis and degradation of 
ketone bodies 
ACAT1 8 0.125 
Glycerolipid metabolism 
AGPAT6, B4GALT2, DGKA, LIPG, PLD1, 
PLA2G3, YWHAZ 
60 0.117 
Biosynthesis of steroids DHCR7 18 0.056 
Fatty acid biosynthesis (path 2) ACAT1 18 0.056 
Glycerophospholipid metabolism AGPAT6, DGKA, PLA2G3, PLD1 77 0.052 
Fatty acid metabolism ACADSB, ACAT1 51 0.039 
Linoleic acid metabolism PLA2G3 35 0.029 
Sphingolipid metabolism NEU3 38 0.026 
Bile acid biosynthesis ACADSB 40 0.025 
Androgen and estrogen 
metabolism 
HEMK1 53 0.019 
Arachidonic acid metabolism GPX7 57 0.018 
Purine metabolism ADCY1, ADCY2, ADCY6, AK2, AMPD3, 155 0.123 
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ATP6V1G2, MPP3, NT5E, PAPSS2, 
PDE11A, PDE2A, PDE4A, PDE4C, POLG, 
POLH, POLQ, POLR3D, RECQL5, RRM2B 
Pyrimidine metabolism 
EHD4, NT5E, POLG, POLH, POLQ, 
POLR3D, RRM2B, TK2, TXNDC2 
93 0.097 
Phenylalanine metabolism ALDH3B1, ALDH3B2, MAOB, MPO 30 0.133 
Methionine metabolism AHCYL1, MAT1A 16 0.125 
Alanine and aspartate 
metabolism 
ASL, DARS2, IL1A 25 0.12 
Histidine metabolism ALDH3B1, ALDH3B2, HEMK1, MAOB 41 0.098 
Tyrosine metabolism ALDH3B1, ALDH3B2, DBH, HEMK1, MAOB 60 0.083 
Arginine and proline metabolism ADC, ASL, MAOB, PARS2 58 0.069 
Glutamate metabolism ADC, GCLC 31 0.065 
Lysine degradation ACAT1, EHMT1, OTUB2 52 0.058 
Tryptophan metabolism ACAT1, DHCR24, HEMK1, MAOB, WARS2 86 0.058 
Valine, leucine and isoleucine 
degradation 
ACADSB, ACAT1, MCCC2 54 0.056 
Glycine, serine and threonine 
metabolism 
DLD, MAOB 45 0.044 
Urea cycle and metabolism of 
amino groups 
ASL 26 0.038 
Selenoamino acid metabolism AHCYL1, HEMK1, MAT1A, PAPSS2 34 0.118 
Aminophosphonate metabolism HEMK1 20 0.05 
Glutathione metabolism GCLC, GPX7 41 0.049 
beta-alanine metabolism ACADSB 27 0.037 
Keratan sulfate biosynthesis 
B3GNT6, B4GALT2, FUT8, ST3GAL1, 
ST6GAL1 
15 0.333 
O-Glycan biosynthesis 
B4GALT2, GALNT4, GALNT10, GALNT11, 
ST3GAL1, ST6GALNAC6 
25 0.24 
N-Glycan biosynthesis 
ALG2, B4GALT2, FUT8, MAN2A2, MGAT5, 
NEU3, ST6GAL1 
37 0.189 
Glycosylphosphatidylinositol(GPI)-
anchor biosynthesis 
B4GALT2, PIGS, PIGL 23 0.13 
N-Glycan degradation NEU3 16 0.063 
Glycosaminoglycan degradation HYAL1 17 0.059 
Glycosphingolipid metabolism B4GALT2, NEU3 43 0.047 
Glycan structures - biosynthesis 1 GALNT4 107 0.009 
Thiamine metabolism TPK1 6 0.167 
Ubiquinne biosynthesis NDUFB2, NDUFS1 15 0.133 
Boitin metabolism OTUB2 8 0.125 
Nicotinate and nicotinamide 
metabolism 
NMNAT2, NT5E, NUDT12, QPRT 43 0.093 
One carbon pool by folate EHD4 16 0.063 
Folate biosynthesis DDX52, FBXO18 37 0.054 
Porphyrin and chlorophyll 
metabolism 
ALAD 36 0.028 
1,1,1-Trichloro-2,2-bis(4-
chlorophenyl)ethane  
DHCR24 3 0.333 
Nitrobenzene degradation HEMK1 15 0.067 
1- and 2-Methylnaphthalene 
degradation 
ACADSB 27 0.037 
Benzoate degradation via CoA ACAT1 31 0.032 
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ligation 
RNA polymerase POLR3D 25 0.04 
Basal transcription factors TAF9B 36 0.028 
Aminoacyl-tRNA synthetases DARS2, WARS2 32 0.063 
Ribosome RPL28 131 0.008 
Proteasome PSMD12 31 0.032 
Protein export SEC61A1 13 0.077 
Ubiquitin mediated proteolysis CUL3, CUL1, NEDD4 45 0.067 
DNA polymerase POLG, POLH, POLQ 25 0.12 
ABC transporters - General ABCC3, ABCG2, TAP2 43 0.07 
Cytokine-cytokine receptor 
interaction 
CCR5, CNTF, CSF3R, CX3CR1, EDA, 
FLT3LG, IL1A, IL1RAP, IL10RA, IL12RB1, 
IL12RB2,  IL18R1, IL2RB, IL21R, IL22RA1,  
IL22RA2, 1L23R, IL28RA, IL6ST,  IL8, LEP, 
MPL, NGFR, OSM, PDGFRB, TGFB1, 
TNFSF12, TNSSF4, TNFSF8, 
255 0.114 
Cell adhesion molecules (CAMs) 
CD28, CD4, CD8A, CD80, CNTN2, CLDN1, 
CLDN10, ITGB7,  ITGAL,   OCLN, PVRL1 
132 0.083 
ECM-receptor interaction 
COL4A6, GP5, ITGA2, ITGB3, ITGB7, SV2C, 
VTN 
87 0.08 
Neuroactive ligand-receptor 
interaction 
APLN, AVPR2, BDKRB2, CRHR2, CYSLTR2, 
EDG6, F2RL1, GABBR2, GABRE, GABRA4, 
HRH1, HRH2, HTR4, LEP, MC1R, NMUR1, 
NTSR1, NTSR2, P2RY2, P2RY6,  P2RX7, 
PTHR1, TACR1, UCN2 
302 0.079 
Calcium signaling pathway 
ADCY1, ADCY2, ADCY6, AKAP5, ATP2B1, 
BDKRB2, CACNAID, CACNA1G, 
CACNA2D4, CACNG3, CAMK2A, CYSLTR2, 
ERBB3, HDAC6, HDAC8, HRH1, HRH2, 
HTR4, NFATC4, NTSR1, P2RX7, PDGFRB,  
PLCB2, PLCB4, PRKACB, TACR1, TNNI1 
176 0.153 
Phosphatidylinositol signaling 
system 
CDC25B, DGKA, DUSP3, DUSP18, INPP5D, 
PLCB2, PLCB4,  PTPN3, PTPRU, SIRPA 
79 0.127 
Jak-STAT signaling pathway 
CNTF, CSF3R, JAK3, IL2RB, IL10RA, 
IL12RB1, IL12RB2, IL21R, IL22RA1, 
IL22RA2, IL23R,  IL28RA, IL6ST, LEP, MPL, 
OSM, STAT5A, SPRY3, TYK2 
153 0.124 
MAPK signaling pathway 
ACVR1C, ARRB1, CASP10, CDC25B, 
DUSP3,  ELK4, FGF7, FGR, GNA12, IKBKG,  
IL1A, MAP2K3, MAP3K8, MAP3K14, 
MAPK4, MAPKAPK2, MOBKL2C, NFATC4, 
PDGFRB, PLA2G3, PRKACB, RASGRF1, 
RRAS,  SHC3, STK4, TGFB1, TP53, ZAK 
271 0.103 
TGF-beta signaling pathway 
ACVR1C, BMPR2, CDKN2B, CHRD, CUL1, 
SMAD6, TGFB1 
84 0.083 
Wnt signaling pathway 
CUL1, CAMK2A, DAAM2, DVL3, NFATC4, 
PLCB2, PLCB4, PRKACB, TP53, WNT8A 
147 0.068 
Notch signaling pathway DVL3, NUMB, PSEN2 46 0.065 
Hedgehog signaling pathway PRKACB, WNT8A 57 0.035 
VEGF signaling EIF1AX, PXN 72 0.028 
Regulation of actin cytoskeleton 
ARHGEF6, BDKRB2, FGF7, FGD1, FGD3, 
GNA12, IL17RE, ITGA2, ITGAL, ITGB3, 
206 0.083 
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ITGB7, PDGFRB, PPP1R12B, PXN, RRAS, 
SLC9A1, WASF2 
Apoptosis 
ATM, BIRC4, CAPN5, CASP10, FADD, 
IKBKG,  IL1A, IL1RAP, MAP3K14, NGFR, 
PRKACB, TRAF1, TRAF3, TP53 
84 0.167 
Cell cycle 
ATM, CDC14B, CDC25B, CDKN2A, 
CDKN2B, CUL, E2F6, FGR, HDAC6, HDAC8, 
ORC2L, SMC1L1, TGFB1, TP53, YWHAZ, 
112 0.134 
Gap junction 
ADCY1, ADCY2, ADCY6,  MC1R, PDGFRB, 
PLCB2, PLCB4, PRKACB, RRAS, SRC 
99 0.101 
Focal adhesion 
BIRC4, CAPN5, COL4A6, FGR, HCK, IGF1, 
ITGA2, ITGB3, ITGB7, PARVA, PDGFRB, 
PXN, RRAS, SHC3, SHC4, SRC, STYK1, VTN 
194 0.093 
Tight junction 
AMOT, AMOTL1, CLDN10, CLDN1, 
EPB41L1,  OCLN,  RRAS, SRC, VAPA, ZAK 
119 0.084 
Adherens junction ACVR1C, PVRL1, SRC, WASF2 77 0.052 
Cell communication COL4A6, DSC2, GJB3, KRT4, VTN 122 0.041 
Adipocytokine signaling pathway ADIPOQ, JAK3, LEP, TYK2 69 0.058 
Insulin signaling pathway 
INPP5D, MOBKL2C, PRKACB, RRAS, SHC3, 
SHC4 
135 0.044 
B cell receptor signaling pathway 
CAMK2A, GAB2, IKBKG, INPP5D, MALT1, 
MAP2K3, MAP3K8, MAP3K14, NFATC4, 
PIK3AP1, RRAS 
63 0.175 
Hematopoietic cell lineage 
CD33, CD4, CD59, CD8A, CSF3R, FLT3LG, 
GP5, IL1A, ITGA2, ITGB3, ITGB7 
88 0.125 
T cell receptor signaling pathway 
CD4, CD28, CD8A, IKBKG, ITK, MALT1, 
MAP3K8, MAP3K14, NFATC4, RELB, RRAS 
93 0.118 
Natural Killer cell mediated 
Cytotoxicity 
ACVR1C, ARRB1, CACNA1D, CACNA1G, 
CACNA2D4, CACNG3, CASP10, CDC25B, 
DUSP3, ELK4, FGF7, GNA12, HSPA1B, 
IKBKG, IL1A, MAP2K3, MAP3K14, 
MAP3K8, MAPKAPK2, NFATC4, PDGFRB, 
PLA2G3, PRKACB, RASGRF1, RRAS, STK4, 
TGFB1, TP53, ZAK 
271 0.107 
Complement and coagulation 
cascades 
BDKRB2, C7, CD59, MASP1, MBL2, 
PLAUR, SERPINA5 
69 0.101 
Toll-like receptor signaling 
pathway 
ATM, CD80, FADD, IL8, IKBKG, MAP2K3, 
MAP3K14, RELB, TICAM2 
91 0.099 
Antigen presenting pathway TAP2, TAPBP 86 0.023 
Dorso-ventral axis formation ETV6, ETV7, RRAS 28 0.107 
Axon guidance 
EPHA8, NFATC4, PLXNA2, PLXNB2, RRAS, 
SEMA4F, SRGAP3, UNC50 
130 0.062 
Circadian rhythm ARNTL2 18 0.056 
Amyotrophic lateral sclerosis 
(ALS) 
SLC1A2, TP53 17 0.118 
Huntington's disease HAP1, TGM2, TP53 30 0.1 
Neurodegenerative Disorders NGFR, PSEN2 35 0.057 
Alzheimer's disease PSEN2 22 0.045 
Type I diabetes mellitus CD28, CD80, IL1A 44 0.068 
Type II diabetes mellitus ADIPOQ, Cacna1d, CACNA1G 44 0.068 
 
 
Chapter 9. Appendices 
 
  
266 
 
  
9.7.     Gene ontology data for the human MIR-containing genes. 
 
The gene ontology identification number and term are listed.  The percentage of MIR-
containing genes is included and the p value.  The ontologies are categorised as follows; A) GO 
terms relating to protein binding; B) growth and development; C) neuronal function; D) 
mammalian reproduction; E) cell compartment and F) immune responses. 
 
 
A) GO terms relating to protein binding. 
 
GO ID Gene Ontology Term                                                             MIRs (%) P value 
GO:0046914 Metal ion binding 37.83 5.32E-05 
GO:0043169 Cation binding 35.2 0.000141201 
GO:0042277 Peptide binding 1.9 0.0300147 
GO:0005509 Calcium ion binding 8.68 0.252313 
GO:0030246 Carbohydrate binding 2.32 0.291063 
GO:0005524 ATP binding 16.42 0.305178 
GO:0000166 Nucleotide binding 14.56 0.422993 
GO:0005529 Sugar binding 1.55 0.446001 
GO:0008289 Lipid binding 3.06 0.495413 
GO:0003677 DNA binding 17.54 0.527381 
GO:0005102 Receptor binding 5.61 0.645644 
GO:0005525 GTP binding 3.45 0.853497 
GO:0003723 RNA binding 3.82 0.994431 
 
 
B) GO terms pertaining to growth and development. 
 
 
GO ID Gene Ontology Term                                                             MIRs (%) P value 
GO:0001501 Skeletal development  3.63 0.00128131 
GO:0048856 Anatomical structure development 17.89 0.00328912 
GO:0048513 Organ development 11.79 0.0253845 
GO:0009887 Organ morphogenesis 4.41 0.0421475 
GO:0009888 Tissue development 3.89 0.0586727 
GO:0007568 Aging 0.33 0.163553 
GO:0021675 Nerve development  0.13 0.282332 
GO:0055001 Cell development 13.73 0.288051 
GO:0001701 Embryonic development 2.28 0.384237 
GO:0001558 Regulation of cell growth 1.55 0.61238 
GO:0016049 Cell growth 1.69 0.643293 
GO:0007548 Sex differentiation 0.36 0.906218 
GO:0007389 Pattern specification 0.68 0.9597 
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C) GO terms related to neuronal function. 
 
 
GO ID Gene Ontology Term                                                             MIRs (%) P value 
GO:0007611 Neurotransmitter transport 1.46 0.000341128 
GO:0006836 GPCR receptor activity 1.84 0.0211317 
GO:0043005 Neuron projection 1.35 0.0360011 
GO:0046928 Transmission of nerve impulse 3.04 0.243314 
GO:0030901 Neurite development 0.17 0.250773 
GO:0048666 Synaptic transmission 2.59 0.420828 
GO:0048168 learning and/or memory 0.46 0.430455 
GO:0001764 Regulation of neuronal synaptic plasticity 0.34 0.459277 
GO:0007218 Midbrain development 0.17 0.514246 
GO:0030900 Neuron development 3.97 0.540783 
GO:0030182 Neuron differentiation 3.97 0.540783 
GO:0007417 Regulation of neurotransmitter secretion 0.99 0.591897 
GO:0007268 Neuron migration 0.52 0.645013 
GO:0031175 Central nervous system development 1.82 0.659488 
GO:0008528 Neuropeptide signaling pathway 0.77 0.798758 
GO:0019226 Forebrain development 0.15 0.806132 
 
 
D) GO terms pertaining to mammalian reproduction. 
 
 
GO ID Gene Ontology Term                                                             MIRs (%) P value 
GO:0007595 Lactation 0.61 0.00444562 
GO:0007567 Parturition 0.24 0.130172 
GO:0009790 Embryonic development 2.28 0.384237 
GO:0030317 Sperm motility 0.12 0.546723 
GO:0007369 Gastrulation 0.36 0.554173 
GO:0001890 Placenta development 0.15 0.574902 
GO:0046661 Male sex differentiation 0.26 0.634846 
GO:0007565 Pregnancy 0.49 0.63798 
GO:0019098 Reproductive behaviour 0.11 0.697223 
GO:0019953 Sexual reproduction 1.89 0.835177 
GO:0007276 Gametogenesis 1.6 0.846263 
GO:0009566 Fertilisation 0.24 0.867359 
GO:0042698 Menstrual cycle 0.12 0.893952 
GO:0046660 Female sex differentiation 0.13 0.895515 
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E) GO terms relating to the cell compartment. 
 
GO ID Gene Ontology Term                                                             MIRs (%) P value 
GO:0005886 Plasma membrane 20 0.000723 
GO:0005794 Golgi apparatus 6.8 0.001245 
GO:0030425 Dendrite 0.75 0.031293 
GO:0043005 Neuron projection 1.35 0.036001 
GO:0001917 Photoreceptor 0.22 0.03732 
GO:0043203 Axon hillock 0.12 0.125862 
GO:0031982 Vesicle 2.41 0.131283 
GO:0031982 Endoplasmic reticulum 9.35 0.154074 
GO:0005768 Endosome 1.7 0.210515 
GO:0019861 Flagellum 0.37 0.273242 
GO:0005773 Vacuole 2.38 0.301798 
GO:0005929 Cilium 0.51 0.330358 
GO:0030424 Axon  0.5 0.338993 
GO:0043205 Fibril 0.12 0.375564 
GO:0044456 Synapse part 0.66 0.671878 
GO:0005581 Collagen 0.25 0.70366 
GO:0005737 Cytoplasm 34 0.757031 
GO:0005856 Cytoskeleton 10.37 0.760973 
GO:0005739 Mitochondrion 8.67 0.780529 
GO:0005829 Cytosol 4.25 0.914759 
GO:0005634 Nucleus 45.75 0.957493 
GO:0005694 Ribosome 1.36 0.995429 
 
 
F) GO terms pertaining to immune responses. 
 
GO ID Gene Ontology Term                                                             MIRs (%) P value 
GO:0048535 Cytokine receptor activity 1.58 4.61E-05 
GO:0019882 Immune response 7.78 0.00228131 
GO:0046649 Wound healing 1.94 0.00633122 
GO:0045321 Lymphocyte activation 2.19 0.0729672 
GO:0006956 Leukocyte activation 2.17 0.111272 
GO:0002706 Lymphocyte mediated immunity 0.91 0.283123 
GO:0042119 Neutrophil activation 0.13 0.328416 
GO:0006954 Inflammatory response 2.67 0.349137 
GO:0006956 Complement activation 1.32 0.358703 
GO:0006959 Humoral immune response 0.99 0.379501 
GO:0006935 Chemotaxis 1.3 0.480615 
GO:0019882 Antigen presentation 0.78 0.628384 
GO:0042379 Chemokine receptor binding 0.16 0.972179 
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9.8.     MIR elements which are spliced, and are within coding sequences of human 
genes 
 
The gene symbol and accession number were obtained from Entrez gene at NCBI.  The 
transcript no has been provided if the exonisation occurs in a reference sequence (-) signifies 
that there is only one sequence and the exonisation occurs in the reference sequence.  
Abbreviations: Ex, exon; Int, intron; UTR, untranslated region; CDS, coding sequence; ATG, 
methionine sequence; TAG, stop codon; Alt, alternative; Acc, acceptor; Don, donor; Con, 
constitutive; SS, splice site; RT, read through exon.  Intronic sequences are in lowercase and 
exonic nucleotides capitals.  Start and stop codons are bold and italicised.   
 
Gene symbol 
Transcript 
No.  
MIR 
type 
mRNA 
region 
RefSeq. 
region 
Splicing 
event 
SS:    3’ = 23-mer 
         5’ = 9-mer  
ABCC2 - MIR CDS Ex 7 
Middle 
Con Ex 
- 
ABHD14B 1, 2 MIRb 5' UTR Ex 2 Con Acc SS ttattgttcccatatttcagATC 
ABHD2 1 
MIR 
MIR3 
MIR3 
5' UTR 
3' UTR 
3’ UTR 
Int 1 
- 
- 
Alt 
Acc/Don 
SS 
tttcctcacctctaaaacagAAA 
AGGgtaagc 
ACACA nr MIRb CDS Int 1 Alt Don SS AAGgtaggc 
ADAMTS7 nr 
MIR_Mars 
MIRb 
CDS 
TAG 
- 
Ex 15 
Alt TAG 
/Ex 15 RT 
CATGGATGAGGCAGG 
ADAMTSL5 - MIRb ATG Ex 2 Con ATG GGCTCTATGGACTCG 
ADRA1A nr MIR CDS Int 1 Alt Acc SS  ctaagtctttacttttacagATG 
AHI1 4 MIRc TAG Int 15 Alt TAG AAGCACTAGACTCAGG 
ANAPC5 nr MIRb TAG Int 11 
Alt Acc SS / 
Alt TAG 
ttgttatccctatttcacagAAC 
TAAAGA 
ANKRD49 nr 
MIR_Mars 
MIRb 
TAG 
3’ UTR 
Int 2 
Alt TAG / 
Ex 2 RT 
TCTGCTTGGCCACTT 
ANKRD9 - 
MIR3 
MIR3 
5' UTR 
5' UTR 
Ex 1  
Ex 2 
Con Acc SS 
Con 
Acc/Don 
SS  
gcaggggacctgagttctagGCC 
acccctcccctttcttacagATA/ 
CAGgtaggt 
ARL10 nr 
MIRb 
MIRb 
CDS 
TAG 
EX 3 
Alt TAG 
/Ex 3 RT 
TTTTTTTGAGACAGA 
ARNTL 1 MIRb 5’ UTR Ex 3 Alt Don SS GTGgtaagc 
ART1 - MIR ATG Ex 2 Con Acc SS 
ttaacactgcaattttccagATG 
ACCAGCATGCAGATG 
BCL2L1 nr MIRb CDS Int 2 Alt Don SS TGGgtacta 
BTN3A3 a, b MIR 
TAG 
3' UTR 
Ex 11 Con TAG CTTTACTGATATTCA 
C10orf118 nr MIRc 5' UTR Int 1 Alt Acc SS cccatcttgattttgtttagAGG 
C11orf51 - MIRb 5' UTR Ex 2 
Con 
Acc/Don 
SS 
ttattatccccattttacagATG/ 
CAGgtctgt 
C12orf36 - 
MIRc 
MIR3 
ATG 
3’ UTR 
Ex 2 
 
Con Don 
SS 
GAGgtgagt 
- 
C12orf52 - MIRb 5' UTR Ex 2 
Con Don 
SS 
tttcacttccaccgttttagCTT 
C12orf76 - MIR CDS Ex 3 
Con Don 
SS 
GAGgtaata 
C14orf178 - 
MIR_Mars 
MIRb 
CDS 
TAG  
Ex 3 
Middle ex 
Con TAG 
- 
GGGTAATGA 
C15orf33 nr MIR3 TAG Ex 10 Alt TAG AACTAGTAA 
C16orf47 - MIR CDS Ex 3 Con Acc SS attattactcccactttacagATA 
Chapter 9. Appendices 
 
  
270 
 
  
C19orf39 - MIR TAG Ex 2 Con TAG CCCTGAGCT 
C1orf220 - MIRb ATG Ex 2 Con ATG CCCATGATC 
C3orf35 b MIR CDS Ex 6 Alt TAG GGATAGAAA 
C6orf114 - 
MIRb 
MIRb 
TAG  
3' UTR 
Ex 2 Con TAG ACATAGTAC 
C7orf65 - MIRb CDS Ex 2 
Con 
Acc/Don 
SS 
tgcctgctcttattgtgcagGTA/ 
GAGgtaata 
CACNA1G 15 MIRb 
TAG  
3' UTR 
Ex 23 
Ex 23 RT 
/Alt TAG 
GGGTAAGGG 
CCDC82 - MIRb 5' UTR Ex 2 
Con Don 
SS 
TCGgtaagt 
CCNO - MIRb ATG Ex 1 Con ATG ATCATGGTG 
CD300LG nr 
MIR3 
MIR 
TAG 
3’ UTR 
Int 6 
Alt Acc 
SS/Alt TAG 
ctttccatccccccttttagAAT 
GTTTGAAGC 
CD99L2 nr MIRb CDS Int 2 Alt Don SS AAGgtgagt 
CDC20B - 
MIR  
THER1_MD  
MIR 
TAG 
3’ UTR 
3’ UTR 
Ex 12 Con TAG TACTAGCAC 
CDC42BPG - MIR3 CDS Ex 2 
Middle con 
ex 
- 
CHRD 2 MIR TAG Int 2 
Alt Acc/ 
Don SS 
attattatccccattttccaGAC 
AGGgtaagtcttg 
CHRDL2 - MIR CDS Ex 10 
Con Acc / 
Don SS 
attattatccccattttacagATG 
CCAgtaagt 
CHRNA1 1 MIR3 CDS Ex 4 Alt Don SS GAGgtcagt 
CIITA nr MIR TAG Ex 11 
Ex 11 RT  
Alt TAG 
AGATGAGGA 
CPA5 2 MIRc 5' UTR Int 1 
Alt Acc/ 
Don SS 
ataatacattgcattttgcagGCT 
GAGgtaggg 
CRELD1 nr MIR CDS Int 10 Alt Acc SS tgtgtcagatgctgttctagGTG 
CSF3R 
a, b,  
c, d 
MIR3 5’ UTR Ex 2 
Con Acc/ 
Don SS 
atgttatttctttcccacagATG 
CTGgtaagt 
DISC1 S MIR TAG Int 9 Alt TAG GCCTGAGGA 
DMWD - 
MIR 
MIR3 
CDS 
3’ UTR 
Ex 4 
Con Acc/ 
Don SS 
agacccctctgtctccgtagTTC 
CAAgtcagt 
DNAJB13 nr MIR3 ATG Int 6 
Alt Acc 
SS/Alt ATG 
cataagatttcattgtacagATG 
GACATGGAG 
DPM2 2 MIRb TAG Int 2 
Ex 2 RT/Alt 
TAG 
TCTTGAACT 
DUOX1 1 MIR3 5' UTR Int 1 Alt Acc SS  aggcatatttgctcccatagCTG 
EIF4G3 nr MIRb 5’ UTR Int 1 
Alt Acc/ 
Don SS  
ttattttgctaattctttccagCAA 
AAGgtaatc 
ELMO2 1 MIRb 5' UTR Int 2 Alt Don SS  AAGgtagga 
EPB41L1 nr MIR 5' UTR Int 1 
Alt Acc SS 
Alt ATG 
tctgtttcttatctgtaaaCAG 
CTCATGGTT 
EPHB2 nr MIR TAG Int 6 
Alt Acc SS 
Alt TAG 
ttactatcccccttttacagATG 
AGTTAAGGA 
FAM109A - MIR 5' UTR Ex 2 Con Acc SS gttacgatcccattttacagATG 
FAM189B nr MIR TAG Ex 5 Alt TAG  TGGTAAGGC 
FAM23B - MIR TAG Ex 5 Con TAG ATTTGAGGT 
FAM53B nr MIR TAG Int 4 
Alt Acc SS 
Alt TAG 
cctgttgtattttctcctccagATA  
CCATGAGGA 
FBXO18 1 MIR3 ATG Int 1 
Alt ATG 
Alt Don SS 
CTCATGAGC 
CAGgcaagt  
FHAD1 nr MIRc CDS Int 33 Alt Acc SS cgatgatccctattttacagATG 
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FIGNL1 
1 
 
2 
 
MIR 
MIR 
MIR 
MIR 
5' UTR 
5' UTR 
5' UTR 
5' UTR 
Ex 2 
Ex 2 
Ex 2 
Ex 3 
Con Acc SS  
Alt Don SS  
Alt Don SS  
Con Acc SS  
tgttgctgcgcttcttttatagGTG 
TGAgtaggc 
CAAgtaagt 
TTGgtactg 
FXYD4 - MIR 5' UTR Ex 2 
Con Acc / 
Don SS 
tgatgatcctccttttacagGAC 
TTGgtaagt 
GAFA2 - MIR CDS Ex 1 
Middle 
Con  Ex 
- 
GCET2 1,2 
MIR3 
MIR3 
MIRm 
TAG 
3' UTR 
3' UTR 
Ex 6 Con TAG TTATAGTGA 
GDPD5 nr 
MIR 
MIRb 
5' UTR Int 2 
Alt Acc / 
Don SS 
tgcaaatccttccttcctagGGC 
CAGgtttgt 
GGA1 nr MIRb CDS Int 9 Alt Acc  atcttatttactacccgcagCTG 
GIPC1 1, 2 MIR 5' UTR Int 1 
Alt Acc / 
Don SS 
ggaattccacccatttttcagATG 
CTGgtaagt 
GPR171 - MIR 5' UTR Ex 2 
Con Don 
SS 
TGGgtaagt 
GSG1L nr MIR CDS Int 4 
Alt Acc / 
Don SS 
ccaaagtgatgggattacagGTG 
CTGgtaagt 
HHIPL1 b MIR3 TAG Ex 8 Alt TAG AAATGAGCA 
HIF3A 3 MIR3 TAG Ex 13 
Ex 13 RT 
/Alt TAG 
TGGTAGGCC 
HM13 4 
MIRb 
MIR 
MIRb 
 
TAG 
3' UTR 
3' UTR 
Ex 3 
Ex 3 RT/ 
Alt TAG 
GGATGAGAA 
HNF4A 3 MIR TAG Ex 8 
Ex 8 RT/ 
Alt TAG 
GCTTAACCT 
HTR3E - MIR ATG Ex 1 Con ATG CAAATGTTA 
IBRDC1 - MIR TAG Ex 9 Con TAG TTGTAAAAA 
IKBKG 2 MIR3 ATG Ex 1 Alt ATG CCCATGGCC 
IL6ST 1, 2 MIRb 5’ UTR Ex 2 
Con Acc / 
Don SS 
agactctcctctctttacagTGA 
TGGgtaagt 
INPP5J nr MIR 5’ UTR Int 1 Alt Acc SS cccatcccttcattttacagACA 
ITGB7 - MIR 5' UTR Ex 2 Con Acc SS tcaacttctccactttgcagATG 
KIF19 nr MIR TAG Ex 12  
Ex 12 RT/ 
Alt TAG 
GTTTGAGAG 
KIFC3 nr 
MIRb 
MIRb 
MIRb 
5' UTR 
5' UTR 
TAG 
Int 3 
Alt Don SS 
Alt TAG 
CAAgtaagt 
CTCTAGAGG 
KLC1 1 MIRb TAG Int 13 
Alt Acc / 
Don SS 
Alt TAG 
gtcctccccacattttaaagATG 
AACTGACTT 
ATGgtgagt 
LAS1L - MIR3 CDS Ex 9 
Con Acc / 
Don SS 
ccaacatcctcatgttacagATG 
ACAgtgagt 
LIG4 1, 2 MIRb 5' UTR Int 1 Alt Don SS CAGgtattc 
LINS1 1 MIRb CDS Ex 8 
Middle con 
Ex 
- 
LMBR1L nr MIR_Mars ATG Int 2 Alt ATG 
ataacatttctgatggtcagTTT 
GAGATGGTT 
MICA - MIR TAG Ex 6 Con TAG GCCTAGACT 
MORF4L2 
1, 6, 8 
12, 13, 
14, 15, 16 
MIR 5' UTR Int 2 
Alt Acc / 
Don SS 
taatagttcctacttcatagGAT  
CATgtaagt 
MPG a MIR ATG Int 2 Alt ATG AGGATGGTC 
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MRRF nr MIR CDS Int 4 Alt Acc SS tttttgttattggtccactagGAA 
MS4A10 - 
MIRb 
MIR3 
TAG 
3’ UTR 
Ex 8 
Con Acc SS 
Con TAG 
ttaatatctccatttcatgcAGG 
AACTGAAGA 
MST150 - 
THER1_MD  
MIR3  
MIRb   
5’ UTR 
ATG 
3’ UTR 
Ex 1 Con ATG GACATGTCC 
MTIF2 1, 2 MIR3 5’ UTR Ex 2 
Con Don 
SS 
GGAgtaagt 
MUC15 a, c MIRb 5' UTR Int 1 
Alt Acc / 
Don SS 
ttgcctcttccattttccagCTT 
GTTgtaagt 
MYEOV - 
MIR   
MIRb 
TAG 
3' UTR 
Ex 3 Con TAG TGTTGAGGA 
MYO15A - 
MIR   
MIR 
CDS 
3’ UTR 
Ex 33 
Con Don 
SS 
AAGgtcaac 
MYO7A 3 MIRb TAG Int 27 Alt TAG AGTTAGGAC 
MYT1L - MIRm 5’UTR Ex 2 Con Acc SS ttgctttttatattttacagATG 
NCR2 - MIRb CDS Ex 5 
Middle 
Exon 
- 
NDST2 - MIR 5' UTR Ex 2 
Con Don 
SS 
AAGgttcta 
NDUFB2 nr MIR ATG Int 1 Alt ATG GTGATGGAG 
NEK11 1, 2 MIR 3  5’ UTR Int 1 
Alt Acc 
/Don SS 
attctgtccttctctaaaagGAA 
TCTgtaagt 
NFXL1 nr MIR3 TAG Int 16 
Alt Acc SS 
Alt TAG 
gtatactctttgttttgcagATA 
ATTTAAATA 
NIPSNAP1 - MIR3 ATG Ex 1 Con ATG AACATGGCT 
NSD1 nr MIRb CDS Int 2 Alt Don SS GGGgtaagc 
NTRK3 3 MIR3 CDS Int 13 Alt Don SS ATGgtggag 
NUMB 
1,2, 
3,4 
MIRb 5’ UTR Ex 3 
Con Acc / 
Don SS 
ttattattctcattttacagATG 
CAGgtctgt 
OTUB2 nr MIRb TAG Ex 3 Alt TAG TTCTAACTT 
OTUD6B nr MIR3 ATG Int 3 
Alt ATG 
Alt Don SS 
AAGgtgctt 
PAQR3 nr MIR TAG Int 5 
Alt ATG 
Alt Don SS 
GTTTGAGAA 
TAAgtaagt 
PAX7 1 MIR TAG Int 8 Alt TAG TACTAGGGC 
PBOV1 - MIR CDS Ex 1 
Middle con 
Ex 
- 
PCTK3 nr MIR TAG Int 12 Alt TAG ACTTAGCTG 
PELI3 2 MIRb CDS Int 2 
All Acc / 
Don SS 
tcatttcaatcttcacaaagATG 
CTGgtaagt 
PFKFB4 nr MIRc CDS Int 3 Alt Don SS 
 
gtcaccccctacttttacagATG 
PGGT1B nr 
MIR 
MIR3 
5’ UTR 
ATG 
Int 1 Alt ATG GGCATGGTG 
PHF19 2 MIRb TAG Int 5 
Ex 5 RT / 
Alt TAG 
TTGTAGACT 
PSD4 - 
MIRm   
MIRm 
CDS 
3’ UTR 
Ex 3 
Con Don 
SS 
TGGgcaagt 
PTGS1 nr MIRb CDS Int 2 
Alt ATG 
Alt Don SS 
CAAATGAGG 
TCAgtaggt 
PUS10 nr 
MIR 
MIRb 
CDS 
3’ UTR 
Int 2 Alt Acc SS 
 
atgattgtctctattttcagATG 
 
RGAG1 - MIRb 5' UTR Ex 1 Con Don TGGgtaagt 
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MIRb 
MIRb 
5' UTR 
3' UTR 
- 
- 
SS 
RHBDD2 1, 2 MIRb TAG Ex  4/5 Con TAG CCCTGAGAG 
RHBDD3 - MIRm 5' UTR Ex 2 
Con Acc / 
Don SS 
gatatccttggtttctacagAAG 
AAGgtaggc 
RNASEL nr 
MIR 
MIR3 
MIRb 
MIRC 
TAG 
3' UTR 
3' UTR 
3' UTR 
Int 4 
Alt Acc SS 
Alt TAG 
aatcatctatatttttgcagATG 
CAGTAAGGG 
RNF7 nr MIR CDS Int 2 Alt Acc SS gtattgtcccttttttacagATG 
RNFT2 1 MIRb TAG Ex Alt TAG GTGTAAGGA 
RNFT2 2 MIRb TAG Int 11 Alt TAG GTGTAAGGA 
SAPS3 - MIR 5' UTR Ex 2 Con Acc SS  tctaaacctctcatttacagATA 
SCN1B b MIRm TAG Ex 3  
Ex 3 RT / 
Alt TAG 
GTTTGAGCC 
SGIP1 nr MIRb CDS Int 15 
Alt Acc / 
Don SS 
ttatctttccctttttacagATG 
CAGgtctgt 
SIAE nr MIR TAG Int 2 
Ex 3 RT/Alt 
TAG 
ACTTAACAA 
SLC22A23 2 MIRb 5' UTR Int 2 Alt Don SS AAGgtagag 
SLC6A13 nr 
MIR3 
MIRb 
TAG 
3’ UTR 
Ex 2T 
Ex 2 RT 
/Alt TAG 
CCATAGATG 
SLC9A1 nr MIR TAG Ex 5  
Ex 5 RT 
/Alt TAG 
AAGTGAGAA 
SLIC1 2 MIR3 TAG Int 3 
Alt Acc SS 
Alt TAG 
tcactcacctctgtttacagATG 
CTCTGAGAG 
SPATA12 - 
MIR 
MIRb 
CDS 
3’ UTR 
Ex 2 
Middle con  
Ex 
- 
SPTBN4 Σ5 MIR TAG Ex 27  
Ex 27 RT 
/Alt TAG 
GAATGACAA 
SRRM2 - MIRb CDS Ex 4 
Middle con 
Ex 
- 
ST3GAL1 1, 2 MIRb 5' UTR Ex 3 
Con Don 
SS 
tattttcttctgtttttcagATG 
ST6GALNAC6 - MIRb ATG Ex 2 Con ATG CACATGGCT 
ST7L 1, 2, 3 MIRb TAG Ex 15 Alt TAG GGCTGAGCC 
STAB1 nr MIR3 CDS Ex 21  
Ex 21 RT 
/Alt TAG 
AATTAGAGA 
STRA6 5 
MIRm 
MIRb 
MIRb 
TAG 
3’ UTR 
3’ UTR 
Ex 6  
Ex 6 RT 
/Alt TAG 
ATTTGAACC 
TCL6 
a1, a2, a3, 
b1 
MIR3 
MIRb 
MIRc 
5’ UTR 
ATG 
3’ UTR 
Int 4 Alt ATG AGGATGGAG 
TGFBR2 1 MIRb CDS Int 1 Alt Acc SS ataattatcctgttttacagATG 
TGM2 nr 
MIR 
MIR 
MIRb 
MIR 
MIRb 
MIRc 
MIR3 
5- UTR 
ATG 
CDS 
CDS 
3- UTR 
3- UTR 
3- UTR 
Int 10 Alt ATG AGGATGAAG 
TIMM8B 
 
nr MIRb CDS Int 1 Alt Acc SS cctccctctgctccttgcagGCC 
TIPARP - MIRb CDS Ex 6 
Middle con 
Ex 
- 
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TMEM14C nr MIRc 5' UTR Int 1 All Acc SS actgagacttaggttgcgtagCTT 
TMUB2 2, 3 
MIR 
MIRb 
5' UTR 
5' UTR 
Int 1 Alt Don SS GAGgtaggt 
TNFSF12 nr MIR TAG Int 5 
Alt Acc SS 
Alt TAG 
taattacctccattttacagATG 
CCATGAGAT 
TP53I11 nr MIRb 5' UTR Int 1 
Alt Acc / 
Don SS 
ttttgccccgggctccctagGAA 
GAGgtaagg 
TRAF3 1, 2 MIR3 5' UTR Int 1 Alt Acc SS ccaatccctttattttacagATG 
TRIM10 2 MIR3 TAG Int 7 Alt TAG GCATAGAAA 
TRIM35 nr MIR CDS Int 1 Alt Acc SS atcctttgcccatttttaagGTG 
TRIOBP - MIRb TAG Ex 8 Con TAG ATTTGAGCG 
TYK2 - MIR 5’ UTR Ex 1 
Con Don 
SS  
CCGGTGGGT 
UBE2V1 1, 2, 3 MIRb ATG Int 1 
Alt Acc 
/Don SS 
Alt ATG 
ggaaagcattttatctccacAGC 
AAGATGGCA 
AAGgtgagt 
USH2A b MIR3 CDS Ex 45 
Middle 
Con Ex 
- 
VASH1 nr MIR3 TAG Ex 4  
Ex 4 RT 
/Alt TAG 
GGTTGAATG 
WBSCR27 - MIRc TAG Ex 6 Con TAG AAGTGAGAT 
YIPF1 - MIR 5' UTR Ex 2 Con Acc SS gttatgcacccattttacagATG 
ZBTB44 nr MIR TAG Int 5 Alt TAG TGTTGATTA 
ZFAND5 a MIR3 5’ UTR Int 1 Alt Don SS CAGgtgagt 
ZFHX2 nr MIR3 TAG Int 4 
Alt Acc SS 
Alt TAG 
actgctggacttctataaaaGGA 
AAATGATCT 
ZNF211 nr MIR CDS Int 2 
Alt TAG 
Alt Don SS 
TGGATGAGG 
CAGgttaga 
ZNF546 - 
MIRb 
MIR 
TAG 
3’ UTR 
Ex 7 Con TAG ATGTAAAGA 
ZNF639 - MIRm CDS Ex 12 Con Acc SS tcttccaaatccctttttacAGA 
ZNF767 - MIRc TAG Ex 4 
Con Acc SS 
Con TAG 
tattgtcttccatttgacagATG 
GATTGAGTA 
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9.9.     Human EST sequences which contained spliced MIR elements 
 
The gene symbol and accession number are listed, 73 EST sequences in total. 
 
Gene Name Accession No. Gene region Gene Name Accession No. Gene region 
ABCA10 DB226553 CDS PCSK2 BE257514 CDS 
AGTRAP BM772673 CDS PGAP3 BI518652 CDS 
ANKK1 CR741028 CDS PIP5K1B AL705046 5' UTR 
ARPC4 DB140773 CDS PLCB4 BX414883 CDS 
BCL2L14 DA920483 5' UTR POLG CN411689 5' UTR 
C10orf57 DB468324 CDS POMT2 BP331592 TAG 
C16orf45 BF309500 CDS PPP2R2A DA828841 CDS 
CARM1 CN352771 CDS RPL18 BM009191 CDS 
CCDC149 BE710079 5' UTR RUFY4 BX641664 5' UTR 
CCT7 DC355319 CDS RUNX1T1 AU117637  CDS 
CDH5 DC423813  5' UTR SAP30BP DA684650 CDS 
CHD6 BM799444 5' UTR SCYL2 AA280659 CDS 
CLN5 DA018669 TAG SDF2 CF126565 CDS 
COG7 BM821557 CDS SEC13 AL548842  5’ UTR 
CYP4F12 CD694538 CDS SGSH BP285106 CDS 
DDX27 BI914073 CDS SLC25A32 BG714806 CDS 
FAM35A CB111653  CDS SMCR7L BP315581 5' UTR 
FREM1 CN425444 3' UTR SMPDL3B BE747168 CDS 
GALE BI826045 5' UTR SPC25 BI912854 CDS 
GAS7 DC418644 CDS SSTR2 DB000266 5' UTR 
GBA2 AA203694 CDS STAT6 CR979664 CDS 
GLTP BI752839 CDS TBL1XR1 CN256124 5' UTR 
GNPDA1 DA733468  5' UTR THOC1 CN288816 CDS 
GPR137B CD521447 CDS TIMM17A BM826653 CDS 
IFNAR2 CA309324 CDS TLL2 AL530454 CDS 
KARS BQ437255 CDS TMEM68 CN429772 CDS 
KIF1B BI829019 CDS TRAF4 BQ056660 CDS 
MAGI3 CR996494 CDS TRNAU1AP DR007034 CDS 
MAPKAP1 BG327258 5' UTR TTC4 BG180840 CDS 
MCM8 CA495297 CDS TTLL3 AL045121 CDS 
METAP1 DA136874 5' UTR UROS BM476860 CDS 
MFN2 BG723252 CDS WWOX AW874690 CDS 
NDUFA12 BG179091 CDS YES1 DA764027 5' UTR 
NSUN5B BI765473 5' UTR YJEFN3 DA289550 CDS 
NSUN5C BI765473 5' UTR ZFPM2 BX088883 CDS 
NSUN7 BG718408 CDS ZNF470 CR984692 5' UTR 
NUMA1 BP277968 5' UTR    
  
 
 
